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Abstract
Nature and its huge biodiversity harbor an endless source of compounds containing
unique chemical structures with interesting antimicrobial activity. Particularly, those from
microorganisms have played an important role in the discovery of therapeutic agents for
infectious diseases.
The recent rise in multidrug resistance (MDR) bacteria, and particularly Methicillin-
resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE),
has become a major concern due to the increased morbidity and mortality, presenting a
negative economic and social impact. Therefore, it is urgently needed to identify and
develop new antibacterial compounds or alternative anti-infectious strategies.
During several decades, in some regions of Portugal, a slug was used as traditional
medicine in the treatment of cutaneous infections. In a previous work we demonstrated a
strong in vitro anti-staphylococci activity of this slug linked to bioproducts produced by an
isolate identified as Bacillus pumilus. This evidence justified the interest on a deeper
characterization of B. pumilus isolates, and their antimicrobial(s) singularity, due to the
potential therapeutic or biotechnological interest, which were the main goals of this thesis.
For this purpose, a collection of previously identified B. pumilus isolates from different
origins was characterized at different levels (phylogeny, antimicrobial susceptibility,
virulence and identification and characterization of peptides with potential antibacterial or
anti-biofilm activity).
Phylogenetic analyses derived from gyrB and rpoB gene sequences determined the
reclassification of most (93%, 38 of 41) isolates from the collection, which were now
assigned to B. safensis or to a previously unrecognized clade. Moreover, distinctive
phenotypic, genotypic and chemotaxonomic features of these isolates allowed the
recognition of a new species within B. pumilus group, recovered from health’s product
contaminants in Portugal, and for which the name Bacillus invictus sp. nov. is proposed. In
addition, it was demonstrated that these B. pumilus group species encompass a clonally
diverse population, which can justify their high adaptability to different niches. Delineation
of these B. pumilus group species was also supported by congruent protein profiles,
assessed by matrix assisted laser desorption-ionization time-of-flight mass spectrometry
(MALDI-TOF/MS), and cellular composition by Fourier Transform Infrared Spectroscopy
(FTIR), demonstrating the suitability of these methodologies for their rapid and low cost
discrimination.
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All B. pumilus group species revealed the absence of antibiotic resistance and virulence
genes, which consist on safety features required for their application in the food and/ or
pharmaceutical industries.
Most isolates of B. pumilus and B. safensis revealed surface-active properties compatible
with biosurfactant compounds production. Analysis by liquid chromatography-electrospray
tandem mass spectrometry (LC-ESI/MS/MS) of these compounds revealed a mixture of
antimicrobial peptides composed of specific pumilacidin and surfactin variants in B.
safensis, whereas in B. pumilus only specific pumilacidin variants were detected.
In conclusion, most B. pumilus correspond to the less well known B. safensis and to a
new species here proposed as Bacillus invictus sp. nov.. This taxonomic reassignment is
congruent with the antimicrobial peptides types produced by these different species.
Moreover, and beyond the contribution to accurately discriminate B. pumilus group
species, the present work also demonstrates for the first time their genomic plasticity,
which can justify their widespread to different environments and, consequently, its ability
to produce this diverse array of distinct compounds with a broad range of activities.
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Sumário
A natureza e a sua biodiversidade são uma fonte inesgotável de compostos naturais com
estruturas químicas únicas, que possuem uma relevante atividade antimicrobiana.
Compostos produzidos por microrganismos têm desempenhado um papel
particularmente importante na descoberta de agentes com interesse terapêutico em
doenças infeciosas.
O crescente aumento de infeções provocadas por bactérias resistentes a múltiplos
antibióticos (MDR), com particular relevo para Staphylococcus aureus resistentes à
meticilina (MRSA) e enterococos resistentes à vancomicina (VRE), tornou-se uma grande
preocupação, pelo aumento de morbilidade e mortalidade que condicionam, assim como
pelo impacto socioeconómico. Assim, é premente a necessidade de identificar e
desenvolver novos compostos antibacterianos e estratégias alternativas de combate a
infeções.
Durante várias décadas, em algumas regiões de Portugal, uma lesma foi utilizada como
medicina tradicional para o tratamento de infeções cutâneas. Ensaios preliminares, in
vitro, evidenciaram a presença neste gastrópode de um isolado de Bacillus pumilus com
elevada atividade anti-estafilocócica. Este dado justificou o interesse numa
caracterização mais detalhada de isolados desta espécie, assim como dos seus
produtos, tendo em vista a potencial aplicação na prevenção e tratamento de infeções
bacterianas. Assim, e decorrente da atividade antimicrobiana reportada, bem como da
sua importância farmacêutica e biotecnológica, procedeu-se à caracterização de uma
coleção de isolados de B. pumilus a diferentes níveis (filogenia, susceptibilidade a
antimicrobianos, virulência e identificação e caracterização de péptidos com potencial
atividade antibacteriana ou anti-biofilme).
A análise filogenética, tendo por base as sequências genéticas de gyrB e rpoB,
determinou a reclassificação da maioria dos isolados (93%, 38 de 41) como B. safensis e
a identificação de um novo grupo de isolados até então não reconhecidos. A
caracterização fenotípica, genotípica e quimiotaxonómica permitiu o reconhecimento de
uma nova espécie no grupo B. pumilus, num isolado encontrado em Portugal como
contaminante de um medicamento, para o qual o nome Bacillus invictus sp. nov. foi
proposto. Por outro lado, as espécies caracterizadas pertencentes ao grupo B. pumilus
revelaram uma estrutura clonal diversificada, o que pode justificar a sua grande
capacidade de adaptação a diferentes nichos.
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A diferenciação destas espécies foi também suportada pelos perfis proteicos e de
composição celular obtidos por MALDI-TOF/MS e FTIR, respetivamente, demonstrando a
adequabilidade destas metodologias, rápidas e de baixo custo, na sua diferenciação.
Todos os isolados pertencentes ao grupo de B. pumilus revelaram ausência de genes de
resistência a antibióticos e genes de virulência, características necessárias para
assegurar a sua inocuidade aquando de uma possível aplicação na indústria alimentar
e/ou farmacêutica.
A maioria dos isolados de B. pumilus e B. safensis estudados revelaram propriedades
compatíveis com a produção de compostos biosurfactantes. A caracterização obtida por
LC/ESI-MS/MS revelou a presença de uma mistura de péptidos antimicrobianos contendo
variantes de pumilacidina e surfactina detetadas apenas em isolados de B. safensis,
enquanto que em B. pumilus apenas uma variante especifica de pumilacidina foi
verificada.
Decorrente deste estudo, a maioria dos isolados previamente identificados como B.
pumilus são agora classificados como B. safensis, ou como pertencentes a uma possível
nova espécie, a que foi proposta a designação de Bacillus invictus sp. nov.  Verificou-se
ainda que a reclassificação taxonómica é congruente com a os tipos de péptidos
antibacterianos produzidos pelas diferentes espécies. Para além do contributo para a
correta e rápida discriminação das espécies do grupo B. pumilus, o presente trabalho
demonstra ainda, pela primeira vez, a plasticidade genómica destas bactérias, o que
pode justificar a sua dispersão em diferentes ambientes e, consequentemente, a sua
capacidade de produção de um conjunto diversificado de biocompostos, com uma ampla
gama de atividades.
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Research Aims 
The intensive use and misuse of antibiotics have generated a strong selective pressure 
for the emergence of multi-drug resistant bacteria, which stimulates efforts to identify and 
develop new antibacterial compounds from natural sources or alternative anti-infectious 
strategies 
During several decades, in some regions of Portugal, a terrestrial black slug (Arion ater) 
was used as a traditional medicine in the treatment of cutaneous infections, including 
wounds and abscesses. Previous work demonstrated a strong in vitro anti-staphylococci 
activity of this slug throughout the contribution of bioproducts produced by an isolate 
identified as Bacillus pumilus. Despite previous reports on the production of a molecule 
with a putative anti-staphylococci activity by B. pumilus, no known application has been 
recognized. Moreover, the recently disclosed diversity within this species suggests a 
neglected potential of bioproducts produced by species from the B. pumilus group.  In the 
present work, and due to the difficulty to accurately distinguish B. pumilus and its closely 
related counterparts, we deeply characterized an extended collection of isolates 
previously identified as B. pumilus. 
Our hypothesis consists on that the medicine-slug isolate corresponds to an Arion ater 
adapted clonal lineage that produces antimicrobial compound(s) with anti-staphylococci 
activity, which might be unusual among B. pumilus group strains. These antimicrobial 
properties confer to the medicine-slug isolate or to its anti-stapphylococci compound(s) a 
pharmaceutical or biotechnological interest. 
The global objective of this proposal is to assess the singularity of the medicine-slug 
isolate and to characterize its antimicrobial compound(s).   
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The specific objectives are: 
• To position phylogenetically the medicine-slug isolate, evaluating its niche-clonal
specificity.
• To investigate the potential of high-throughput approaches such as Matrix-
Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-
TOF) and Fourier Transform Infrared Spectroscopy with Attenuated Total
Reflectance (FTIR-ATR), coupled with chemometric tools, to discriminate within B.
pumilus group species.
• To investigate, in the slug-medicine isolate and closely related species, the
presence of safety features (antibiotic resistance and virulence) required for their
application in humans and agriculture.
• To characterize the antibacterial compound(s) produced by the medicine-slug
isolate.
• To evaluate the diversity and anti-adhesive or anti-biofilm properties of
biosurfactant compounds produced in slug-medicine isolate and its closely related
species, and to provide biochemical characterization of these surface-active
compounds.
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Outline 
The structure of this thesis is organized in a sequential order of work and the rational 
integration of each chapter is described as follows: 
Chapter 1 presents an overview of the state of the art of the contents involved in the 
study, which is divided in three sections. In section I the diversity and phylogenetic 
positioning of B. pumilus group members, as well as fundaments of high-throughput 
methodologies for bacterial identification were addressed. Moreover, B. pumilus group 
members’ pathogenicity, virulence, antibiotic resistance and biotechnological potential 
were also reviewed. Section II addresses the the diversity and spectrum of activity of 
different class of antimicrobial peptides produced by Bacillus spp. Finally, section III, 
properties, diversity, distribution and the potential applications of biosurfactants produced 
by Bacillus spp. are reviewed. 
Chapter 2, 3 and 4 presents the findings that would answer the specific aims of the thesis. 
Such results have been organized throughout the papers (n=9; 1 publication in peer 
review scientific journal, 4 manuscripts submitted, 2 in preparation for publication and and 
2 manuscripts awaiting patentability assessment). 
In Chapter 2, the diversity, differentiation by high-throughput methods and biosafety 
of B. pumilus group species is presented throughout the following papers: 
• R. Branquinho, L. Meirinhos-Soares, J. A. Carriço, M. Pintado, L. V. Peixe. 2014.
Phylogenetic and clonality analysis of Bacillus pumilus isolates uncovered a highly
heterogeneous population of different closely related species and clones. FEMS
Microbiology Ecology (submitted).
• R. Branquinho, C. Sousa, H. Osório, L. Meirinhos-Soares, J. Lopes, A. Abdulmawjood,
G. Klein, H-J. Busse, P. Kämpfer, M. E. Pintado, L. V. Peixe. 2014. Bacillus invictus
sp. nov., isolated from healthy products in Portugal (manuscript in preparation to
International Journal of Systematic and Evolutionary Microbiology).
• R. Branquinho, C. Sousa, J. Lopes, M. E. Pintado, L. V. Peixe, H. Osório. 2014.
Differentiation of Bacillus pumilus and Bacillus safensis using MALDI-TOF/MS. Journal
of the American Society for Mass Spectrometry (submitted).
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• C. Sousa, R. Branquinho, J. Lopes, L. Peixe. 2014. Differentiation of Bacillus pumilus
and Bacillus safensis by Fourier transform infrared spectroscopy and chemometry.
Journal of Food Microbiology (submitted).
• R. Branquinho, J. Pires, M. Amorim, M. E. Pintado. 2014. Safety profile of Bacillus
subtilis complex: antibiotic and virulence features (manuscript in preparation).
Chapter 3, Characterization of the antibacterial compound produced by Bacillus 
safensis Bs1 , the medicine-slug isolate is presented. Results were organized in the 
paper: 
• R. Branquinho, H. Osório, P. Pereira, M. E. Pintado, L. V. Peixe. 2014.
Characterization of a new antimicrobial peptide with anti-MRSA activity produced
by Bacillus safensis Bs1 (manuscript in preparation - Patentability under evaluation).
In Chapter 4, Biosurfactants in B. pumilus group species: diversity and anti-biofilm 
activity of a surfactin-like biosurfactant, addresses the screening, diversity and 
chemical identification of tension-active compounds produced by B. pumilus group 
members, also including the assessment of a B. safensis biosurfactant as an agent 
preventing biofilm formation of S. epidermidis is also presented. Results were organized in 
the following papers:  
• R. Branquinho, L. V. Peixe, J. Pires, M. E. Pintado, M. G. Martinotti, L. Fracchia, G.
Allegrone. 2014. Species-specific surfactin-like combinations of biosurfactants within
Bacillus pumilus group. Bioresource Technology (submitted).
• M. Barros, R. Branquinho, F. Grosso, L. Peixe, C. Novais. 2014. Emergence of
Methicillin and Linezolid Resistant ST2/CC5 Staphylococcus epidermidis, Portugal
2012: First Cases Report. Emerging Infectious Diseases (In Press).
• R. Branquinho, J. Pires, G. Allegrone, M. E. Pintado, L. Fracchia, L. V. Peixe. 2014.
Anti-biofilm activity in Staphylococcus epidermidis and structural characterization of
Bacillus safensis biosurfactant (manuscript in preparation - Patentability under
evaluation).
Highlighted results from these studies are reflected in the general conclusions 
described in Chapter 5.  
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CHAPTER 1
INTRODUCTION 

Chapter 1 
I. Bacillus spp.: phylogeny, antimicrobial resistance and virulence 
1. Bacillus spp.
Members of the genus Bacillus (Kingdom Bacteria; Phylum Firmicutes; Class Bacilli; 
Order Bacillales; Family Bacillaceae) include Gram-positive, spore-forming, rod-shaped, 
aerobic or facultative anaerobic bacteria, which are phenotypically and genotypically 
heterogeneous (Earl et al., 2008; Satomi et al., 2006). This polyphyletic genus was 
discovered by Cohn in 1872 (Cohn, 1872), includes currently near two hundred species 
(Parte, 2013), and has been subjected to frequent restructuration’s with the continuous 
recognition of new species (Lai et al., 2014; Liu et al., 2013; You et al., 2013; Shivaji et al., 
2006).  
Phylogenetically, Ash et al. (1991) clustered Bacillus species into five RNA groups 
(RNA group 1, RNA group 2, RNA group 3, RNA group 4 and RNA group 5), and more 
recently, Nielsen et al (1995) reported the presence of an additional RNA group 
(RNA group 6) for alkaliphilic and alkalitolerant species (Nielsen et al., 1995). For the 
purpose of this thesis, only RNA group 1, where Bacillus pumilus group species are 
included, will be detailed. The phylogenetic affiliation of Bacillus spp. and other related 
This chapter contains the state of the art on the phylogeny, virulence 
and antibiotic resistance aspects of interest to Bacillus pumilus group, 
the subject of this thesis. Its general properties and relevance are 
reviewed, with special emphasis on their diversity, peptides with 
antimicrobial activity and biosurfactants. Furthermore, important human 
and environmental safety features will be discussed. 
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Gram positive representative species, based on 16S rRNA gene is shown in Figure 1  
(Felsenstein, 1993). 
Figure 1. Schematic outline of the phylogenetic relationships between aerobic 
representatives of Gram-positive bacteria based on 16S rRNA gene sequences. Areas of 
the triangles represent closeness’s of the number of species included in the taxa covered 
by the triangle. The circle indicates the uncertainty of the order at which the lineages 
diverge from each other. Adapted from (Berkeley et al., 2008). 
A more detailed phylogenetic analysis within Bacillus members, based upon the neighbor-
joining method is illustrated in Figures 2 and 3. 
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Figure 2. Detailed neighbour-joining tree of Bacillus species of RNA groups 1, 2 and 5. 
The dotted area indicates the uncertainty of the order at which the lineages diverge from 
each other. The area was chosen somewhat arbitrarily and cover more recent 
branching points. The bar indicates 10% nucleotide substitutions. B, Bacillus; T, type 
strain. (Adapted from: Berkeley et al., 2008). 
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Figure 3. Detailed neighbor-joining tree of Bacillus species members of RNA groups 3, 4 
and 6, other Bacillus species, and lineages containing reclassified Bacillus species. The 
dotted areas indicate the uncertainty of the order at which the lineages diverge from each 
other. The areas are chosen somewhat arbitrarily and may more recent branching points. 
The bar indicates 10% nucleotide substitutions. Gra, Gracilibacillus; Amb, Amphibacillus; 
B, Bacillus; Bv, Brevibacillus; Ex, Exiguobacterium; Hb, Halobacillus; Pb, Paenibacillus; 
Sb, Salibacillus; T, Type strain; Vg, Virgibacillus. (Adapted from: Berkeley et al., 2008). 
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1.1. Bacillus RNA group 1 
This group constitutes the core of Bacillus spp. and displays the name of one of the first 
organisms of which the complete genome was published (Kunst et al., 1997) - Bacillus 
subtilis (Figure 2). This group is highly heterogeneous, encompassing several consistent 
clusters and single-species lineages, including those of the Bacillus pumilus group. One of 
the subgroups that embraces Bacillus RNA group I encloses B. subtilis relatives, which 
actually encompasses 19 species including, Bacillus subtilis subs. subtilis, B. vallismortis, 
B. mojavensis, B. amyloliquefaciens, B. atrophaeus, B. licheniformis, B. pumilus, 
presented in Figure 2, whereas the species most recently discovered B. subtilis subsp. 
inaquosorum, B. subtilis subs. spizizenni, B. tequilensis, B. sonorensis, B.axarquiensis, B. 
malacitensis, B. velezensis, B. safensis, B. aerophilus, B. stratosphericus, B. altitudinis 
and B. xiamenensis are not (Jeyaram et al., 2011; Earl et al., 2008)  
A second subgroup encompasses B. cohnii, B. horikoshii and B. halmapalus. A third one 
harbors B. cereus, B. pseudomycoides, B. anthracis, B. thuringiensis, B. 
weihenstephanensis, B. mycoides and a novel thermotolerant species, B. cytotoxicus 
(Guinebretière et al., 2013), which can be compiled under the term B. cereus sensu lato or 
B. cereus group (Ehling-Schulz & Messelhaeusser, 2013; Kolsto et al., 2009). A fourth 
subgroup embraces B. simplex and B. psychrosaccharolyticus. Based on the reported 
characteristics, RNA group 1 can also group other bacterial genera as Virgibacillus, 
Salibacillus, Halobacillus and Gracilibacillus (Figure 3). 
Phenotypically, all these Bacillus species produce acids from a wide range of sugars and 
also present oval endospores, which are generally located centrally/subterminally 
(Leuschner, 2003). Moreover, some species such as B. cereus and B. liqueniformis are 
facultative anaerobes.  
2. Bacillus pumilus group
2.1. General features 
Bacillus pumilus group, encompasses B. pumilus, the first species described, and the 
closely related species B. safensis, B. aerophilus, B. stratosphericus, B. altitudinis and B. 
xiamenensis (Lai et al., 2014; Liu et al., 2013; Satomi et al., 2006; Shivaji et al., 2006). 
These bacteria are readily isolated from diverse natural envirnments such as soil and
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marine settings, plants and air of high altitudes (Lai et al., 2014; Liu et al., 2013; Freitas 
et al., 2008; Satomi et al., 2006; Shivaji et al., 2006). General morphologic characteristics 
of these species include Gram-positive, rod-shaped, aerobic growth and the presence of 
spore located terminally or sub-terminally (Berkeley et al., 2008). 
This group has a high economic relevance, derived from the wide range of applications of 
these microorganisms or their products into biotechnological, environmental and 
biopharmaceutical purposes (Pérez-García et al., 2011; Aunpad & Na-Bangchang, 2007; 
Hong et al., 2005; Sanders et al., 2003; Lehman et al., 2001), which will be further 
detailed in sub-section 4. Although rarely, B. pumilus group species have also been 
associated with food poisonings and human infections, mainly in immunocompromised 
patients, including anthrax-like cutaneous lesions (Johnson et al., 2008; Bentur et al., 
2007; From et al., 2007a; Tena et al., 2007; Haymore et al., 2006; Ozkocaman et al., 
2006; Castagnola et al., 2001) (see sub-section 3, for more detailed information) 
The B. pumilus species, firstly designated in 1901 (Gottheil, 1901) has been the most 
extensively described member of this group (Boone et al., 2005), being described from 
soils, plants, foods, health products, cosmetics, clean room environments, water and 
even animals (Liu et al., 2013; Branquinho et al., 2012; Ouoba et al., 2004; Wei et 
al., 1996). Nevertheless, only one genome is completely sequenced (B. pumilus 
SAFR-032 strain, isolated from the Spacecraft Assembly Facility at National 
Aeronautics and Space Administration (NASA)), comprising 3.7 Mb and coding for 3679 
proteins. 
A large range of applications has been attributed to B. pumilus, mainly related with the 
production of peptides with antimicrobial activity or its use  as animal and human 
probiotics (EFSA, 2011; Hong et al., 2005; Sanders et al., 2003), phytosanitary products 
(Pérez-García et al., 2011) or plant growth promoters (Joo et al., 2005). In addition, 
although infrequently, it has also been reported their involvement in human and animal 
diseases (Kimouli M et al., 2012; Johnson et al., 2008; Bentur et al., 2007; From et al., 
2007a; Callegan et al., 2006; Haymore et al., 2006; Ozkocaman et al., 2006; Galanos et 
al., 2003; Castagnola et al., 2001; Peltola et al., 2001; Turnbull, 1997). 
B. safensis was initially reported by NASA as one of the major contaminants in 
spacecraft, associated with contamination of clean room assembly-facility surfaces due 
to its highly resistance to gamma and UV radiation (Satomi et al., 2006). More 
recently
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recently it was identified in African oil and locust  bean seeds for the production of 
fermented food condiments (Agbobatinkpo et al., 2013; Ahaotu et al., 2013), plant 
rhizosphere and from marine environments (Liu et al., 2013). Nevertheless, only one 
partially sequenced genome (3.68 Mb) of B. safensis VK strain, isolated from the 
rhizosphere of a cumin plant growing in the saline desert of India is available (Kothari 
et al., 2013). 
B. altitudinis, primarily isolated from cryogenic tubes used for collecting air samples from 
high altitudes (Shivaji et al., 2006), seems to be the most common species from this group 
in marine environments (Liu et al 2013). No information of complete genome sequences is 
available. 
B. stratosphericus and B. aerophilus were originally isolated from air samples (Shivaji et 
al., 2006). Soils and estuarine sediments were also reported as habitats for B. 
stratosphericus (Zhang et al., 2012; Yadav et al., 2011). Nevertheless, the type strai of 
these species are no longer available in public collections. 
Finally, B. xiamensis was recently identified (Lai et al., 2014) in the intestinal tract 
contents of a flathead mullet, Mugil cephalus, captured from the sea off Xiamen Island, 
China. One draft genome of strain HYC-10, containing 3.6 Mb and comprising 3687 
protein-coding genes is available. 
2.2. Evolution and phylogenetic boundaries 
Many methods have been applied to identify and discriminate among closed related 
species, as B. pumilus group members. Beyond the classical  morphological, 
physiological and biochemical characteristics, phylogenetic analysis based on single or 
multilocus sequence typing (MLST) of housekeeping genes, have been frequently used to 
depict phylogenetic affiliations among members of Bacillus genus (Helgason et al., 2000). 
2.2.1 Phenotypic based phylogeny 
Members of the B. pumilus group present very similar phenotypic characteristics, which 
hinders its identification merely based on biochemical and/or morphological properties. 
Nevertheless, some distinct aspects related with carbohydrates and amino acid 
metabolization profiles can be assigned, as summarized in Table 1. 
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Table 1. Biochemical and physiological characteristics of B. pumilus group species. 
B. pumilus 
ATCC 7061T 
B. safensis FO-
036bT 
B. xiamenensis 
HYC-10T 
B. altitudinis 
41KF2bT 
Temperature range 
(optimum) (ºC) 
30 30 30–37 30–37 
NaCl range 
(optimum) (%, w/v) 
1–3 1–3 1–3 1–3 
pH range (optimum) 6–8 6–8 6–8 6–8 
Carbohydrates acid production profile 
Cellobiose - + + + 
D-Arabinose + + - + 
Erythritol + + - - 
Glucose - + - - 
Inositol + - - - 
Maltose + - - + 
Mannitol + + + + 
Mannose + - + + 
Raffinose + - + - 
Rhamnose - - + + 
Sorbitol - - + + 
Starch - - + + 
Amino acid utilization 
L-Arginine - - - + 
2.2.2 Genotypic based phylogeny 
B. pumilus group species present a remarkable high level of 16S rRNA gene similarity 
(>99%) (Liu et al., 2013; Satomi et al., 2006). In fact, limitations of 16S rDNA sequences 
to decipher relationships at species level have been recognized as a result of its 
conserved nature for different species (Adékambi et al., 2008; Wang et al., 2007; 
Konstantinidis & Tiedje, 2005; ). In fact, strains belonging to B. subtilis group showing 
≥99% 16S rDNA sequences similarity, may not belong to the same species. A 
phylogenetic tree based on the 16S rRNA genes of marine bacteria belonging to the B. 
pumilus group is presented in Figure 4. 
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Despite the high similarity observed for 16S rDNA sequences between the isolates 
analized, B. pumilus members from marine settings are divided into two groups: i) the B. 
altitudinis and B. xiamenensis and ii) B. pumilus and B. safensis (Liu et al., 2013). 
Figure 4. Phylogenetic affiliation based on 16S rRNA genes of B. pumilus group members 
recovered from marine sources. The tree was constructed using the neighbor-joining 
method. Bootstrap values over 50% (1000 replications) were shown at each node. Bar, % 
estimated substitution. B. cereus ATCC 14579T was used as outgroup. (Adapted from: 
Liu et al., 2013). 
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The ability to order prokaryotic taxa hierarchically has been constantly improved by ad hoc 
committee (Stackebrandt et al., 2002). In fact, current consensus determines that an 
informative level of phylogenetic data would be obtained from the determination of a 
minimum of five protein-coding gene sequences, which should be diverse at chromosomal 
loci and widely distributed among taxa and, for which, extensive DNA±DNA intraspecific 
diversity has been evaluated (Stackebrandt et al., 2002). It consists on an extension of the 
MLST approach, increasingly used for the indexing and organizing of within-species 
genetic variability, which has not been extensively applied to Bacillus species other than 
B. cereus group members.  
In which concerns B. pumilus group species,  recently Liu et al. (2013) proposed the use 
of 7 concatenated housekeeping genes, namely gyrB (β-subunit of DNA gyrase), rpoB (β-
subunit of RNA polymerase), pycA (pyruvate carboxylase A), pyre (orotate 
phosphoribosyltransferase), mutL (DNA mismatch repair protein), aroE (shikimate 
dehydrogenase) and trpB (tryptophan synthase) (Figure 5) to depict taxonomic affiliations 
among B. pumilus, B. safensis, B. altitudinis and B. xiamenensis isolates recovered from 
marine environments. Their results evidenced that phylogenetic trees obtained from 
individual genes and concatenated genes exhibited similar topology structures, 
suggesting that, with the exception of rpoB, these genes are appropriate to depict 
phylogenetic affiliations within species of this group and that the taxonomic status of these 
species is far to be completely known.  
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Figure 5. Phylogenetic tree based on seven concatenated housekeeping genes of marine 
B. pumilus group isolates. Groups represent: (A) B. altitudinis, (B) B. xiamenensis, (D) B. 
pumilus, (F) B. safensis and (C and E) could not be assigned. Tree constructed using the 
neighbor-joining method. Bootstrap values over 50% (1000 replications) were shown at 
each node. Bar, % estimated substitution. B. cereus ATCC 14579T was used as 
the outgroup. (Adapted from: Liu et al., 2013). 
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Still, using this criterion, important aspects regarding the conditions in which different 
groups of bacteria diverge from each other, and also which molecular, biochemical, 
structural or physiological properties of Bacillus pumilus group species allow their 
discrimination, remain to be understood. Moreover, cut-off values for its randomization 
still remain unclarified. 
In agreement with Gevers et al., (2006) any effort to produce a robust definition of 
species is hindered by the effect of biological processes and divergence between species 
(Gevers et al., 2006). Therefore, it is important to develop other means to clarify these 
critical aspects of microbial evolution (Gupta & Griffiths, 2002). Indeed, the markers that 
are ideally suited for evolutionary/taxonomic studies should be homologous 
apomorphic characters that evolved only once (synapomorphy) during the course of 
evolution (Stackebrandt, 2006). The presence or absence of these markers in 
orthologous sequences should also be readily discernible and it should be minimally 
affected by factors as long-branch attraction effect, differences in evolutionary rates and 
horizontal gene transfer (Delsuc et al., 2005).  
More recently, whole-genome sequencing analysis delivered new metrics to evaluate the 
taxonomic relationships among bacterial species (Chan et al., 2012). In this sense, ANI 
(average nucleotide identity) values ≥ 95% correspond to the traditional 7% DDH 
threshold (Goris et al., 2007; Konstantinidis & Tiedje, 2005). However, the scarce 
availability of whole genome sequences of B. pumilus members hinders their identification 
and differentiation.  
2.2.3. Chemotaxonomic based phylogeny 
Chemotaxonomic analysis enables differentiation of bacteria by studying their cell 
components, as fatty acids, membrane and cellular proteins, polysaccharides and/or 
nucleic acids (Herbel et al., 2013), characteristic components of each particular species, 
allowing their differentiation. Among chemotaxonomic methods used for strain 
differentiation, different spectroscopic-based methods such Matrix-assisted 
Laser Desorption/Ionization with Time-of-Flight mass spectrometry (MALDI-TOF/MS) 
(Conway et al., 2001; Claydon et al., 1996) and Fourier-Transformed Infrared 
Spectroscopy (FTIR) (Oberreuter et al., 2002; Helm et al., 1991a; Helm et al., 1991b) 
are increasingly being used for bacterial differentiation at species and subspecies levels 
(Novais et al., 2014; Sousa et al., 2014; Sousa et al., 2013; Vaz et al., 2013; Sousa et al., 
2012; Wolters et al., 2011; Barbuddhe et al., 2008). 
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These methods are also recommended by ad hoc committee (Stackebrandt et al., 2002) 
but they have scarcely been applied to B. pumilus group members.   
2.2.3.1 Application of MALDI-TOF MS in Bacillus systematics 
MALDI-TOF MS is a fingerprinting approach that relies on the reproducible detection of 
large molecules which can be used for microbial identification, at different taxonomical 
levels (Clark et al., 2013; Keys et al., 2004), by comparing experimental mass spectra with 
a library of known reference strains or by comparing information of species-specific 
biomarkers identities (Clark et al., 2013; Lartigue, 2013; Emonet et al., 2010; Mellmann et 
al., 2009). It has emerged as an accurate, fast, robust, sensitive and low cost 
technique for characterization of large molecules, which has significantly impacted 
bacterial identification procedures, especially in clinical microbiology laboratories 
(Clark et al., 2013).
This mass spectroscopic technique is based on desorption and ionization of large 
molecules from a target plate with the aid of a matrix solution. The ionized molecules fly 
through the MALDI tube and reach the detector according to their size being the obtained 
spectra a graphical representation of the intensity versus the mass-to-charge ratio of the 
detected molecules. Concerning microbial typing, MALDI-TOF MS is mainly used for 
protein fingerprinting and the obtained mass spectra reflect the peptide and/or protein 
bacterial composition, most of which are ribosomal (Clark et al., 2013; Fenselau & 
Demirev, 2001). The quality of the mass spectra obtained for chemotaxonomic analysis 
depends on different factors such as  culture media components, batch and manufacturer, 
bacterial growth time or matrix used (Chen et al., 2008) and requires strict standardization 
and optimization protocols. The most common matrices used are α-cyano-4-
hydroxycinnamic acid (CHCA) (Williams et al., 2003), ferulic acid (FA) (Dickinson et al., 
2004), sinapinic acid (SA) (Donohue et al., 2006; Lee et al., 2003) or 2,5-dihydroxybenzoic 
acid (DHB) (Moura et al., 2008), which favour the visualization of different types of 
biomolecules. 
The obtained mass spectra can be directly compared with previously established 
databases to bacterial species identification (Clark et al., 2013; Sandrin et al., 2013) or 
used to identify species specific biomarkers through protein databases (e.g. MASCOT 
(Perkins et al., 1999) and SEQUEST (Eng et al., 1994)). Additionally, a multi variate 
data analysis approach, usually designated by chemometry, can be used 
allowing
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allowing the establishment of mathematical models through which more detailed 
information about the microorganisms can be extracted. This approach makes use 
of some chemometric models (Sousa et al., 2012; Naes, 2002; Alsberg et al., 1998) 
such as principal component analysis (PCA), hierarchical clustering analysis (HCA) 
and partial least square discriminant analysis (PLSDA) to explain spectral differences 
among bacterial species and/or clones.  
MALDI-TOF MS has already been used in Bacillus spp. for the identification of B. 
anthracis and its close relatives (Hotta et al., 2011; Lasch et al., 2009), of B. subtilis, B. 
cereus and B. licheniformis (Fernandez-No et al., 2013). Nevertheless, scarce information 
is available considering isolates from B. pumilus group. Preliminary studies evaluating the 
discriminatory ability of MALDI-TOF MS in these species included only a few isolates 
from some species and/or were not conclusive (Farfour et al., 2012; Bohme et al., 
2011; Dickinson et al., 2004; ). 
Concerning the identification of species-specific biomarkers in Bacillus spp., some reports 
showed that beyond ribosomal proteins, small acid-soluble spore proteins (SASPs) from 
spores could potentially be used as species-specific biomarkers. These proteins are 
generally highly conserved within and between the various species of Bacillus (Dybwad et 
al., 2013). 
The rapid and accurate identification of proteins/peptides from mass spectra can only be 
achieved by using TOF/TOF devices (providing higher resolution of mass/charge), 
bioinformatic tools and databases.  
Nevertheless, further and detailed studies are required to identify and elucidate these 
protein biomarkers in B. pumilus group members and reduce the difficulties of spectral 
interpretation. The increasing availability of bacterial genome information should afford a 
basis for the attribution of chemical structures to some of the biomarkers signals detected.  
2.2.3.2 Application of FTIR in Bacillus Systematics 
FTIR is a vibrational spectroscopic technique, based on the interaction of infrared 
radiation with a sample, providing a specific fingerprint that reflects the structure and 
composition of the whole cell (Blum & John, 2012; Naumann et al., 1991). It represents a 
non-destructive, fast, easy to use, and highly sensitive method for bacterial 
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characterization and identification, also providing information about bacterial metabolism 
(Becker et al., 2006), growth phase (Al-Qadiri et al., 2008) and antibiotic resistance 
determinants (Amiali et al., 2008). The infrared spectra reflects bacterial composition of 
lipids (3000–2800 cm−1), proteins/amides I and II (1700–1500 cm−1), 
phospholipids/DNA/RNA (1500–1185 cm−1), polysaccharides (1185–900 cm−1) and the 
fingerprint region (900–600 cm−1) (Naumann et al., 1991). Some reports have been 
published using FTIR spectroscopy for rapid identification of species from B. cereus 
group (Mietke et al., 2010; Ehling-Schulz et al., 2005a), B. subtilis (Filip et al., 2004), 
B. atrophaeus, B. circulans, B. lentus, B. thuringiensis and B. megaterium (Brandes 
Ammann & Brandl, 2011; Forrester et al., 2009), however no reports were found 
on the differentiation within B. pumilus group species.  
Despite the interest of several DNA-based methods for bacterial systematics, it is 
recommended a polyphasic approach resulting from the integration of genotypic, 
chemotaxonomic, phenotypic and ecological information for the construction of a reliable 
phylogenetic framework (Thompson et al., 2013). 
3. Clinical Relevance, antimicrobial Resistance and Virulence within Bacillus spp.
Being Bacillus species widely used as feed additives for both humans and animals and 
deliberately introduced in the food chain, the European Food Safety Authority (EFSA) 
requires a status of Qualified Presumption of Safety (QPS) for these species  (EFSA, 
2007). This approach was created for the risk assessment of those microorganisms used 
in food/feed production, in order to avoid risk for consumers. Particular aspects that 
require attention in order to establish the safety of these microorganisms or their products 
in the industrial sector are the antimicrobial susceptibility profile and the virulence potential 
of a given species or taxonomic group (EFSA, 2012). 
3.1 Clinical Relevance 
B. cereus and closely related species are most often associated with human 
pathogenicity, where exotoxins, phospholipases, proteinases and haemolysins present a 
relevant role in the pathogenesis (Økstad & Kolstø, 2011). B. anthracis, the causative 
agent of anthrax, is responsible for the classic fatal systemic infection. The pathogenicity 
of B. anthracis is associated with the presence of two plasmids, pXO1 (coding form for the 
anthrax toxin) and pXO2 (coding for capsule formation) (Koehler, 2009).  
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Some Bacillus spp. are associated with opportunistic infections, e.g. in traumatic or post-
surgical wounds, cancer patients or immunocompromised individuals (Wiedmann & 
Zhang, 2011). Infections of eyes, respiratory tract, central nervous system, septicemia, 
cases of fulminant necrotizing soft tissue and even endocarditis, have also been 
reported (Økstad & Kolstø, 2011; Bottone, 2010). In particular, species belonging to B. 
pumilus group have also occasionally been involved in human diseases (Kimouli et 
al., 2012; Johnson et al., 2008; Bentur et al., 2007; From et al., 2007a; Callegan et al., 
2006; Haymore et al., 2006; Ozkocaman et al., 2006; Castagnola et al., 2001;  Galanos 
et al., 2003; Peltola et al., 2001; Turnbull, 1997). In the hospital setting, B. pumilus 
group have been reported as causal agents of opportunistic infections mainly in 
chronically ill and immunosuppressed patients (Bentur et al., 2007; Haymore et al., 
2006; Ozkocaman et al., 2006; Castagnola et al., 2001), in most cases associated with 
contaminated medicines, antiseptics and medical equipment, such as intravenous 
catheters or other medical devices (Bentur et al., 2007). 
3.2. Antimicrobial Susceptibility of Bacillus spp. 
The development of antibiotic resistance constitutes a serious concern, affecting a wide 
range of bacteria. Resistance to antimicrobial agents can be due to either (i) intrinsic 
properties  (sometimes called ‘natural resistance’), characteristic of all the strains of a 
certain species or by (ii) mutation of indigenous genes or the acquisition of resistance 
genes through mobile genetic elements, such as plasmids or transposons (Commission, 
2002). Such intrinsic or acquired properties could make the bacteria capable of rapid 
inactivation of specific antibiotics through degradation, exportation of the antibiotics out of 
the cell, through the efflux system, or by alteration of the antibiotic target site (Butaye et 
al., 2003; Commission, 2002; Roberts et al., 1999). The presence of genes coding for 
antimicrobial resistance carried by mobile genetic elements, presents a greatest risk for 
horizontal dissemination of antimicrobial resistance between isolates from the same or 
even from different species   (Devirgiliis et al., 2011; Reenen & Dicks, 2011). 
According to the Panel on Additives and Products or Substances used in Animal Feed 
(FEEDAP), all bacterial products intended for use as feed additives must be examined to 
establish its susceptibility profile to a relevant range of antimicrobials of human and 
veterinary importance, e.g. ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, 
erythromycin, clindamycin, tetracycline and chloramphenicol (EFSA, 2012). Specifically in 
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the case of Bacillus spp., EFSA determined as a basic requirement the determination of 
minimum inhibitory concentrations (MIC) and its interpretation according to microbiological 
cut-off values defined by the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST, http://www.eucast.org/) and the European monitoring program, as shown in 
Table 2.  
Table 2. Bacillus spp microbiological cut-off values (μg/mL) for different antimicrobials 
according to FEEDAP panel (EFSA, 2012). 
Antimicrobials Microbiological cut-off value (μg/mL) 
Vancomycin 4 
Gentamicin 4 
Kanamicin 8 
Streptomycin 8 
Erytromycin 4 
Clindamycin 4 
Tetracycline 8 
Chloramphenicol 8 
According to these guidelines, a bacteria presenting a MIC value higher than the cut-off 
value for a given antibiotic has an acquired resistance mechanism (EFSA, 2012), and 
according to the FEEDAP Panel when observed for one or more antimicrobials, it is 
recommended to explore the nature of resistance. The growing health concern about 
antimicrobial susceptibility profiles in Bacillus spp. is mainly due to the possible source of 
transfer of antibiotic resistance genes between bacteria (Gevers et al., 2003; Witte, 2000). 
Antibiotic resistance genes database (ARDB) (http://ardb.cbcb.umd.edu/) provides a 
centralized compendium of information on antibiotic resistance, providing a list of antibiotic 
resistance gene sequences identified in Bacillus spp. (Table 3).  
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Table 3. Antibiotic resistance genes and antibiotic resistance profiles identified in Bacillus 
spp. members enclosed in ARDB database. 
Species 
Antibiotic resistance 
gene 
Antibiotic Resistance 
Profile 
Acession 
number 
B. anthracis str. sterne 
bacA Bacitracina YP_027565 
bl2A_1 Penicillinb YP_029502 
fosB Fosfomycinc YP_030068 
B. cereus str. E33L 
bacA Bacitracin 
YP_082869 
AAU18978 
Q63DZ3 
fosB Fosfomycin  
Q63CC5 
YP_083442 
AAU18406 
B. cereus str. Q1 
bacA Bacitracin YP_002529178 
bl2A Penicillin YP_002530963 
fosB Fosfomycin  YP_002529744 
B. cereus str. B4264 
bacA Bacitracin YP_002366165 
bl2A Penicillin 
YP_002368151 
YP_002367214 
fosB Fosfomycin  YP_002366749 
B. thuringiensis bl2A Penicillin Q45726 
B. thuringiensis serovar konkukian str. 
97-27 
bacA Bacitracin 
AT61949 
YP_035603 
B. subtilis subsp. subtilis str. 168 
bl2A Penicillin 
AAT60435 
YP_037541 
fosB Fosfomycin  
YP_036189 
AAT59669 
bacA Bacitracin 
ZP_03592903 
NP_390993 
Blt 
Chloramphenicol, doxor
ubicin,fluoroquinolone, 
puromycind 
NP_390536 
AAC36944 
ZP_03592438 
Bmr 
Chloramphenicol, 
fluoroquinolone 
AAB81539 
ZP_03592168 
NP_390281 
fosB Fosfomycin  
ZP_03591517 
NP_389667 
lmrB Lincomycine 
NP_388149 
ZP_03589930 
tetL Tetracyclinef 
ZP_03593907 
NP_391957 
BAA05208 
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tmrB Tunicamycin 
NP_388196 
ZP_03589973 
B. subtilis subsp. subtilis str. NCIB 
3610 
bacA Bacitracin ZP_03597187 
Blt 
Chloramphenicol, doxor
ubicin, fluoroquinolone, 
puromycin     
ZP_03596719 
Bmr 
Chloramphenicol, 
fluoroquinolone 
ZP_03596450 
fosB Fosfomycin  ZP_03595797 
lmrB Lincomycin  ZP_03594212 
tetL Tetracycline  ZP_03598190 
tmrB Tunicamycin ZP_03594255 
B. pumilus str. SAFR-032 bacA Bacitracin YP_001487997 
B. pumilus catA Chloramphenicol P00487 
B. licheniformis
bcrA Bacitracin  
P42332 
P42334 
bl2A Penicillin  P00808 
ermD 
Lincosamide, 
macrolide, 
streptogramin Bg   
Q03986 
P45438 
B. amyloliquefaciens str. FZB42 
bacA Bacitracin 
YP_001422387 
ABS75156 
fosB Fosfomycin  
YP_001420711 
ABS73480 
lmrB Lincomycin    
ABS72697 
YP_001419928 
B. clausii str. KSM-K16 bacA Bacitracin 
BAD65785 
YP_176746 
Q5WCX5 
B. halodurans str. C-125 fosB Fosfomycin  
NP_242644 
BAB05497 
B. circulans
aph3iva 
Butirosin, kanamycin, 
neomycin, 
paromomycin, 
ribostamycin   
CAA27061 
P00553 
0910185A 
vanA 
teicoplanin, 
vancomycinh 
CAB61227 
CAB61228 
CAB61229 
CAB61230 
CAB61231 
CAB61224 
vanZ Teicoplanini CAB61225 
aUndecaprenyl pyrophosphate phosphatase, which consists in the sequestration of Undecaprenyl 
pyrophosphate. 
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bClass A beta-lactamase. This enzyme breaks the beta-lactam antibiotic ring open and deactivates the 
molecule's antibacterial properties. 
cGlutathione transferase, metalloglutathione transferase which confers resistance to fosfomycin by catalyzing 
the addition of glutathione to fosfomycin.
dMajor facilitator superfamily transporter. Multidrug resistance efflux pump. 
eABC transporter system, Macrolide-Lincosamide-Streptogramin B efflux pump. 
fMajor facilitator superfamily transporter, tetracycline efflux pump. 
grRNA adenine N-6-methyltransferase, which can methylate adenine at position 2058 of 23S rRNA, conferring 
resistance to erythromycin. 
hVanA type vancomycin resistance operon genes, which can synthesize peptidoglycan with modified C-
terminal D-Ala-D-Ala to D-alanine--D-lactate. 
iVanZ confers low-level VanZ confers low-level resistance to the glycopeptide antibiotic teicoplanin. 
Moreover, other multidrug resistance genes such as cfr (conferring resistance to five 
chemically unrelated antimicrobial classes, including phenicols, lincosamides, 
oxazolidinones, pleuromutilins and streptogramin A) have been identified in 
Bacillus species isolates, located in some of them in a plasmid carrying other resistance 
genes (Wang et al., 2012; Zhang et al., 2011; Dai et al., 2010). Therefore, the potential 
dissemination of these resistance genes among different bacterial species is worrisome 
and should be under surveillance. 
3.3. Virulence potential of Bacillus spp. 
3.3.1. B. cereus group 
The first guidance to access virulence (toxigenic) potential of species of the Bacillus 
genus was developed by the Scientific Committee on Animal Nutrition (SCAN) and 
published in 2000 (Commission, 2000). In that document, it is assumed that toxins 
(enterotoxins) found in Bacillus species other than those of Bacillus cereus group would 
have sufficiently similar properties to be detected by the same detection methods. After 
2000, few incidents of food poisoning were reported in non-pathogenic Bacillus-group, 
which were mostly related with the presence of heat-stable surfactins and similar cyclic 
lipopeptides. Examples of toxic peptides produced by Bacillus spp. comprise amylosin (B. 
amyloliquefaciens) (Mikkola et al., 2007), fengycin and surfactin from (B. subtilis and B. 
mojavensis) (Hwang et al., 2009; From et al., 2007a) or lichenysin (B. licheniformis) 
(Nieminen et al., 2007). Toxic effects have been detected only when they are produced in 
amounts able to cause demonstrable cell disruption, which is far from the typical 
concentration of its production and use (EFSA, 2013). 
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Pathogenicity potential is much more characterized for B. cereus group species than in 
other Bacillus species. The main enterotoxins associated with B. cereus virulence and that 
should be sought by diagnostic tools are the: i) non-hemolytic enterotoxin (Nhe, three-
component toxin), ii) hemolysin BL (Hbl, three-component toxin), iii) and cytotoxin K 
(CytK, single-component toxin of the β-barrel pore-forming toxin family) (Stenfors Arnesen 
et al., 2008; Lund et al., 2000; Lund & Granum, 1996; Beecher & Macmillan, 1991) and iv) 
emetic toxin cereulide synthetase (Cereulide, cyclic heat stable depsipeptide) (Ehling-
Schulz et al., 2006b; Ehling-Schulz et al., 2005b) (Table 4). 
Table 4. Bacillus spp. toxins responsible for gastro-intestinal disorders. 
(Adapted from: Stenfors Arnesen et al., 2008). 
Toxin Gene Nature 
Gatrointestinal disorders 
infection/intoxication 
Nhe nhe Protein, 3 components Diarrheal 
Hbl hbl Protein, 3 components Diarrheal 
CytK cytK Protein Diarrheal 
Cereulide ces Cyclic peptide, 1.2 kDa Emetic 
The protein nhe is the most commonly found enterotoxin gene complex, is probably 
ubiquitous in B. cereus group members and exhibits haemolytic activity towards 
erythrocytes from several mammalian species (Fagerlund et al., 2008)  (Stenfors Arnesen 
et al., 2008). The hbl complex constitutes another pore-forming enterotoxin in the B. 
cereus group exhibiting also haemolytic activity towards erythrocytes from several animal 
species. (Wiedmann & Zhang, 2011). The cytK is a 34 kDa single-component protein toxin 
of the β-barrel pore-forming toxin family with necrotic, haemolytic, and enterotoxic effects 
(Lund et al., 2000). The emetic toxin (cereulide) is a small (1.2. kDa) non-ribosomally 
synthesized dodecadepsipeptide, which is heat stable, acid and protease resistant 
(Stenfors Arnesen et al., 2008). Its expression is affected by factors like oxygen, pH, and 
temperature and is regulated by the transitional state regulator AbrB (Lücking et al., 
2009). Whereas the genes encoding the enterotoxins Nhe, Hbl and CytK are 
chromosomally encoded, the emetic toxin cereulide is encoded by a 208 kb plasmid, 
pCER270, with similarity to B. anthracis pXO1 and other pXO1-like plasmids (Rasko 
et al., 2007; Ehling-Schulz et al., 2006a; Hoton et al., 2005), highlighting the risk for lateral 
gene transfer between strains. 
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Several other candidate proteins have been suggested as potential contributors to the 
enterotoxigenic activity of B. cereus, for which more detailed information can be found in a 
review from Arnesen et al., (Stenfors Arnesen et al., 2008). 
In the very few reports evaluating the cytotoxicity and production of putative emetic toxins 
in species other than those of the B. cereus group recovered from foods, water and food 
plants, the authors found only 8 out of 333 Bacillus strains tested to be putative toxin 
producers, particularly among B. subtilis, B. mojavensis, B. pumilus, or B. fusiformis 
isolates, but none of them produced B. cereus-like toxins (From et al., 2005). Although 
rare, the identification of toxins in non-B. cereus species  from water, food, and food 
environments highlights the risk for food poisining and the need for further 
characterization of toxins and genes involved to improve detection methods (From et al., 
2005). 
It is also important to refer that the sole presence or absence of an individual toxin gene 
does not fully explain the pathogenicity or virulence potential of a certain strain, and 
consequently molecular methods used should always be accompanied by sensitive and 
accurate toxin quantification systems (Bauer et al., 2009). 
3.3.2. B. pumilus group 
Although rarely, some evidences of toxic properties of Bacillus pumilus have been 
reported, namely its cytopathic effects in Vero cells, haemolytic activity, lecithinase 
production, and proteolytic action on casein (From et al., 2005; Hoult & Tuxford, 1991). In 
addition, pumilacidin from B. pumilus was also reported as presenting toxic properties 
(From et al., 2007b) . Moreover, it also produces a toxin that has been detected in guinea 
pigs with experimentally induced enterocolitis associated with clindamycin (Knoop, 1979). 
4. Biotechnological and industrial applications of Bacillus pumilus group members
Besides the high diversity characterizing Bacillus species at the taxonomic level, the 
diversity of their metabolic features is also noticeable (Novak et al., 2012; Gaggìa et al., 
2010; Schallmey et al., 2004). Beyond their ability to produce a wide range of metabolites 
with very different natures and structures, they also display broad spectrum of activities, 
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including enzymes with great interest in detergent industry and food sectors; production of 
primary metabolites as vitamins (Schallmey et al., 2004) and ribonucleosides (Srivastava 
et al., 2012) and secondary metabolites comprising antibiotics, insecticides, 
biosurfactants agents and also growth promoting formulations (Lehman et al., 2013; 
Martinotti et al., 2013; Mulligan et al., 2014; Fracchia et al., 2012; Lehman et al., 2001; 
Schallmey et al., 2004), originally designed to enable the bacterium to survive in its 
natural environment (Stein, 2005). 
The world market for industrial enzymes is estimated to be 1.6 billion $US, divided 
between food enzymes (29%), feed enzymes (15%), and general technical enzymes 
(56%), for which is estimated that enzymes from Bacillus spp. constitute about 50% of the 
total of enzyme market (Berkeley et al., 2008). B. pumilus is involved in the alkaline serine 
proteases (subtilisins) production, with a reported primary application in 
household detergents, as Alcalase (Novo Nordisk) (Schallmey et al., 2004; Chen et al., 
1995).  
Among ribonucleosides, D-Ribose is frequently used as a flavor enhancer in food, 
pharmaceuticals, cosmetics, health food, and animal feed, as well as for the treatment of 
myocardiac ischemia and muscular pain, for which some B. pumilus are involved in its 
production (Srivastava et al., 2012). 
In addition, poly-γ-glutamic acid (γ-PGA) is a water-soluble, eatable, and biodegradable 
compound with industrial applications in the food, cosmetics, and in medical fields and 
also in wastewater treatment as thickener, hemectant, cryoprotectant, drug carrier, highly 
water adsorbant hydrogel, biopolymer flocculent, heavy metal absorber, and animal feed 
additive (Shih & Van, 2001). Several Bacillus species, including B. pumilus, have been 
reported to produce γ-PGA, however, B. licheniformis and B. subtilis are the most widely 
studied species (Bhat et al., 2013). 
The biosynthesis of several antibiotics and biosurfactant compounds is also noticeable 
from species belonging to Bacillus genus and B. pumilus group members in particular. 
Detailed information regarding theses aspects are given in Section III from this chapter. 
Probiotic-containing products with Bacillus species are available for human nutrition, as 
animal feed supplements, and also for aquaculture (Hong et al., 2005; Rolfe, 2000; 
Verschuere et al., 2000), with potential attributes as colonization, immunostimulation and 
antimicrobial activity. Originally, many commercial products were sold as products that 
carry B. subtilis spores, but recent studies have shown that most products are mislabeled 
and carry other Bacillus species, including B. pumilus  (Green et al., 1999; Hoa et al., 
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2000). In addition, other B. pumilus species were reported as antidiarrhoeal 
prophylactic agents by its probiotic activity (Sanders et al., 2003; Mazza, 1994). 
Moreover, it is generally known that several microorganisms exhibit biological activity 
useful to control plant diseases. Indeed, B. pumilus is not considered an anti-insect 
pathogen like other members of the genus Bacillus, such as B. thuringiensis or B. 
sphaericus (Phelps & McKillip, 2002; Schirmer et al., 2002). Nevertheless, some reports 
identified this species as a biopesticide, with previous studies showing its activity against 
a broad range of phytopathogenic fungi (Lehman et al., 2013) and as an inducer of 
systemic acquired resistance (SAR) in plants (EFSA, 2013). 
Regarding other species belonging to B. pumilus group, no evidences were found 
concerning its application for industrial or biotechnological purposes. Nevertheless, since 
appropriated identification methods of members of this group is a critical and still 
controversial step, which is being suffering considerable changes, it is unknown to which 
extent species form B. pumilus group are clearly discriminated in many of the available 
studies. Appropriated delineation of species and/or of clonal lineages adapted to particular 
niches will thus be of relevance to open new perspectives for biotechnological applications 
of B. pumilus group species. 
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II. Antimicrobial peptides of Bacillus spp.
Almost 90 years elapsed since Fleming discovered lysozyme, the first natural 
antimicrobial. Since then, more than 1200 types of antimicrobial peptides (AMPs) have 
been isolated from bacteria, animals, insects, and plants, and their use had a great impact 
in human health (Nakatsuji & Gallo, 2012) 
The intensive and inappropriate use of antibiotic compounds has generated a strong 
selective pressure for the emergence of multi-drug resistant pathogens leading to a high 
percentage of morbidity and mortality rates (WHO, 2012), e.g. multidrug-resistant 
Staphylococcus aureus and vancomycin-resistant Enterococcus spp. (VRE) (CDC, 2013). 
Moreover, nearly all of the antibiotics used today belong to classes discovered between 
1941 and 1968 and it is particularly problematic that only two novel structural classes 
have become available on the market in the last 40 years: oxozolidiones and cyclic 
lipopetides (Calza et al., 2004; Jacqueline et al., 2004; Wagenlehner & Naber, 2004). 
More than ever, efforts are urgently needed to identify and develop new antibacterial 
compounds, more effective and with novel modes of action (Mills et al., 2011; Barsby et 
al., 2001). 
In this sense, the screening of microbial natural products represents an important route to 
the discovery of novel chemicals, for development of new therapeutic agents and for 
evaluation of the potential of lesser-known and/or new bacterial taxa (Lazzarini et al., 
2000). Therefore, exploration for new compounds from well-known and proficient 
microorganisms, such as Bacillus, due to the fact that only a small range of their 
biosynthetic capacity is currently exploited, has been conducted. In fact, recent advances 
in genome sequencing have highlighted the genus Bacillus as a source of antibiotic-like 
compounds resulting from their secondary pathways (Fickers, 2012). 
5. Antimicrobial peptides (AMPs) types from Bacillus spp.
AMPs (AMPs, 2014) are natural products of metabolism that are not essential for normal 
growth, development or reproduction of an organism,   generally comprise 10–50 amino-
acid residues and are characterized by cationic amphipathic properties (Seo et al., 2012). 
In opposition to primary metabolites, these compounds are not ubiquitous in the living 
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organisms that produce them, neither are necessarily expressed continuously (Demain & 
Fang, 2000).  
In fact, the function and importance of AMPs to the producer organism is usually related to 
ecological nature, as they are produced in nature for defense against predators, 
interspecies competition and to facilitate the reproductive processes contributing for the 
survival of the producers (Demain & Fang, 2000). Therefore, the ecological consequence 
of production of these compounds is the promotion and the maintenance of biodiversity in 
microbial communities through establishment of interaction networks.  
Moreover, it seems that there is no relation between the presence of specific consensus 
amino-acid sequences associated and its biological activity, although most of them retain 
certain common chemical features as positive charge and relatively hydrophobic and 
amphipathic structures involved in their mechanism of action (Nakatsuji & Gallo, 2012; Lai 
& Gallo, 2009). 
Generally, AMPs interact with microbial membranes, resulting in two possible modes of 
action, depending on the peptide-type and of microbial species (Nakatsuji & Gallo, 
2012). The peptide can be membrane-disruptive resulting in cell lysis (Kjos et al., 2011; 
Diep et al., 2007; Cotter et al., 2005), or alternatively, membrane interaction  which can 
lead to the formation of transient pores and to the transport of the peptides inside the 
cell, bringing them into contact with intracellular targets (Marlow et al., 2009; Mattiuzzo 
et al., 2007). Both mechanisms are related with peptide amphipathic features allowing 
them to interact with negatively charged phospholipid head groups and hydrophobic 
fatty acid chains of microbial membranes, resulting in pore formation and 
consequent release of cytosol components (Glaser et al.; Wimley, 2010). 
The Bacillus genus produces distinct and heterogeneous AMPs which present different 
basic chemical structures (Gebhardt et al., 2002; Stein, 2005). These compounds can be 
subdivided into different classes, comprising: bacteriocins, bacteriocin-like inhibitory 
substances (BLIS), polyketides (PKs), nonribosomal peptide (NRPs), as well as other 
unusual and miscelaneous peptides.  
In fact, B. subtilis produces more than two dozen of antibiotic compounds (Stein, 2005). If 
all pathways are considered, their production requires more than 350 kb, corresponding to 
a remarkable 10% of the annotated ORFs. It should also be emphasized that all known B. 
subtilis strains are able to produce individual antibiotic cocktails, which encompass only a 
portion of the compounds depicted (Stein, 2005).  The potential of a given B. subtilis strain 
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for antibiotic syntheses is comparable with B. amyloliquefaciens (six operons of 340 kb, 
8.5% of the genome) (Chen et al., 2009b). Moreover, while analyzing specific gene 
clusters and their functions, some researchers discovered additional AMPs gene clusters, 
leading to the hypothesis that most of the investigated microorganisms have a broader 
genetic capacity to produce natural products than the suggested by the number of 
compounds isolated from a particular strain (Gross, 2007). 
5.1. Bacteriocins 
Bacterial antimicrobial peptides of ribosomal synthesis that are lethal to bacteria, other 
than the producing strain, are commonly referred as bacteriocins (Riley & Wertz, 2002a; 
Riley & Wertz, 2002b; Vuyst & Vandamme, 1994). These heterologous groups of 
proteinaceous antimicrobial substances exhibit variable molecular weights and 
biochemical properties and also display a high degree of target specificity (Abriouel et al., 
2011; Riley & Wertz, 2002a; Riley & Wertz, 2002b). Moreover, their potential use as 
natural preservatives in foods has been explored in the recent years (Abriouel et al., 2011; 
Deegan et al., 2006; Gálvez et al., 2008). 
The first bacteriocin described was designated colicin and was produced by Escherichia 
coli (Cascales et al., 2007). Nevertheless, currently, the most studied bacteriocins are 
those produced by lactic acid bacteria (LAB), due to their applicability as biopreservatives 
in the food industry, and those produced by food chain important Bacillus species, 
including B. subtilis group members, which also possesses a history of safe use in 
industry  (Pedersen et al., 2002). 
Among Bacillus genus, Bacillus RNA group I members seem to be those with a greater 
significance concerning the production of these compounds, although other members of 
the remaining RNA groups also revealed the potential to produce them. Table 5 
summarizes the bacteriocins described in the scientific literature among several Bacillus 
spp. 
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Table 5. Bacteriocins produced by Bacillus species. 
Bacillus species Source Bacteriocin/BLIS Molecular 
weight (kDa) 
Special features Class Reference 
Bacillus spp. RNA group I 
Bacillus subtilis group sensu lato 
B. subtilis 
Culture collection Subtilin 3.34 A-lantibiotic, binds lipid II Subclass I.1 (Banerjee & Hansen, 1988; Stein, 2005) 
Culture collection Subtilin B 3.42 Succinylated subtilin, A-lantibiotic, binds lipid II Subclass I.1 
(Chan et al., 1993) 
Chinese herbs, 
dairy product, soil, 
wild strains 
Subtilosin A Subtilosin 
A1 3.393.41 
Macrocyclic lantibiotic Macrocyclic 
lantibiotic, variant 
Subclass 
I.4Subclass I.4 
(Huang et al., 2009; 
Stein, 2005; Zheng et 
al., 1999) 
Culture collection Mersacidin 1.82 Tetracyclic, B-lantibiotic, binds lipid II Subclass I.2 (Bierbaum et al., 1995; Stein, 2005) 
– Sublancin 168 3.88 AII-lantibiotic, unusual lantibiotic Subclass I.2 (Paik et al., 1998; Stein, 2005) 
Fermented 
soybeans Betacin – Produced by a SPβ lysogenic strain –* 
(Hemphill et al., 1980) 
– MJP1 4.5 Antibacterial and antifungal activity –* (Yang & Chang, 2007) 
– Ericin S 3.44 Lantibiotic; active againstClavibacter Subclass I.1 (Stein et al., 2002) 
Plant rhizosphere Ericin A 2.98 Lantibiotic Subclass I.1 (Stein et al., 2002) 
Chinese herbs Bac 14B 21 Antibacterial and antifungal activity –* (Hammami et al., 2009) 
LFB112 6.3 Activity against Gram-positive and Gram-negative bacteria –* 
(Xie J et al., 2009) 
B. pumilus Water Pumilicin 4 1.99 Active against VRE and MRSA –* (Aunpad & Na-Bangchang, 2007) 
B. licheniformis 
Buffalo rumen Lichenin 1.4 N-terminal: ISLEICXIFHDN Subclass II.3 (Pattnaik et al., 2001) 
Dairy product Bacillocin 490 2 – – (Martirani et al., 2002) 
Culture collections Lichenicidin (α, β) 3.25 and 3.02 Two-peptide lantibiotic Subclass I.3 (Begley et al., 2009) 
Soil Peptide A-12 C 0.77 Antibacterial and antifungal activity –* (Gálvez et al., 1993) 
B. amyloliquefaciens Yogurt beverage Subtilosin A 3.39 Macrocyclic bacteriocin from B. subtilis –* 
(BABASAKI et al., 
1985) 
Bacillus cereus group sensu lato 
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B. cereus 
Food Cerein GN105 9 Active against other B. cereus strains –* (Naclerio et al., 1993) 
Soil Cerein 7ª 3.94 – Subclass II.3 (Oscáriz & Pisabarro, 2000) 
Soil Cerein 7B 4.89 sec-independent leader peptide with GG Subclass II.3 
(Oscáriz et al., 2006) 
Woodland Cerein 8ª 26 Aromatic amino acid residues –* (Bizani & Brandelli, 2002) 
Aquatic plant roots Cerein MRX1 3.14 N-terminal: DWTCWSCLVCAACSVELL Subclass II.2 
(Sebei et al., 2007) 
Deep-surface oil 
reservoir Cereicidin – Lantibiotic –* 
(Xiong et al., 2009) 
B. anthracis Culture collection Heterocyclo-anthracins 9.62 Subfamily of putative thiazole-containing heterocyclic bacteriocins –* 
(Haft, 2009) 
B. thuringiensis 
Culture collection Thuricin HD-2 >950 Phospholipase A activity –* (Favret & Yousten, 1989) 
Culture collection Thuricin 439 2.92 and 2.80 Two singly active peptides Subclass II.3 (Ahern et al., 2003) 
Soybean rot 
nodules Thuricin 17 3.16 N-terminal: DWTXWSXL Subclass II.2 
(Gray et al., 2006a; 
Gray et al., 2006b)  
Honey Thurincin H 3.14 Three structural genes, N-terminal DWTXWSXL Subclass II.2 
(Lee et al., 2009) 
Culture collection Thuricin S 3.14 N-terminal: DWTXWSXL Subclass II.2 (Chehimi et al., 2007) 
Soil litter Bacthuricin F4 3.16 N-terminal: DWTXWSXL Subclass II.2 (Kamoun et al., 2005) 
Human fecal 
sample Thuricin CD 2.76 and 2.86 
Dimer of two peptides; active 
against C. difficile –* 
(Hill et al., 2009) 
Culture collection Entomocin 110 4.8 Active against L. monocytogenes –* (Cherif et al., 2008) 
Culture collection Entomocin 9 12.4 – –* (Cherif et al., 2003) 
Soil Thuricin 7 11.6 – –* (Cherif et al., 2001) 
Culture collection Tochicin 10.5 – –* (Paik et al., 1997) 
Culture collection Morricin 269 10 Wide inhibitory spectrum –* (Barboza-Corona et al., 2007)  
Culture collection Kurstacin 287 10 Wide inhibitory spectrum –* (Barboza-Corona et al., 2007) 
Culture collection Kenyacin 404 10 Wide inhibitory spectrum –* (Barboza-Corona et al., 2007) 
Culture collection Entomocin 420 10 Wide inhibitory spectrum –* (Barboza-Corona et al., 2007) 
Culture collection Tolworthcin 524 10 Wide inhibitory spectrum –* (Barboza-Corona et 
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al., 2007) 
Other Bacillus spp. belonging to RNA group I 
B. megaterium 
Soil Megacin A-216 32.85; 21.02, 11.85* Phospholipase A activity Class III 
(Kiss et al., 2008) 
– Megacin A-19213 39 Phospholipase A activity Class III (Von Tersch & Carlton, 1983) 
– Megacin BII – Narrow spectrum –* (Stahl, 1989) 
Soil Megacin C 150 Large protein –* (Donoghue, 1972) 
Soil Megacin Cx 210 Large protein –* (Brusilow & Nelson, 1981) 
Vegetable wastes Megacin 19 3.5–6.5 Broad spectrum against food-spoilage bacteria –* 
(Khalil et al., 2009b) 
Soil Megacin 22 3.5–6.5 Broad spectrum against food-spoilage bacteria –* 
(Khalil et al., 2009a) 
B. coagulans Animal feces Coagulin 4.6 Pediocin-like bacteriocin Subclass II.1 (Le Marrec et al., 2000) 
B. circulans Poultry environment SRCAM 1580 3.5 Pediocin-like bacteriocin; anti-
Campylobacter Subclass II.1 
(Svetoch et al., 2005) 
Bacillus spp. RNA group IV 
B. brevis 
Soil Bacillocin Bb <10 Broad spectrum, potential medical or food uses –* 
(Saleem et al., 2009) 
Wheat field Brevicin AF01 – Active against MRSA –* (Faheem et al., 2007) 
Mud/water samples Thermoleovorin-N9 36 Broad spectrum –* (Novotny & Perry, 1992) 
Broiler chicken, crop SRCAM 37 3.5 Pediocin-like bacteriocin; anti-
Campylobacter Subclass II.1 
(Svetoch et al., 2005) 
Broiler chicken, 
intestine SRCAM 602 3.5 
Pediocin-like bacteriocin; anti-
Campylobacter Subclass II.1 
(Svetoch et al., 2005) 
Kimchi Paenibacillin 2.98 Lantibiotic Subclass I.2 (He et al., 2007) 
Bacillus spp. RNA group VI 
B. atrophaeus Culture collection Subtilosin A 3.39 Macrocyclic bacteriocin from B. 
subtilis –* 
(Stein et al., 2004) 
B. halodurans Soil Haloduracin (A1, A2) 3.04 and 2.33 Two-peptide-lantibiotic Sunclass I.3 (McClerren et al., 2006) 
*considered as BLIS
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Recently, Abriouel et al. (Abriouel et al., 2011) proposed a specific scheme for 
Bacillus bacteriocins (Table 6), based on the main classification scheme for LAB ones.  
Table 6. Proposed classification of bacteriocins of Bacillus species and comparison 
with ones from LAB. (Adapted from: Nes et al., 2007). 
Proposed classification of Bacillus bacteriocins 
Bacteriocins 
examples 
LAB bacteriocins 
correspondence 
Class I. Post-translationally modified peptides 
Class I. Lantibiotics 
Subclass I.1. Single-peptide, elongated lantibiotics 
Subtilin 
Ericin S 
Ericin A 
Subclass I.2. Other single-peptide lantibiotics 
Sublancin 168 
Mersacidin 
Subclass I.3. Two-peptide lantibiotics 
Haloduracin 
Lichenicidin 
Subclass I.4. Other post-translationally modified peptides Subtilosin A 
Class II. Nonmodified peptides 
Class II. Small, linear 
peptides 
Subclass II.1. Pediocin-like peptides Coagulin 
Class IIa 
Subclass II.2. Thuricin-like peptides 
Thurincin H 
Thuricin S 
Thuricin 17 
Bacthuricin F4 
Cerein MRX1 
Subclass II.3. Other linear peptides 
Cerein 7A 
Cerein 7B 
Lichenin 
Thuricin 439 
Class III. Large proteins 
Megacin A-216 
Megacin A-19213 
Class III. Large heat-labile 
bacteriocins 
Both class I and II bacteriocins are small (3–10 kDa), cationic, amphiphilic and 
membrane-active peptides (Lee & Kim, 2011). Moreover, class I includes antimicrobial 
peptides that undergo different types of post-translational modifications, essential for the 
antimicrobial activity of the final peptide (Abriouel et al., 2011). This class can be 
subdivided into four subclasses. Subclasses I.1–I.3 include peptides with modifications 
typical of lantibiotics (e.g. formation of lanthionine and β-methyl lanthionine residues), 
while subclass I.4 includes other unique modifications as particular sulfide bonds among 
79
Chapter 1 
others. Subclass I.1 includes type A lantibiotics with an elongated structure, such as 
subtilin. Subclass I.2 includes the type B globular lantibiotic mersacidin, and other 
lantibiotics such as sublancin 168. Subclass I.3 includes the two-component lantibiotics. 
Subclass I.4 includes the unique cyclic peptide subtilosin A that contains a head-to-tail 
peptide bond as well as particular sulfide bridges formed between cysteine groups and 
dehydrated amino acid residues (Abriouel et al., 2011).  
Moreover, the proposed classification seems to be coherent with clustering obtained from 
the comparative analysis of published amino acid sequences, as detailed in Figure 6. The 
subtilin and ericins form a coherent cluster, which is characterized by highly conserved 
regions in the mature peptide as well as in the leader peptide sequences. Interestingly, 
the A1 and A2 subunits of haloduracin and lichenicidin also form coherent clusters, 
suggesting that both two-peptide lantibiotics share a common origin. Mersacidin also 
shows homology with the A1 subunit of the two-peptide lantibiotics, and especially with 
the lichenicidin A1 subunit, with 25 conserved residues at identical positions, indicating its 
relatedness to the two-peptide lantibiotics (Abriouel et al., 2011). 
Figure 6. Dendrogram showing the relatedness of Bacillus spp. bacteriocins according to 
primary amino acid sequence homologies. Shaded characters indicate identical 
amino acid residues. (Adapted from: Abriouel et al., 2011).  
Bacteriocins of class II include small (0.77–10 kDa), non-modified and linear peptides, 
which are heat and pH stable (Table 6). This class can be subdivided into four 
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subclasses. Subclass II.1 includes pediocin-like peptides with a conserved YGNGVXC 
motif near the N-terminus (Figure 6), and the coagulin produced by B. coagulans I4. 
Subclass II.2 includes thuricin-like peptides with a conserved DWTXWSXL motif 
neighboring the N-terminus produced by B. thuringiensis, and cerein MRX1 produced by 
B. cereus. Comparative amino acid sequence analysis of thuricin-like peptides shows a 
coherent cluster (Figure 6). Subclass II.3 includes other linear peptides, such as lichenin 
produced by B. licheniformis, or cereins 7A and 7B. 
Class III bacteriocins includes large proteins (430 kDa) with phospholipase activity such 
as megacins A-216 and A-19213 produced by B. megaterium (Table 6). Many other 
antimicrobial polypeptides of intermediate size (10–30 kDa) and other large antimicrobial 
proteins produced by bacilli are not included in this classification scheme due to the lack 
of data on their protein or gene sequences. 
Moreover, bacteriocin production and secretion seems to be correlated with bacterial 
stationary phase (Khalil et al., 2009a). Nevertheless, depending on the transcription 
regulation system, its expression may also be influenced by factors such as carbon 
sources (Drosinos et al., 2005), cell-density (Riley & Wertz, 2002b), temperature (Diep et 
al., 1994), or even the presence of a bacteriocin-sensitive strain (Barefoot et al., 1994).  
Bacteriocins encoding genes are typically located in mobile genetic elements such as 
plasmids and transposons (Riley & Gillor, 2007) i. In fact, the production of a particular 
bacteriocin involves the co-expression of other genes that encode proteins associated 
with immunity and when required, secretion, regulation and biosynthesis (Jack et al., 
1995; Nes et al., 1996). Thus, bacteriocins and the associated genes are usually 
expressed in an operon, but may involve expression of up to four separate operons (Heng 
et al., 2006). 
Some of specific aspects of most common bacteriocins produced from Bacillus spp., 
namely subtilin, ericin, sublancin, mersacidin, subtilosin A, haloduracin and lichenicidin 
are detailed and compared in Figure 7 a), b) and c). 
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Figure 7. (a) Comparison of subtilin and ericin structures with that of the lactococcal lantibiotic nisin A. Conserved residues at identical positions to all 
four bacteriocins are highlighted in green, while those conserved only in subtilin and ericins are depicted in yellow; other conserved residues are in 
light red. (b) Structures of the single-peptide lantibiotics sublancin, mersacidin and subtilosin A. The structure of the A1 subunit of haloduracin is also 
included for comparison with mersacidin. The conserved residues are highlighted in orange color. Cysteines involved in disulfide bridge formation are 
highlighted in blue. For subtilosin A, residues involved in sulfur to a-carbon linkages are shown in green, while residues involved in head-to-tail amide 
bond formation are in light blue. (c) Comparison of the two-peptide lantibiotics haloduracin and lichenicidin from Bacillus, and lacticin 3147 from 
Lactococcus lactis. Conserved residues of the A1 peptides are highlighted in orange and light yellow. A conserved Pro residue between lichenicidin 
A1 subunit and mersacidin is shown in light blue. Conserved residues of the A2 peptides are highlighted in green, deep yellow, light orange and 
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violet. The C-terminal parts of the A1 subunits also share two conserved loops of 11 and eight amino acid residues. The C-terminal parts of A2 
peptides share the same pattern of lanthionine (Ala–S–Ala) and methyllanthionine (Abu–S–Ala) bridges. Non-identical residues are in white. 
(Adapted from: Abriouel et al., 2011). 
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Concerning bacteriocins commercially available, unfortunately, only Nisin is currently 
approved by the US Food and Drug Administration for application as a natural 
preservative in food. Mersacidin is a compound with remarkably interest. It inhibits the 
synthesis of S. aureus cell wall, also demonstrating activity against MRSA, with a similar 
efficiency of vancomycin (Jenssen et al., 2006). Therefore, since its mode of action differs 
from vancomycin, a possible combination of mersacidin with this antibiotic could be a 
promising alternative. 
5.2. Bacteriocin-like inhibitory substances (BLIS) 
The term BLIS is often used when the peptide nature of the antimicrobial compound has 
not been confirmed, whereby ribosomal synthesis is presumed, but may be unknown 
(Abriouel et al., 2011). Main features of the described BLIS from different Bacillus species 
are presented in Table 5. 
Different BLIS with distinct spectra of activity against both Gram-positive and Gram-
negative bacteria were described in B. subtilis (Stein et al., 2004; Stein et al., 2002; 
Stein, 2005; Paik et al., 1998; Bierbaum et al., 1995).  Pumilicin was reported in B. 
pumilus and is a plasmid-encoded peptide (Aunpad & Na-Bangchang, 2007; Lovett et 
al., 1976). This compound presents a molecular weight of 1994.62 Da, heat stability up to 
121 ºC, is active in a pH range of 3–9 and demonstrates remarkable antibacterial 
activity against MRSA, vancomycin-resistant E. faecalis (VRE) and several Gram-
positive test bacteria (Aunpad & Na-Bangchang, 2007). 
5.3. Unusual peptides 
Bacillus spp. are able to synthetize other unusual antibiotic peptides, such as rhizocticins 
and phosphonate oligopeptide which contain C-terminal nonproteinogenic amino acid (Z)-
l-2-Amino-5-Phosphono-3-Pentenoic Acid (APPA) (Borisova et al., 2010; Kino, 2010; Kino 
et al., 2009). These molecules are synthesized by the called L-amino acid ligase, which is 
able to catalyze the formation of an alpha-peptide bond from L-amino acids in an ATP-
dependent manner (Tabata et al., 2005).  
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Rhizocticin A is able to prevent the growth of yeast and filamentous fungi by protein 
synthesis inhibition but is not active against bacteria (Borisova et al., 2010; Kino et al., 
2009; Diddens et al., 1979; Laber et al., 1994). Furthermore, some strains of B. 
subtilis produce the dipeptide bacilysin composed of L-alanine and the unusual amino 
acid L-anticapsin (Walker & Abraham, 1970).  
5.4. Other antibiotic compounds (miscellaneous) 
Miscellaneous antibiotics comprise a class of compounds that are structurally different 
from the remaining AMPs families and from each other and for this reason cannot be 
classified into the other classes. Examples of representatives agents produced by B. 
subtilis include bacilysocin 2 (Tamehiro et al., 2002), 3,3´-neotrehalosadiamine (NTD) 3 
(Inaoka & Ochi, 2007) and amicoumacin 4 (Pinchuk et al., 2002) (Figure 8).  
Figure 8. Chemical structures of miscellaneous antibiotics bacilysocin 2, 3,3
´-neotrehalosadiamine (NTD) 3 and amicoumacin 4. (Adapted from: Sansinenea & 
Ortiz, 2011). 
b) 3,3´-Neotrehalosadiamine (NTD) 3
a) Bacilysocin 2
c) Amicoumacin 4
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Bacilysocin 2 (Figure 8a) is an antimicrobial phospholipid derived from the major B. 
subtilis phospholipid phosphatidylglycerol through YtpA-catalysed acyl ester hydrolysis 
(Tamehiro et al., 2002).  
NTD 3 (Figure 8b), structurally 3,3´- diamino-3,3´-dideoxy-a,b-trehalose (Tsuno et al., 
1986), inhibits S. aureus and Klebsiella pneumoniae and functions as an auto inducer and 
also as a glucose uptake modulator in B. subtilis by activating its own biosynthetic operon 
(Inaoka & Ochi, 2007).  
Amicoumacins 4 (Figure 8c) present antibacterial and anti-inflammatory activities, namely 
in Helicobacter pylori, which make these compounds attractive for the treatment of chronic 
gastritis and peptic ulcer in humans (Pinchuk et al., 2002). 
5.5. Polyketides and non-ribosomal peptides 
Polyketides (PKs) are a highly active class of secondary metabolites produced by almost 
all living organisms, currently used in human and animal health and in agriculture as 
antibiotic (erythromycin, rifamycin), antifungal, immunosuppressant and antitumor agents 
(Li et al., 2011; Nakano et al., 2009; Resmi & Soniya, 2012). Structurally, they encompass 
organic compounds exhibiting remarkable diversity in terms of their structure, which can 
be divided into three classes, type I, II and III (Chen et al., 2006). Some PKs from B. 
subtilis and also fungi and plants, are grouped in the third class (Resmi & Soniya, 2012; Li 
et al., 2011; Nakano et al., 2009).  
Concerning PKs produced by Bacillus spp., they are synthesized on modularly organized 
assembly lines by elongation of activated monomers of amino and hydroxyl acid building 
blocks following the same logic as NRPs (Hertweck et al., 2007). 
Difficidin, macrolactin and bacillaene are three examples of PKs isolated from B. 
amyloliquefaciens (Arguelles-Arias et al., 2009; Chen et al., 2007) (Figure 9).  
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Figure 9. Chemical structures of polyketides antibiotics a) difficidin, b) bacillaene and c) 
macrolactin (Adapted from: Sansinenea & Ortiz, 2011). 
Difficidin (Figure 9a) is an unsaturated 22-membered macrocylic polyene lactone 
phosphate ester with a broad spectrum of antibacterial activity. It inhibits protein 
biosynthesis and was recently  used as a grow suppressive agent against Erwinia 
amylovara, a devasting plant pathogen causing necrotrophic fire blight disease of apple, 
pear and other rosaceous plants (Chen et al., 2009b).  
Bacillaene (Figure 9b) and macrolactin (Figure 9c) are antimicrobial agents that could be 
potentially useful in human medicine. Both are prokaryotic protein synthesis inhibitors 
which display antimicrobial activity toward human pathogens such as Serratia 
marcescens, K. pneumonia and S. aureus (Chen et al., 2009a; Patel et al., 1995). 
Macrolactin consists of a 24-membered ring lactone which has the ability to inhibit murine 
melanoma cancer cells as well as mammalian herpes simplex viruses, and also showed 
effective activity in protecting lymphoblast cells from HIV (Gustafson et al., 1989). 
Moreover, 17 macrolactins have been described and one of them, 7-O-malonyl 
macrolactin A, was effective against Gram-positive bacterial pathogens (Romero-Tabarez 
et al., 2006).  
c) Macrolactin 12
b) Bacillaene 11
a) Difficidin 10
(Oxydifficidin)
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Currently, NRPS comprehend hundreds of molecules, which can be found in Norine 
database (Caboche et al., 2008).  
Since the discovery of the linear polypeptide produced by B. brevis named gramicidin 
(Kapoerchan et al., 2012), in the early 1970’s, (Figure 10a), used primarily as a topical 
antibiotic against Gram-positive bacteria, many other bioactive NRPs have been isolated 
and their biosynthetic clusters characterized.  
A NRPS widely used is Bacitracin (Figure 10b) which is composed by a mixture of related 
cyclic polypeptides produced by B. licheniformis and related counterparts and is used in 
human medicine, inhibiting the biosynthesis of the bacterial cell wall by interacting with 
undecaprenyl pyrophosphate, involved in peptidoglycan synthesis (Stone & Strominger, 
1971). This antibiotic was primarily used in topical formulations against Gram positive 
bacteria namely Streptococcus spp and S. aureus (Awais et al 2008). Recently, 2010, 
injectable bacitracin was approved by US FDA for the treatment of infants with 
staphylococcal pneumonia and empyema (Sagent, 2010).  
Polymyxin B (Figure 10c), a cyclic cationic lipopeptide produced by B. polymyxa, was 
introduced in 1960 due to the rise of MDR Gram negative bacteria, and is now frequently 
the last resort for several infections (Kwa et al., 2008). 
Finally, daptomycin (Figure 10d), a lipopeptide antibiotic, active against Gram-positive 
bacteria involved in skin and soft tissue infections, is currently the most frequent 
bactericidal drug on the market and is used as a reserve antibiotic against MDR Gram 
positive cocci like  methicillin-resistant S. aureus (MRSA and vancomycin-resistant 
enterococci (VRE) (Steenbergen et al., 2005). 
5.6. Non-ribosomal peptides (NRPs)
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Figure 10. Chemical structures of polypeptide antibiotics a) gramicidin, b) bacitracin, c) 
polymyxin B and d) daptomycin. 
Moreover, other interestingly molecules enclosed in this class, namely lipopeptide 
compounds, will be detailed in section III of this chapter. 
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III. Biosurfactants production within Bacillus spp.
6. General features of Bacillus spp. biosurfactants
Biosurfactants are amphipathic molecules of microbial origin with both hydrophilic and 
hydrophobic (generally hydrocarbon) moieties, which partition preferentially at the 
interface between fluid phases with different degrees of polarity, such as oil/water or 
air/water interfaces (Desai & Banat, 1997). They include low molecular-weight 
compounds, such as lipopeptides, glycolipids and proteins, and high-molecular-weight 
polysaccharides, lipopolysaccharides, proteins or lipoproteins (Mulligan, 2005), which 
exhibit pronounced tensioactive properties, namely surface and emulsifying activities. 
Moreover, these compounds are considered relatively nontoxic, biodegradable and 
effective at extreme temperatures or pH values, but perhaps more importantly, present a 
unique chemical structure with a high structural diversity (Martinotti et al., 2013). 
In fact, they are usually produced as complex mixtures of up to 40 analogues, among 
which the hydrophilic head group are fairly conserved and the hydrophobic tail group 
present considerable variation among the families (Soberón-Chávez, 2010). In contrast to 
common synthetic surfactants that typically possess alkyl chains of ten or more carbon 
units, many natural biosurfactants possess short alkyl chains enhancing their aqueous 
solubility by means of relatively weak Van der Waals attractive interactions. Biosurfactants 
generate aggregates in solution and consequently, exhibit powerful surfactant activity at 
both liquid and solid phases. Despite their aqueous solubility, they can have remarkably 
low critical micelle concentration (CMC) when compared to structurally similar synthetic 
surfactants (Martinotti et al., 2013). 
Nevertheless, the main commercialized surfactants are synthetic molecules, although its 
high cost of production constrains their use on a large scale. So far, only biosurfactants 
belonging to rhamnolipids classes are commercially available for industrial use, since they 
are the only compouds that had been approved by US Environmental Protection Agency 
for use in food products, cosmetics, and pharmaceuticals (Nitschke & Costa, 2007).  
Although most biosurfactants are considered as bacterial secondary metabolites, some of 
them play essential roles for the survival of the microorganisms that produce them, either 
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through facilitating nutrient transport, microbe-host interactions or as biocide agents. In 
general, biosurfactant roles include the increase of the bioavailability of hydrophobic 
water-insoluble substrates, heavy metal binding capacity, bacterial pathogenesis, quorum 
sensing and biofilm formation (Singh & Cameotra, 2004b).  
As a result of their remarkable properties, there is a wide interest in these molecules 
for diverse applications, such as bioremediation of organics (Mulligan, 2009; Chen et al., 
2005; Shin et al., 2005; Uysal & Turkman, 2005; Urum & Pekdemir, 2004; Garcia-Junco et 
al., 2003; Schippers et al., 2000) and metals (Wang & Mulligan, 2009; Dahrazma & 
Mulligan, 2007; Neilson et al., 2003; Ron & Rosenberg, 2002; Mulligan et al., 2001a), 
cosmetic additives (Soberón-Chávez, 2010; Yoneda et al., 2001), pharmaceutical 
preparations (Fracchia et al., 2012; Singh & Cameotra, 2004b) and also as coatings 
agents (Rodrigues & Teixeira, 2010; Meylheuc et al., 2006; Rodrigues et al., 2006a;  
Rodrigues et al., 2006b; Rodrigues et al., 2004). 
Nevertheless and despite recent developments in the optimization of production 
processes and in its engineering, many of the potential applications depend on whether 
they can be cost effective. The possibility of production of biosurfactants from inexpensive 
waste substrates, thereby decreasing their production costs, has also been reported (Sen, 
2010). Additionally, legal aspects such as stricter regulations concerning the 
environmental pollution by industrial activities will strongly influence the chances of 
biodegradable biosurfactants to replace their chemical counterparts (Sen, 2010). 
6.1. Biosurfactants basic structure and classification 
In general, a biosurfactant consists in lipophilic and hydroplilic portions. The lipophilic 
moiety consists usually on hydrocarbon (alkyl) tails of one or more fatty acids, which may 
be saturated, unsaturated, hydroxylated or branched (Cameotra et al., 2010). Fatty acid 
are linked to the hydrophilic moiety (carbohydrate, amino acid, cyclic peptide, phosphate, 
carboxylic acid or alcohol) by a glycosidic ester or amide bond in Figure 11.  
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Figure 11. Representative structures of different biosurfactants. 
The physicochemical characteristic that defines a biosurfactant is its ability to increase the 
apparent water solubility of hydrophobic compounds, to form water hydrocarbon 
emulsions, and to reduce surface tension (Desai & Banat, 1997), which is a measure of 
the surface free energy per unit area required to bring a molecule from the bulk phase to 
the surface (Soberón-Chávez, 2010). Effective biosurfactants lower the surface tension 
between water and air from 72 to 35 mN/m and the interfacial tension between water and 
n-hexadecane from 40 to 1 mN/m. When surfactant monomers are added to the solution, 
the surface or interfacial tension will decrease until the surfactant concentration reaches 
what is known as the Critical Micelle Concentration (CMC) (Figure 12), which is 
dependent on the molecule structure, pH, ionic strength, and temperature of the solution 
(Soberón-Chávez, 2010). 
Figure 12. Relationship of surface tension, interfacial tension and CMC related 
to surfactant concentration. (Adapted from: Mulligan, 2005). 
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Above the CMC no further reduction in surface or interfacial tension is expected and, at 
the CMC, surfactant monomers begin to spontaneously associate into structured 
aggregates such as micelles, vesicles, and lamellae (continuous bilayers). These 
aggregates are created as a result of numerous weak chemical interactions between the 
polar head groups and the nonpolar tail groups including hydrophobic, Van der Waals, 
and hydrogen bonding, and its structure is dependent on the solvent polarity in which the 
surfactant is dissolved (Soberón-Chávez, 2010).  
On the basis of their molecular mass, biosurfactants are generally divided into two groups: 
(i) low molecular weight compounds, including lipopeptides and glycolipids and (ii) high 
molecular weight agents, including lipoproteins, proteins, polysaccharides, 
lipopolysaccharides, phospholipids, fatty acids, neutral lipids or complexes (e.g. polymeric 
and particulate compounds) (Mulligan, 2005).  
Low molecular weight biosurfactants comprise compounds that are more effective in 
lowering surface tension and interfacial tension. They usually appear as a mixture of 
related compounds with major components ranging in size from 979 to 1091 Da (Fracchia 
et al., 2012). Moreover, glycolipids are the most common class of known biosurfactants 
consisting in mono or disaccharides compounds (carbohydrates) in combination with 
acylated long-chain aliphatic acids or hydroxyaliphatic acids. Among them, rhamnolipids, 
mannosylerythritol lipids (MELs), sophorolipids and trehalolipids are the best-studied 
structural subclasses (Fracchia et al., 2012). 
High molecular weight biosurfactants, also known as bioemulsifiers, are generally 
effective stabilizers of oil-in-water emulsions, and thus, possess effective emulsifying 
activity. The heteropolyssaccharide backbone contains a repeating trisaccharide of N-
acetyl-D-galactosamine, N-acetylgalactosamine uronic acid, and an unidentified N-acetyl 
amino sugar and fatty acids are covalently linked to the polysaccharide through o-ester 
linkages (Fracchia et al., 2012). 
6.2. Biosurfactants diversity 
Little is known about the distribution and frequency of biosurfactants produced by Bacillus 
spp. in natural ecossystems. Several Bacillus species isolated from soil- and plant-
associated environments and also deep sea sediments (Raaijmakers et al., 2010), 
injection brine (Raaijmakers et al 2010), fermented food (Mukherjee & Das, 2005) and 
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human gastrointestinal tract (Hong et al., 2009) revealed the ability to produce 
lipopeptides biosurfactants (LPBSs), althought their function in these ecological niches 
remains poorly explored. 
Additionally, biosynthesis of some LPBSs seems to be correlated with some Bacillus 
species (e.g. iturins and B. subtilis, B. amyloliquefaciens and B. pumilus or surfactin and 
fengycin which are widespread among multiple species)  (Kim et al., 2009; Pueyo et al., 
2009; Snook et al., 2009; Li et al., 2008; Huszcza & Burczyk, 2006; Kim et al., 2004; 
Kalinovskaya et al., 2002; Tsuge et al., 1999), or even to the geographic origin of the 
strains (Price et al., 2007). The authors speculate that this species-specificity allows the 
Bacillus populations to compete better with the microbial communities indigenous to each 
particular habitat, and also provide an an adequate response to changes in abiotic 
and biotic conditions in their natural habitats (Price et al., 2007). 
However, stability and persistence of LPBSs in complex environments have also not yet 
been extensively studied.  
6.3. Lipopeptides Biosurfactants (LPBSs): a high diversity of structures 
Most of LPBSs produced by Bacillus spp. are classified into different families 
encompassing surfactins (Arima et al., 1968), iturins (Delcambe et al., 1977), fengycins 
(Vanittanakom et al., 1986), kurstakins (Hathout et al., 2000), bacillomycins 
(Roongsawang et al., 2010) and mycosubtilin (Duitman et al., 1999) (Table 7). In addition, 
other lipopeptides have also been identified in Bacillus species, although they have not 
yet been assigned to a family.  
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Table 7: Primary structure and fatty acid chains of representative LPBSs families produced by Bacillus spp. 
Name Primary structure of the peptide moiety Main fatty acid chains References 
Surfactin family Heptapeptide closed by a lactone ring with the β -OH group of the fatty acid 
chain 
β-OH fatty acids 
Surfactin L-Glu-L-XS2-D-Leu-L-XS4-L-Asp-D-Leu-L-XS7 iC14, nC14 iC15, aC15 Peypoux et al., 1999 
Lichenysin L-XL1-L-XL2-D-Leu-L-XL4-L-Asp-D-Leu-L-XL7 iC13, aC13, nC13 iC15, aC15 Grangemard et al., 
1999; Lin et al., 1994; 
Bamylocin A Glu-Leu-Met-Leu-Pro-Leu-Leu-Leu C13 
Lee et al., 2007 
Esperin L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-XE7-COOH C13, C14, C15 Thomas & Ito, 1969 
Iturin family Heptapeptide closed by a lactam ring with the β -NH2 group of the acid chain β-NH2 fatty acids 
Bacillomycin D L-Asn-D-Tyr-D-Asn-L-Pro-L-Glu-D-Ser-L-Thr nC14, iC15, aC15 Peypoux et al., 1981 
Bacillomycin F L-Asn-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Thr nC16, iC17, aC17 Peypoux et al., 1985 
Bacillomycin L or Lc or 
Bacillopeptin L-Asn-D-Tyr-D-Asn-L-Ser-L-Glu-D-Ser-L-Thr nC14, iC15, aC15 
Volpon et al., 2007 
Iturin A L-Asn-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Ser nC14, iC15, aC15 Peypoux et al., 1978; 
Isogai et al., 1982 
Iturin AL L-Asn-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Ser nC16, iC16 Winkelmann et al., 
1983 
Iturin C L-Asp-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Ser nC14, iC15, aC15 
Peypoux et al., 1986; 
Volpon et al., 2007 
Mycosubtilin L-Asn-D-Tyr-D-Asn-L-Gln-L-Pro-D-Ser-L-Asn nC16, iC16, aC17 
Peypoux et al., 1986; 
Duitman et al., 1999 
Fengycin family Decapeptide with a lactone ring between carboxy-terminal group of Ile10 and 
OH group of Tyr3 
β-OH fatty acids 
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Fengycin A L-Glu-D-Orn-D-Tyr-D-a Thr-L-Glu-D-Ala-L-Pro-L-Gln-L-Tyr-L-Ile aC15, iC16, nC16 
Volpon et al., 2000; 
Schneider et al., 1999 
Fengycin B L-Glu-D-Orn-D-Tyr-D-a Thr-L-Glu-D-Val-L-Pro-L-Gln-L-Tyr-L-Ile aC15, iC16, nC16, C17 
Volpon et al., 2000; 
Schneider et al.,1999 
Plipastatin A L-Glu-D-Orn-D-Tyr-D-a Thr-L-Glu-D-Ala-L-Pro-L-Gln-D-Tyr-L-Ile nC16, aC17 
Nishikiori et al., 1986; 
Volpon et al. 2000 
Plipastatin B L-Glu-D-Orn-D-Tyr-D-a Thr-L-Glu-D-Val-L-Pro-L-Gln-L-Tyr-L-Ile nC16, aC17 
Nishikiori et al., 1986 
Kurstakin family Heptapeptide with a lactone ring between carboxy-terminal group of Gln7 and 
OH group of Ser4 
β-OH fatty acid chain 
Kurstakin D-Thr-Gly-D-Ala-Ser-His-D-Gln-Gln iC11, nC12, iC12, iC13 Hathout et al., 2000 
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Each LPBSs family comprises several variants, which can differ in their fatty acid chain 
and their peptide moiety (Figure 13). Moreover, the existence of several different 
compounds with the same molecular weight emphazises the need to a precise 
characterization of their chemical structure. 
Figure 13. Detailed structure of some representative biosurfactants produced by Bacillus 
spp. 
6.3.1. Surfactin family 
The family of surfactin encompasses about 20 different LPBSs (also named surfactin-like 
compounds) (Bonmatin et al., 2003). With exception of esperin (Thomas & Ito, 1969), all 
of them present a common structural trait, which include a heptapeptide with a chiral 
sequence “LLDLLDL” interlinked with a β-hydroxy fatty acid (C14 to C17) and with a D-Leu 
in position 3 and 6 and L-Asp in position 4. Amino acid residues present in position 2, 4 
and 7 belong to the aliphatic group, and include Val, Leu and Ile (Bonmatin et al., 1995; 
Itokawa et al., 1994; Peypoux et al., 1991). 
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Moreover, LPBSs are usually a mixture of compounds with different lengths and types of 
fatty acid (FA), β-hydroxy FA (FA-β-OH), β-amino FA (FA-β-NH2) or guanidylated-β-OH 
FA (gFA-β-OH), in which the β-OH or β-NH2 group of FA forms an ester or a peptide bond 
with the carboxyl group of the C-terminal amino acid. The presence of these variants is a 
result of the biosynthesis mechanism of these compounds that involve non-ribosomal 
peptide synthetases (NRPSs), a process detailed in sub-section 6.4.  
In the literature it is established that lipopeptides which present a Glu in position 1 are 
named surfactin, while those that possess a Gln are named lichenysin, since it was 
discovered from a B. licheniformis isolate (Horowitz et al., 1990). This surfactin-like 
compound is at least 2-fold more efficient than surfactin, reducing the surface tension of 
water from 72 to 27 mN/m at a CMC of 25–220 mg/L depending on its variants 
and determined conditions (Grangemard et al., 1999; Arima et al., 1968). Moreover, 
the occurrence of an Asn in position 4 was first mentioned in the structure 
described for lichenysin A by Yakimov et al. (Yakimov et al., 1995). In addition, 
other surfactin-like compound, constituted by Leu4, Val7 or Ile7 surfactin, was isolated 
from a B. pumilus and was named pumilacidin (Morikawa et al., 1992). 
Esperin differs from the surfactin by a lactone ring involving the β-carboxyl of Asp in 
position 4, instead of the α-carboxyl of the terminal Leu. The β-hydroxy fatty acid chain 
linked to these different peptide moieties can contain 12 - 16 C atoms and exhibit n, iso 
and anteiso configurations. The main fatty acid chains are usually C14 and C15 (Soberón-
Chávez, 2010). 
Bamylocin A, a recently described lipopeptide, was isolated from B. amyloliquefaciens 
(Lee et al., 2007). The peptide chain of this molecule is Glu-Leu-Met-Leu-Pro-Leu-Leu-
Leu and the molecular weight of the C13 form differs by less than 0.1 mass unit from the 
standard surfactin C14 isoform. This new result demonstrates the need of a precise mass 
spectrometry analysis of surfactin molecules to precisely confirm their primary structure. 
For fengycin, circulocins, fusaricidin, and kurstakin, the carboxyl group of the C-terminal 
amino acid is lactonised with the hydroxyl group of Tyr3, Thr1, Thr1, and Ser4, respectively 
(Roongsawang et al., 2010).  
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6.3.2. Iturin family 
Iturin A, the best well studied lipopeptide from the iturin family, is a heptapeptide 
interlinked with a β-amino acid fatty acid, that present a length from C14 to C17 (Peypoux et 
al., 1978). Six other members of the iturin family were also recognized, which include 
iturin C, bacillomycin D, F, L and Lc and also mycosubtilin (Bonmatin et al., 2003). 
Generally, all iturins present the same “LDDLLDL” chiral sequence with a common part in 
the peptidic portion, β-amino acid L-Asx-D-Tyr-D-Asn (Soberón-Chávez, 2010). With the 
exception of Iturin C, the first amino acid of the peptide chain is L-Asn. Moreover, Volpon 
et al. (Volpon et al., 2007) confirmed the presence of L-Asn in position 1 of bacillomycin L 
instead of L-Asp as initially described, which demonstrates that bacillomycin Lc and 
bacillomycin L present the same structure. In opposition to some surfactin variants, 
members of the iturin family probably result from different synthetases. Additionally, the 
main length of the fatty acid chain differs on its members, of which FA of iturin A, iturin C, 
bacillomycin D and L presented a length of C14, C16 (Winkelmann et al., 1983) and C15, 
while C16 and C17 are representatives of bacillomycin F and mycosubtilin (Soberón-
Chávez, 2010).  
6.3.3. Fengycin family 
This family includes lipodecapeptides (as fengycins), which differ by their amino acid 
residue in position 6: Ala (present in form A) or Val (form B) (Soberón-Chávez, 2010). 
They present an internal lactone ring in the peptidic moiety between the carboxyl terminal 
amino acid (Ile), and the hydroxyl group, in the side chain of the tyrosine residue (position 
3). Different β-hydroxy fatty acid chains (C14 to C18) can be linked with an amide bond to 
the N-terminal amino acid residue (Glu) (Nishikiori et al., 1986; Vanittanakom et al., 1986), 
although representative fatty acid chains are C15, C16 and C17. With the exception of a 
single lipopeptide isolated from the supernatant of B. thuringiensis, which present a fatty 
acid chain with one double bond between carbons 13 and 14 (Kim et al., 2004), all of 
them are saturated (Soberón-Chávez, 2010).  
Two differences were initially identified in fengycin and plipastatin molecules, which 
included a Gln instead of a Glu in position 8, and the L and D forms of tyrosine, which are 
presented in position 3 and 9, respectively, for plipastatins and 9 and 3 for fengycins 
(Soberón-Chávez, 2010).  
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6.3.4. Other Lipopeptide Compounds: Kurstakins 
Kurstakins are a novel class of lipopeptides which include several lipoheptapeptide with 
the same amino acid sequence: Thr-Gly-Ala-Ser-His-Gln-Gln (Hathout et al., 2000). 
Different fatty acyl chains (isoC11, nC12, isoC12 and isoC13) are linked by an amide bond to 
the N-terminal amino acid residue. Moreover, each lipopeptide has a lactone linkage 
between the carboxyl terminal amino acid and the hydroxyl group on the side chain of the 
serine residue. The L and D forms of the amino acid residues are not yet characterized. 
However, the recent identification of the genes involved in the biosynthesis of such or 
similar compounds indicated that amino acids in positions 1 and 6 could be in presented 
D-form (Bumpus et al., 2009; Abderrahmani et al., 2011).  
6.4. Biosynthesis of LPBSs: from genes to biomolecules 
Non-ribosomal peptide synthetases (NRPSs) are responsible for the biosynthesis of most 
LPBSs from Bacillus spp. by a thiotemplate process although polyketide synthetases 
(PKS) as well as fatty acid synthetases are also involved (Soberón-Chávez, 2010). 
Moreover, analysis of metabolic profiles of Bacillus species shows that single strains can 
simultaneously produce representatives of different lipopeptide familes, but also multiple 
structural analogues of one particular lipopeptide. 
6.4.1. The non-ribosomal peptide synthesis machinery 
Non-ribosomal peptide synthesis involves large multienzymatic proteins organized in 
modules, named non-ribosomal peptide synthetases (NRPSs), which are multi-modular 
enzymes that recognize, activate, modify and link the amino acid intermediates to the 
product peptide (Koglin & Walsh, 2009; Sieber & Marahiel, 2005). Additionally, they are 
capable of synthesizing peptides that incorporate unusual amino acids, including D-, β- 
and hydroxy- or N-methylated amino acids.  
a) Primary catalytic domains
The catalytic domains within the NRPSs modules can be classified into several different 
types. The four main types of domains include the adenylation (A), the thiolation (T) or 
peptidyl carrier protein (PCP), the condensation (C), and the thioesterase (TE), which 
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together comprise the minimal set of domains required for a fully working NRPS, creating 
a linear assembly (Figure 14). 
Figure 14. Overview of NRPS relationship between genes, modules and domains. Each 
gene is related with a single protein, which can then be prepared through one of more 
modules. These modules are organized into domains, represented here by colors (A, 
adenylation domain; C, condensation domain; PCP, peptidyl carrier protein and 
E, epimerisation domain). (Adapted from: Jenke-Kodama & Dittmann, 2009). 
The Adenylation (A) domain is responsible for the amino acid recognition and ATP-
dependent activation of an amino acid to form an acyl-adenylate intermediate. Then, the 
adenylated amino acid binds covalently to a phosphopantetheine carrier of the adjacent 
thiolation (T) or peptidyl carrier protein (PCP) domain. In addition, peptide bond formation 
of two consecutively amino acids is catalysed by the condensation (C) domain and 
modification domains such as the epimerization (E) catalyse the conversion of L-amino 
acids to D-isomers. Finally, cyclization and release of the product peptide are carried out 
by C-terminal thioesterase (Te) domain, which is associated with a termination module 
(Roongsawang et al., 2010). An example of this structured multi-modular complex is 
shown in Figures 14, 15 and 16. 
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Figure 15. General representation of biosynthesis and structure of surfactin (srf) operon. 
Assembly line of surfactin biosynthesis with condensation domains are colored in gray, 
adenylation domains in red and peptidyl carrier proteins in green. Epimerization domains 
are shown in blue, the thioesterase domain in orange. (Adapted from: Kraas et al., 2010). 
Figure 16. Surfactin biosynthesis by the Modular Peptide Synthetase. (A) The srf operon 
(top) presente three genes srfA-A, srfA-B, and srfA-C, which coded for surfactin 
synthetase subunits, shown below the genes. Bars indicate the module position within the 
protein, whereas the individual domains are shown as colored balls: A, adenylation 
domain; PCP, peptidyl carrier protein domain; C, condensation domain; E, epimerization 
domain; TE, thioesterase domain. 4′-phosphopantetheinyl cofactors with active thiol 
groups were shown with the corresponding peptides attached at their current synthesis 
states. The growing peptide chain is passed from left to right, until the linear product at the 
last PCP domain is cyclized to the lipopeptide by the TE domain. (B) The SNAC (S-N-
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acetyl cysteamine) acyl peptide can be cyclized by the genetically excised SrfTE domain. 
The native peptide (R = DLeu) and the soluble substrate (R = DOrn) are illustrated. 
(Adapted from: Bruner et al., 2002) 
b) Secondary catalytic domains
A second thioesterase domain can be also encoded within the NRPS gene cluster, and 
can be called type II thioesterases (TEII). It presents only 10% of sequence identity with 
the type I thioesterases and can be involved in the regeneration of carrier proteins that 
have been mis-acylated. In fact, as A-domains are specific to a substrate, there is a 
chance, depending on the selectivity of the A-domain, to load the wrong amino acid onto 
the carrier protein. If this occurs, as had been shown within the gene clusters of some 
NRPS such as surfactin (TEIIsr f) and bacitracin (TEIIbac), TEII are responsible for the 
hydrolysis of the misacylated thiol groups of the 4´-phosphopantetheine arm (Schwarzer 
et al., 2002). 
6.4.2. Diversity of NRPSs in Bacillus spp. 
Several gene clusters encoding NRPS for the biosynthesis of LPBSs in Bacillus spp., 
have been cloned and characterized (Figure 17). They present similarities in the modular 
architecture of their repetitive catalytic units and assembly-line mechanism, although 
some distinct unique features can be recognized. Characteristics of these LPBSs families 
and corresponding NRPSs are detailed in subsequent sections. 
104
Chapter 1 
Figure 17. Multidomain organization of the representative gene clusters encoding NRPSs 
in Bacillus spp. genes encompassing each peptide synthetase operon, including their 
sizes and organization within the modules. Surfactin, liquenysin, fengycin/plipastatin, 
mycosubtilin, Iturin A and bacillomycin D are represented. (Adapted from: 
Roongsawang et al., 2010). 
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6.4.2.1. Surfactin and Lichenysin Synthetases 
The surfactin (Cosmina et al., 1993) and lichenysin (Konz et al., 1999) biosynthetic gene 
clusters, particularly srfA and lic, are highly homologous and presented 25 kb (Fig. 7). 
They enclose four open reading frames (ORFs), srfA-A/licA, srfA-B/licB, srfA-C/licC, 
and srfA-Te/lic-Te. Moreover, amino acid sequences of the first three ORFs are 
homologous to other NRPSs, whereas the last ORF encodes a putative type II-Te. SrfA 
and Lic carry six typical C-domains that catalyse amide bond formation. SrfA and Lic 
encompass the conventional E-domains essential for the transformation of L-amino acids 
into D-amino acids and also a C-terminal type I Te-domain that releases the final product. 
In addition to the C-terminal type I Te-domain, SrfA and Lic have an external type II Te 
protein, SrfA-Te/LicTe. This protein is involved in regenerating misprimed T-domains by 
removing short acyl chains from the 4′-phosphopantetheine cofactors and thereby 
regenerates functional NRPSs (Schwarzer et al., 2002). Moreover, (Yeh et al., 2004) 
suggested that the type II Te also hydrolyzes incorrectly loaded amino acids, which are 
not processed by the nonribosomal machinery (Yeh et al., 2004). Additionally, SrfA-Te 
also functions as the thioesterase/acyltransferase that supports and stimulates the 
formation of β-hydroxymyristoyl-glutamate, an initiation substrate of surfactin synthesis 
(Steller et al., 2004; Menkhaus et al., 1993). 
6.4.2.2. Fengycin Synthetase 
Fengycin, is also referred as plipastatin when Tyr is present in positions 3 and 9, as the L-
and D-form, respectively. Fengycin forms a lactone between the hydroxyl group of L-
Tyr3 and C-terminal carboxyl group of L-Ile. Fengycin synthetase (Fen) contains five 
NRPS subunits, namely, fenC (287 kDa), fenD (290 kDa), fenE (286 kDa), fenA (406 
kDa), and fenB (146 kDa), which are ordered accordingly (FenC-FenD-FenE-FenA-FenB). 
Like SrfA and Lic, Fen is also composed of an N-acyl domain at the N-terminus of fenC, 
commonly E-domains, and also presents a typical type I Te-domain (Leclère et al., 2006) 
(Figure 17).  
6.4.2.3. Iturin, Bacillomycin and Mycosubtilin Synthetases 
Iturin family encompasses the cyclic lipoheptapeptides iturin, bacillomycin, and 
mycosubtilin. NRPS gene cluster of bacillomycin D (bam/bmy), mycosubtilin (myc), and 
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iturin A (itu) are composed by four large ORFs (Figure 17) (Koumoutsi et al., 
2004; Moyne et al., 2004; Duitman et al., 1999; Tsuge et al., 2001a). 
bam and bmy present identical gene clusters, which encode multifunctional hybrid 
enzymes of a fatty acid synthase, an aminotransferase and a peptide synthetases. 
Moreover, the first ORF-bmyD, ituD, and fenF encodes a malonyl-CoA transacylase, and 
the second ORF-bmyA, ituA, and mycA encode the acyl-CoA ligase, an acyl carrier 
protein (ACP), a β-ketoacyl synthetase and an aminotransferase domain, before the 
conventional module of NRPS (Aron et al., 2007; Hansen et al., 2007; Aron et al., 2005). 
Mycosubtilin and iturin A present the same structure except that D-Ser6 and L-
Asn7 residues in mycosubtilin molecules are replaced by D-Asn6 and L-Ser7 in iturin A 
(Tsuge et al., 2001a). 
6.4.3. Gene Regulation in Bacillus spp. 
Two component systems and quorum sensing play an important role in gene regulation of 
LPBSs produced by Bacillus spp. (Duitman et al., 2007; Sullivan, 1998). Among all, the 
surfactin biosynthesis system is the most extensively studied. The expression of surfactin 
genes is associated with increased cell density and occurs mainly in the transition from 
exponential to stationary growth phase, whereas in the expression of fengycins and iturin 
genes occurs usually later in the stationary phase (Mulligan et al., 2014). 
Generally, in the surfactin biosynthesis system, the expression of the gene srfA is 
controlled by several peptide pheromones, which include ComA/ComP, the cell-density 
dependent pheromone ComX, and the phosphatase RapC (Magnuson et al., 1994). 
Bacillus subtilis encodes eight Phr peptides (PhrA, PhrC [CSF], PhrE, PhrF, PhrG, PhrH, 
PhrI, and PhrK) also referred as the competence stimulating factors, and 11 aspartyl-
phosphate phosphatase proteins (RapA to RapK). Each Phr peptide inhibits the activity of 
the co-transcribed Rap protein. Moreover, RapC, RapF and RapK act as negative 
regulators of srfA (Auchtung et al., 2006) and ComX interacts with the membrane-bound 
histidine kinase ComP, which auto-phosphorylates upon stimulation and consequently 
transfers its phosphate to a serine residue in the response regulator ComA. The 
phosphorylated ComA binds to promoter region of srfA, particularly in ComA boxes 
(T/GCGG-N4-CCGCA) located upstream of the srfA promoter and thus initiates 
transcription of srfA (Yakimov & Golyshin, 1997; Roggiani & Dubnau, 1993).  
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The complexity of the regulatory network is further exemplified by the observation that 
expression of the srf genes is also modulated by other transcription factors such as DegU 
(Mäder et al., 2002) or the H2O2 stress-responsive PerR (Hayashi et al., 2005), both 
acting as positive regulators. Additionally, overexpression of RapD, RapG, and RapH 
inhibits srfA transcription, and production of these Rap proteins is suppressed by RghR 
(Ogura & Fujita, 2007; Hayashi et al., 2006). Mutation in sodA, which encodes 
superoxide dismutase, inhibits transcription of the comQXP quorum-sensing locus, 
thereby preventing srfA expression (Ohsawa et al., 2006). Moreover, at high 
concentrations of the amino acids Ile, Leu, and Val, CodY represses transcription 
of srfA byinteracting specifically with the srfA promoter (Serror & Sonenshein, 1996). 
Similar to CodY, AbrB also negatively regulates srfA transcription. Expression of srfA is 
also repressed by the RNA polymerase-binding protein Spx (Nakano et al., 2003). On the 
other hand, the Spx-RNA polymerase interaction is required for positive transcriptional 
control of genes in response to thiol-oxidative stress (Reyes & Zuber, 2008).  
Furthermore, 4′-phosphopantetheinyl transferase (Sfp/PPTase) encoded by the sfp gene 
located downstream of srfABCD (Steller et al., 2004) is required for the activation of SrfA 
enzymes by converting the inactive apo-forms of the T-domains to the active holo-forms 
(Quadri et al., 1998). An acyltransferase SrfA-Te is also required in the initial step of 
transferring a hydroxyl fatty acid to the first amino acid in the peptide. Finally, the surfactin 
self-resistance protein, YerP, is required for surfactin exportation (Tsuge et al., 2001b). An 
overview of this mechanism is shown in Figure 18. 
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Figure 18. Overall model of gene regulation involved in surfactin biosynthesis. Closed-
head arrows indicate positive regulation whereas closed circles indicate 
negative regulation. (Adapted from: Roongsawang et al., 2010). 
The regulation of fengycin/plipastatin genes is positively controlled by DegQ, an enhancer 
of extracellular protease production (Tsuge et al., 1999) in which, degQ is the regulatory 
gene that controls the production of several hydrolytic enzymes (Msadek et al., 1991). 
Moreover, a Sfp-like protein, Lpa-8, is also required for plipastatin production in B. 
subtilis YB8 (Tsuge et al., 1996).  
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Gene regulation of the iturin family was first demonstrated within mycosubtilin-
producing B. subtilis ATCC6633. Expression of the myc operon is independent of ComA, 
but still appears to be regulated via quorum sensing, since PhrC strongly stimulates 
expression. Moreover, sigma H factor, Spo0H, also influences expression of 
the myc operon. Transition state regulator AbrB represses expression of myc, since 
deletion of abrB culminate in the increased of myc expression (Duitman et al., 2007).  
6.5. Natural functions of LPBSs 
LPBSs influence the ecological fitness of the procucer bacterial strain, being important for 
their establishment in a specific environment (Ron and Rosenberg 2001). Therefore, the 
main physiological role of biosurfactants is to support the growth of microorganisms on 
water-immiscible substrates by reducing the surface tension at the phase boundary 
making the substrate more readily available for uptake and metabolism.  
6.5.1. Antagonism 
It has been proposed that, in natural habitats, lipopeptides may confer a competitive 
advantage in interactions with other microorganisms. When tested in vitro, biosurfactants 
produced by Bacillus spp., exhibit lytic and growth-inhibitory activities against a broad 
range of microorganisms, including viruses, mycoplasmas, bacteria, fungi and oomycetes 
(Raaijmakers et al., 2010). (This specific topics will be further discussed in sub-section 
6.6) 
6.5.2. Motility 
Movement of bacteria on surfaces has been extensively studied in vitro and several 
distinct forms have been recognized, which include swimming, swarming and twitching 
(Harshey, 2003; Henrichsen, 1972). By changing the viscosity of surfaces, biosurfactants 
can influence cell differentiation and motility. Nevertheless, no comprehensive studies 
concerning the influence of lipopeptides produced by Bacillus spp. in motility have been 
performed (Allison et al., 1993; McCarter & Silverman, 1990).  
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6.5.3. Plant pathogenesis and induction of systemic resistance 
Recent studies have also shown that some lipopeptides have beneficial effects on plants, 
throughout the stimulation of the plant immune system. Indeed, purified fengycins and 
surfactins, but not iturins, induced significant protection in bean and tomato leaves against 
the fungal pathogen Botrytis cinerea (Ongena et al., 2007). Moreover, Wang et al., and 
Kim et al., (Kim et al., 2007; Wang et al., 2007) showed that some lipopeptides from 
nonpathogenic Bacillus species can be perceived by plants to trigger a defense response. 
Nevertheless, to further exploit these potential beneficial effects, knowledge about the 
structural features and constituents of lipopeptides involved is required. 
6.5.4. Biofilm formation and development 
The attachment of single bacterial cells to surfaces and, after cell division and 
proliferation, the formation of dense aggregates by the secretion of polymers as 
polysaccharides and proteins results in a structure known as biofilm (Stewart & Franklin, 
2008). The extracellular matrix of the biofilm protects bacteria against adverse 
environmental conditions (Hall-Stoodley et al., 2004), and biofilms can also provide 
protection against protozoa predation and are a niche for horizontal gene transfer 
(Danhorn & Fuqua, 2007).  
In the case of Bacillus spp., LPBSs play an important role in surface attachment and 
biofilm formation, although the effect may vary according to the type of lipopeptide, which 
could be partially attributed to differences in their physicochemical properties and to the 
potential effects of these compounds on hydrophobicity of the cell surface and/or in the 
substratum. Hofemeister et al. (Hofemeister et al., 2004) showed that surfactin was 
required for biofilm formation of B. subtilis strain A1/3, where the production of the 
lipopeptide appears important but not always sufficient for pellicle formation, as observed 
in a comparative study of five different B. subtilis strains (Chollet-Imbert et al., 2009). A 
crucial role for surfactin has also been demonstrated in the formation of aerial fruiting 
bodies that represent another type of structured bacterial communities (Branda et al., 
2001). 
Taking into account the great structural diversity of LPBSs described, differences in 
hydrophobicity, cell surface charge, substratum, ionic conditions of pH the role of 
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particular molecules in biofilm formation may be distinct (de Bruijn et al., 2008; Neu, 
1996). 
Surfactin can also act as a signalling molecule in triggering cannibalism and matrix 
formation in biofilms (López et al., 2009a; López et al., 2009b). Thus, biofilm formation 
was stimulated by surfactin and also by other molecules that cause potassium leakage, 
whereas other compounds as iturin failed to induce multicellularity (López et al., 2009a). 
Moreover, Lopez et al. (López et al., 2009b) showed that the cannibal/matrix-producing 
can also be created in response to antimicrobial compounds produced by other 
microorganisms. Based on these findings, they hypothesized that other organisms, which 
produce compounds that mimic the action of surfactin, may activate toxin production and 
biofilm formation in B. subtilis as a defense mechanism (López et al., 2009b).  
These compounds may also adversely influence the attachment to surfaces and biofilm 
formation by other microorganisms, suggesting that lipopeptides may unfavorably affect 
the early stages of biofilm formation and, in some cases, can suppress existing biofilms of 
other microorganisms (Fracchia et al., 2012). 
6.5.5. Chelation of metal ions and degradation of xenobiotics 
Chelation of metal ions has been described for several biosurfactants, including 
lipopeptides and rhamnolipids. Actually, the capacity for lipopeptides chelation can be 
affected by structural changes. For example, for surfactin, it was shown that when the 
leucine at position 2 was substituted by isoleucine, a threefold increase in affinity for Ca2+ 
occurred, possibly by an increase in accessibility of the acidic side chains and carboxylate 
groups that organize the calcium-binding site (Grangemard et al., 1997). Additionally, 
binding of surfactin to Ca2+ resulted in a conformational change of the peptide moiety 
allowing its incorporation into a phospholipid bilayer (Maget-Dana & Ptak, 1995). The 
actual functions of LPBSs in relation to metal chelation and degradation of xenobiotics are 
not clear, and even the benefits to the producing bacteria need to be clarified. Possible 
hypothesis are: i) a protective role due to chelation of metal ions; ii) bacteria use the 
biosurfactants for sequestering specific metal ions as micronutrients. With respect to the 
degradation of xenobiotics, lipopeptides and other biosurfactants may provide access to 
persistent aromatic compounds with low solubility in water and use these compounds as 
carbon and/or nitrogen sources (Ron & Rosenberg, 2002).  
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6.6. Applications of LPBSs 
6.6.1. Lipopeptides in pharmaceutical industry 
The rapid increase and incidence of bacterial infections, particularly of multidrug resistant 
(MDR) bacteria, renewed the interest in the development of novel antibiotics for infection 
control purposes (Mandal et al., 2013). Nature and its huge biodiversity seems to be an 
endless source of compounds containing unique chemical structures, some of them 
having been exploited for this purpose. However, their commercial exploitation depends 
largely on a cost-effective production and demonstration of low toxicity. The most well-
studied biosurfactant (surfactin) has been highlighted for different applications (Figure 19). 
Figure 19. Application sector and exploited properties of surfactin. 
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A high number of scientific publications and patents have been developed but its 
application as an antibacterial agent is slowered by high production costs and also the 
suspected toxicity (From et al., 2007). Thus, this section will focus on the application of 
biosurfactant agents produced by Bacillus spp. in a pharmaceutical overall perspective. 
Lipopeptides present potent antibacterial activity due to the ability of these molecules to 
self-associate and form a pore-bearing channel or micellar aggregate inside the lipid 
membrane (Deleu et al., 2008). Previously identified lipopeptides and their presumptive 
activity for microbial infection control are summarized in Table 8 and Table 9. 
Surfactin, in particular, acts non-specifically causing membrane disruptions on both Gram-
positive and Gram-negative bacteria (Lu & Mosier, 2007), which has recently been 
suggested as the next generation of antibiotics (Rodrigues & Teixeira, 2010).  
Similar bioactive fractions from the marine B. circulans, present antimicrobial activity 
against various Gram-positive and Gram negative pathogens, including Micrococcus 
flavus, B. pumilis, Mycobacterium smegmatis, Acinetobacter calcoaceticus, 
Bordetella bronchiseptica and several Enterobacteriaceae species (Das et al., 2008).  
In addition to surfactin, B. subtilis strains produce other bioactive peptides (fengycin and 
iturin families) with great potential of antimicrobial activity, namely iturin A (Besson et al., 
1978; Peypoux et al., 1978; Peypoux et al., 1984), mycosubtilin (Peypoux et al., 1986) 
and bacillomycin (Peypoux et al., 1984), all of which membrane-active agents.  
Lichenysin, pumilacidin and polymyxin B (Landman et al., 2008; Grangemard et al., 2001; 
Yakimov et al., 1995;  Naruse et al., 1990; ) are other examples of antimicrobial 
lipopeptides produced by B. licheniformis, B. pumilus and B. polymyxa, respectively. 
Polymyxin B, in particular, due to its high affinity to the lipid moieties of 
lipopolysaccharide, presented antibacterial activities against a wide range of Gram-
negative pathogens (Landman et al., 2008). Being a cationic agent, it binds to the anionic 
bacterial outer membrane, leading to a detergent effect that disrupts membrane integrity.  
Another promising example of an antimicrobial lipopeptide that is under commercial use is 
daptomycin (Cubicin®), with applications in the treatment of skin infections (Seydlová & 
Svobodová, 2008). Moreover, Daptomycin, produced by Streptomyces roseosporus has a 
potent activity against clinically-relevant methicillin-resistant Staphylococcus aureus 
(MRSA), vancomycin-resistant Enterococci (VRE), glycopeptide-intermediate-
susceptible S. aureus (GISA), coagulase-negative Staphylococci (CNS), and penicillin-
resistant Streptococcus pneumoniae (PRSP) pathogens (Tally et al., 1999). In addition, 
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glycolipids, both rhamnolipids (Benincasa et al., 2004) and sophorolipids (Van Bogaert et 
al., 2007) have also shown remarkable antimicrobial activities particularly against B. 
subtilis (Benincasa et al., 2004), B. cereus, S. aureus, Micrococcus luteus, Mucor miehei 
and Neurospora crassa (Nitschke et al., 2010) and also MRSA (Mimee et al., 2009). 
Studies also showed that surfactin has an anti-mycoplasma activity  allowing the specific 
inactivation of mycoplasmas contaminating mammalian cells, without significantly 
damaging effects on cell metabolism (Fassi et al., 2007; Kumar et al., 2007; Vollenbroich 
et al., 1997). It has also been shown that this compound exhibit a synergistic effect in 
combination with enrofloxacin, which resulted in mycoplasma-killing activity of about two 
orders of magnitude greater when compared with the molecules used separately (Fassi et 
al., 2007). 
Caspofungin (Arendrup et al., 2012; Letscher-Bru & Herbrecht, 2003), pneumocandin 
(Schwartz et al., 1988), aculeacin (Mizuno et al., 1977) and other related compounds have 
been associated with antifungal activities (Hino et al., 2001). Other lipopeptides presenting 
this function  include ciclic lipopetides (surfactin, iturin and fengycin) (Chen et al., 2009; 
Kim et al., 2010; Snook et al., 2009) and glycopeptides (cellobiose lipids and 
rhamnolipids) (Banat et al., 2010). 
Surfactin and its analogues also present a strong antiviral activity (Naruse et al., 1990), 
especially against enveloped viruses (retroviruses and herpes viruses), suggesting that 
this activity may be due to the formation of ion channels on the virus envelope, and 
consequently the lost of viral proteins (Seydlová & Svobodová, 2008; Jung et al., 2000). 
Additionally, in vitro experiments showed that surfactin and fengycin produced by a B. 
subtilis strain were able to inactivate cell-free virus of porcine parvovirus, pseudorabies, 
newcastle disease and bursal disease and, which could effectively inhibit its infection and 
replication (Huang et al., 2006). 
In addition, few peptides are already marketed as vaccines. In fact, most of them 
are applied in HIV immunization, combining an HIV derived peptide and a lipid tail 
(Rizos et al., 2007; Durier et al., 2006). Moreover, Monash Institute of Pharmaceutical 
Sciences has recently developed a novel lipopeptide antibiotic to target Gram-
negative multi-drug-resistant bacteria, promising to be less apoptopic than polymyxins 
and with a longer half-life (patent no. PCT/AU2010/000568). 
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Different studies have also demonstrated that particular lipopeptides (mainly surfactins) 
have anti-inflamatory, anti-tumoral or immuno-modulatory properties (Cao et al., 2010; 
Park et al., 2010; Park & Kim, 2009; ). The anti-inflamatory activity has been associated 
with oxid nitric induction and reduction of pro-inflammatory cytokines, including tumor 
necrosis factor-α and interleukin (IL)-1β, IL-6 and IL-12 (Byeon et al., 2008; Park et al., 
2010). The anti-tumoral activity is related with the involvement of lipopeptides in signal 
transduction, cell differentiation and cell immune responses, having been demonstrated 
that surfactin induces apoptosis in human breast cancer (Cao et al., 2011; Osada, 1998). 
Moreover, Park et al. (2009) also demonstrated a potent immunosuppressive capability for 
surfactin, which suggests an important therapeutic implication to transplantation and also 
to autoimmune diseases, including allergy, arthritis and diabetes (Park & Kim, 2009). 
The colonization of medical or prostheses with microbial biofilms is a hazardous 
occurrence, particularly if the bacteria become highly resistant to antibiotic, since they 
can seriously compromise antimicrobial therapy (Morikawa, 2006).  
Several reports have suggested that, in addition to their direct action against 
pathogens, biosurfactants are able to interfere with biofilm formation, modulating 
microbial interaction with interfaces (Rodrigues et al., 2007; Rasmussen & Givskov, 
2006; Rodrigues et al., 2006b; Rodrigues et al., 2006c; Merk et al., 2005; Federle & 
Bassler, 2003;  Neu, 1996; ), which seems to be an attractive alternative to more 
conservative approaches (coating of medical surfaces with antimicrobial agents) 
(Basak et al., 2009; von Eiff et al., 2005). Indeed, biosurfactants have the 
advantages of precisely target biofilm growth, while causing no adverse toxicity in the 
environment. 
Surfactin, for example, has shown to be an important biofilm controlling agent, able 
to inhibit biofilm formation of Salmonella Typhimurium, Salmonella enterica, E. coli 
and Proteus mirabilis in polyvinyl chloride wells, as well as vinyl urethral catheters 
(Mireles et al., 2001).
A recent study showed that two lipopeptide biosurfactants produced by B. subtilis V9T14 
and B. licheniformis V19T21, evidenced the capacity to selectively inhibit biofilm formation 
of S. aureus ATCC 29213 and E. coli CFT073 on polystyrene surfaces (Rivardo et 
al., 2009). Chemical characterization of V9T14 lipopeptide biosurfactant carried out by 
Liquid Chromatography – Electrospray Tandem Mass Spectrometry (LC/ESI-MS/MS) 
revealed that it was composed of 77% of surfactin and of 23% of fengycin (Pecci et al., 
2010). In another study, the V9T14 biosurfactant in association with some 
antibiotics led to a synergistic increase in the efficacy of antibiotics against E. coli 
CFT073 biofilm inhibition and, in some combinations, to the total eradication of the 
uropathogenic strain biofilm producer (Rivardo et al., 2011). 
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Moreover, bioproducts recovered from marine B. pumilus and B. indicus significantly 
inhibited the initial attachment process and biofilm formation of mature biofilms of 
Vibrio spp. strains (Nithya & Pandian, 2010).  
Thus, anti-adhesive activity of biosurfactants against several pathogens highlights their 
potential applicability as coating agents for medical insertional materials, which 
can contribute to a reduction in a large number of nosocomial infections avoiding the 
use of synthetic drugs and/or chemicals. 
Lipopetides can also be used in the context of drug delivery due to their properties of 
detergency, emulsification and foaming (Faivre & Rosilio, 2010). Recently, fengycin and 
surfactin were successfully used in the increasing of aciclovir concentration in the 
epidermis (Nicoli et al., 2010). Moreover, microemulsions of water/oil/surfactant are being 
explored as liquid vehicles for future drug delivery systems due to its long-term stability, 
easy preparation and high solubilization capacity (Date & Nagarsenker, 2008). 
Gene transfection into the cells is a fundamental technology not only for molecular and 
cellular biology processes but also for clinical gene therapy (Mulligan et al., 2014). 
Although several methods for gene transfection have been investigated (Mulligan et al., 
2014), More efficient and safe systems are desirable for gene transfection (Ueno et al., 
2007), and lipofection (based on the use of liposomes) is considered a promising method 
for introduction of a foreign gene into the targeted cells (Nakanishi, 2003; Inoh et al., 
2001). In fact, glycolipids have received particular attention in this area, when compared 
with lipopepides produced by Bacillus spp. (Ueno et al., 2007; Igarashi et al., 2006; Inoh 
et al., 2001) reported that MEL-A promoted DNA transfection efficiently by induction of 
membrane fusion between the target cells and the cationic liposomes. 
In addition to the known antimicrobial agents comprising low molecular weight 
antimicrobial substances and bacteriocins, probiotics have long been known for their 
ability to interfere with the adhesion and formation of pathogen biofilms to epithelial cells 
of urogenital and intestinal tracts (Reid et al., 2001) by releasing of surface active 
molecules (Gudiña et al., 2010; Rodrigues et al., 2006b; Rodrigues et al., 2006c). 
Several studies pointed out that probiotic microorganisms (mainly Streptococcus 
thermophilus and Lactobacillus spp. strains) and their biosurfactants may antagonize 
the growth and the development of potentially pathogenic microorganisms 
including S. aureus, S. epidermidis, Streptococcus spp., E. faecalis, Candida 
albicans, Candida tropicalis (van Hoogmoed et al., 2000; Busscher et al., 1997).  
Thus, considering their importance for human health and their recognized safety, probiotic 
organisms may represent a safe and effective intervention for infection control purposes. 
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Probiotics themselves or their products (biosurfactants), could be applied to patient care 
equipment, such as tubes or catheters, with the aim of decreasing the colonization of 
these sites by nosocomial pathogens and potentially impede a central step in the 
pathogenesis of nosocomial infections (Falagas & Makris, 2009). 
Table 8. List of identified active lipopeptides produced by Bacillus, which can be used for 
infection control purposes. 
Lipopeptides Source Activity Reference 
Surfactin 
B. subtilis 
Enterococcus faecalis ATCC 
2912 
Lactococcus garviae KCCM 
40698 
Streptococcus parauberis DSM 
6631 
Flexibacter tractuosus ATCC 
23168 
Vibrio harveyi ATCC 14126 
Kim et al., 2009 
Mycosubtilin Micrococcus luteus Peypoux et al., 1979 
Fusaricidin A 
MRSA  
S. aureus  
S. epidermidis  
Vancomycin-resistant E. faecium 
Stawikowski & Cudic, 
2009 
Lichenycin 
Corynebacterium variabiliss 
Acinetobacterr sp. 
Nerurkar, 2010 
Bacillomycin D Antifungal (Sclerotinia sclerotiorum) Kumar et al., 2012 
Iturin A Antifungal (Fusatium oxysporum) 
Thimon et al., 1995 
Yuan et al., 2011  
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Table 9. Recent patents on lipopeptide as infection control agents. 
Patent no. Year Patent Name Source Inventors 
US 
2011/0224129 
A1 
2011 Lipopeptide compounds and their use Modified friulimicin Boyce et al. 
US 
2011/0030103 
A1 
2011 Lipopeptides and lipopeptide synthetases 
Engineered lipopeptide 
synthetase polypeptide Reznik et al. 
US 7868135 B2 
2011 
Composition of lipopeptide antibiotic 
derivatives and methods of use 
thereof 
Amphomycin or 
aspartocin derivative 
Cameron et 
al. 
US 7795207 B2 2010 Lipopeptide compositions Cyclodextrin derivatives 
Labischinski 
et al. 
US 
2010/0184649 
A1 
2010 Novel antibacterial agents for the treatment of Gram-positive infections 
Isolated combined 
compounds 
MetCalf,III et 
al. 
US 7671011 B2 2010 Antimicrobial and anticancerlipopeptides Conjugate lipopeptide Shai et al. 
US 7655623 B2 
2010 
Dab9 derivatives of lipopeptide 
antibiotics and methods of making 
and using the same 
Synthetic amphomycin-
type Fardis et al. 
US 
2009/0233870 
A1 
2009 Antimicrobial peptides Synthetic Blondelle et al. 
US 
2009/0202519 
A1 
2009 
Compositions and methods for 
treating Gram positive bacterial 
infection in a mammalian subject 
Synthetic Beutler et al. 
US 7408025 B2 2008 Lipopeptides as antibacterial agents Synthetic Hill et al. 
US 6911525 B2 2005 Lipopeptides as antibacterial agents Synthetic Hill et al. 
US 6750199 B2 2004 Antimicrobial sulfonamide derivativesof lipopeptide antibiotics Lipopeptide derivatives Curran et al. 
US 6696412 B1 
2004 
High purity lipopeptides, lipopeptides 
micelles and processes for preparing 
same 
Daptomycin Kelleher et al. 
US 6624143 B1 
2003 
Calcium salts of lipopeptide 
antibiotics, method for producing 
same and their use 
Synthetic Vértesy et al. 
US 6511962 B1 2003 Derivatives of laspartomycin andpreparation and use thereof Laspartomycin Borders et al. 
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6.6.2. Lipopeptides in cosmetic industry 
In the last few decades, several lipopeptides have been extensively used in the cosmetics 
industry due to their exceptional surface properties, presenting anti-wrinkle and 
moisturizing activities on human skin (Kanlayavattanakul & Lourith, 2010). Moreover, they 
are also characterized by their capacity of  stimulate the producing new collagen and 
elastin and their antioxidant properties (Singh & Cameotra, 2004b) delaying lipid 
peroxidation, in addition to the healthy skin physiology support, with potential application 
in types of facial cosmetics and lotions. Nevertheless, few cosmetic companies have 
already developed and marketed their lipopeptide-formulated products that directly help to 
stimulate collagen and elastin production as anti-aging agents (Kanlayavattanakul & 
Lourith, 2010) due to their high production cost.  
Surfactin has received greatest attention due to its low CMC value and consequent 
suitability for topical dermatological application (Kanlayavattanakul and Lourith, 2010). In 
fact, these compounds have attested safe application and minor irritation to human skin 
being used in dermatological products and in cleansing cosmetics (Kanlayavattanakul & 
Lourith, 2010).  
To expand biotechnology to a profitable industry, in the future, genetic manipulation of 
organisms should be essential for high yield and high quality production of lipopeptides. 
6.6.3. Lipopeptides in food industry 
In the food industry, lipopeptides are mainly used as emulsifiers in the processing of raw 
materials and as preservatives during processing step to avoid microbial pathogenic 
spoilage. Among bio-preservatives, several antimicrobial compounds (more than 
500) have been accepted to effectively control food pathogens (Stein, 2005; Ricca et al., 
2004). Nevertheless, the use of these antimicrobial compounds as food preservatives, 
proteins and/or peptides, are limited due to their sensitivity to proteases. Iturins, 
fengycins and surfactins families are known as protease resistant, exhibiting strong 
growth inhibition of a wide range of pathogens (Touré et al., 2004). Notwithstanding, 
in the baking industry, surfactins and rhamnolipids are also used to maintain stability, 
texture, and volume, and also to help in the emulsification of fat tissue in order to 
control fat globule agglomeration (Campos et al., 2013). 
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Additionally, biosurfactants can have also benefit on its use as pre-treatment of material 
surfaces found in food-processing environments. In fact, pathogenic bacteria implicated in 
food-borne illness outbreaks are able to form biofilms on food contact surfaces that are 
more resistant to sanitation than free-living cells (Kim et al., 2006; Stepanovic et al., 
2004; Kalmokoff et al., 2001). Thus, pre-conditioning surfaces using microbial surface-
active compounds may be an interesting strategy for preventing the adhesion of 
food-borne pathogens to solid surfaces. Recently, Nitschke et al., (Nitschke et al., 2009) 
investigated the effect of rhamnolipid and surfactin biosurfactants on the adhesion 
of the food pathogens Chronobacter, Listeria monocytogenes and S. enteritidis to 
polypropylene and stainless steel surfaces (Nitschke et al., 2009) and concluded that 
preconditioning with surfactin, rather than rhamnolipid, caused a reduction in the 
number of adhering cells particularly of L. monocytogenes and Chronobacter on 
stainless steel. Thus, lipopeptides satisfy several characteristics of beneficial additives 
for emulsifying, antiadhesive, and antimicrobial activities which suggest their 
application as multipurpose ingredients, additives or even in developing strategies to 
prevent or delay microbiological colonization of industrial plant surfaces used in foodstuffs 
preparation.  
6.6.4. Lipopeptides in biotech and nanotech industry 
In a market where biosurfactants production is highly expensive, efforts have been 
conducted with special emphasis on the utilization of various cheap agro-industrial 
substrates and large-scale production (Mulligan et al., 2014; Winterburn & Martin, 2012) 
for their management of cost-effective production. In this context, some efforts have been 
made to genetically manipulate or alter the lipopeptide structure to selectively enhance 
antimicrobial activities (Koglin et al., 2010) and reduce their production cost. Lipopeptides 
can also be used in  the synthesis of metal-bound nanoparticles as an alternative 
environmentally friendly technology (Sharma et al., 2009; Ariga et al., 2007; Shimizu et 
al., 2005) due to their ability to self-assemble into hierarchically ordered structures. 
Reddy et al. (Reddy et al., 2009) successfully synthesized surfactin-mediated gold 
and silver nanoparticles using B. subtilis. According to the authors, nanoparticles were 
stabilized by the surface-active molecules i.e., surfactin or other biomolecules released 
into the solution by B. subtilis. 
Surfactin produced by B. amyloliquefaciens KSU-109 was also used for the synthesis of 
cadmium sulfide nanoparticles which remained stable up to six months without 
compromising their functionality (Singh et al., 2011). This kind of molecules works as 
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semiconductors with unique optical properties and unable photo-luminescence, allowing 
potential applications in solar energy conversion, nonlinear optical, photoelectrochemical 
cells and heterogeneous photocatalysis (Singh et al., 2011). Such simple, inexpensive 
and environmental friendly procedure of obtaining surfactin offers a further advantage of 
use in nano-biotechnology for the large-scale production of highly stable metal 
nanoparticles.  
Moreover, some potential therapeutic applications of these compounds have been 
exploited and include anti-HIV, anti-angiogenesis, antimalarial, anti-arthritic, anti-fungal, 
anti-inflammatory, anti-viral, anti-angiogenesis and anti-platelet activities (Mulligan et al., 
2014). 
6.6.5. Environmental application 
Organic and/or inorganic chemical contaminants are highly stable in soil , preventing its 
remediation and influencing negatively the living organisms (Mulligan et al., 2001b) 
(Mulligan & Yong, 2004). The use of biosurfactants can improve bioremediation 
effectiveness of hydrocarbon contaminated environments, by the increase of the 
hydrocarbon bioavailability for microorganisms, and/or by its interaction with the bacterial 
cell surface, allowing the association of hydrophobic substrates with bacterial cells 
(Mulligan & Gibbs, 2004). On the other hand, heavy metal contaminated soil 
bioremediation by biosurfactant activity seems to be associated with the ability to form 
complexes with metals and with chelation properties (Aşçı et al., 2008; Juwarkar et al., 
2007; Mulligan & Gibbs, 2004; Mulligan et al., 2001b; Singh & Cameotra, 2004a). 
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Chapter 2 
2.1. Phylogenetic and clonality analysis of Bacillus pumilus group members 
Publications: 
Phylogenetic and clonality analysis of Bacillus pumilus isolates uncovered a highly 
heterogeneous population of different closely related species and clones 
In this study, throughout phylogenetic analysis of a comprehensive collection of Bacillus 
pumilus isolates we demonstrate that most of them are misnamed, belonging to Bacillus 
safensis or to Bacillus altitudinis. The results obtained also uncovered habitats and a 
human health or biotechnological relevance of B. safensis and B. altitudinis previously 
reported to Bacillus pumilus, e.g. human and animal probiotic and plant growth promoter. 
Moreover, for the first time we demonstrated the genomic plasticity of these species, 
which can justify their widespread and adaptation capacity to different niches.  
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Abstract  
 
Bacillus pumilus is a Gram-positive bacterium with a wide range of attributed applications, 
namely as a plant growth promoter, animal and human probiotic. Although rarely, a 
putative role in human diseases, namely in food poisoning or as anthrax-like cutaneous 
infectious agent, has also been reported. This species is difficult to distinguish from its 
closely related species on the basis of phenotypic or biochemical characteristics and 16S 
rRNA gene sequences. In this study, by phylogenetic analysis of gyrB and rpoB gene 
sequences of a collection of previously identified B. pumilus isolates, we demonstrated 
that most (93%, 38 of 41 isolates) of them belong to B. safensis or to B. altitudinis. 
Moreover, we extend the recognized habitats and unveil a human health or 
biotechnological relevance (e.g. as PGPR or implicated in food poisoning) of B. safensis 
and B. altitudinis. Additionally, we demonstrated that these species encompasses a 
clonally diverse population, which can justify their great adaptation ability to different 
niches, with evidence of a particular clonal host specificity.  
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Introduction  
 
Currently, the polyphyletic Bacillus genus is grouped in six taxa based on phenotypic 
characteristics and on 16S rRNA gene (Stackebrandt et al., 2008). Indeed, it has been 
subjected to frequent restructuration’s with the continuous recognition of new species 
(Shivaji et al., 2006; You et al., 2013; Liu et al., 2013; Lai et al., 2014). One of the groups 
that has been suffering constant taxonomic adjustments is RNA group I, to which belong 
Bacillus pumilus group species (Earl et al., 2008; Jeyaram et al., 2011). Members of this 
last group encompass B. pumilus, the first species described, Bacillus safensis, Bacillus 
altitudinis, Bacillus stratosphericus, Bacillus aerophilus and Bacillus xiamenensis (Satomi 
et al., 2006; Liu et al., 2013; Lai et al., 2014).  
The ubiquity of B. pumilus group species range from diverse terrestrial and marine 
settings (Satomi et al., 2006; Freitas et al., 2008; Liu et al., 2013; Lai et al., 2014), and air 
of high altitudes (Shivaji et al., 2006), with spores production capacity pointed out as the 
crucial condition to facilitate their adaptation into different ecological niches (Stackebrandt 
et al., 2008). 
A wide range of applications has been attributed to B. pumilus, including animal and 
human probiotics (Sanders et al., 2003; Hong et al., 2005; EFSA 2011), phytosanitary 
products (Pérez-García et al., 2011) or plant growth promoters (Joo et al., 2004). 
Although rarely, B. pumilus has been also associated with food poisonings and human 
infections including anthrax-like cutaneous lesions (Castagnola et al., 2001; Haymore et 
al., 2006; Ozkocaman et al., 2006; Bentur et al., 2007; From et al., 2007; Tena et al., 
2007; Johnson et al., 2008). Contrastingly, there is scarce data regarding the relevance 
of remaining B. pumilus group species (Agbobatinkpo et al., 2013, Ahaotu et al., 2013).  
Despite significance of the B. pumilus, there are no comprehensive studies on the clonal 
structure of this species, with a recent assay using MLSA (Multilocus Sequence Analysis) 
not demonstrating a suitable intra-species resolution power (Liu et al., 2013).  
Assessing the clonal diversity of previously identified B. pumilus isolates, we realized the 
difficulty in distinguishing this member at the species level, on the basis of phenotypic, 
biochemical characteristics and 16S rRNA genes sequence. Sequencing of β-subunit of 
DNA gyrase (gyrB) and β-subunit of RNA polymerase (rpoB) genes, have proven to be 
171
 Chapter 2 
useful for taxonomic resolution of closely related species and were previously suggested 
for classification of Bacillus spp. members (Konstantinidis et al., 2006; Adékambi et al., 
2008). Recently, these molecular biomarkers were assessed to position phylogenetically 
B. pumilus group species (Liu et al., 2013).  
In this study, a collection of terrestrial isolates previously identified as B. pumilus was 
analyzed phylogenetically, based on gyrB and rpoB genes. Intra-species diversity of the 
depicted species was also assessed to unveil their genomic plasticity and clonal 
dispersion in different settings.  
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Material and Methods 
 
Isolates collection and identification  
A comprehensive collection of forty-one B. pumilus isolates from different origins 
previously identified by phenotypic and biochemical characteristics and 16S rRNA gene 
sequence were studied. It comprises isolates recovered from different terrestrial sources 
and geographic locations, including food samples (n=6) (Norway, Italy and Africa), plant 
growth-promoters (PGPR) (n=4) (USA), gastropods normal flora (n=3) (Portugal), and 
medicines (n=11) and cosmetic (n=4) contaminated products (Portugal). Additionally, 11 
B. safensis, including B. safensis FO-36bT, kindly provided by NASA collection and 
recovered from clean room environments from Mars Odyssey (USA), and B. pumilus 
ATCC 7061T and 14884 were included for phylogenetic comparisons (Table 1). 
 
Sequencing of 16S rRNA, β-subunit of DNA gyrase (gyrB) and β-subunit of RNA 
polymerase (rpoB) genes  
The DNA was prepared using InstaGeneTM Matrix (Bio-Rad Laboratories, Inc., Hercules, 
CA, USA) and was used directly for PCR amplification.  Gene fragments were amplified 
according to primers pairs and PCR conditions outlined in Table 2. For each isolate, 
nucleotide sequences of the 16S rRNA, gyrB and rpoB genes were obtained by 
sequencing of amplified products. All sequences were deposited in the GenBank 
database; the accession numbers are listed in Table 1. 
 
Phylogenetic analysis 
The sequences of 16S rRNA, gyrB and rpoB genes obtained in this study were compared 
with the ones available in GenBank nucleotide and protein databases using BLASTN and 
BLASTX algorithms. Nucleotide sequences were aligned and species similarity score for 
each gene were generated using MEGA version 5.2.2 (http://www.megasoftware.net/) 
(Tamura et al., 2011). Phylogenetic trees were constructed from the alignment of 
similarity scores using neighbour-joining (NJ) (Saitou et al., 1987) method. During the 
analysis of alignments, genetic distances were estimated using Kimura´s 2-parameter 
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model (Kimura, 1980), where all substitutions were included in pairwise distance 
calculations. The reliability of internal branches was assessed from bootstrap based on 
1000 resamplings. In order to establish phylogenetic relationships, homologous 
nucleotide sequence data from B. pumilus group members were also included. 
Sequences (n=72) found deposited on GenBank (accession numbers detailed in table 1 
and 3) correspond to B. pumilus strain SAFR-032, B. altitudinis 41KF2bT. and B. pumilus 
(n=11), B. safensis (n=11) and B. altitudinis (n=48) recovered from marine environments. 
Unfortunately, sequences of B. stratosphericus, B. aerophilus and B. xiamenensis are not 
available in the databases neither the isolates available from public collections, therefore 
it was not possible their inclusion for phylogenetic purposes. Moreover, B. subtilis subsp. 
subtilis str. 168, B. amyloliquefaciens DSM7T, B. licheniformis ATCC 14580T and B. 
cereus ATCC 14579T were used as outgroups. Therefore the total number of strains 
analyzed was one hundred and seventeen.  
 
Genetic diversity analysis  
Intra-species diversity was assessed by a modified PFGE protocol (Kaufmann, 1998), 
using a higher bacterial cell concentration and ApaI (New England Biolabs, Beverly, 
Mass.) for DNA macrorestriction.  Briefly, Bacillus isolates were grown overnight in TSB 
(Tryptic Soy Broth, BD, Germany) in a shaking water bath at 30ºC and collected by 
centrifugation during 12 min at 2200 g-1. Cells were washed with 0.5 mL of PET-IV buffer 
[10 mMTris-HCl (Sigma-Aldrich, St. Louis, MO) and 1M NaCl (Sigma-Aldrich, St. Louis, 
MO), pH=7.5], resulting in a high cell concentration, and subsequently mixed with an 
equal volume of molten (55ºC) 1.6 % low-melting point agarose (SeaKem Gold, 
SKG)  (FMC BioProducts, Denmark). Plug sections were included in a 1.6 % agarose 
with running conditions of 3.5s – 15s for 27h at 14ºC in a Tris Boric Acid-EDTA (TBE, 
0.5X) supplemented with thiourea (100µM; Sigma-Aldrich, St. Louis, MO). 
ApaI profiles were analyzed by InfoQuest FP version 5.4 software (Bio- Rad Laboratories, 
USA), and the percentage similarity was calculated by applying the unweighted-pair 
group method using average linkages (UPGMA) algorithm based on the Dice coefficient, 
and 1.0% of band tolerance and 1.0% of optimization. PFGE-types were defined using 
Tenover criteria (Tenover et al., 1995).    
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Results and Discussion 
 
Phylogenetic analyses  
Phylogenetic tree analysis based on 16S rDNA gene sequences (≅ 1,500bp) showed that 
the isolates tested in this study clustered as well as other B. pumilus group members 
available in GenBank, in a separated branch from the remaining B. subtilis group species 
(B. subtilis subsp. subtilis, B. amyloliquefaciens and B. licheniformis), and also from B. 
cereus, with an overall 93.4% of homology achieved among all isolates (Fig.1). Moreover 
based on genetic distances calculated to 16S rRNA gene for all B. pumilus group 
members tested, phylogenetic tree revealed a level of homology ranging between >99.4-
100% (Fig.1 and Fig. 4a).  
Interestingly, and despite the high homology, 16S rRNA topology tree shows that most of 
isolates from the terrestrial collection characterized in this study, did not organize within 
the groups enclosing mostly of B. altitudinis, B. pumilus or B. safensis deposited in 
GenBank (Fig.1). It’s worth to mention that these groups include mostly 16S rRNA gene 
sequences from isolates recovered in the same location, from which we lack information 
on their clonal relationships. Contrastingly, a clonal diversity was observed through the 
use of PFGE, which will be further discussed in the genetic diversity analysis section.  
Due to limitations of 16S rRNA gene sequences to decipher relationships at the species 
level, as previously recognized for strains belonging to B. subtilis group (Satomi et al., 
2006; Wang et al., 2007), gyrB and rpoB genetic markers, which presented a higher 
variability, have been used (Satomi et al., 2006; Wang et al., 2007; Liu et al., 2013).  
Phylogenetic affiliation based on gyrB gene sequences (≅1070 bp in length) was shown 
in Figure 2. Accordingly to the bacterial genus under study, different sequence similarity 
values have been required for taxonomic assignments on the basis of the gyrB gene (La 
Duc et al., 2004). In the case of B. subtilis complex, where B. pumilus and consequently, 
B. safensis and B. altitudinis belong, around 95% similarity of gyrB gene was accordant 
with 70% of DNA-DNA relatedness (Wang et al., 2007). A similar cut-off, 95-96% of 
homology, to distinguish at species level the B. pumilus group members was recently 
proposed (Liu et al., 2013). 
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Analysis disclosed from Figure 2, delineated seven distinct phylogenetic clusters among 
all sequences analyzed, including B. subtilis subsp. subtilis, B. amyloliquefaciens, B. 
licheniformis, B. cereus, B. pumilus, B. safensis, B. altitudinis, with an overall 72.5% of 
homology. Moreover, gyrB sequence-based phylogenetic topology clearly divided the B. 
safensis, B. pumilus, and B. altitudinis into three distinct clusters, gyrB1, gyrB2 and gyrB3, 
respectively.  
The group gyrB1, which included B. safensis FO-36bT, also comprised 12 isolates 
previously assigned to B. pumilus recovered from food samples, plants, gastropods 
normal flora, and medicines and cosmetic products, and 26 isolates from marine settings, 
with 98% of homology supported by a bootstrap value of 100%. This group is more 
closely related to B. pumilus isolates grouped in gyrB2 (genetic distance of 0.094), than to 
B. altitudinis ones (gyrB3) (genetic distance of 0.104), which were supported by bootstrap 
values of 99% and 97%, respectively. With the reassignment as B. safensis of several B. 
pumilus isolates identified in gastropods or used as PGRP we extended the recognized 
habitats and significance of B. safensis. 
.Group gyrB2 comprised the B. pumilus ATCC 14884 and 7061T, the unique B. pumilus 
(SAFR-032) until now completely sequenced, 3 of 41 B. pumilus isolates characterized in 
this study recovered from medicine’s and 14 marine isolates. The gyrB sequences of this 
clade shared 98.6% of homology. Moreover, this clade presented a genetic distance of 
0.070 with group gyrB3 and was supported by a bootstrap value of 100%. Therefore, 
these results demonstrated that B. pumilus are not the most widespread bacterial group 
among our collection, in contrast to general conception on this subject (Stackebrandt et 
al., 2008). 
Finally, gyrB3, a third group, representing B. altitudinis included 9 isolates from the 
terrestrial collection tested, including a PGPR and a food poisoning isolate, and 49 from 
marine environments, which presented 98.8% of homology among them (bootstrap value 
support of 97%). Nevertheless, the topology of gyrB3 tree seems to segregate our 
terrestrial isolates in a new branch as well as 4 isolates from marine sources (Ba28m, 
Ba52m, Ba56m and Ba73m). Results disclosed by its phenotypic and biochemical 
characterization support the distinction found between them and B. altitudinis. Further, 
genome sequencing and chemotaxonomic studies will elucidate their relatedness with B. 
altitudinis.  Thus, this data extend the niches of B. altitudinis and unveils its relevance as 
a possible source of interesting bioproducts.  
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Analysis disclosed from rpoB gene analysis confirmed the previously clustering obtained 
by gyrB gene phylogenetic tree, presenting an overall congruent topology structure. 
According to Adékambi et al., (2008), for complete rpoB gene, a cutoff of 97.7% and 
98.2% could be applied to delineate the species and subspecies, respectively. In this 
study, two rpoB gene fragments were used for the phylogenetic assignments constructed 
using Neighbor Joining algorithm and Kimura´s 2-parameter model to calculate genetic 
distances between isolates: (i) the entire rpoB gene sequence and (ii) the hypervariable 
region, located between positions 2300 and 3300 pb. Our results showed that this last 
region of rpoB gene proved to be appropriated for the identification of these B. pumilus 
group species and the alignment pattern achieved was the same when compared with 
analysis of the entire gene. Thus, our comparison analysis was conducted using the 
hypervariable region of rpoB gene (Figure 3). 
Global analysis of phylogenetic tree derived from the hypervariable region of this gene 
also revealed the presence of seven distinct clusters among all Bacillus isolates under 
study, which shared ≤97.7% of similarity between them, in accordance with the species 
cut-off defined. Furthermore, a marked differentiation was also observed among B. 
pumilus group members, grouping similarly the isolates into three main clades, herein 
rpoB1, rpoB2 and rpoB3. 
The group rpoB1, comprise the same 38 B. safensis isolates as the correspondent gyrB 
sequence gene analysis, with a 99.2% of homology, supported by a bootstrap value of 
97%. This group demonstrated a genetic distance of 0.025 with group rpoB2 and 0.039 
with group rpoB3, which in accordance with gyrB gene sequence analysis and with the 
cutoff established to differentiate among species, clearly depicts three independent and 
closed species. 
Also similar to gyrB gene topology, the rpoB2 group, which included B. pumilus, was 
comprised of the same 17 isolates (herein with 99.1% of homology, supported by a 
bootstrap value of 99%). This group demonstrated a genetic distance of 0.034 with group 
rpoB3. 
Remarkably, group rpoB3 seems to form the same segregation pattern achieved in gyrB 
gene analysis, related to those nine isolates recovered from terrestrial sources with some 
discrepancies in their neighbors (Fig. 3). These terrestrial isolates shared 98.7% of 
homology with B. altitudinis group, 96.6% with B. pumilus and 96.1% with B. safensis.  
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Congruently with the phylogenetic positioning revealed by gyrB gene, rpoB gene analysis 
reveals that just a few (3 of 41 isolates) of previously identified terrestrial B. pumilus 
isolates were correctly assigned, as mostly of them belong to B. safensis or to B. 
altitudinis.  
Overall, genetic distances shown in Fig. 4b demonstrate that these two housekeeping 
genes presented remarkably higher resolution than the correspondent 16S rRNA gene to 
discriminate among B. pumilus group members. Moreover, and contrasting with the work 
of Liu et al. (2013), our analysis clearly revealed that hypervariable region of rpoB gene is 
an adequate marker to infer phylogenetic discrimination among closely related species of 
this group, probably due to the inclusion of a larger number of isolates of terrestrial origin, 
which strengthens the taxonomic affiliation.  
Finally, trees constructed based on amino acid sequence of RpoB and GyrB (supporting 
information material, Figures S1 and S2) showed that most nucleotide substitutions were 
synonymous, i. e., did not result in amino acid changes, which is not surprising since 
rpoB and gyrB encoded proteins vital for cellular function (Case et al., 2007). Thus, B. 
pumilus group RpoB and GyrB proteins analysis shared the same topology as the 
correspondent genes analysis. 
 
Clonal diversity analysis  
In order to assess the intra-species diversity within the B. pumilus group species 
assigned by gyrB and rpoB gene sequencing, macrorestriction followed by pulsed-field 
gel electrophoresis (PFGE) was performed. The discriminatory power of PFGE in the 
population analysis of different bacterial species is recognized and it was not superseded 
by MLSA in short time period bacterial evolutionary studies (Wolska 2012; Freitas et al., 
2013). Moreover, and despite the interest of MLSA, especially for long-term investigations 
of bacterial population structures, an attempt to establish a scheme for B. pumilus group 
species was not successful (Liu et al., 2013). 
PFGE band patterns, using a macrorestriction with ApaI enzyme, were obtained for 
isolates belonging to the B. pumilus group species phylogenetically assigned in this study 
(Fig. 5). Previous attempt to assess clonally structure of B. pumilus by PFGE were 
restricted to a few isolates (Ouoba et al., 2004). 
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Two distinct genomic profiles (comprising ca. 19 to 20 bands), which shared a global 
similarity value of 66.7%, were obtained for B. pumilus isolates (Fig. 5a). The PFGE-type 
Ip corresponds to a clone contaminating medicine products of a pharmaceutical 
production unit. As expected, the three isolates belonging to this clone shared 100% of 
homology in the correspondent rpoB and gyrB sequences. PFGE-type IIp, which shared a 
global similarity value of 66.7% with PFGE-type Ip corresponds to B. pumilus ATCC 
14884.  
A high genetic diversity was observed among B. safensis isolates (Fig 5b) (n=24; 64.3% 
of similarity in the DICE/UPGMA dendrogram), in which two major groups, arbitrarily 
designated as A (n=14, 72.3% of similarity) and B (n=9, 94.8% of similarity) were defined. 
These groups, which shared a global similarity value of 67.3%, were sub-divided into 
fourteen different pulsed-field types.  PFGE-type Vs (of group A) comprised all animal 
isolates (Bs1, Bs2 and Bs3), obtained in different regions and years, which suggests the 
presence of a B. safensis clone highly adapted to a gastropod. This ecological specificity 
was also supported by gyrB and rpoB sequences analysis, which revealed 99.9% and 
100% of similarity, respectively. PFGE-types IIs, VIs, XIs and XIIs encompassed isolates 
recovered from cosmetic products of different manufacturers and PFGE-types IIIs, IVs and 
VIIs comprised three isolates recovered from medicine products of a pharmaceutical 
production unit, also demonstrating the interest of this methodology to trace B. safensis 
contamination in industrial production lines. PFGE-types XIIIs and XIVs clustering into 
group B, enclosed nine isolates recovered by NASA from clean room assembly-facility 
surfaces, indicating the dissemination in this environment of a major clone (type XIIIs) to 
which belong B. safensis type strain. The remaining PFGE-types (Is, VIIIs, IXs and Xs), 
with a low similarity with the remainders, involved isolates from the PGPR and food 
contaminants. A more distantly related clone (PFGE type XVs) was found in another food 
isolate.  
In, figure 5c the clonal relationship of B. altitudinis isolates is shown. These isolates 
shared a 65.3% of genetic similarity and included 6 PFGE-types. PFGE-type Ia 
corresponds to a clone found in three medicine products of a pharmaceutical production 
unit, indicating a clonal contamination of a medicine production line. Congruently, these 
isolates shared by rpoB and gyrB sequences analysis 100% and 99.9% of homology, 
respectively. The remaining PFGE-types included isolates collected from other medicines 
contaminants, PGPR, food condiments products and the isolate associated with the 
foodborne poisoning outbreak (Ba26), which also presented a unique PFGE-type. 
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Thus, macrorestriction with ApaI enzyme followed by PFGE allowed the assessment of 
intra-species diversity of B. pumilus group species, depicting a high heterogeneity among 
B. pumilus, B. safensis and B. altitudinis isolates. Interestingly, our data also suggests a 
host clonal specificity supporting a great adaptability of B. pumilus members, which 
possibly justify the multiple ranges of activities formerly attributed to B. pumilus, and 
highlights the relevance of characterization at strain level of these species. 
In conclusion, genomic characterization of a collection of isolates previously identified as 
B. pumilus revealed a highly heterogeneous population comprising different species (B. 
pumilus, B. safensis and Bacillus altitudinis) and clones. Moreover, we extend previous 
recognized niches and relevance of B. safensis and Bacillus altitudinis. Additionally, we 
also demonstrated that these species encompass a clonally diverse population, able to 
adapt to different hosts, which could justified the range of niches/hosts and activities 
previously attributed to B. pumilus.  
Thus, this study contributed to unveil the population diversity, niches, and relevance of B. 
pumilus, B. safensis and B. altitudinis, which is of significance for understanding the 
ecology of B. pumilus group members and for the sectors where these microorganisms 
are intentionally used or can act as frequent contaminants. 
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Table1. Phylogenetic assignment and pulsotypes of Bacillus pumilus group isolates from diverse terrestrial sources. 
Species 
Isolate Origin/Product Year/ Location 
GenBank accession numbers PFGE-
type References Previous identification 
Phylogenetic 
assignment1) 16S rDNA 
gene gyrB gene rpoB gene 
B. pumilus B. pumilus 
Bp ATCC14884 JF749284 KC895462 KC895450 IIp 
Reference 
strain 
Bp ATCC7061T EU138517 AY167869 AB353945 NA Type-strain 
Bp7 
Medicine´s 
contaminants (n=3) 
2005/Portugal1 JN699029 JX183193 JX183164 
Ip 
Branquinho 
et al., 2012 Bp11 2005/Portugal
1 JN699027 JX183196 JX183167 
Bp15 2005/Portugal1 JN699025 JX183200 JX183171 
B. safensis 
B. safensis 
BsFO-36bT Clean-room/ air 
particulate (n=1) 
1999/USA6 AF234854 AY167867  KC895451 
XIIIs 
Satomi et al., 
2006 
Bs32 Clean-room/entrance 
floor (n=1) 
2001/USA6 AY167886 AY167877 KC895453 
Bs42 Clean-room/anteroom 
(n=1) 
2001/USA6 AY167884 AY167876 KC895454 Non 
typeable 
Bs34 
Clean-room/floor (n=2) 
2001/USA6 AY167881 AY167873 KC895455 Non 
typeable 
Bs35 2001/USA6 AY167880 AY167872 KC895456 XIVs 
Bs36 Clean-room/cabinet top 
(n=1) 
2001/USA6 AY030327 AY167878 KC895452 XIIIs 
Bs37 
Clean-room/Mars 
Odyssey spacecraft 
surface (n=5) 
2001/USA6 AF526907 KC895457 KC895445 
XIIIs 
Bs38 2001/USA6 AF526902 KC895458 KC895446 
Bs39 2001/USA6 AF526898 KC895459 KC895447 
Bs40 2001/USA6 AF526896 KC895460 KC895448 
Bs41 2001/USA6 AF526895 KC895461 KC895449 
B. pumilus 
Bs1 
Animals Gastropods 
(n=3) 
2004/Portugal1 JN699032 JX183188 JX183159 
Vs 
Branquinho 
et al., 2012 
Bs2 2005/Portugal1 JX183146 JX183189 JX183160 
Bs3 2007/Portugal1 JN699031 JX183190 JX183161 
Bs13 
Medicine´s 
contaminants (n=3) 
2005/Portugal1 JX183149 JX183198 JX183169 VIIs 
Bs16 2005/Portugal1 JN699024 JX183201 JX183172 IIIs 
Bs17 2005/Portugal1 JX183151 JX183202  JX183173 IVs 
Bs5 Cosmetic´s 2002/Portugal1 JN699030  JX183191 JX183162 XIs 
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Bs18 contaminants (n=4) 2002/Portugal1 JN699023 JX183203 JX183174 VIs 
Bs19 2002/Portugal1 JN699022 JX183204 JX183175 XIIs 
Bs27 2002/Portugal1 JN699021 JX183212 JX183183 IIs 
Bs24 
Food´s 
contaminants/salame 
(n=3) 
2004/Italy3 JX183156 JX183209 JX183180 XVs 
Matarante et 
al., 2004 
Bs25 2004/Italy3 JX183157 JX183210 JX183181 VIIIs 
Bs33 2004/Italy3 KC895444 KC895463 JX183187 Non 
typeable 
Bs22 Plant Growth Promoters 
(PGPR) (n=2) 
1997/USA4 JX183154 JX183207 JX183178 IXs Jetiyanon 
1997 Bs23 1997/USA4 JX183155 JX183208 JX183179 Is 
Bs31 Food/beans (n=1) 2003/Africa
5 KC895443 JX183215 JX183186 Xs 
Ouoba et al., 
2004 
B. altitudinis 
Ba6 
Medicine´s 
contaminants (n=5) 
2005/Portugal1 JX183147 JX183192 JX183163 
Ia Branquinho 
et al., 2012 
Ba8 2005/Portugal1 JN699028 JX183194 JX183165 
Ba9 2005/Portugal1 JX183148 JX183195 JX183166 IIIa 
Ba12 2005/Portugal1 JN699026 JX183197 JX183168 Ia 
Ba14 2005/Portugal1 JX183150 JX183199 JX183170 IIa 
Ba26 Food´s 
contaminants/rice (n=1) 
2006/Norway2 JX183158 JX183211 JX183182 VIa 
From et al., 
2007 
Ba20 
Plant Growth Promoters 
(PGPR) (n=2) 
1996/USA4 JX183152 JX183205 JX183176 Non 
typeable 
Wei et al., 
1996 
Ba21 1997/USA4 JX183153 JX183206 JX183177 Va 
Jetiyanon 
1997 
Ba30 Food/beans (n=1) 2003/Africa
5 KF060662 JX183214 JX183185 IVa 
Ouoba et al., 
2004 
1)Species identification according to the phylogenetic affiliation obtained with rpoB and gyrB genes.
NA – not applicable. 
B. pumilus
B. safensis
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Table 2. PCR primers sequences and amplification conditions for detection of 16S rRNA, gyrB and rpoB genes. 
Gene 
Primer 
name 
Primer sequences 5´- 3´ 
PCR amplification 
References 
Denaturation Annealing Cycles Final extension 
16S rDNA 
Seq_A AGAGTTTGATCHTGGYTYAGA 
94ºC for 30 s 55ºC for 60 s 30 72ºC for 120s 
Héritier et al., 
2003 Seq_B ACGYTACCTTGTTACGACTTC 
β-subunit of DNA 
gyrase (gyrB) 
UP-1S 
GAAGTCATCATGACCGTTCTGCAYGCNGG
NGGNAARTTYGA 
94ºC for 60 s 60ºC for 60 s 30 72ºC for 120s 
Yamamoto et al., 
1995 
UP-2Sr 
AGCAGGGTACGGATGTGCGAGCCRTCNAC
RTCNGCRTCNGTCAT 
β-subunit of RNA 
polymerase (rpoB 
gene) 
rpoB1_fw CAGAAGCTACGCACGCATAA 
94ºC for 30 s 56ºC for 60 s 30 72ºC for 120s This study 
rpoB1_rv GCGTCCAACATTTGCTAGGT 
rpob2_fw CAACACGCTGGAAAAAGACA 
rpoB2_rv TTCTCGGCGTCACTTTACCT 
rpoB3_fw CACCAGAGGGTCCAAACATT 
rpoB3_rv GGTTGCGTAAAGCATCTTCC 
rpoB4_fw CATGAGTGAGCGCCTTGTAA 
rpoB4_rv CGTCTGCTTTCTTCGTTTCC 
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Table 3. Gene sequences of 16S rRNA, gyrB and rpoB for Bacillus pumilus group isolates deposited on GenBank and included in the phylogenetic 
analysis. 
Species Isolate Origin Region GenBank accession numbers References16S rDNA gene gyrB gene rpoB gene 
B. pumilus 
Bp10m 
Sediment 
Pacific Ocean JX680074 JX680151 JX679996 
Liu et al., 2013 
Bp42m 
Indian Ocean 
JX680106 JX680183 JX680028 
Bp46m JX680110 JX680187 JX680032 
Bp53m Indian Ocean JX680117 JX680194 JX680039 
Bp51m 
Atlantic Ocean 
JX680115 JX680192 JX680037 
Bp66m JX680129 JX680206 JX680051 
Bp43m 
Surface water 
Pacific Ocean JX680107 JX680184 JX680029 
Bp44m Pacific Ocean JX680108 JX680185 JX680030 
Bp67m 
White shrimp 
Shrimp farm JX680130 JX680207 JX680052 
Bp68m Shrimp farm JX680131 JX680208 JX680053 
Bp69m Aquaculture water Shrimp farm JX680132 JX680209 JX680054 
Bp SAFR-032 
Spacecraft Assembly 
Facility - NASA Jet 
Propulsion Laboratory 
USA NR074977 NC009848 CP000813 Gioia et al., 2007 
B. safensis 
Bs30m 
Sediment 
South China Sea 
JX680094 JX680171 JX680016 
Liu et al., 2013 
Bs35m JX680099 JX680176 JX680021 
Bs36m JX680100 JX680177 JX680022 
Bs37m JX680101 JX680178 JX680023 
Bs49m 
Arctic Ocean 
JX680113 JX680190 JX680035 
Bs50m JX680114 JX680191 JX680036 
Bs64m Bering Sea JX680127 JX680204 JX680049 
Bs45m 
Surface water 
Pacific Ocean JX680109 JX680186 JX680031 
Bs62m Arctic Ocean JX680126 JX680203 JX680048 
Bs71m Aquaculture water Shrimp farm JX680134 JX680211 JX680056 
Bs60m Intestinal tract contents of fish Xiamen island JX680124 JX680201 JX680046 
B. altitudinis 
Ba3m 
Sediment Pacific Ocean 
JX680068 JX680144 JX679989 
Ba4m JX680069 JX680145 JX679990 
Ba6m JX680070 JX680147 JX679992 
Ba7m JX680071 JX680148 JX679993 
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Ba9m JX680073 JX680150 JX679995 
Ba11m JX680075 JX680152 JX679997 
Ba12m JX680076 JX680153 JX679998 
Ba13m JX680077 JX680154 JX679999 
Ba14m JX680078 JX680155 JX680000 
Ba15m JX680079 JX680156 JX680001 
Ba20m 
Indian Ocean 
JX680084 JX680161 JX680006 
Ba52m JX680116 JX680193 JX680038 
Ba47m Atlantic Ocean JX680111 JX680188 JX680033 
Ba48m 
Arctic Ocean 
JX680112 JX680189 JX680034 
Ba74m JX680137 JX680214 JX680059 
Ba8m 
South China Sea 
JX680072 JX680149 JX679994 
Ba19m JX680083 JX680160 JX680005 
Ba28m JX680092 JX680169 JX680014 
Ba29m JX680093 JX680170 JX680015 
Ba31m JX680095 JX680172 JX680017 
Ba32m JX680096 JX680173 JX680018 
Ba33m JX680097 JX680174 JX680019 
Ba38m JX680102 JX680179 JX680024 
Ba39m JX680103 JX680180 JX680025 
Ba40m JX680104 JX680181 JX680026 
Ba17m 
Surface water 
Xiamen island JX680081 JX680158 JX680003 
Ba18m Indian Ocean JX680082 JX680159 JX680004 
Ba24m 
Yellow Sea 
JX680088 JX680165 JX680010 
Ba26m JX680090 JX680167 JX680012 
Ba25m East China Sea JX680089 JX680166 JX680011 
Ba16m 
Bottom water 
Indian Ocean JX680080 JX680157 JX680002 
Ba27m Pacific Ocean JX680091 JX680168 JX680013 
Ba21m 
South China Sea 
JX680085 JX680162 JX680007 
Ba22m JX680086 JX680163 JX680008 
Ba23m JX680087 JX680164 JX680009 
Ba72m JX680135 JX680212 JX680057 
Ba75m Aquaculture water Shrimp farm JX680138 JX680215 JX680060 
Ba54m 
Coral Dongshan island 
JX680118 JX680195 JX680040 
Ba55m JX680119 JX680196 JX680041 
B. altitudinis Liu et al., 2013
Sediment
Pacific Ocean
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Ba56m JX680120 JX680197 JX680042 
Ba57m JX680121 JX680198 JX680043 
Ba58m JX680122 JX680199 JX680044 
Ba2m 
Intestinal tract contents of 
fish Xiamen island 
JX680067 JX680143 JX679988 
Ba61m JX680125 JX680202 JX680047 
Ba73m JX680136 JX680213 JX680058 
Ba76m 
White shrimp Shrimp farm 
JX680139 JX680216 JX680061 
Ba77m JX680140 JX680217 JX680062 
Ba78m JX680141 JX680218 JX680063 
Ba41KF2bT High-elevation air sample India AJ831842 JX680219 JX680064 Shivaji et al., 2006 
B. altitudinis Liu et al., 2013 
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Figure 1. Neighbour-joining (NJ) tree based on the 16S rRNA gene sequences 
comparison, showing the relationship of B. pumilus group members, namely B. safensis, 
B. pumilus and B. altitudinis. Genetic distances were constructed using Kimura´s 2-
parameter model. Numbers at branch points indicated bootstrap percentages (1000 
replications) from NJ analysis and only values greater than 70 % were shown. Bacillus 
subtilis subsp. subtilis str. 168, B. amyloliquefaciens DSM7T, B. licheniformis ATCC 
14580T and B. cereus ATCC 14579T were used as outgroups. Accession numbers were 
given in parentheses. Symbols represent: B. pumilus from terrestrial () and marine () 
settings; B. safensis from terrestrial () and marine () settings and B. altitudinis from 
terrestrial () and marine () settings. Bar: genetic distance of 0.005.
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Figure 3. Neighbour-joining (NJ) tree based on the gyrB gene sequences comparison, 
showing the relationship of B. pumilus group members, namely B. safensis, B. pumilus 
and B. altitudinis. Genetic distances were constructed using Kimura´s 2-parameter model. 
Numbers at branch points indicated bootstrap percentages (1000 replications) from NJ 
analysis and only values greater than 70 % were shown. Bacillus subtilis subsp. subtilis 
str. 168, B. amyloliquefaciens DSM7T, B. licheniformis ATCC 14580T and B. cereus ATCC 
14579T were used as outgroups. Accession numbers were given in parentheses. Symbols 
represent: B. pumilus from terrestrial () and marine () settings; B. safensis from 
terrestrial () and marine () settings and B. altitudinis from terrestrial () and marine 
() settings.  Bar: genetic distance of 0.05. 
191
Chapter 2 
192
Chapter 2 
Figure 3. Neighbour-joining (NJ) tree based on the hypervariable region of  rpoB gene 
sequences comparison, showing the relationship of B. pumilus group members, namely B. 
safensis, B. pumilus and B. altitudinis. Genetic distances were constructed using Kimura´s 
2-parameter model. Numbers at branch points indicated bootstrap percentages (1000 
replications) from NJ analysis and only values greater than 70 % were shown. Bacillus 
subtilis subsp. subtilis str. 168, B. amyloliquefaciens DSM7T, B. licheniformis ATCC 
14580T and B. cereus ATCC 14579T were used as outgroups. Accession numbers were 
given in parentheses. Symbols represent: B. pumilus from terrestrial () and marine () 
settings; B. safensis from terrestrial () and marine () settings and B. altitudinis from 
terrestrial () and marine () settings. Bar: genetic distance of 0.02. 
193
Chapter 2 
 
Figure 4. a) Inter- and b) intra-species similarity ranges of 16S rRNA, gyrB and rpoB 
genes in Bacillus pumilus group members. 
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Figure 5. Dendrogram resulting from cluster analysis of PFGE fingerprints of ApaI-
digested DNA from typeable B. pumilus (a), B. safensis (b) and B. altitudinis (c) isolates. 
First and second columns (right) represented the isolate name and PFGE-types, 
respectively. Similarity values were achieved using UPGMA method. Band lines were 
automatically generated by InfoQuest software to better elucidate its position in the gel. 
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Figure S1. Phylogenetic tree inferred from GyrB protein sequences in B. pumilus group 
members. Genetic distances were constructed using Jones-Taylor-Thornton (JTT) model. 
Numbers at branch points indicate bootstrap percentages from Neighbor-Joining method 
analysis and only values greater than 70 % were shown. B. cereus was used as the 
outgroup taxon. Symbols represent: B. pumilus from terrestrial () and marine () 
settings; B. safensis from terrestrial () and marine () settings and B. altitudinis from 
terrestrial () and marine () settings. Bar: genetic distance of 0.05. 
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Figure S2. Phylogenetic tree inferred from RpoB protein sequences (based on 
hypervariable region of the rpoB gene) in B. pumilus group members. Genetic distances 
were constructed using Jones-Taylor-Thornton (JTT) model. Numbers at branch points 
indicate bootstrap percentages from Neighbor-Joining method analysis and only values 
greater than 70 % were shown. B. cereus was used as the outgroup taxon. Symbols 
represent: B. pumilus from terrestrial () and marine () settings; B. safensis from 
terrestrial () and marine () settings and B. altitudinis from terrestrial () and marine 
() settings. Bar: genetic distance of 0.05. 
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2.2. Bacillus invictus sp. nov., isolated from healthy products in Portugal 
 
Publications: 
Bacillus invictus sp. nov., isolated from healthy products in Portugal 
 
During a study adressing Bacillus spp. diversity, we uncover the presence of a different 
species closely related with members of B. pumilus group in contaminants of healthy 
products.The prediction of a new species is supported by DNA-DNA hybridization studies, 
rpoB and gyrB genes homologies, Matrix Assisted Laser Desorption Ionization-Time of 
Flight Mass Spectrometry (MALDI-TOF/ICMS) and Fourier Transform Infrared 
Spectroscopy with Attenuated Total Reflectance (FTIR-ATR) analysis, reinforced by 
chemometric analysis (PCA) of respectively spectral data. 
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Abstract 
 
Three Gram-positive, rod-shaped endospore-forming Bacillus isolates Bi.FFUP1, Bi.FFUP2, 
and Bi.FFUP3 recovered in Portugal from health´s products contaminants were subjected to 
a polyphasic study and comparison with Bacillus pumilus, Bacillus safensis, Bacillus 
altitudinis and Bacillus xiamenensis the phenotypically and genotypically closest species.  
Acid production from cellobiose, glucose and mannose and absence of acid production 
when D-arabinose, erythritol, inositol, maltose, mannitol, raffinose, rhamnose, sorbitol, 
starch and L-tryptophan is tested, discriminate these new isolates from their closely 
related ones. Additionally, a significant different protein and carbohydrate signature was 
evidenced by spectroscopic techniques, MALDI-TOF/MS and FTIR-ATR. PCA (principal 
component analysis) of this spectral data clearly delineated the novel species isolates. 
The quinone system is MK-7 and major polar lipids are diphosphatidylglycerol, an 
unidentified phospholipid and an unidentified glycolipid. Strain Bi.FFUP1T showed ≥99% 16S 
rRNA gene similarity with B. safensis FO-036bT, B. pumilus (ATCC 14884 and ATCC 
7061T), B. altitudinis 41KF2bT and B. xiamenensis HYC-10T Differences in strain Bi.FFUP1T 
gyrB and rpoB sequences together with their phylogenetic tree topology also supported 
the delineation of a new species. Moreover, only 49-50% DNA relatedness (DDH studies) 
was observed between Bi.FFUP1 and B. safensis FO-036bT and 61.90% with Bi.FFUP1 and B. 
altitudinis 41KF2bT. Variable DDH values were obtained when Bi.FFUP1 was compared with 
B. pumilus ATCC 14884 (39.75% ±0.35) and ATCC 7061T (69.40%±2), despite the 
genotypic and phenotypic similarity of these two B. pumilus strains, highlighting the 
ambiguities in the taxonomic grouping based on a strict DDH cut-off.  
Therefore, the three isolates represent a novel species of Bacillus genus, for which the 
name Bacillus invictus sp. nov. is proposed with strain Bi.FFUP1 as the type strain. 
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Members of the Bacillus group, currently including near two hundred species (Parte, 
2013), are well known to withstand resistance to heat, radiation, chemical oxidizing agents 
and desiccation, due to its spore production, which indeed represent the crucial condition 
to facilitate their adaptation into different ecological niches (Stackebrandt et al., 2008). It is 
this resistance to acute stress factors that make them difficult to eliminate from clean room 
environments and, consequently, representing a frequent cause of significant 
contamination of many industrial products, including pharmaceuticals. Recently, National 
Aeronautics and Space Administration (NASA) have reported B. safensis and B. pumilus 
(Satomi et al., 2006), as some of the major contaminants in spacecraft and associated 
clean rooms assembly-facility surfaces. Taxonomically, Bacillus pumilus group species 
belong to RNA group I and encompass B. pumilus, the first species described, Bacillus 
safensis, Bacillus altitudinis, Bacillus stratosphericus, Bacillus altitudinis and the more 
recently species discover Bacillus xiamenensis (Satomi et al., 2006; Liu et al., 2013; Lai et 
al., 2014).  
During a study assessing the diversity of Bacillus spp. isolates recovered from terrestrial 
sources, we disclosed the presence as contaminant of healthy products of a different 
species closely related with members of B. pumilus group. Thus, in the present study, 
chemotaxonomic characteristics, which included carbohydrate and amino acid metabolic 
profiles, whole-cell fatty acid methyl ester, respiratory quinones, polar lipids, protein and 
carbohydrate content, together with phylogenetic features derived from DNA-DNA 
hybridization (DDH) studies, 16S rRNA, rpoB and gyrB gene sequences were assessed in 
our isolates and compared with ones from B. safensis, B. pumilus, B.  altitudinis, B. 
xiamenensis, the available closest phenotypic and genotypic species, supporting the 
description of a novel species, which is of relevance in food and pharmaceutical quality 
control and for infection control purposes. 
 
Three Bacillus sp. isolates were recovered from healthy products in Portugal, designated 
Bi.FFUP1, Bi.FFUP2, and Bi.FFUP3, (n=3), being Bi.FFUP1T classified as the type-strain. All strains 
were maintained on Trypticase Soy Agar (TSA; Sigma-Aldrich) for short-term storage and 
in Tryptic Soy Broth (TSB; Sigma-Aldrich) supplemented with 20% (v/v) glycerol at -80 ºC 
for long-term storage. Liquid cultures were grown in TSB at 37 ºC for 24 h. In addittion, 
the most phenotypically and genotypically closest species, B. safensis FO-036bT, B. 
pumilus ATCC 14884 and 7061T, B.  altitudinis 41KF2bT and B. xiamenensis HYC-10T 
were obtained from the respective culture collections and cultivated at 37 ºC in TSA, 
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which were used as references for most of the comparative analysis applied during the 
study. 
In order to phenotypically characterize the isolates, standard phenotypic tests were 
performed. Gram staining was determined using the bioMérieux Gram Stain kit according 
to the manufacturer´s instruction. Oxidase activity was tested by oxidation of 1% (w/v) 
tetramethyl-p-phenylenediamine (Merck) and catalase activity was evaluated by the 
production of oxygen bubbles in 3% (v/v) aqueous hydrogen peroxide solution. Growth at 
different concentrations of salt was determined in salt-free TSB supplemented with 0, 5.0, 
7.5, 10.0, 12.5 and 15.0% (w/v) NaCl. The pH range of growth was determined on TSA at 
pH values ranging from 6.0 to 8.0 for 3 weeks. Optimum and limiting temperatures were 
determined by growing cells on TSA at 4, 25, 37, 50 and 60 ºC. Carbohydrate and amino 
acid metabolic profiles were obtained with a commercial BBL Crystal Gram Positive ID Kit 
(Becton Dickinson) and API 50CH (bioMérieux), which were interpreted according to the 
manufacturer’s instructions. 
For quantitative analysis of whole-cell fatty acid methyl ester profiles, novel isolates were 
cultivated on TSA at 30 ºC for 24 h. Preparation and analysis of fatty acid methyl esters 
were conducted according to the instructions of the Sherlock® Microbial Identification 
System (MIS) (Microbial Identification System, Sherlock). Moreover, quinones and polar 
lipids were harvest from Bacillus sp. biomass grown in PYE broth and extracted and 
analysed according to the integrated procedure described by Tindall (1990 a and b) and 
Altenburger et al. (1996). HPLC analysis was carried out using the HPLC apparatus 
described by Stolz et al. (2007). Further, polar lipids were separated by two-dimensional 
silica gel thin layer chromatography and then identified according to a previously 
described method (Tindall et al., 2007). 
The snapshot of different protein compositions detected by matrix-assisted laser 
desorption ionization-time of flight mass spectrometry (MALDI-TOF/MS) was acquired by 
a MALDI-TOF/TOF mass spectrometer (4800 Plus MALDI TOF/TOF Analyzer, AB SCIEX) 
operating in linear positive mode. Each spectrum was the accumulated sum of at least 
2000 laser shots for m/z 2500-12000 due to the good reproducibility of the spectral profile 
in that mass range. All the spectra were externally calibrated using a commercial mixture 
of angiotensin I, ACTH and insulin (AB SCIEX) and analyzed with the Data Explorer 
software (Version 4.6, AB SCIEX). Bacillus sp. isolates were grown under aerobic 
conditions on LB agar (Merck) for 24 h at 37 °C. Cells were harvested by transferring the 
equivalent of three full blue plastic loops (≈ 30 μl) from each agar plate into 20 μl of sterile 
water and bacterial material resuspended by vortexing. Sample inactivation was carried 
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out applying the modified trifluoroacetic acid (TFA) (Sigma-Aldrich) inactivation protocol 
(Lasch et al., 2008). Subsequent supernatant filtration (0.22 µm) was carried out. For 
MALDI-TOF/MS experiments, 2 μl of the filtrated microbial dilution were mixed with 2 μl of 
a 12-mg/ml α-cyano-4-hydroxycinnamic acid (CHCA) (Sigma-Aldrich) solution in 100% 
ACN and 0.3% TFA. 1 μl of the mixture was spotted onto a stainless steel MALDI sample 
plate and allowed to dry at room temperature. For each isolate, two biological replicates 
(obtained from two different agar plates) were carried out and the mean spectra were 
considered for the analysis. Mass spectra were baseline corrected, noise-filtered and m/z 
values were extracted from the raw experimental mass spectra that included all the mass 
peaks with a relative signal to noise (S/N) ratio intensity above 2.  
In addition, whole cell content of the bacterial isolates studied was analyzed by Fourier 
transform infrared spectroscopy with attenuated total reflectance (FTIR-ATR). Spectra 
were acquired using a FTIR System spectrophotometer (PerkinElmer Spectrum BX) in the 
ATR mode with a PIKE Technologies Gladi ATR accessory from 4000-600 cm-1 and a 
resolution of 4 cm-1 and 32 scan co-additions. Isolates were grown for 37 ºC at 17 h, on 
Mueller Hinton Agar (MH; BioMérieux) and colonies were directly applied in the ATR 
crystal and dried in a thin film. For each isolate, six spectra were acquired, corresponding 
to three biological replicates (obtained from two different agar plates) and two instrumental 
replicates (obtained from the same agar plates) and the mean spectra was considered in 
the analysis.  
Chemometric analysis of MALDI-TOF/MS and FTIR-ATR spectra were performed in 
Matlab version 6.5 release 13 (MathWorks) and the PLS Toolbox version 3.5 for Matlab 
(Eigenvector Research). FTIR-ATR spectra were processed with standard normal variate 
(SNV) (Næs et al., 2002) followed by the application of a Savitzky-Golay filter (9 
smoothing points, 2nd order polynomial and second derivative) (Savitzky & Golay, 1964) 
and mean-centred. MALDI-TOF/MS spectra were mean-centred. Spectra were analysed 
by principal component analysis (PCA) (Hotelling, 1933) considering the whole spectra for 
MALDI-TOF/MS and the carbohydrates region (1200-900 cm-1) for FTIR-ATR. 
Carbohydrates region was chosen due to its higher variability among the isolates.  
Comparative phylogenetic analyses were also performed with the newly described 
Bacillus isolates and reference strains. The 16S rRNA gene amplification was conducted 
using the universal primer pair Seq_A and Seq_B (Héritier et al., 2003). β-subunit of DNA 
gyrase (gyrB gene) was amplified as described previously (Yamamoto et al., 1995) using 
the degenerate primers UP-1S and UP-2Sr. β-subunit of RNA polymerase (rpoB gene) 
was amplified using combinations (rpoB1_fw and rpoB1_rv, rpob2_fw and rpoB2_rv, rpoB3_fw 
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and rpoB3_rv, rpoB4_fw, and rpoB4_rv) of primer pairs, which are shown in Supplementary 
Table S2. The identity of a given PCR product was verified by sequencing analysis. 
Sequences obtained were compared to 16S rRNA, gyrB and rpoB gene sequences of B. 
safensis FO-036b, B. pumilus ATCC 14884 and 7061, B. altitudinis 41KF2b and B. 
xiamenensis HYC-10, available on GenBank database, according to Table 2, using the 
BLAST search. Nucleotide sequences were aligned and species similarity score for each 
gene were generated using MEGA version 5.2.2 (http://www.megasoftware.net/) (Tamura 
et al., 2011). Phylogenetic trees were constructed from the alignment similarity scores 
using neighbour-joining (NJ) (Saitou & Nei, 1987) and maximum-likelihood (ML) 
(Felsenstein, 1981) algorithms. During the analysis of alignments, genetic distances were 
estimated using Jukes-Cantor model (Jukes & Cantor, 1969), where all substitutions were 
included in pairwise distance calculations. The reliability of internal branches was 
assessed from bootstrap based on 1000 resamplings (Felsenstein, 1985). To establish 
phylogenetic analysis, rpoB and gyrB sequences described in B. subtilis subsp. subtilis 
str. 168, B. amyloliquefaciens DSM7T, B. licheniformis ATCC 14580T and B. cereus ATCC 
14579T were used as outgroups. Nucleotide sequences of the 16S rRNA, rpoB, gyrB and 
genes obtained in this study from Bi.FFUP1, Bi.FFUP2, and Bi.FFUP3 isolates were deposited 
into GenBank and assigned with NCBI accession numbers (Table 2). 
Accordingly Adékambi et al. (2009), the total genomic G+C content can be inferred from 
the G+C content of universally conserved genes, with a strong correlation (coefficient of 
determination (r2) = 0.97) between the G+C content of the rpoB gene and that of the 
correspondent genome. Thus, the genomic G+C content (GCg) of Bi.FFUP1 was estimated 
by the rpoB gene GC content (GCr) using the following formula: GCg = 1.2065 x GCr – 
11.495 (Adékambi et al., 2009). 
For DNA-DNA hybridization studies, cells were disrupted using a Constant Systems TS 
0.75 KW (IUL Instruments, Germany) and the DNA in the crude lysate purified by 
chromatography on hydroxyapatite, as described by Cashion et al. (1977).  DNA-DNA 
hybridization was conducted as described by De Ley et al. (1970) under consideration of 
the modifications described by Huss et al. (1983) using a model Cary 100 Bio UV/VIS-
spectrophotometer equipped with a Peltier-thermostatted 6x6 multicell changer and a 
temperature controller with in situ temperature probe.  
 
The novel isolates were Gram-positive rods, aerobic, motile and contained terminally/ 
subterminally located spores, similar to their closely related species B. safensis, B. 
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pumilus, B. altitudinis and  B. xiamenensis. When grown at 37 ºC for 24 h on TSA, 
colonies are round, smooth, yellowish in color, have irregular margins and were 
approximately 2.8 ±0.2mm in diameter. The cells were oxidase- and catalase-positive. 
Growth occurred at 25 ºC, 37 ºC and 50 ºC but not at 4 ºC or 60 ºC. Growth occurred in 
the range 0-10% (w/v) NaCl and at pH 6.0–8.0. Phenotypic details derived from metabolic 
tests obtained with BBL Crystal Gram Positive ID Kit and API 50 CH were detailed in 
species description and in supplementary Table S1. Acid production from cellobiose, 
glucose and mannose and absence of acid production when D-arabinose, erythritol, 
inositol, maltose, mannitol, raffinose, rhamnose, sorbitol, starch and L-tryptophan is 
tested, allowed the discrimination of the novel isolates from the related species (Table 1).  
The major fatty acids profiles of novel isolates were C15:0 iso (41.3%), C15:0 anteiso 
(35.3%), C17:0 iso (4.9%) and C17:0 anteiso (6.6%), similar to previously described to their 
closed species (Table 3). 
Moreover, quinones system consisted predominantly of menaquinone MK-7 (99.4%), 
which is consistent with members of Bacillus genus (Lai et al., 2014), and also traces of 
MK-6 (0.3%) and MK-8 (0.2%).  
Related to the polar lipid profile (Figure 5) diphosphatIdylglycerol (DPG), an unidentified 
phospholipid (PL1) and an unidentified glycolipid (GL2) were detected. Furthermore, 
moderate amounts of phosphatidylglycerol (PG), another unidentified glycolipid (GL1) and 
three lipids (L1-3) not containing a sugar, phosphate or amino residue were detected. In 
addition some other minor lipids were observed, including a third unidentified glycolipid 
(GL3), an aminolipid (AL1) and two lipids (L4, L5), not containing a sugar, phosphate or 
amino residue. However, GL2 showed a chromatographic motility similar to a glycolipid 
detected in Bacillus subtilis and considered to be β-gentiobiosyldiacylglycerol (Kämpfer et 
al., 2006). 
Mass spectra of whole bacterial cells provide a snapshot of the bacterial protein 
composition and have been widely used to achieve specific biomarkers of closely related 
species (Šedo et al., 2011).  Spectral profiles comparison of B. pumilus ATCC 7061T, B. 
safensis FO-36bT and Bi.FFUP1 showed the presence of several species-specific mass 
peaks (Figure 1a, marked with *). Peaks with m/z values of 6100 was specific for Bi.FFUP1; 
3707, 4414, 5290, 5575, 6124, 6798 for B. safensis FO-36bT and 3853, 4189, 4507, 4693, 
5556, 5933, 6414, 6622, 6941, 7509, 8378, 9394, 11120 for B. pumilus ATCC 7061T.  
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A PCA of all isolates (B. pumilus ATCC 14884 and 7061T, B. safensis FO-036bT and 
Bi.FFUP1, Bi.FFUP2, and Bi.FFUP3) clearly revealed the presence of three distinct clusters 
(Figure 1b), comprising each one a different species. Moreover, from this analysis B. 
pumilus and B. safensis were discriminated from Bi.FFUP1 in the first principal component 
(PC1), which accounts for 72.6% of the spectral variability, meaning that Bi.FFUP1 was the 
most distinct species presented. Further studies comprising mass spectra’s of B.  
altitudinis and  B. xiamenensis should also be performed. 
Bacterial infrared spectra of the whole bacterial cell content have already demonstrated 
great potential for bacterial identification at different taxonomic levels (Kuhm et al., 2009; 
Sousa et al., 2012). Whereas other methods require the use of specific marker to allow 
the bacterial differentiation, the infrared analysis provides an entire range of molecular 
information on the bacteria of interest. Spectra profiles of the type strains B. pumilus 
ATCC 7061T, B. safensis FO-036bT and Bi.FFUP1 were also clearly distinct, considering the 
carbohydrates region comprised between 1200-900cm-1 (Figure 2a), which evidenced a 
different sugar composition among the three species. Furthermore and similarly to the 
MALDI-TOF/MS analysis, PCA (Figure 2b) of FTIR-ATR spectra revealed three perfectly 
individualized groups, each one containing a different species. The first principal 
component (PC1) allowed the discrimination of Bi.FFUP1 from B. pumilus and B. safensis 
and accounted for 83.0% of the spectral variability. These results support Bi.FFUP1 as a 
different species and also as the species more distantly related, when B. pumilus and B. 
safensis were compared. Similar to MALDI-TOF/MS approach, further studies comprising 
infrared spectra of the whole bacterial cell content of B.  altitudinis and  B. xiamenensis 
should also be performed 
Phylogenetic analysis of 16S rRNA gene sequences grouped the three Bi.FFUP1, Bi.FFUP2 
and Bi.FFUP3 isolates close to B. pumilus ATCC 14884 and 7061T, B. safensis FO-036bT, B.  
altitudinis 41KF2b T and B. xiamenensis HYC-10T with ≥99% of identity. Since limitations 
of 16S rRNA sequences to decipher relationships at species level are recognized, in 
which strains with >99% 16S rRNA sequences similarity may not belong to the same 
species (Wang et al., 2001), comparative rpoB and gyrB gene sequence analyses were 
carried out.  
The isolates Bi.FFUP1, Bi.FFUP2 and Bi.FFUP3 (revealing 99.8% of similarity among their rpoB 
gene sequence) shared 96.9%, 97.1%, 96.2%, 98.5% and 97.9% in rpoB sequence 
similarity with B. pumilus ATCC 14884 and 7061T and B. safensis FO-036bT, B.  altitudinis 
41KF2bT and B. xiamenensis HYC-10T, respectively. In addition, a 92.7%, 92.9%, 90.8%, 
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98.5% and 92.1% of similarity was achieved in gyrB gene sequence analysis between 
Bi.FFUP1, Bi.FFUP2 and Bi.FFUP3 (sharing 100% of similarity among them) and B. pumilus 
ATCC 14884 and 7061T and B. safensis FO-036bT, , B.  altitudinis 41KF2bT and B. 
xiamenensis HYC-10T, respectively. Moreover, these rpoB and gyrB genes sequences 
comparison were supported by a bootstrap value of >78% (Figure 3 and 4). 
Thus, rpoB and gyrB genes sequence-based phylogenetic topology proved to be more 
discriminative than 16S rRNA gene sequences, also supporting the high degree of 
polymorphism recognized to these genes, grouping these strains monophyletically in a 
cluster separate from B. pumilus ATCC 14884 and 7061T and B. safensis FO-036bT, B.  
altitudinis 41KF2bT and B. xiamenensis HYC-10T representatives.  
The DNA G+C content for Bi.FFUP1 was 41 mol%. 
DNA hybridization analyses was carried out to evaluate the genomic DNA-DNA 
relatedness between strain Bi.FFUP1 and the most closely related reference strains B. 
pumilus ATCC 14884 and 7061T, B. safensis FO-036bT and B. altitudinis 41KF2bT. Values 
of 39.75% ±0.35, 69.40 ±2, 49.65% ±0.50 and 61.90 were respectively obtained (Table 4). 
Moreover, further analysis comprising DNA-DNA relatedness of B. xiamenensis should 
also be performed, although metabolic profile and phylogenetic affiliations derived from 
gyrB and rpoB genes clearly distinguish these species. According the DNA-DNA criteria 
for bacterial species definition recommended by the ad hoc committee (Wayne et al., 
1987) a similarity-threshold value of 70% must be considered. Nevertheless, some reports 
ambiguities were recognized (Adékambi et al., 2008; Nhung et al., 2007) when a DDH cut-
off equal to or higher than 70% was applied as a threshold for delineation of species, 
demonstrating that this value should not be used as a strict species boundary. In fact the 
novel species demonstrated approximately 70% DDH similarity with type strain of B. 
pumilus ATCC 7061T, but only ~40% with a reference strain B. pumilus ATCC 14884, 
despite the similarity on 16S rRNA, gyrB and rpoB sequence genes and phenotypic 
characteristics among these two B. pumilus collection strains, highlighting the ambiguities 
in the taxonomic grouping based on a rigorously DDH cut-off.  
Data from the polyphasic studies described above, clearly supporting the claim that the 
three isolates from health´s products represented a novel species within the genus 
Bacillus, for which the name Bacillus invictus sp. nov. is proposed. 
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Our results also demonstrated: (i) the suitability of the gyrB and rpoB as adequate 
markers for the phylogenetic discrimination between Bacillus invictus sp. nov., B. pumilus, 
B. safensis, B. altitudinis and B. xiamenensis and (ii) the reliability and the interest of two 
different spectroscopic techniques (MALDI-TOF/MS and FTIR-ATR) on the differentiation 
of closely related B. pumilus group species, namely among B. pumilus, B. safensis and B. 
invictus sp. nov.  
Description of Bacillus invictus sp. nov. 
Bacillus invictus (in.vi´.ctus. adj. masc. invictus pertaining to Oporto city). 
Vegetative cells are rod-shaped and 0.5 – 0.7 mm in diameter an 1.0 – 1.5 mm in length, 
Gram-positive, motile and catalase- and oxidase-positive. Does not grow anaerobically. 
Growth occurs at 25-50 ºC (optimum, 30-37 ºC) but not at 4 or 60 ºC. Growth occurs in 
the range 0-10% (w/v) NaCl and at pH range 6.0–8.0. Colonies are round, smooth, 
yellowish in color, have irregular margins and approximately 2.8 ±0.2 mm on TSA plates 
incubated at 37 ºC for 24 h. Nitrate is not reduced to nitrogen gas but gelatine, esculin and 
citrate is utilized.  
ONPG, L-proline, L-leucine, L-phenylalanine are decomposed but not L-valine, L-
tryptophan, L-arginine L-ornithine, L-lysine or urea. β-haemolytic on 5% sheep blood agar. 
Acid is produced from glycerol, D-ribose, glucose, fructose, mannose, arbutin, esculin, 
salicin, cellobiose, sucrose, trehalose, gentiobiose, D-tagatose and L-arabinose, but not 
from L-xylose, adonitol, sorbose, rhamnose, dulcitol, inositol, mannitol, D-sorbitol, 
methyl α-D-glucoside, maltose, melibiose, inulin, raffinose, starch, glycogen, xylitol, 
turanose, D-lyxose, D-fucose, L-fucose, D-arabitol, L-arabitol, erythritol, methyl β-D-
xyloside, melezitose, gluconate, 2-ketogluconate or 5-ketogluconate, D-arabinose and 
lactose. Reactions from D-xylose, D-galactose, α methyl-D-mannoside, N-
acetylglucosamine and amygdalin vary among strains. The chain composition of the 
whole-cell fatty acids is C15:0 iso (41.3%), C15:0 anteiso (35.3%), C17:0 iso (4.9%) and C17:0 
anteiso (6.6%). Quinone system is menaquinone MK-7. Polar lipid profile consist of the 
major lipids diphosphatIdylglycerol, an unidentified phospholipid phosphatidylglycerol two 
unidentified glycolipids and three lipids not containing a sugar, phosphate or amino 
residue. The DNA G+C content is 41 mol%. MALDI-TOF mass spectra reveal peaks with 
m/z values of 3690, 3824, 4305, 5272, 5950, 6100, 6704 and 7416 for Bi.FFUP1. A 
characteristic carbohydrate pattern by FTIR-ATR spectroscopy is also demonstrated. The 
type strain BiFFUP1 (DSM 26896 and CCUG 64113), was isolated from health´s 
contaminated products in Portugal. 
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Table 1. Differential metabolic profiles of strain Bi.FFUP1T and closely related B. pumilus ATCC 7061T, B. safensis FO-036bT, B. xiamenensis HYC-10T 
and B. altitudinis 41KF2bT. 
 Bi.FFUP1T B. pumilus ATCC 7061T B. safensis FO-036bT B. xiamenensis HYC-10T B. altitudinis 41KF2bT 
Carbohydrates acid production profile    
Cellobiose + - + + + 
D-Arabinose - + + - + 
Erythritol  - + + - - 
Glucose  + - + - - 
Inositol  - + - - - 
Maltose - + - - + 
Mannitol - + + + + 
Mannose + + - + + 
Raffinose - + - + - 
Rhamnose - - - + + 
Sorbitol - - - + + 
Starch - - - + + 
Amino acid utilization      
L-Arginine - - - - + 
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Table 2. Bacillus spp. used in this study, their sources and correspondent GenBank 
accession numbers. 
Origin Isolate 
Year/Origin/ 
Location 
GenBank acession numbers 
16S rRNA gene  rpoB gene gyrB gene  
Health Products (Medicines) 
Bi.FFUP1 a 
2005/health 
products/Pt a 
JX183147 JX183163 JX183192  
Bi.FFUP2  a 
2005/health 
products/Pt a 
JN699028 JX183165 JX183194 
Bi.FFUP3  a 
2005/health 
products/Pt a 
JN699026 JX183168 JX183197 
ATCC (B. pumilus reference 
strain)  
ATCC14884  JF749284 KC895450 KC895462 
ATCC (B. pumilus type 
strain) 
ATCC 7061T   GQ911554.1 EU138862.1 AY167869.1 
B. safensis type strain FO-036b T 
1999/Clean-room 
air particulate/USA 
AF234854  KC895451 AY167867 
B. xiamenensis type strain HYC-10T 
2014/mullet-Mugil 
cephalus/China 
JX680066 JX679987 JX680142 
B. altitudinis type strain 41KF2bT 
2006/ High-
elevation air 
sample/India 
AJ831842 JX680064 JX680219 
a Isolates obtained to this study from Quality Control Department (INFARMED), Lisbon, Portugal. 
ATCC, American Type Culture Collection, Manassas, VA, USA.  
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Table 3. Major fatty acids profiles of novel isolates from Bacillus sp. and their closely 
related species. 
 Fatty Acids 
 iso-C15:0 iso-C17:0 anteiso-C15:0 anteiso-C17:0 
Bi.FFUP1T 41.3 4.9 35.3 6.6 
B. xiamenensis HYC-10T 39.1 13.1 22.7 5.8 
B. altitudinis 41KF2bT 46.1 7.4 25.5 5.7 
B. safensis FO-036b T 44.2 10.1 23.1 6.7 
B. pumilus ATCC 7061T 22.2 7.8 36.3 10.5 
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Table 4. DNA-DNA hybridization relatedness (%±SD) of the Bacillus invictus sp. nov. with 
reference strains B. pumilus ATCC 14884, B. pumilus ATCC 7061T, B. safensis FO-036bT 
and B. altitudinis 41KF2bT. 
Strains B. invictus Bi.FFUP1 
B. pumilus ATCC 14884 39.75% ±0.35 
B. pumilus ATCC 7061T 69.40% ± 2.00 
B. safensis FO-036bT 49.65% ±0.50 
B. altitudinis 41KF2bT 61.90% 
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Figure 1. a) Mass spectra comparison of Bi.FFUP1T and closed related B. safensis FO-36bT and B. pumilus ATCC 7061T generated by MALDI-
TOF/MS. Species-specific peaks are indicated by (*). A. u. means arbitrary intensity. b) Score plot corresponding to the first three components of the 
PCA regression model of isolates Bi.FFUP1T, Bi.FFUP2, Bi.FFUP3, B. safensis FO-36bT, B. pumilus ATCC 7061T and B. pumilus ATCC 14884 analyzed. 
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Figure 2. a) FTIR-ATR spectra of Bacillus invictus sp. 
nov. Bi.FFUP1T and closely related B. safensis FO-36bT 
and B. pumilus ATCC 7061T processed with SNV and 
Savitzky-Golay (9 points filter size, 2nd degree 
polynomial, 2nd derivative) in the region 1200-900 cm-1. 
b) Score plot corresponding to the first three 
components of the PCA regression model of isolates 
Bi.FFUP1T, Bi.FFUP2, Bi.FFUP3, B. safensis FO-36bT, B. 
pumilus ATCC 7061T and B. pumilus ATCC 14884 
analyzed. 
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Figure 3. Neighbour-joining (NJ) tree based on the rpoB gene sequences comparison, showing the relationship of strains Bi.FFUP1, Bi.FFUP2 and Bi.FFUP3 
with related species. Genetic distances were constructed using Jukes-Cantor model. Numbers at branch points indicated bootstrap percentages from 
both NJ (before the slash ‘/’) and ML analyses (after the slash ‘/’). As NJ tree was very similar to the ML tree, only the first is shown. B. subtilis subsp. 
subtilis str. 168, B. amyloliquefaciens DSM7T, B. licheniformis ATCC 14580T and B. cereus ATCC 14579T were used as outgroups. Accession 
numbers were given in parentheses. Bar: genetic distance of 0.02. 
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Figure 4. Neighbour-joining (NJ) tree based on the gyrB gene sequences comparison, showing the relationship of strains Bi.FFUP1, Bi.FFUP2 and Bi.FFUP3 
with related species. Genetic distances were constructed using Jukes-Cantor model. Numbers at branch points indicated bootstrap percentages from 
both NJ (before the slash ‘/’) and ML analyses (after the slash ‘/’). As NJ tree was very similar to the ML tree, only the first is shown. B. subtilis subsp. 
subtilis str. 168, B. amyloliquefaciens DSM7T, B. licheniformis ATCC 14580T and B. cereus ATCC 14579T were used as outgroups. Accession 
numbers were given in parentheses. Bar: genetic distance of 0.05. 
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Figure 5. Total polar lipid profile of Bi.FFUP1T after two-dimensional thin layer 
chromatography and detection with 5% ethanolic molybdatophosphoric acid. DPG, 
diphosphatidylglycerol; PG, phosphatidylglycerol; GL1-2, unidentified glycolipids; PL1, 
unidentified phospholipid; AL1, unidentified aminolipid; L1-5 unidentified polar lipids not 
containing a phosphate, an amino or sugar residues. 
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Table S1. Physiological and phenotypic characteristics of B. invictus strains Bi.FFUP1T, 
Bi.FFUP2 and Bi.FFUP3 (data from this study).  
Characteristics Bi.FFUP1T Bi.FFUP2 Bi.FFUP3 
Growth ability 
NaCl range (%, w/v) 0-10 0-10 0-10 
pH range 6-8 6-8 6-8 
Temperature range 25-50 ºC 25-50 ºC 25-50 ºC 
Optimum temperature 30-37 ºC 30-37 ºC 30-37 ºC 
Hydrolysis of  
Esculin + + + 
Gelatin + + + 
Citrate + + + 
Nitrate - - - 
Carbohydrates acid production profile 
D-Arabinose - - - 
D-Galactose +/- +/- +/- 
L-Arbinose  + + + 
Erythritol  - - - 
D-Xylose +/- +/- +/- 
L-Xylose  - - - 
Adonitol  - - - 
ß-Methyl – D-Xyloside  - - - 
Glucose  + + + 
Fructose  + + + 
Sorbose  - - - 
Rhamnose  - - - 
Inositol  - - - 
Sorbitol  - - - 
a-Methyl-D-Mannoside +/- +/- +/- 
a-Methyl-D-Glucoside  - - - 
N-Acetyl Glucosamine  +/- +/- +/- 
Amygdalin  +/- +/- +/- 
Arbutin  + + + 
Trehalose  + + + 
Inulin  - - - 
Glycogen  - - - 
Xylitol  - - - 
Gentiobiose  + + + 
Turanose  - - - 
D-Lyxose  - - - 
D-Tagatose  + + + 
D-Fucose  - - - 
L-Fucose  - - - 
D-Arabitol - - - 
L-Arabitol  - - - 
Gluconate  - - - 
2-Keto Gluconate - - - 
5-Keto Gluconate - - - 
Cellobiose + + + 
Lactose - - - 
Maltose - - - 
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Mannose + + + 
Melezitose - - - 
Melibiose - - - 
Raffinose - - - 
D-Ribose + + + 
Salicin + + + 
Starch - - - 
Sucrose + + + 
Dulcitol - - - 
Glycerol + + + 
Mannitol - - - 
Amino acid utilization    
L-Arginine - - - 
L-Leucine + + + 
L-Proline + + + 
L-Ornithine - - - 
L- Phenylalanine + + + 
L-Tryptophan - - - 
L-Lysine - - - 
L-Valine - - - 
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Table S2. PCR primers sequences and amplification conditions for detection of 16S rDNA, rpoB and gyrB genes. 
Gene 
Primer 
name 
Primer sequences 5´- 3´ 
PCR amplification 
References 
Denaturation Annealing Cycles 
Final 
extension 
16S rDNA 
Seq_A AGAGTTTGATCHTGGYTYAGA 
94ºC for 30 s  55ºC for 60 s 30 72ºC for 120s [6] 
Seq_B ACGYTACCTTGTTACGACTTC 
β-subunit of 
RNA 
polymerase 
(rpoB gene) 
 
rpoB1_fw 
rpoB1_rv 
rpob2_fw 
rpoB2_rv 
rpoB3_fw 
rpoB3_rv 
rpoB4_fw 
rpoB4_rv 
CAGAAGCTACGCACGCATAA 
GCGTCCAACATTTGCTAGGT 
CAACACGCTGGAAAAAGACA 
TTCTCGGCGTCACTTTACCT 
CACCAGAGGGTCCAAACATT 
GGTTGCGTAAAGCATCTTCC 
CATGAGTGAGCGCCTTGTAA 
CGTCTGCTTTCTTCGTTTCC 
94ºC for 30 s 56ºC for 60 s 30 72ºC for 120s This study 
β-subunit of 
DNA gyrase 
(gyrB) 
UP-1S 
UP-2Sr 
GAAGTCATCATGACCGTTCTGCAYGCNGGNGGNAARTTYGA 
AGCAGGGTACGGATGTGCGAGCCRTCNACRTCNGCRTCNGTCAT 
94ºC for 60 s  60ºC for 60 s 30 72ºC for 120s [23] 
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2.3. Differentiation of Bacillus pumilus and Bacillus safensis using MALDI-
TOF/MS 
Publications: 
Differentiation of Bacillus pumilus and Bacillus safensis using MALDI-TOF/MS 
In this study, supported on a diversity of isolates and using vegetative cell forms treated 
with a protocol enriching proteins, were demonstrated the ability of MALDI-TOF/MS to 
provide a reproducible and significant protein profiling of B. pumilus and B. safensis. 
Moreover, for the first time, a combination of MALDI-TOF/MS and chemometric methods 
were proved to differentiate these closed species. Species-specific peaks were identified, 
being also for the first time some of them putatively assigned as ribosomal or spore’s 
proteins.  
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Abstract 
 
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF/MS) is increasingly used as a rapid method for microbial identification at different 
taxonomic levels. This method is of especially interest in species difficult to differentiate by 
other conventional methodologies, such as Bacillus pumillus and Bacillus safensis, for 
which biotechnological and pharmaceutical significance has been underlined by the 
production of several compounds with a wide range of applications. 
In this study, we demonstrate the suitability of MALDI-TOF/MS protein profiling for a 
reliable B. pumillus and B. safensis differentiation, using a comprehensive and 
genotipically well characterized collection of isolates recovered from different origins and 
geographic locations. The resulting mass fingerprints, obtained from vegetative cell forms 
coupled with a protein enrichment treatment, were analyzed and characteristic peaks at 
the species level were assigned. Results showed that spectral fingerprints provided 
reproducible species-specific ion peaks signals.  Using a chemometric approach the score 
plot generated by partial least square discriminant analysis (PLSDA) of mass spectra 
demonstrated the presence of two individualized clusters, each one enclosing isolates 
belonging to a species-specific spectral group. In addition, the generated pool of species-
specific proteins was compared and some characteristic species-specific ion peaks 
tentatively assigned. Therefore, in B. pumilus the specific ion m/z peak of 5271 can be 
associated with one small acid-soluble spore protein (SASP O) or with 50S protein L35, 
whereas in B. safensis specific ion m/z peaks of 5288 and 5568 can be correlated with 
SASP J and P, respectively, and m/z of 6413 with 50S protein L32. 
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Introduction 
Bacillus pumilus and Bacillus safensis are the most widespread and relevant terrestrial 
species among Bacillus pumilus group [1, 2, 3, 4, 5]. Their biotechnological and 
pharmaceutical significance has been highlighted by a wide range of applications, mostly 
supported on the production of peptides and/or lipopeptides with antibacterial and 
antifungal properties [6, 7], including as probiotics [8, 9, 10], animal feed supplements [11, 
12], as well as phytosanitary-based products [1, 3] in different plants production. 
Moreover, these species are common contaminant agents into industrial units, namely in 
food and/or pharmaceutical sectors, posing a serious problem to the quality control of 
these areas [2, 4]. 
B. pumilus and B. safensis are difficult to distinguish on the basis of phenotypic and 
biochemical characteristics and present a remarkably high level of 16S rRNA gene 
similarity (>99%) [5]. Sequencing of housekeeping genes such as gyrB and rpoB could be 
used as a valuable tool to discriminate them, although difficult to implement in routine 
microbiology laboratories [4, 5].  
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-
TOF/MS), being an accurate, fast and affordable emerging technique has been 
increasingly used for identification of bacteria at different taxonomical levels [13, 14]. As a 
proteomics technique, MALDI-TOF/MS relies on the reproducible detection of microbial 
protein patterns, which can be used for microbial identification by comparing experimental 
mass spectra with a library of known reference strains or by comparing information of 
species-specific biomarkers identities [15, 16].  
Dickinson et al. [17], using directly spore forms of B. pumilus and B. safensis recovered 
from a spacecraft unit and assembly-facility surfaces proposed their differentiation based 
on a single m/z peak by MALDI-TOF/MS. Nevertheless, there is a need for further studies 
in order to assess the validity of this discriminatory tool. Moreover, Lash et al. [18, 19] 
suggested that bacterial vegetative cell forms through an adequate sample preparation 
encompassing protein enrichment could provide a more informative mass spectra pattern 
than that obtained with bacterial spore forms [18, 19]. 
The snapshot of different protein compositions detected by MALDI-TOF/MS may also 
constitute a valuable approach for the exploration of bacterial species-specific biomarkers. 
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Indeed, in Bacillus spp. ribosomal proteins and small acid-soluble spore proteins (SASPs) 
have been associated to several MS signals detected [19], and thus, can be used as 
potential species-specific biomarkers. Despite this characterization has been successfully 
applied to Bacillus cereus group species [19] it has not been considered in members of B. 
pumilus group. In this work, through the implementation of a protocol that enhances 
proteins extraction [19], combined with chemometric tools, we assessed the potential of 
MALDI-TOF/MS fingerprinting to discriminate B. safensis and B. pumilus, using a 
comprehensive collection of isolates. Moreover, the presumptive assignment of their 
species-specific protein biomarkers was also performed. 
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Material and Methods 
Isolates collection and identification 
Five B. pumilus isolates and twenty-two B. safensis previously identified by phenotypic 
and genotypic (16S rRNA, gyrB and rpoB gene sequences) methods were studied [5, 20]. 
They comprise diverse PFGE-types and were recovered from different geographic 
terrestrial locations and sources, including food samples (Norway, Italy and Africa) (n=4), 
plants (USA) (n=2), gastropods (Portugal) (n=3), medicines (n=6) and cosmetic (n=4) 
products (Portugal), clean room environments from Mars Odyssey (USA) (n=5) as well as 
type and reference strains (B. pumilus ATCC 7061T and 14884, and B. safensis FO-36bT) 
(table 1).  
Sample preparation 
For MALDI-TOF/MS analysis, soluble proteins were extracted from Bacillus spp. cultures 
grown under aerobic conditions on LB agar (Merck, Darmstadt, Germany) for 24 h at 37 
°C. Bacterial cells were harvested by transferring three full loops (ca. 30 μl) from each 
agar plate into 20 μl of sterile water and afterward resuspended by vortexing. Sample 
inactivation was carried out applying the modified trifluoroacetic acid (TFA) (Sigma-
Aldrich, St. Louis, MO) inactivation protocol [18], with some modifications previously 
established to improve the accuracy of the mass spectra [18]. Briefly, 80 μl of pure TFA 
was added to 20 μl of the bacterial water suspensions. After gentle shaking for 5 min at 
room temperature, the solution was centrifuged during 20 min at 13000 rpm at 4 ºC 
followed by 10-fold dilution with HPLC grade water. The supernatant was then filtered 
through 0.22 µm pore size filter (Millipore Corp., Bedford, MA) and stored at -20 ºC to 
further analyses. 
Mass spectrometry methods 
Snapshots of different protein compositions were detected and acquired by a MALDI-
TOF/TOF mass spectrometer (4800 Plus MALDI TOF/TOF Analyzer, AB SCIEX, 
Framingham, MA) operating in linear positive mode. Each spectrum was the accumulated 
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sum of at least 2000 laser shots for m/z 2500-12000 due to the good reproducibility of the 
spectral profile in that mass range. All the spectra were externally calibrated using a 
commercial mixture of angiotensin I, ACTH and insulin (AB SCIEX, Framingham, MA) and 
analyzed with the Data Explorer software (Version 4.6, AB SCIEX, Framingham, MA). 
For MALDI-TOF/MS experiments, 2 μl of the filtrated microbial dilution were mixed with 2 
μl of a 12-mg/ml α-cyano-4-hydroxycinnamic acid (CHCA) (Sigma-Aldrich, St. Louis, MO) 
solution in 100% ACN and 0.3% TFA. 1 μl of the mixture was spotted onto a stainless 
steel MALDI sample plate and allowed to dry at room temperature. For each isolate, two 
biological replicates (obtained from two different agar plates) were carried out and the 
mean spectra were considered for the analysis. Mass spectra were baseline corrected, 
noise-filtered and m/z values were extracted from the raw experimental mass spectra that 
included all the mass peaks with a relative signal to noise (S/N) ratio intensity above 2.  
 
Chemometric methods 
MALDI-TOF/MS spectra were mean-centred and analysed by partial least squares 
discriminant analysis (PLSDA) [21]. The PLSDA scores were used as the source for 
hierarchical cluster analysis (HCA). The purpose of HCA was the generation of 
dendrograms highlighting the association between isolates. Dendrograms were performed 
directly on unprocessed PLSDA scores using the Euclidean distance and the Median’s 
algorithm [22]. All chemometric models were performed in Matlab version 6.5 release 13 
(MathWorks, Natick, MA) and the PLS Toolbox version 3.5 for Matlab (Eigenvector 
Research, Manson, WA). 
 
Biomarker identification 
Intact protein masses were used to generate a pool of candidate’s proteins for the 
identification of specific markers. The selected distinct mass information was submitted to 
a web-based TagIdent software tool (http://web.expasy.org/tagident/) using 1% mass error 
and searching Bacillus pumilus as the taxonomy search tool. No restrictions on protein 
isoelectric point were used. This tool allowed the identification of proteins based on the 
experimental masses acquired by mass spectrometry using the information available at 
the UniProtKB/Swiss-Prot and UniProtKB/TrEMBL protein sequence databases. 
Moreover, ribosomal proteins of genome-sequenced type strains, including B. pumilus 
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ATCC 7061T available in the database developed by Hotta et al. [23] were also included 
for comparison. For tentative assignments, N-terminal methionine loss was first 
considered based on the “N-end rule” [24], where N-terminal methionine is cleaved from 
specific penultimate amino acid residues such as glycine, alanine, serine, proline, valine, 
threonine and cysteine. To validate the candidate peak assignments of the species-
specific-peaks, molecular masses of the presumed assignments were further confirmed 
by MALDI-TOF/MS in the reflector positive acquisition mode. 
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Results and Discussion 
 
One of the current challenges in bacterial taxonomy is to integrate timely and accurate 
typing methods for a meaningful identification of microorganisms [13], which is particularly 
problematic for closely related species such as B. pumilus and B. safensis [2, 5]. 
Discrimination of these species by sequencing of molecular markers (e.g. gyrB), a time 
demanding and expensive methodology not readily available for routine laboratories, was 
recently demonstrated [4, 5]. Because of the range of applications, from animal feed 
supplements to plant-growth promoters, and medical and industrial relevance of B. 
pumilus and B. safensis isolates, reliable, easy and rapid methodologies for their correct 
differentiation are needed. Despite the interest of MALDI-TOF/MS in bacterial 
differentiation there are no comprehensive studies assessing its potential on B. pumilus 
and B. safensis discrimination. Moreover, presumptive assignment of B. pumilus and B. 
safensis species-specific protein biomarkers was not previously attempted. 
 
Sample preparation conditions 
Identification of bacterial species by MALDI-TOF/MS, is based on their mass profile 
considering analytes with low mass weight (less than 20 000 Da) obtained from whole 
bacterial cells suspensions. Therefore, for MS applications it is imperative to define a 
standardized protocol including the establishment of a rigorous sample preparation and 
cultivation conditions (culture medium, temperature and time), which should provide an 
adequate number of ion mass peaks to allow identification and discrimination of closely 
related bacterial species. Additionally, definition of strict parameters for spectral data 
acquisition is also required. 
The protein enrichment reported by Lash et al [18] for B. cereus group members, using a 
protocol combining a TFA treatment, centrifugation, and filtration steps was successfully 
applied to B. pumilus and B. safensis isolates clonally diverse and collected from different 
terrestrial origins [4]. Therefore, we demonstrate that this easy sample preparation 
approach can be applied to these species to generate reproducible mass spectra data 
with sufficient number of mass peaks, reinforcing the potential for the successful 
application of the MS technique in routine laboratories. 
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Mass spectrometry analysis 
The figure 1 displays arithmetic means of MALDI-TOF/MS profiles from the two Bacillus 
species under study: (a) B. pumilus (5 spectra) and (b) B. safensis (22 spectra), in the 
range 2000 to 12000 m/z. In fact, MALDI-TOF/MS profile analysis revealed the presence 
of species-specific mass signals. Table 2 compiles the characteristic peak masses for 
each spectral group and the respective m/z peak present in both species.  
As expected, similar fingerprints could be observed for isolates belonging to the same 
species, exhibiting several common peaks. For instance, ion peaks at m/z values of 
2069.5, 2170, 3060, 3608.5, 5271 and 6122 are characteristic of B. pumilus isolates, while 
m/z values of 2063.5, 2623.5, 2730, 3049, 3396, 5288, 5568, 6094 and 6413 are related 
to B. safensis. Moreover, B. pumilus and B. safensis isolates, demonstrated common ion 
peaks at m/z 2287.5, 2399.5, 2511.5, 3692.5, 3821.5, 4305.5, 5948.5, 6704, 6793.5 and 
7415 (table 2), which can be considered characteristic peaks for both species, 
corroborating the similarities among them.  
Remarkably, some spectral variability was observed within isolates belonging to the same 
spectral group, including the presence or absence of some ion peaks beyond those listed 
in table 2 (data not shown). This observation is not surprisingly, since we noticed that both 
species comprises a clonally diverse population, in which specific peptide profile probably 
reflects their evolution towards an adaptation to different niches [4]. 
Few studies have explored the potential of MALDI-TOF/MS to correctly identify B. pumilus 
or B. safensis isolates [17, 25, 26, 27]. The characterization of an unknown spectrum can 
be limited to the bacterial species present in a specific database and therefore, bacterial 
identification is only possible inside the frame of this reference library. Moreover, few well 
characterized B. pumilus isolates are available in public databases, as SpectraBank 
(http://www.spectrabank.org), namely the type strain ATCC 7061T and the reference 
strains ATCC 14884, and no B. safensis was yet included, which constrains its 
identification.  
Farfour et al. [25] applying MALDI-TOF/MS supported by Andromas database and 
analyzing the samples without previous preparation, showed that it was not possible to 
differentiate B. pumilus and B. safensis isolates, highlighting the need for the improvement 
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and enlargement of the database and eventual sample treatment before MS analysis to 
improve sensitivity.  
Moreover, using B. pumilus reference strains (ATCC 7061T and 14884) and a sample 
extraction procedure comprising bacterial biomass harvest in a solvent followed by a 
centrifugation step, Böhme et al. [26] suggested the presence of ion peak values at m/z of 
3620, 5297, 6617 and 7237 as specific for this species when compared with Bacillus 
subtliis, Bacillus amyloliquefaciens, Bacillus licheniformis, Bacillus megaterium, Bacillus 
thuringiensis and Bacillus cereus. In addition, the presence of m/z of 3620, 6617 and 7238 
were also detected by Fernández-No et al. [27] in the same reference strains. Analysis of 
our MALDI-TOF/MS profiles did not reveal these ion m/z peaks as B. pumilus species-
specific, nevertheless, a closer inspection of mass spectra of B. pumilus ATCC 7061T and 
14884 recognizes the presence of ion peaks at m/z values of 3621, 5290 and 6624, 
although the peak 7238 m/z was not detected. The differences found in these bacterial 
profiles can be justified by the distinct culture medium used and the sample preparation 
procedure employed. 
Dickinson et al. [17] presented MALDI-TOF/MS as a useful taxonomic tool for 
differentiating spores of B. pumilus and B. safensis. Results revealed the presence of two 
groups of characteristic peaks, comprising B. pumilus (m/z of 6860, 7230 and 9606) and 
B. safensis (m/z of 6860, 7230, 7620 and 9606). The authors claimed the presence of the 
additional ion peak at m/z of 7620 Da in the spectra profile of B. safensis as a species-
specific biomarker, allowing the discrimination of these two species. Nonetheless, analysis 
of our B. safensis spectral data (n=22) did not reveal the presence of this m/z peak, 
probably because the obtained MALDI-TOF/MS profiles were from vegetative cell forms. 
Additionally, the spectral profile obtained from spore cell forms seems to be insufficient to 
appropriately discriminate among these closely related species, since spectral data with 
few number of ion peaks were generated.  
 
Chemometric analysis 
B. pumilus and B. safensis were clearly discriminated by a combined MALDI-TOF/MS and 
chemometrics approach. Score plot generated by partial least square discriminant 
analysis (PLSDA) of mass spectra of all isolates tested, exhibited two individualized 
clusters, each one enclosing isolates belonging to a particular spectral group, which 
included reference and type strains (Fig. 2) of (a) B. pumilus and (b) B. safensis. The 
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PLSDA scores were also presented in a form of dendrogram corroborating the species 
discrimination into two distinct clusters (Fig. 2). Moreover, this approach allowed the 
discrimination of the two Bacillus species with 100% of sensitivity and specificity. 
Despite the recognized proficiency of chemometric tools for the analysis and identification 
of bacteria based on their fingerprint, in the case of Bacillus spp, this characterization was 
only previously applied in B. cereus group species [19]. Therefore, this is the first 
successful application of this approach considering members of B. pumilus group, 
stressing its relevance for discrimination among closed related species. 
Putative molecular biomarkers assignments 
The possibility of biomarkers identification is one of the most valuable aspects of the MS-
based identification techniques. The assignment of 25 mass signals in the spectra of B. 
pumilus and B. safensis represent the first consistent evidence of relation between these 
ion m/z peaks and the specific candidate protein sequences, which are presented in table 
3. Nevertheless, as only two B. pumilus genomes, with numerous proteins defined as
unknown can be found in UniProtKB/Swiss-Prot and UniProtKB/TrEMBL (B. pumilus 
SAFR-032 and ATCC 7061T) and no B. safensis were deposited, the identification of 
putative biomarkers is hindered. In fact, this type of assignments can be only tentatively 
used to establish potential connections between protein sequences and ion mass signals, 
and thus, should be prudently interpreted.  
Ribosomal proteins and small, acid-soluble spore proteins (SASPs) have been suggested 
to be responsible for many mass signals detected by MALDI-TOF/MS profiles [19]. Since 
up to 21% of the overall cellular protein content is ribosomal and because of the fact that 
ribosomal proteins are part of the cellular translational machinery constitutively expressed 
in vegetative cells, they constitute a stable ensemble of protein biomarkers suitable for 
use by fingerprinting techniques [28]. Moreover SASPs, a group of species-specific 
proteins present in large amounts in the core region of Bacillus endospores, have been 
also suggested as biomarkers for rapid differentiation and identification of Bacillus spp. 
using mass spectrometry approaches [29, 30, 31].  
We found evidences of B. pumilus and B. safensis specific biomarkers, associated with 
ion peaks at m/z 4305.5, 5948.5, 6793.5 and 7415, which can correspond to 50S 
ribosomal subunits proteins, respectively, L36, L33, L28 and L35 of B. pumilus SAFR-032 
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(correspondent amino acidic sequences were also presented in table 3). Moreover, for the 
remaining ion peaks detected, four were not assigned (m/z of 2287.5, 2399.5, 2511.5 and 
3821.5) and two showed correspondences with membrane proteins of B. subtilis subsp. 
subtilis str 168, the YyzG and YjzG at m/z of 3692.5 and 6704, respectively. 
The tentative assignment of B. pumilus specific biomakers revealed the possible 
correspondence of the ion peak at m/z 5271 with the 50S ribosomal subunit protein L34 or 
with a SASP O and the m/z of 6122 with an uncharacterized membrane protein (YyzG) or 
with a transcriptional regulator – SlrA of B. subtilis subsp. subtilis str 168. Additionally, ion 
peaks at m/z of 2069.5, 2170, 3060 and 3608.5 were not possible to assign. 
Concerning B. safensis specific ion peaks at m/z of 5288, 5568 and 6413, potentially 
correspond with two specific SASP (SASP J and SASP P) and with a 50S ribosomal 
subunit protein L32 also found in B. pumilus SAFR-032. The remaining ion peaks 
detected were not possible to designate. Therefore, the proposed characteristic 
biomarkers, which could be used to differentiate between B. pumilus and B. safensis are 
summarized in table 4.  
In order to proof these putative peak assignments, molecular masses of species-specific 
peaks were evaluated using MALDI-TOF/MS in reflector positive mode, where the 
degradation of peptides was avoided to confirm its molecular weights (Fig. 3). 
Thus, our results suggest that ribosomal and spore proteins constitute most of the B. 
pumilus and B. safensis biomarkers. A more detailed analysis could be carried out with 
MS/MS peptide fragmentation of the specific proteins assigned and subsequent 
comparison in protein databases or even with MS/MS peptide de novo sequencing. 
Nevertheless, within the context of the present work, which aimed to establish a MALDI-
TOF/MS fingerprint classification for B. pumilus and B. safensis these results may be 
beneficial and improve further accuracy of MS-based detection methods in identifying 
these species. 
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Conclusion 
MALDI-TOF/MS profiles combined with chemometric analysis (PLSDA) proved to be 
valuable tools for discrimination of B. pumilus and B. safensis, allowing its rapid 
identification. These high throughput approaches should be promptly considered for 
Bacillus species identification due to the inaccuracy of conventional techniques in the 
identification of closely related species of this genus. In this sense, it is imperative to 
standardize a sample preparation protocol, which should include a protein extraction and 
enrichment step, to provide informative and reproducible mass spectra. Moreover, 
tentative assignment of B. pumilus and B. safensis protein biomarkers suggest that most 
of them are ribosomal and spore proteins. 
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Table 1. Origins of Bacillus spp. isolates (n=27) included in this study. 
Isolate Origin Year/Location References 
Bacillus pumilus 
Bp ATCC14884 Reference strain 
Bp ATCC 7061T Type Strain 
Bp7 
Medicine´s (n=3) 
2005/Portugal1 
[32] Bp11 2005/Portugal1 
Bp15 2005/Portugal1 
Bacillus safensis 
Bs1 
Animals Gastropods (n=3) 
2004/Portugal1 
[32] 
Bs2 2005/Portugal1 
Bs3 2007/Portugal1 
Bs13 
Medicine´s (n=3) 
2005/Portugal1 
Bs16 2005/Portugal1 
Bs17 2005/Portugal1 
Bs5 
Cosmetic´s (n=4) 
2002/Portugal1 
Bs18 2002/Portugal1 
Bs19 2002/Portugal1 
Bs27 2002/Portugal1 
Bs24 
Food´s /salame (n=3) 
2004/Italy2 
[33] Bs25 2004/Italy2 
Bs33 2004/Italy2 
Bs22 
Plant Growth Promoters (PGPR) (n=2) 
1997/USA3 
[34]  
Bs23 1997/USA3 
Bs31 Food/beans (n=1) 2003/Africa4 [35] 
Bs FO-36bT Clean-room/ air particulate (n=1) 1999/USA5 Type Strain, [21] 
Bs35 Clean-room/floor (n=1) 2001/USA5 
[2] 
Bs36 Clean-room/cabinet top (n=1) 2001/USA5 
Bs37 Clean-room/Mars Odyssey spacecraft surface (n=2) 2001/USA5 Bs38 
Bs42 Clean-room/anteroom (n=1) 2001/USA5 
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1Isolates obtained from the Quality Control Department (INFARMED), Lisbon, Portugal. 
2Isolates FEL 55 from salame felino, UNG22 from salame ungherese and MIL46 from salame milano obtained from the Istituto di Scienze delle Produzioni Alimentari 
(ISPA), Bari, Italy. 
3Isolates SE 49 (AP3) and SE 52 (AP7) from cucumber roots obtained from the Culture collection of the Department of Entomology and Plant Pathology, Auburn 
University, Alabama, USA. 
4Isolates Bs31 from African locust beans for Soumbala production obtained from Ouagadougou, Africa. 
5Isolates F036-b, SAFN-027, SAFN-037, KL-052, 51-3C and 82-2C from spacecraft and assembly-facility surfaces obtained from California Institute of Technology, 
California, USA. 
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Table 2. Species-specific ion peaks values (average) of B. pumilus and B. safensis 
isolates. 
Experimental average m/z values* 
B. pumilus B. safensis 
B. pumilus 
2069.5 
2170 
3060 
3608.5 
5271 
6122 
B. safensis 
2287.5 
2399.5 
2511.5 
3692.5 
3821.5 
4305.5 
5948.5 
6704 
6793.5 
7415 
2063.5 
2623.5 
2730 
3049 
3396 
5288 
5568 
6094 
6413 
* average m/z values (±2Da)
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Table 3. Overview of biomarkers tentative assignment of MALDI-TOF/MS mass signals of B. pumilus group species. Protein identity was determined 
by the TagIdent software and compared with ribosomal subunit proteins developed by Hotta et al [23] described in Materials and Methods section.  
Specie(s) Observed Mass (Da) 
Predicted 
Mass (Da)  
UniProt 
Accession 
ID 
Protein 
Description Peptide sequence Organism
c 
B. pumilus 
2069.5 NA Unassigned NA NA 
2170 NA Unassigned NA NA 
3060 NA Unassigned NA NA 
3608.5 NA Unassigned NA NA 
5271 
5270 A8FJG4 50S 
bRP subunit 
L34 MKRTFQPNNRKRSKVHGFRSRMSSKNGRLVLKRRRSKGRKKLSA 
B. pumilus 
SAFR-032 
5266.89 A8FDQ9 SASP O MTKRKANHVINGMNAAKSQGNGAGYIEDDQLVLTAEQRQNNKKRKKNQ B. pumilus SAFR-032 
6122 
6114 C0H3U0 
Uncharacterized 
membrane 
protein YyzG 
MQTNRVILLAVMICLVSAITVFLLNGCKVDFLDIGGTIIGCFLGIFVVVRIQKKQS 
B. subtilis 
subsp. 
subtilis str. 
168 
6126 P0C8M5 Transcriptional regulator SlrA MKTHVKKDLDKGWHMLIQEARSIGLGIHDVRQFLESETASRKKNHKKTVRQD 
B. subtilis 
subsp. 
subtilis str. 
168 
B. safensis 
2063.5 NA Unassigned NA NA 
2623.5 NA Unassigned NA NA 
2730 NA Unassigned NA NA 
3049 NA Unassigned NA NA 
3396 NA Unassigned NA NA 
5288 5299.88* A8FHD4 SASP J MSFFQKDKKAKSEKDHKQVDQLLEEASKELAGDPLQEAVQKKKNNDQ B. pumilus SAFR-032 
5568 5544 A8FDQ8 SASP P MTNKNTGKDIRQNSPKEHQSGQPEPLSGSKKVKNRNHTRQKHNSHHDM B. pumilus SAFR-032 
6094 NA Unassigned NA NA 
6413 6411.7* A8FCW7 bRP subunit L32 MAVPFRRTSKMKKRLRRTHFKLQVPGMVACPECGEMKISHRVCKSCGTYKGKDVKSN B. pumilus ATCC 7061T 
B. pumilus and B. 
safensis  
2287.5 NA Unassigned NA NA 
2399.5 NA Unassigned NA NA 
2511.5 NA Unassigned NA NA 
3692.5 3698 C0H3V1 UPF0752 membrane 
MSGYSNGGGYGGISSFALIVVLFILLIIVGTAFVGGF B. subtilis 
subsp. 
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protein YczN subtilis str. 
168 
3821.5 NA Unassigned NA NA 
4305.5 4305 A8F9A9 50S 
bRP subunit 
L36 
MKVRPSVKPICEKCKVIRRKGKVMVICENPKHKQKQG B. pumilus 
SAFR-032 
5948.5 5932 A8FF72 50S 
bRP subunit 
L33 2 
MRVNITLACTECGERNYITKKNKRNNPDRVEFKKYCSRDKKQTVHRETK B. pumilus 
SAFR-032 
6704 6691 C0H3Z1 Uncharacterized protein YjzG 
MMKNGFAYKNGKLVNIFCGKEELYNELKAFLVKTFSINVKEVSRPSIYRRTKSKQLE B. subtilis 
subsp. 
subtilis str. 
168 
6793.5 6793* B4AE40 50S 
bRP subunit 
L28 
MARKCVITGRKTKAGNNRSHAMNSTKRTWGANLQKVRILVDGKPKRVYVSARALKSGKVERV B. pumilus 
ATCC 7061T 
7415 7410.8* B4AM90 50S 
bRP subunit 
L35 
MPKMKTHRGSAKRFKKTGSGKLKRSHAYTSHLFANKSTKQKRKLRKSAIVSAGDFKRIKQQLANIK B. pumilus 
ATCC 7061T 
aSASP - Small, acid-soluble spore protein. 
bRP – Ribosomal protein. 
cOrganism – bacterial strain where the protein was described. 
NA – not applicable. 
* Predicted Mw proposed by Hotta et al [23], considering “N-end rule” [24] where N-terminal methionine is cleaved from specific penultimate amino acid residues
such as glycine, alanine, serine, proline, valine, threonine and cysteine.
B. pumilus and B. 
safensis
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Table 4. Candidate species-specific biomarkers assignments of B. pumilus and 
B.safensis.  
Peak masses are presented as m/z values. The presence/absence of a peak in each 
spectral group is represented by +/-, respectively. 
Species 
Ion peaks 
(m/z) B. pumilus B. safensis 
4305.5 + + 
5271 + - 
5288 - + 
5568 - + 
5948.5 + + 
6122 + - 
6413 - + 
6793.5 + + 
7415 + + 
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Figure 1. Mean mass spectra obtained by MALDI-TOF/MS of  (a) B. pumilus (5 spectra), 
(b) B. safensis (22 spectra) in the range 2000 to 12000 m/z. Spectra were obtained by 
averaging the respective experimental mass spectra from all isolates (see text for details). 
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Figure 2. Score plot of the PLSDA regression model (a) and respective dendrogram (b), with B. pumilus and B. safensis isolates.  Legend:  B. 
pumilus isolates and  B. safensis isolates. Unfiled symbols correspond to the type strains of both species. 
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Figure 3. Representative description of the evaluation of molecular masses of species- 
specific peaks using MALDI-TOF/MS in linear mode (a) and the correspondent reflector 
positive mode (b) of B. pumilus ATCC 7061T and B. safensis F036-bT spectra. 
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2.4. Differentiation of Bacillus pumilus and Bacillus safensis by Fourier 
transform infrared spectroscopy and chemometry 
Publications: 
Differentiation of Bacillus pumilus and Bacillus safensis by Fourier transform 
infrared spectroscopy and chemometry 
In this study was demonstrated the ability FTIR-ATR combined with chemometrics to 
discriminate Bacillus pumilus and Bacillus safensis. Moreover, these results are of high 
significance due to the current limitations in the discrimination of these two species, either 
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technique. 
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Abstract  
 
In this work we assessed the ability of Fourier transform infrared spectroscopy with 
attenuated total reflectance (FTIR-ATR) combined with partial least squares discriminant 
analysis (PLSDA), to discriminate Bacillus pumilus and Bacillus safensis, two closely 
related species belonging to B. pumilus group and of high relevance for the food sector, 
either as they are used as probiotic in human and animals or as food contaminants.  
Twenty-four previously well characterized B. pumilus and B. safensis isolates recovered 
from different origins and geographic locations were tested. Infrared spectra of both 
species present a very similar peak pattern, underlining their similarity, with only few 
differences in the regions of carbohydrates and phospholipids/DNA/RNA vibrations. The 
score map obtained from the PLSDA model showed two perfectly distinct clusters, each 
one containing one single species. This accurate, quick and low cost vibrational 
spectroscopic technique proved to be able to discriminate isolates from these closely 
related species often difficult to identify by standard phenotypic and genotypic methods. 
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1. Introduction
Bacillus genus is ubiquitous in nature and some of its species as Bacillus pumilus and 
Bacillus safensis owns a high biotechnological and pharmaceutical interest, with a wide 
range of applications in the food sector, namely as animal feed supplements (EFSA, 
2011), antibacterial and/or antifungal agents (Lehman et al., 2001; Aunpad et al., 2007). 
On the other hand, they can be found as contaminants in liquid packaging boards and 
blanks (Pirttijärvi et al., 1996), raw milk taken from farm milk machines and bulk tanks, 
milk tankers, diary silos and pasteurised milk (Sutherland & Murdoch, 1994; Coorevits et 
al., 2008) and gelatin (de Clerck et al., 2004) being also responsible for several foodborne 
illness outbreaks (From et al 2007; Van Doren et al., 2013). Moreover, under stressful 
conditions, they can produce highly resistant spores to physical and chemical agents that 
can remain in a dormant state for very long periods and undergo germination due to 
temperature abuse during storage and handling, which represent a serious threat in food 
preservation (Slepecky & Hemphill, 2006; Stecchini et al., 2013).  
B. pumilus and B. safensis are difficult to distinguish on the basis of phenotypic and 
biochemical characteristics, presenting a remarkably high level of 16S rRNA gene 
similarity (>99%) (Satomi et al., 2006) leading to frequent erroneous identifications. 
Sequencing of gyrB, a housekeeping gene, could be used as a valuable tool to 
discriminate them (Liu et al, 2013), although this approach is time-consuming, laborious 
and expensive. Fourier transform infrared spectroscopy (FTIR) has been successfully 
applied over the past decades to bacterial identification of pure cultures at different 
taxonomic levels (Nauman 1991, Maquelin 2002, Sousa et al. 2012, Vaz et al. 2012, 
Sousa et al. 2014) and showed a great potential even when microorganisms are 
embedded in complex matrices as food (Argyri et al., 2010; Davis et al., 2010). This 
spectroscopic technique due to its inherent sensitivity, small sample size requirement, 
rapidity, simplicity and high reproducibility (Blum & Harald, 2012) became a reliable 
alternative to discriminate and/or identify bacterial isolates.  
In this work we proved the ability of Fourier transform infrared spectroscopy with 
attenuated total reflectance (FTIR-ATR) combined with chemometrics, namely partial least 
squares discriminant analysis (PLSDA), to accurately discriminate the closely related 
species B. pumilus and B. safensis using a collection of isolates recovered from diverse 
settings and geographic origins. 
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2. Material and methods 
 
2.1. Bacterial isolates 
Four B. pumilus isolates and twenty B. safensis previously identified by phenotypic and 
genotypic (16S rRNA, gyrB and rpoB gene sequences) methods were studied. This 
collection comprises isolates of diverse PFGE-types, recovered from different geographic 
terrestrial locations and sources mainly from food samples (Italy and Africa) (n=4), plants 
(USA) (n=2), gastropods (Portugal) (n=3), health (n=6) and cosmetic (n=4) products 
(Portugal) and clean room environments from Mars Odyssey (USA) (n=3). The type 
strains B. pumilus ATCC 7061T and B. safensis FO-36bT were also included (table 1). 
Details about the collection are provided in table1. 
 
2.2. FTIR-ATR experiments 
Bacillus isolates were grown on Mueller Hinton agar (37ºC, 16h) and colonies were 
directly transferred from the agar plates to the ATR crystal. FTIR-ATR spectra were 
acquired using a PerkinElmer Spectrum BX FTIR System spectrophotometer with a PIKE 
Technologies Gladi ATR accessory from 4000-600 cm-1 with a resolution of 4 cm-1 and 32 
scan co-additions. For each isolate, three instrumental replicates (obtained in the same 
day) and two biological replicates (obtained in two different days from different agar 
plates) were obtained and analysed corresponding to a total of six spectra for each 
isolate. Between each isolate measurement, a background was acquired.  
 
2.3. Chemometric analysis 
FTIR-ATR spectra were analysed by partial least squares discriminant analysis (PLSDA) 
after being processed with standard normal variate (SNV) (Næs et al., 2002) followed by 
the application of a Savitzky-Golay filter (7 smoothing points, 2nd order polynomial and first 
derivative) (Savitzky & Golay, 1964) and mean-centred. PLSDA is a supervised 
chemometric method based on the PLS regression method (Geladi & Kowalsky, 1986; 
Alsberg et al., 1998) and it requires a previous knowledge of assigned classes (species) 
for all isolates tested. All chemometric models were performed in Matlab version 6.5 
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release 13 (MathWorks, Natick, MA) and the PLS Toolbox version 3.5 for Matlab 
(Eigenvector Research, Manson, WA). 
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3. Results and Discussion 
 
In this work, we demonstrate for the first time that FTIR-ATR spectroscopy combined with 
PLSDA is a reliable, quick and low cost method to accurately discriminate B. pumilus and 
B. safensis isolates. Some previous studies used FTIR to discriminate Bacillus isolates at 
genus (Whittaker et al. 2003; Maity et al. 2013) and species (Mietke et al. 2010; Ammann 
& Brandl 2011; Lücking et al. 2013) levels; however none of them included the closely 
related species and highly relevant B. pumilus and B. safensis. Infrared spectra of the 
isolates included in this study revealed the presence of bands associated with bacterial 
components such as lipids (3000-2800 cm-1), proteins/amides I and II (1700-1500 cm-1), 
phospholipids/DNA/RNA (1500-1185 cm-1), polysaccharides (1185-900 cm-1) and the 
fingerprint region (900-600 cm-1) (Naumann et al. 1991). A high degree of spectral 
similarity was observed among both species (Figure 1) remarking their phylogenetics (Liu 
et al., 2013; Satomi et al., 2006). Similarly to previous works (Coutinho et al., 2009; Sousa 
et al., 2012; Vaz et al., 2013; Sousa et al., 2014), the main spectral differences (marked 
with black arrows in Figure 1) were found in the phospholipids/DNA/RNA and the 
polysaccharides regions (1500-900cm-1), which were chosen for further comparisons. 
Those differences reflects the cellular composition dissimilarity between both species 
which mainly corresponds to vibrations associated with C−H bending of alkanes (1461 cm-
1); (CH3)3N+ symmetric bending (lipids) and C−H bending of alkenes =CH2 (1414 cm-1); 
C−O stretching of RNA ribose (1165 cm-1); alcoholic C−OH vibration of polysaccharide 
fraction and >PO2
-   stretching (1070 cm-1);  S=O stretching of organic sulfoxides (1052 cm-
1), P−O−P stretching (phospholipids, ribose phosphate chain pyrophosphate and 
glycipeptides) and C−O stretching of nucleic acids (1030-980 cm-1). In addition, a PLSDA 
of the infrared spectra in the selected region revealed two perfectly distinct clusters, each 
one containing isolates of one single species (Figure 2).  Moreover, model statistics (data 
not shown) revealed that 98.05% of the isolates perfectly fit the developed model, being 
the first three latent variables (that encompass 52.97% of spectral variability) responsible 
for species discrimination. Although the results obtained herein only include two species 
of the B. pumillus group they strongly indicated that FTIR-ATR possess a high potential in 
the discrimination of Bacillus spp. Moreover, FTIR-ATR seems to possess the same 
discriminatory power as other high throughput techniques such as matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (unpublished 
results) with the advantage of having a smaller cost, concerning equipment and analysis 
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and be totally free of reagents. The reliability of this technique for species discrimination 
should be further tested in a higher number of species of the B. pumillus group as B. 
altitudinis, B. stratosphericus, B. aerophilus and the newly described B. xiamenensis (Lai 
et al. 2014) as well as in a higher number of isolates of B. pumillus and B. safensis. At this 
moment one doesn’t possess conveniently characterized isolates of B. altitudinis and B. 
xiamenensis and it was not possible to obtain B. stratosphericus and B. aerophilus in the 
type culture collections neither with the authors responsible for their first description.  
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4. Conclusions
We demonstrated that species-specific cellular components of B. pumilus and B. safensis 
isolates detected by FTIR-ATR can differentiate these closed species. This achievement 
is of high relevance due to the possibility to reliably differentiate isolates belonging to 
these closely related species rapidly and with low cost, which is of interest for quality 
control purposes in different industrial production units. Furthermore, this study unveils 
molecular signatures (e.g. carbohydrates and phospholipids) of these species that could 
be further explored to improve the overall knowledge of these bacteria. 
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Table 1. Features of Bacillus pumilus and B. safensis included in this study.  
 Isolate PFGEa Origin Year/Location References 
Bacillus pumilus 
ATCC 7061T NA ---- ---- Type Strain 
Bp7 
Ip Health products (n=3) 
2005/Portugal 
Branquinho et al., 2012 Bp11 2005/Portugal 
Bp15 2005/Portugal 
Bacillus safensis 
Bs1 
Vs Animals Gastropods (n=3) 
2004/Portugal 
Branquinho et al., 2012 
Bs2 2005/Portugal 
Bs3 2007/Portugal 
Bs13 VIIs 
Health products (n=3) 
2005/Portugal 
Bs16 IIIs 2005/Portugal 
Bs17 IVs 2005/Portugal 
Bs5 XIs 
Cosmetic´s (n=4) 
2002/Portugal 
Bs18 VIs 2002/Portugal 
Bs27 IIs 2002/Portugal 
Bs24 XVs 
Food´s /salame (n=3) 
2004/Italy 
Matarante et al., 2004 Bs25 VIIIs 2004/Italy 
Bs33 Non typeable 2004/Italy 
Bs22 IXs 
Plant Growth Promoters (PGPR) (n=2) 
1997/USA 
Jetiyanon et al., 1997 
Bs23 Is 1997/USA 
Bs31 Xs Food/beans (n=1) 2003/Africa Ouoba et al., 2004 
FO-36bT XIIIs Clean-room/ air particulate (n=1) 1999/USA Satomi et al., 2006 (Type Strain) 
Bs35 XIVs Clean-room/floor (n=1) 2001/USA 
Satomi et al., 2006 
Bs37 
XIIIs 
Clean-room/Mars Odyssey spacecraft 
surface (n=2) 
2001/USA 
Bs38 
Bs42 Non typeable Clean-room/anteroom (n=1) 2001/USA 
aPFGE- Pulsed Field Gel Electrophoresis; NA - not applicable.
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Figure 1. FTIR-ATR mean spectra of B. pumillus and B. safensis isolates processed with 
SNV and Savitzky-Golay (7 points filter size, 2nd degree polynomial, 1st derivative) in the 
region 1500-900 cm-1. Legend: ▬ B. pumillus and ▬ B. safensis. 
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Figure 2. Score plot corresponding to the three first LVs of the PLSDA regression model 
using the 1500-900 cm-1 spectral region. Legend: ● B. pumillus and ● B. safensis. 
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2.5. Safety profile of Bacillus subtilis complex: antibiotic and virulence 
features 
Publications: 
Safety profile of Bacillus subtilis complex: antibiotic and virulence features 
This study focus the absence of critical features for the usage of B. subtilis complex 
isolates in the food sector as recommended in FEEDAP guidelines, also enabling the 
extension of its application for other relevant biotechnological purposes. 
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The biotechnological and pharmaceutical relevance of Bacillus subtilis group members is 
mainly supported by their ability to produce compounds with different biological activities, 
namely antibacterial (Mannanov and Sattarova 2001; Seydlová et al 2011; Balciunas et 
al., 2013), antifungal (Gupte et al., 2002; Zhao et al., 2013), insecticide (Revathi et al., 
2013), biosurfactant (Fracchia et al., 2013; Martinotti et al., 2013), probiotic and plant 
growth promoters (USEPA 2004; Pérez-García et al., 2011). In order to be used as feed 
additives, biotechnological products containing Bacillus species need to attain the 
Qualified Presumption of Safety (QPS) status (EFSA, 2013). For this purpose, EFSA-
FEEDAP guidelines state that microorganisms cannot be resistant to antibiotics of human 
and veterinary importance, neither possess acquired antibiotic resistance genes and toxin 
encoding genes (EFSA, 2011).  
In this study, we determined the susceptibility and presence of resistance genes to 
several antimicrobials, β-lactamase activity and presence of genes encoding for entero-, 
emetic- and cyto-toxins in a collection of Bacillus subtilis complex isolates, contributing for 
the establishment of their safety profile. 
Forty-three Bacillus subtilis complex isolates (27 B. safensis, 9 B. altitudinis, 4 B. pumilus 
and 3 B. subtilis) previously identified by phenotypic and genotypic (16S rRNA, gyrB and 
rpoB gene sequences) methods, were tested (Branquinho et al., 2014) (Table S1). 
Minimum inhibitory concentrations (MIC) to different antibiotics were determined by broth 
microdilution method and interpreted according to clinical breakpoints (CLSI M45-A, 2006) 
or microbiological cut-offs (Table 1) (EFSA, 2012). All MIC experiments were performed in 
duplicate. β-lactamase activity was assessed through the nitrocefin test (Antunes et al., 
2004). Transferable genes encoding resistance to tetracylines, macrolides, 
aminoglycosides, glycopeptides, phenicols and oxazolidinones, and toxins usually present 
in B. cereus (cytotoxin K, non-hemolytic enterotoxins, haemolysin and emetic toxins) were 
screened by PCR using primers and conditions outlined in Table S2.  
All isolates presented MICs to the different antibiotics lower than the established 
microbiological cut-offs for the detection of acquired antibiotic resistance genes, 
suggesting their absence, which was further confirmed by the absence of resistance 
genes.  Remarkably, isolates were clinically intermediate or resistant to cefotaxime, 
except for B. subtilis isolates. Moreover one B. subtilis presented MIC levels to penicillin 
that would prevent the therapeutical success of this antibiotic. In addition, nitrocefin test 
revealed that 69.7% of the isolates produced β-lactamases (18 B. safensis, 8 B. altitudinis 
and 4 B. pumilus). Furthermore, no amplification for toxins encoding toxins was obtained. 
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According to the FEEDAP guidelines, this collection fulfills the antibiotic resistance 
parameters for the QPS, as none of the isolates would apparently constitute a reservoir 
for mobile antibiotic resistance genes, and thus could be of potential used for industrial 
purposes, including as feed additives. Nevertheless, the identification of isolates with 
intermediate or clinical resistance to cefotaxime or penicillin (both antibiotics 
recommended for testing in CLSI-M45 but not required by the FEEDAP guidelines), 
should be considered in the strains safety evaluations due to the therapeutic failure that 
would be observed with their use. Despite the absence of toxins usually encoded by B. 
cereus, the assessment in these isolates of surfactin-like compounds production should 
be further studied.  
It is widely known that Bacillus spp. can harbor intrinsic β-lactamases (Andrews and Wise, 
2002), however their clinical importance has been poorly studied. Our results show that β-
lactamase production is not correlated with higher MIC values to β-lactams, as the same 
MIC for ampicillin is verified either for β-lactamase producers and non-producers. Despite 
these observations, we should also consider these β-lactamases: i) probably possess 
additional/unknown factors required for their activity; and ii) might have high substrate 
specificity. Besides, Penicilin-Binding-Proteins (PBP) variants with different β-lactam 
affinities might lead to variable susceptibility behavior to these antibiotics, as previously 
observed for other Gram positive bacteria (Leclercq et al., 2013).  
In conclusion, this work demonstrates the absence of antibiotic and virulence features 
required for the usage of B. subtilis complex isolates in the food sector, also enabling their 
safe application for other relevant biotechnological purposes. In addition, future QPS 
assessments should take into consideration the assessment of susceptibility to clinically 
relevant antibiotics, such as cefotaxime and penicillin in Bacillus spp. 
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Table 1.  Susceptibility profile of Bacillus spp. tested. 
Antibiotic Clinical breakpoint
a 
(µg/mL) (S/I/R) 
Microbiologicalb 
cut-off (µg/mL) Species (n) 
MIC (µg/mL) 
range MIC50 (µg/mL) MIC90 (µg/mL) 
Nº of I and R 
Isolates 
Penicillin <0.12 / - / ≥0.25 NA 
B. safensis (n=27) <0.03 <0.03 <0.03 0 
B. altitudinis (n=9) <0.03 <0.03 <0.03 0 
B. pumilus (n=4) <0.03 <0.03 <0.03 0 
B. subtilis (n=3) <0.03->64 <0.03 >64 1 
Oxacillin NA 
B. safensis (n=27) <0.06-0.125 0.125 0.125 
NA B. altitudinis (n=9) <0.06-0.125 <0.06 0.125 
B. pumilus (n=4) <0.06-0.125 0.125 0.125 
B. subtilis (n=3) <0.06 <0.06 <0.06 
Ampicillin ≤0.25 / - / ≥0.5 NA 
B. safensis (n=27) <0.07 <0.07 <0.07 0 
B. altitudinis (n=9) <0.07 <0.07 <0.07 0 
B. pumilus (n=4) <0.07 <0.07 <0.07 0 
B. subtilis (n=3) <0.07 <0.07 <0.07 0 
Amoxicillin NA 
B. safensis (n=27) <0.06 <0.06 <0.06 
NA B. altitudinis (n=9) <0.06 <0.06 <0.06 B. pumilus (n=4) <0.06 <0.06 <0.06 
B. subtilis (n=3) <0.06 <0.06 <0.06 
Piperacillin NA 
B. safensis (n=27) 0.5-2 1 1 
NA B. altitudinis (n=9) <0.5-1 0.5 1 B. pumilus (n=4) 1 1 1 
B. subtilis (n=3) 0.25-0.5 0.25 0.5 
Cefotaxime ≤8 / 16-32 / ≥64 NA 
B. safensis (n=27) 16-64 32 32 27 
B. altitudinis (n=9) 8-64 32 64 8 
B. pumilus (n=4) 16-32 32 32 4 
B. subtilis (n=3) <0.125 <0.125 <0.125 0 
Cefoxitin NA 
B. safensis (n=27) <0.125-4 2 2 
NA B. altitudinis (n=9) 1-4 1 1 B. pumilus (n=4) 1-2 2 2 
B. subtilis (n=3) <0.125-1 <0.125 1 
Ertapenem NA 
B. safensis (n=27) 0.06-0.125 0.125 0.125 
NA B. altitudinis (n=9) 0.03-0.125 0.03 0.06 B. pumilus (n=4) 0.125-0.25 0.125 0.25 
B. subtilis (n=3) <0.016-0.03 0.03 0.03 
Imipenem ≤4 / 6 / ≥16 NA 
B. safensis (n=27) <0.07 <0.07 <0.07 0 
B. altitudinis (n=9) <0.07 <0.07 <0.07 0 
B. pumilus (n=4) <0.07 <0.07 <0.07 0 
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B. subtilis (n=3) <0.07 <0.07 <0.07 0 
Vancomycin ≤4 / - / - 4 
B. safensis (n=27) <0.07-0.25 0.125 0.125 0 
B. altitudinis (n=9) <0.07-0.25 0.125 0.25 0 
B. pumilus (n=4) 0.125 0.125 0.125 0 
B. subtilis (n=3) 0.125 0.125 0.125 0 
Gentamicin ≤4 / 8 / ≥16 4 
B. safensis (n=27) <0.07 <0.07 <0.07 0 
B. altitudinis (n=9) <0.07 <0.07 <0.07 0 
B. pumilus (n=4) <0.07 <0.07 <0.07 0 
B. subtilis (n=3) <0.07 <0.07 <0.07 0 
Amikacin ≤16 / 32 / ≥64 NA 
B. safensis (n=27) <0.06-0.5 0.125 0.125 0 
B. altitudinis (n=9) <0.06-0.25 <0.06 0.125 0 
B. pumilus (n=4) <0.06-0.125 0.125 0.125 0 
B. subtilis (n=3) 0.25-0.5 0.25 0.5 0 
Kanamycin NA 8 
B. safensis (n=27) 0.125-0.5 0.25 0.25 0 
B. altitudinis (n=9) 0.125-0.5 0.25 0.25 0 
B. pumilus (n=4) 0.125-0.25 0.25 0.25 0 
B. subtilis (n=3) 0.25-0.5 0.25 0.5 0 
Streptomycin NA 8 
B. safensis (n=27) 1-2 1 2 0 
B. altitudinis (n=9) 1-2 2 2 0 
B. pumilus (n=4) 2 2 2 0 
B. subtilis (n=3) 1-4 1 4 0 
Erythromycin ≤0.5 / 1-4 / ≥8 4 
B. safensis (n=27) <0.016-0.06 0.03 0.06 0 
B. altitudinis (n=9) <0.016-0.03 <0.016 <0.016 0 
B. pumilus (n=4) 0.03-0.06 0.03 0.06 0 
B. subtilis (n=3) <0.016-0.03 0.03 0.03 0 
Tetracycline ≤4 / 8 / ≥16 8 
B. safensis (n=27) <0.06 <0.06 <0.06 0 
B. altitudinis (n=9) <0.06 <0.06 <0.06 0 
B. pumilus (n=4) <0.06 <0.06 <0.06 0 
B. subtilis (n=3) <0.06 <0.06 <0.06 0 
Chlortetracycline NA 
B. safensis (n=27) <0.125 <0.125 <0.125 
NA B. altitudinis (n=9) <0.125 <0.125 <0.125 B. pumilus (n=4) <0.125 <0.125 <0.125 
B. subtilis (n=3) <0.125 <0.125 <0.125 
Ciprofloxacin ≤1 / 2 / ≥4 NA 
B. safensis (n=27) <0.03-0.06 <0.03 <0.03 0 
B. altitudinis (n=9) <0.03 <0.03 <0.03 0 
B. pumilus (n=4) <0.03 <0.03 <0.03 0 
B. subtilis (n=3) <0.03 <0.03 <0.03 0 
Norfloxacin NA 
B. safensis (n=27) 0.125-1 0.25 0.5 
NA B. altitudinis (n=9) 0.125-0.5 0.25 0.5 
B. pumilus (n=4) 0.25-0.5 0.25 0.5 
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B. subtilis (n=3) <0.07-0.125 <0.07 0.125 
Florphenicol NA 
B. safensis (n=27) 1-2 2 2 
NA B. altitudinis (n=9) 1-2 1 2 B. pumilus (n=4) 2 2 2 
B. subtilis (n=3) 1 1 1 
Tiamulin NA 
B. safensis (n=27) >128 >128 >128 
NA B. altitudinis (n=9) 1->128 >128 >128 B. pumilus (n=4) >128 >128 >128 
B. subtilis (n=3) >128 >128 >128 
Rifampin ≤1 / 2 / ≥4 NA 
B. safensis (n=27) <0.016 <0.016 <0.016 0 
B. altitudinis (n=9) <0.016 <0.016 <0.016 0 
B. pumilus (n=4) <0.016 <0.016 <0.016 0 
B. subtilis (n=3) <0.016 <0.016 <0.016 0 
a CLSI - Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria – Standard M45-A 2006; bFEEDAP - Scientific opinion 
on guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance;   NA – not applicable
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Table S1. Bacillus subtilis complex isolates included in this study. 
Species Isolates Origin Year/Location References 
Bacillus 
pumilus (n=4) 
ATCC 14884 ---- ---- Reference Strain 
Bp7 
Health´s products 
(n=3) 2005/Portugal
1 Branquinho et al., 2012 Bp11 
Bp15 
Bacillus 
altitudinis (n=9) 
Ba6 
Health´s products 
(n=5) 2005/Portugal
1 Branquinho et al., 2012 
Ba8 
Ba9 
Ba12 
Ba14 
Ba26 
Food´s 
contaminants 
(n=1) 
2006/Norway From et al 2007 
Ba30 Food (n=1) 2003/Africa Ouoba et al 2003 
Ba20 Plant Growth 
Promoters 
(PGPR) (n=2) 
1996/USA Wei et al 1996 
Ba21 1997/USA Jetiyanon et al 1997 
Bacillus 
safensis (n=27) 
Bs1 
Animals 
Gastropods (n=3) 
2004/Portugal1 
Branquinho et al., 
2012 
Bs2 2005/Portugal1 
Bs3 2007/Portugal1 
Bs13 
Health´s products 
(n=3) 2005/Portugal
1 Bs16 
Bs17 
Bs5 
Cosmetic´s (n=4) 2002/Portugal1 
Bs18 
Bs19 
Bs27 
Bs24 Food´s 
contaminants 
(n=3) 
2004/Italy2 Matarante et al., 2004 Bs25 
Bs33 
Bs22 Plant Growth 
Promoters 
(PGPR) (n=2) 
1997/USA3 Jetiyanon et al., 1997 Bs23 
Bs31 Food (n=1) 2003/Africa4 Ouoba et al., 2004 
FO-36bT Clean-room/ air particulate (n=1) 1999/USA
5 
Type Strain, 
Satomi et al., 
2006 
Bs32 
Clean-room/floor 
(n=3) 
2001/USA5 
Satomi et al., 
2006 
Bs34 
Bs35 
Bs36 
Clean-
room/cabinet top 
(n=1) 
Bs37 Clean-room/Mars 
Odyssey 
spacecraft 
surface (n=5) 
Bs38 
2002/USA Bs39 
Bs40 
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Bs41 
Bs42 
Clean-
room/anteroom 
(n=1) 
2001/USA5 
Bacillus subtilis 
(n=3) 
Bsb28 Health´s products (n=1) 2005/Portugal
1 This study 
BsbFFUP1 ---- ---- 
FFUP culture 
collection, this 
study 
BsbBGA ---- ---- This study 
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Table S2. Primers and amplification conditions used for detection of enterotoxin and resistance genes 
Target gene Primer name Sequence Amplicon size (bp) 
Annealing 
Temperature (º C) Reference 
Emetic and cytotoxin genes 
Emetic toxin 
cesA 
CER1_Fw ATCATAAAGGACAAGA 
188 52 Ehling-Schulz et al., 2004 EMT1_Rv AAGATCAACCCAACTG 
cesB 
EM1_Fw GACAAGAGAATACAAT 
635 60 Ehling-Schulz et 
al., 2004 EM1_Rv GCAGCCTTCCCACAGT 
Cytotoxin 
cytK 
FC_Fw GTAACTTTCATTTGATGATC 
505 50 Ehling-Schulz et al., 2004 RC_Rv GAATACATAAATAATTGGT 
hblC 
L2_Fw AGAAACTCAACAAGAAAACATGG 
444 50 Ehling-Schulz et al., 2004 L2_Rv TTGCGCAGTTGCCACATTAG 
nheA 
0045_Fw GTTAGGATCACAATCACCGC 
264 50 Ehling-Schulz et al., 2004 4091_Rv CCATATGCATTTGTAAAATCTG 
nheB 
517_Fw CGGTTCATCTGTTGCGACAGC 
335 50 Ehling-Schulz et al., 2004 8368_Rv GATCCCATTGTGTACCATTGG 
nheC 
4924_Fw GCGATTGATCAAAAGGATAG 
411 50 Ehling-Schulz et al., 2004 1141_Rv CGACTTCTGCTTGTGCTCCTG 
Resistance 
genes 
Tetracycline 
tet M 
tetM-F GTTAAATAGTGTTCTTGGAG 
657 53 Aarestrup et al., 2000. tetM-R CTAAGATATGGCTCTAACAA 
tet L 
tetL-F CATTTGGTCTTATTGGATCG 
475 53 Aarestrup et al., 2000. tetL-R ATTACACTTCCGATTTCGG 
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tet S 
tetS-F TGGAACGCCAGAGAGGTATT 
661 56 Aarestrup et al., 2000. tetS-R ACATAGACAAGCCGTTGACC 
tet K 
tetK-F TTAGGTGAAGGGTTAGGTCC 
718 56 Aarestrup et al., 2000. tetK-R GCAAACTCATTCCAGAAGCA 
tet O 
tetO-F CAATATCACCAGAGCAGGCT 
634 53 Aarestrup et al., 2000. tetO-R GATGGCATACAGGCACAGAC 
Macrolides 
ermA 
ermA1-F CTTCGATAGTTTATTAATATTAGT 
645 50 Sutcliffe et al., 1996 ermA2-R TCTAAAAAGCATGTAAAAGAA 
ermB 
ermB1-F CATTTAACGACGAAACTGGC 
402 50 Sutcliffe et al., 1996 ermB2-R GGAACATCTGTGGTATGGCG 
ermC 
ermC1-F TCAAAACATAATATAGATAAA 
642 50 Sutcliffe et al., 1996 ermC2-R GCTAATATTGTTTAAATCGTCAAT 
Glycopeptides 
vanA 
vanA-F GGGAAAACGACAATTGC 
732 54 Dutka-Malen et al., 1995 vanA-R GTACAATGCGGCCGTTA 
vanB 
vanB-F ATGGGAAGCCGATAGTC 
635 54 Dutka-Malen et al., 1995 vanB-R GATTTCGTTCCTCGACC 
Aminoglicosydes 
aph(2'')-Ib 
aph(2'')-IbF CTTGGACGCTGAGATATATGAGCAC 
867 52 Vakulenko et al., 2003 aph(2'')-IbR GTTTGTAGCAATTCAGAAACACCC TT 
aph(2'')-Id 
aph(2'')-IdF GTGGTTTTTACAGGAATGCCATC 
641 52 Vakulenko et al., 2003 aph(2'')-IdR CCCTCTTCATACCAATCCATATAACC 
aph(2'')-Ic 
aph(2'')-IcF CCACAATGATAATGACTCAGTTCCC 
444 52 Vakulenko et al., 2003 aph(2'')-IcR CCACAGCTTCCGATAGCAAGAG 
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aph(3'')-IIIa 
aph(3'')-IIIaF GGCTAAAATGAGAATATCACCGG 
523 52 Vakulenko et al., 2003 aph(3'')-IIIaR CTTTAAAAAATCATACAGCTCGCG 
aac(6')-Ie-
aph(2'')-Ia 
aac(6')-Ie-
aph(2'')-IaF- CATTATACAGAGCCTTGGGAAGATG 
778 52 Vakulenko et al., 2003 aac(6')-Ie-
aph(2'')-IaR GTCTTAAAAAACTGGCAATATCTCGTT 
Phenicols 
fexA 
fexA-F GTACTTGTAGGTGCAATTACGGCTGA 
1272 58 Kehrenberg and Schwarz 2006 fexA-R CGCATCTGAGTAGGACATAGCGTC 
floR 
floR_F CACGTTGAGCCTCTATAT 
868 55 Guerra et al. 2004 
floR_R ATGCAGAAGTAGAACGCG 
Phenicols, 
lincosamides, 
oxazolidinones, 
pleuromutilins 
and 
streptogramin A 
cfr 
cfr-fw TGAAGTATAAAGCAGGTTGGGAGTCA 
746 48 Kehrenberg and Schwarz 2006 cfr-rv ACCATATAATTGACCACAAGCAGC 
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3.1. Characterization of the antibacterial compound produced by Bacillus safensis 
Bs1 
Publication: 
Characterization of a new antimicrobial peptide with anti-MRSA activity produced 
by Bacillus safensis Bs1 
Results disclosed from this work proved the hypothesis proposed for this thesis, in which 
clonal lineage adapted to an Arion ater, Bacillus safensis Bs1, revealed the production of 
a potentially novel cationic peptide (48-residues) with anti-staphylococci activity.  
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Abstract 
We previously demonstrated the, in vitro, anti-staphylococci activity of a Bacillus safensis 
strain (Bs1) recovered from a slug used in the treatment of cutaneous infections. In the 
present work the characterization of an antimicrobial peptide produced by B. safensis Bs1 
is presented. 
The Bs1 antimicrobial peptide was recovered and purified by a combination of SDS-
PAGE, ultrafiltration, ammonium sulfate precipitation and chromatographic approaches. 
The integrity of the purified peptide was verified by mass spectrometry and N-terminal 
sequencing and prediction of its antimicrobial stretches was also attempted, using AMPA 
and CAMP databases. 
The performed characterization revealed a new cationic peptide (48-residues) with 
antimicrobial activity against Gram-positive bacteria, including (Methicillin-resistant 
Staphylococcus aureus) MRSA. No remarkably amino acid sequence homologies were 
detected with other classes of antimicrobial peptides previously described. Further studies 
should be conducted in order to confirm the proposed amino acid composition and also its 
structure elucidation. Moreover, its antimicrobial property against a panel of clinical 
isolates expressing different mechanisms of resistance should also be extended. 
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1. Introduction
Due to the decline in antibiotic discovery, illustrated by a low number of new registered 
entities and a dramatic lack of new antibiotic classes, the increasing of multi-drug resistant 
bacteria causing infection is a serious concern (Carlet et al., 2012). Staphylococcus 
aureus is one of the most disturbing and common human pathogens, being the most 
frequent agent of skin and soft tissues infections, osteomyelitis and bacteremia (Elsayed 
et al., 2004; Weigelt et al., 2005). Higher morbidity and mortality in this species is 
associated with methicillin-resistant S. aureus (MRSA) which often are also resistant to 
diverse antibiotic classes (Appelbaum et al., 2007).  
In fact, in the last decades several pre-existing molecules have been modified in new 
derivatives, in an attempt to circumvent bacterial resistance mechanisms. Nevertheless, 
bacteria have demonstrated the potential to create new mechanisms of resistance 
allowing its surviving due to mutations or acquisition of resistance genes (Martínez and 
Baquero, 2002). It was only recently that linezolid, belonging to oxazolidinones class, was 
introduced in therapeutic use. Afterward, daptomycin and tygecicline also with activity 
upon MRSA, were introduced in therapeutic armamentarium. Nevertheless, and despite 
their recent introduction, linezolid and tygecycline resistant isolates have already emerged 
during treatment of S. aureus infections (Hentschke et al., 2008) being therefore 
imperative the recognition of therapeutic alternatives. 
Therapeutic applications of organic compounds from terrestrial microorganisms have an 
extensive past and present use in the treatment of diseases and serve as agents of 
interest both in their natural form and as templates for synthetic modification. In fact, 
secondary metabolites from natural sources and related drugs are used to treat 87% of all 
categorized human diseases, including antibacterial, anticancer, anticoagulant, 
antiparasitic, and immunosuppressive agents (Chin et al., 2006; Raja et al., 2010).  
The great number of antibiotics occurs as a result of secondary metabolic pathways and 
can be produced by different microorganisms with a diverse chemical nature, and such 
diversity is reflected in its mode of action (Stein, 2005).  
Among the most thoroughly studied secondary metabolites with remarkable therapeutic 
effects are antimicrobial peptides (AMPs) agents. Although their sequences vary, in 
general, they present an overall positive charge, an amphipathic structure and comprised 
of 10–50 amino acids, among which cysteine, lysine, proline or arginine are key 
compositions (Agerberth et al., 1991; Sahl et al., 2005; Groot et al., 2006; Lesmes et al., 
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2009; Scocchi et al., 2011). Moreover, under hydrophobic environment, AMPs can fold 
into four classes of structures, including α-helix, β-sheets, extended structures, and loops 
(Brown and Hancock 2006; Peters et al., 2010). Related to its mechanisms of action, it is 
well known that most of them interact with bacterial membranes (Melo et al., 2009; Peters 
et al., 2010). 
In the case of Bacillus spp., AMPs compounds are subdivided into different classes, 
comprising bacteriocins (Oscáriz and Pisabarro 2000; Bizani and Brandelli 2002; Cherif et 
al., 2001, 2003 and 2008; Abriouel et al., 2011), bacteriocin-like inhibitory substances 
(BLIs) (Korenblum et al., 2005; Cladera-Oliveira et al., 2004; Aunpad and Na-Bangchang 
2007; Xie et al., 2009), polyketides (PKs) (Chen et al., 2007; Arguelles-Arias et al.,  2009), 
nonribosomal peptides (NRPs) (Naruse et al., 1990; Peypoux et al., 1999; Hathout et al., 
2000; Bonmatin et al., 2002; Lee et al., 2007; Caboche et al., 2008; Rodrigues and 
Teixeira 2010; Nerurkar et al., 2010), miscellaneous antibiotics (Tamehiro et al., 2002; 
Pinchuk et al., 2002; Inaoka and Ochi 2007) and unusual peptides (Kino et al., 2009 and 
2010; Borisova et al., 2010)  
Therefore, and considering the enormous diversity of Bacillus spp. in nature and the 
abundance of chemical structure compounds that they are able to produce, reflected also 
on its biological activities (Abriouel et al., 2011), they clearly represent an interesting 
challenge to explore.  
During several decades, in some regions of Portugal, a post mortem terrestrial black slug 
was used as traditional medicine in the treatment of cutaneous infections, including 
wounds and abscesses. Recently, we proved in vitro, a high anti-staphylococci activity, 
including in MRSA, of this slug (Branquinho, 2007). Preliminary data suggests the 
contribution of a peptide compound produced by a Bacillus safensis isolate (Branquinho et 
al 2014) for the observed antimicrobial activity. The high anti-MRSA activity and the 
therapeutic success reported for this traditional medicine together with the absence of 
description of secondary effects justifies the characterization of the bioactive compound(s) 
associated with this traditional medicine. Although some peptides with antibacterial activity 
have been described among B. pumillus group members, none was yet attributed to B. 
safensis.  
Thus, in the present work, throughout the use of advanced analytical and molecular 
methodologies we characterized the anti-bacterial compound produced by B. safensis Bs1 
in a perspective of applicability to the pharmaceutical, biomedical and/or food sectors. 
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2. Material and Methods
2.1. Bacterial strain 
B. safensis isolate Bs1 recovered from a black slug normal flora, which was collected from 
Northern of Portugal, was evaluated in its potential to produce antimicrobial compounds. 
Species identification was assessed by phenotypic, biochemical and genotypic (16S 
rRNA, gyrB and rpoB gene sequences) analysis (Branquinho et al 2014). Bacterium was 
maintained as stock culture at − 80 °C in Tryptic Soy Broth (TSB) (BD, Germany) 
supplemented with 20% (v/v) glycerol.  
2.2. Production of AMP´s 
Pre-inoculum of B. safensis Bs1 isolate was prepared from Tryptic Soy Agar (TSA, BD, 
Germany) plates incubated overnight at 37 ºC. Their subculture was prepared under 
agitation at 250 rpm in 100 mL of TSB (TSB, BD, Germany) at pH=7.0.  Then, for the 
inoculum preparation, 10 mL of pre-inoculum culture was transferred to 500 mL of TSB 
previously diluted (1:2) with sterile water and incubated for 24 h at 37 ºC, under agitation 
conditions (250 rpm). Finally, cells were separated by centrifugation at 8000 rpm during 
20 min at 4 °C. Supernatants were then filtered through 0.45 µm pore-size filter (Millipore 
Corp., Bedford MA) to obtain a cell-free supernatant (CFS) for evaluation of the activities 
in the further tasks.  
2.3. Screening for antimicrobial activity 
CFS was screened for its antimicrobial activity, by the agar well-diffusion method, against 
indicator strains summarized in Table 1. Briefly, indicator strains suspensions adjusted at 
0.5 McFarland were swabbed in Mueller Hinton (MH) agar cation adjusted (bioMérieux, 
France) plates, where 5 mm diameter wells were cut and filled with 50 µL of CFS. Plates 
were then incubated at the optimal temperature and incubation times and inhibition zone 
diameters measured. Un-inoculated TSB broth was used as negative control. The 
experiment was conducted in triplicate on separate conditions. 
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2.4. Purification of AMPs  
2.4.1. Ultrafiltration and precipitation of proteins with ammonium sulfate (partial 
purification) 
Bs1 CFS were firstly concentrated by sequencial ultrafiltration using a 10-kDa and 3-kDa 
Millipore membrane cut-off (Millipore Corp., Bedford MA) and stored at –20 °C until use. 
Proteins were precipitated from 100 ml of the ultrafiltrated Bs1CFS, stirring constantly for 
30 min at 4 °C to reach 20, 40, 60 and 80% (w/v) (NH4)2 SO4 (ammonium sulfate) (Sigma-
Aldrich, St. Louis, USA) saturation. Precipitated proteins were collected by centrifugation 
at 10000 g for 30 min at 4 ºC, dissolved in a 1/20 (v/v) phosphate buffer (0.02 mol l-1, 
pH 6.8), and dialyzed to remove ammonium sulfate. The dialysates were then lyophilized 
and dissolved in phosphate buffer. Finally, the activity of the purified protein(s) was tested 
using the well diffusion test against S. aureus ATCC 29213 as the indicator strains, as 
previously described. 
 
2.4.1.1. Direct in-gel detection of antimicrobial activity and estimation of its 
molecular weight 
Tricine-sodium dodecyl sulfate–polyacrylamide gel electrophoresis (Tricine SDS-PAGE) 
was performed for antimicrobial peptide band identification using 16% polyacrylamide gel 
following the procedure of Schägger and Jagow (Schägger 2006). Twenty microliters of 
ultrafiltered fractions, with confirmed antimicrobial activity against S. aureus ATCC 29213 
and direct Bs1 CFS were applied and separated onto the polyacrylamide gel, in duplicate. 
After electrophoresis, a part of the gel was stained with Coomassie Brilliant Blue (0.1% 
Coomassie R-250, 40% ethanol, 10% acetic acid) for 1 h, de-stained for 1 h (7.5% acetic 
acid, 10% ethanol) and washed during 4 h in sterile distilled water to visualize the protein 
and/or peptide bands. Moreover, the unstained part of the gel was used for in situ 
detection of AMP activity upon fixing it in a mixture of 2-propanol, acetic acid and H2O 
(25:10:65) for 15 min, followed by washing with sterile water for 30 min, repeatedly four 
times. The SDS-PAGE gel lines were then placed in sterile Petri dishes and overlaid with 
10 ml of nutrient agar (0.7%) containing S. aureus  ATCC 29213 as the indicator strain 
(0.5 McFarland adjusted). Plates were finally incubated during 24 h at 37 ºC and diameter 
zones around the bands visualized. 
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2.4.2. FPLC and HPLC purification 
Fractions obtained by ultrafiltration, ammonium sulfate precipitation and direct Bs1 CFS 
were purified by fast protein liquid chromatography (FPLC) and reverse-phase high-
performance liquid chromatography (RP-HPLC). 
Initial purification was accomplished using a size-exclusion FPLC system (Pharmacia 
Biotech, Uppsala, Sweden) with a Superose 12/HR10 column, Amersham Pharmacia 
Biotech) eluted with phosphate buffer (50 mM Na2HPO4 and 50 mM NaH2PO4) pH 7.0 at a 
flow rate of 0.5 ml min-1 and monitored by UV absorption at 280 nm.  
Further purification by RP-HPLC system was achieved using a C18 column (5 µm, 
250×4.6 mm, Phenomenex, USA). Chromatographic separations were conducted under a 
linear gradient of two mobile phases, A, 0.1% Trifluoroacetic Acid (TFA) in H2O, and 
B, 0.1% TFA in 100% acetonitrile. Proteins were eluted over 90 min with 20-80% B 
gradient at a flow rate of 1 ml min-1 and monitored at 220 nm and 280 nm in a diode array 
detector. 
All FPLC and HPLC eluted fractions were collected, concentrated by lyophilization and 
antimicrobial activity was screened by agar well-diffusion as previously detailed. 
2.5. Characterization of the purified AMP 
2.5.1. Mass spectrometry and peptide mass fingerprint (PMF) analysis 
Matrix-assisted laser desorption ionization mass spectrometry (MALDI MS) was used to 
primarily characterize the purified AMP which was excised from bands demonstrating 
antibacterial activity against S. aureus ATCC 29213 recovered directly by SDS-PAGE. 
Selected bands were subjected to digestion with trypsin (Promega). Briefly, the protein gel 
bands were washed with water, destained with methanol/50 mM NH4HCO3 and 
acetonitrile/50 mM NH4HCO3 (1:1 v/v), reduced with 25 mM DTT in 50 mM NH4HCO3 for 
20 min at 56 °C, alkylated with 55 mM IAA in 50 mM NH4HCO3 for 20 min in the dark, and 
in-gel digested with 10 μL of 2 ng/μL trypsin for 3 h at 37 °C in the presence of 0.01% 
surfactant (ProteaseMAX, Promega). Finally, the resulting peptides were extracted with 20 
μL of TFA 2.5% for 15 min. Protein digests were desalted, concentrated, and spotted onto 
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a MALDI plate using C18 ZipTips (Millipore Corp., Bedford MA) following the 
manufacturer’s instructions.  
For the matrix preparation, a solution of 6−8 mg/mL α-cyano-4-hydroxycinnamic acid in 
50% ACN/0.1% TFA was used. Samples were analyzed using a 4700 Proteomics 
Analyzer MALDI-TOF/TOF (AB SCIEX, Framingham, MA). Peptide mass fingerprint 
(PMF) data were collected in positive MS reflector mode in the range of m/z 1000−10000 
and was calibrated with external standards and internally calibrated using trypsin autolysis 
peaks. The MS and MS/MS spectra were processed and analyzed using the software 
GPS Explorer (Version 3.6, AB SCIEX, Framingham, MA) and were searched together 
against the UniProt protein sequence database using the Mascot search engine (Version 
2.1.04, Matrix Science, UK) limited to Firmicutes taxonomy. During database search the 
following parameters were considered: database, maximum missed cleavages, 1; 
precursor tolerance, 0.2 Da; peptide charges, +1; mass, monoisotopic.  
 
2.5.2. N-terminal sequencing 
The purified BS1 peptide was also analyzed by automated N-terminal sequencing in order 
to validate the MS identification. The peptide was previously transferred onto a 
polyvinylidene fluoride membrane (PVDF) (BioRad CA, USA) and then excised and 
subjected to automated Edman degradation using a 492 Procise protein sequencer 
(Applied Biosystems, Foster City, CA).  
 
2.5.3. Secondary structure prediction 
Circular dichroism (CD) measurements of the purified peptide were performed on a Jasco 
J-815 (Jasco Inc.) equipped with a Peltier temperature-controlled cell holder, at 20 º C, in 
the far UV region (190-260 nm) using a path length cuvette (0.2-mm optical path-length). 
Prediction of the protein secondary structure content was estimated using the DichroWeb 
server and Greenfield and Fasman method (Greenfield and Fasman, 1969).  
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2.5.4. Detection of possible post-translational modifications: glycosylation 
The presence of glycosylated proteins was evaluated directly in SDS-PAGE gel, stained 
by the periodic acid-Schiff (PAS) method using the Pierce (Rockford, IL) glycoprotein 
staining kit, which specifically detects glycosylated proteins with sialic acid and other 
oxidizable carbohydrate groups by the presence of magenta bands with a light pink or 
colorless background. 
2.5.5. Prediction of protein antimicrobial regions 
For prediction of sequenced peptide antimicrobial region, and automated web server 
Antimicrobial Sequence Scanning System (AMPA) (http://tcoffee.crg.cat/apps/ampa), was 
used (Torrent et al., 2012). This web application uses an antimicrobial propensity scale 
derived from high-throughput screening, that generate an antimicrobial profile and an 
antimicrobial index (AI), which can be calculated providing a fair assessment of the 
tendency for a specific amino acid to be present in an AMP sequence. As low half 
maximal inhibitory concentration (IC50) values correspond to high activity, amino acids 
with a low index are the most favored to be part of an AMP. Moreover, in order to confirm 
results disclosed by AMPA and compare important chemical proprieties of our peptide, 
Collection of Anti-Microbial Peptides (CAMP) database (http://www.camp.bicnirrh.res.in/) 
was also applied (Thomas et al., 2010). 
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3. Results and Discussion 
 
During a screening for new antimicrobial compounds in natural sources, we verified that a 
B. safensis isolate, Bs1, recovered from the normal flora of a terrestrial black slug, which 
was commonly used as traditional medicine, produced a mixture of compounds with a 
proteinaceous nature, showing a remarkably high anti-staphylococci activity (including 
MRSA) (Branquinho, 2007). The observation of this anti-bacterial activity could justify the 
reported therapeutic success of this traditional medicine applied in the treatment of 
wounds and abscesses. Moreover, the absence of reported adverse effects prompts us to 
further characterize the target compound. In the present work, antibacterial compound 
purification was accessed by a combination of ultrafiltration, ammonium sulfate 
precipitation, chromatographic analysis and SDS-PAGE. Additionally, the integrity of the 
purified peptide(s) was verified by mass spectrometry analysis and N-terminal 
sequencing. Finally, peptide secondary structure prediction, detection of the post-
translational modification (glycosylation) and prediction of its antibacterial stretches were 
also attempted. 
 
3.1. Screening for antimicrobial activity  
The influence of different carbon and nitrogen sources, optimum pH and incubation 
temperature on Bs1 AMP production was previously tested (Branquinho, 2007). 
Therefore, TSB was selected as the best medium for its production at 37 ºC and pH 
7.0±0.2. In addition, the highest AMP in late stationary B. safensis Bs1 growth phase 
(Branquinho, 2007).  
This study revealed that in the presence of CFS from B. safensis Bs1 Gram-positive 
bacteria such as S. aureus, MRSA and Bacillus subtilis were inhibited (presenting 
inhibition zones of 14 mm, 13 mm and 12 mm respectively), and none activity was 
revealed against the Gram-negative bacteria tested. Moreover the antibacterial compound 
did not inhibited B. pumilus, the species phylogenetically more closely related with B. 
safensis. These results suggest a selective antibacterial activity towards some Gram 
positive bacteria.  
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3.3. Antimicrobial activity of the partial purified fractions 
Ultrafiltered fractions were partially purified using ammonium sulfate to obtain 20, 40, 60 
and 80% of saturation. The highest inhibitory activity against S. aureus ATCC 29213 was 
observed in the resolved precipitate with 40 and 60% of saturation (Figure 1) and the 
remaining fractions did not exhibit any effect against this indicator strain. In addition, it was 
verified that after ammonium sulfate precipitation, inhibition zones increased, when 
compared with direct Bs1 CFS, confirming its concentration. Therefore, both active 
precipitates were analyzed by SDS-PAGE (Figure 2) which revealed the presence of one 
isolated protein band with an apparent molecular weight of approximately 5 kDa. 
3.4. Direct in-gel detection of antimicrobial activity and estimation of its molecular 
weight 
The Bs1 CFS was concentrated through sequential ultrafiltration using a 10 kDa and 3 
kDa membranes, following non denaturing electrophoresis, demonstrated the presence of 
several proteins (Figure 3). Moreover, overlaying the gel with nutrient agar containing S. 
aureus ATCC 29213 as indicator strain, an apparent single protein band seems to be 
associated with the detected antimicrobial activity (Figure 3), with an apparent molecular 
weight of approximately 5 kDa. Interestingly, the protein band resolved by ammonium 
sulfate precipitation (Figure 2) showed the same estimated molecular weight of this AMP 
detected directly in-gel for its antimicrobial activity. 
In fact, Bacillus spp. appears to be an abundant source of antimicrobial compounds, since 
many species of this genus demonstrate the capability to synthesize antimicrobial 
peptides (Stein 2005). In the scientific literature, some studies revealed the production of 
AMP agents with an apparent similar molecular weight of that observed in the present 
study. Therefore, Cherif et al., (2008) reported a 4.8 kDa bacteriocin-like substance (BLIS) 
produced by Bacillus thuringiensis subsp. entomocidus, Lisboa et al., (2006) found a 5 
kDa AMP in a Bacillus spp., Xie et al., (2009) described a BLIS produced by Bacillus 
subtilis LFB112 with an apparent molecular weight of 6.3 kDa, Alam et al., (2011) reported 
a BLIS produced by B. subtilis strain BS15 with 3-5 kDa, Baindara et al., (2013) from a 
halotolerant B. subtilis strain SK.DU.4 described a AMP with 5323.9 Da and finally 
Compaoré et al.,  (2013) disclosed a 4kDa compound produced by a B. subtilis subs. 
subtilis strain H4. Nevertheless, characterization of these compounds, namely on its 
319
Chapter 3 
amino acid compositions and correspondent structures elucidation was poorly explored, 
which hinders comparisons. 
 
3.5. Antimicrobial activity of the FPLC and HPLC purified fractions  
In order to separate the active Bs1 peptide, a combination of chromatographic techniques 
were applied and the fractions obtained tested for its antimicrobial activity against S. 
aureus ATCC 29213 using well diffusion assays. In both FPLC and HPLC analysis, the 
presence of active peptide in the different Bs1 CFS extracts was initially confirmed. 
Resulting chromatograms (Figure S1 and S2) beside the active peptide, seems to present 
a large number of other peptides and proteins. 
FPLC elution profiles analysis of ultrafiltered fractions with 10 kDa and 3 kDa membranes, 
followed by ammonium sulfate precipitation at 40% and 60% of saturation (Figure S1), 
showed the presence of an additional peak (when compared with the negative control), in 
the retention time between 50 and 60 min, which possibly corresponds to the previously 
associated active peptide with 5 kDa. After fractions collection, a lyophilization step was 
preceded and then the antimicrobial activity tested. Unfortunately, no fraction exhibited 
antimicrobial activity against the strain indicator tested.  
HPLC chromatograms analysis of the Bs1 active extracts (Figure S2) revealed the 
presence of distinct peaks (when compared with the negative control), after 35 min of 
retention time. Moreover, and under these conditions different inactive peptides seem to 
be also precipitated (Figure S2 (d) and (e)). All fractions derived from ammonium sulfate 
precipitation were collected, lyophilized and antimicrobial activity of each individual peak 
was assessed. Similar to FPLC, no fraction presented antimicrobial activity against the 
indicator organism tested. 
Thus, in order to evaluate the presence of the active peptide in the correspondent pre-
purified steps prior to structural characterization, fractions derived from these steps were 
also purified by C18 ZipTip and the single collected fraction tested for its antimicrobial 
activity. The resulting purified peptide from both 40% and 60% of ammonium sulfate 
precipitation revealed activity against S. aureus ATCC 29213, with inhibition zones of 18 
mm detected by well diffusion assay. 
These results prompt us to suggest that possibly the chromatographic separation induced 
a structural change in the active peptide. Thus, the absence of antibacterial activity in the 
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fractions recovered from FPLC and HPLC can be probably associated to the combination 
of some essential peaks, which cooperatively functionalize the activity of peptide and 
actively changed during HPLC and FPLC separation. Chromatographic separations can 
cause irreversible denaturation of peptide, thereby reducing the potential of their recovery 
in a biologically active form (Aguilar, 2003). Indeed, the nature of the organic solvent can 
influence the peptide conformation and also, the use of longer gradient times, despite 
provides improved separation, can also increase the residence time of the peptide at the 
sorbent surface, which may then result in an increase of the peptide denaturation degree 
(Aguilar 2003). Therefore, this hypothesis could possible justify the results obtained, since 
they can confer an impact on the level of recovery of biologically active material or impose 
important changes in peptide structure. 
3.6. Characterization of the purified AMP 
3.6.1. Mass spectrometry and PMF 
Mass spectrometry analysis of the excised SDS-PAGE gel bands, resolved with 40% and 
60% of ammonium sulfate saturation, which revealed the presence of an antimicrobial 
peptide with approximately 5 kDa, demonstrate the presence of two ion peaks at m/z of 
5372.6 and 5502.5 (Figure 4). This difference probably corresponds to the Met losses (-
131 Da) in the m/z 5372.6. 
Further, primary structure elucidation of these m/z peaks, conducted using their tryptic 
digestion, was accesses by MS/MS. The resulting digestion revealed the presence of two 
main fragment peptides (Figure 5) at m/z 1540.75 and 1991.87, corresponding 
respectively to SAPTCFLQGVGTFR and YYVDRDTGEICTSQER. PMF analysis was 
performed by Matrix Science Mascot UK software, and significant (P<0.05) result was 
obtained. After searching in the MASCOT protein database for amino acid sequences 
identity, the partially resulted sequence, matches the sequence of a hypothetical protein 
including 64 amino acids, which was derived from the genome of B. pumilus ATCC 
7061T (gi 489307730), whose complete sequence is 
MLDRFLNKMTNVQPAASRCILQKLVTSCKSAPTCFLQGVGTFRYYVDRDTGEICTSQERI
RCGC. Our partial sequence identified, present 100% of homology with 30 amino acids of 
the previous one, from position 30 to 59 (SAPTCFLQGVGTFRYYVDRDTGEICTSQER). 
Except for the amino sequence, no any other information such as function, genetic 
location or its relation with any antimicrobial peptide produced by bacteria was never been 
321
Chapter 3 
assigned. The predicted molecular weight of the total protein (7225.42 Da) did not match 
with the observed molecular weights (5372.6 and 5502.5 Da) (Figure 4). In addition, 
MALDI-TOF of the BS1 active peptide allows ascertaining the molecular mass predicted 
by the correspondent SDS-PAGE with higher reliability. One possible explanation which 
can be speculated is the fact that our Bs1 peptide is a result of peptide maturation where 
the N-terminal extension of precursor peptide is cleaved off by the action of a certain 
enzyme that possible cleaves at a Met residue when the adjacent residues are non-bulky 
amino acids (Giglione et al., 2004). 
 
3.6.2. N-terminal amino acid sequencing and analysis 
Bs1 was subjected to automated Edman degradation to determine their N-terminal amino 
acid sequence. Their analysis provided the identification of a partial sequence A(N,V,I,L)-
A(Q,P,I)-?(P,A,R,Q,D)-R(L,F,G,H)-?-I(T,Q,M,G)-L(Q)-Q(K)-K-L(V)-V-T(V,S)-S(T)-?-K(F), 
which present some uncertain positions in the assigned amino acids in brackets. 
However, a database search revealed homology with the same hypothetical protein as 
determined by MS/MS approach, namely gi 489307730 from B. pumilus ATCC 7061T.   
Therefore, custom synthesis was performed and synthetic peptide 
(MLDRFLNKMTNVQPAASRCILQKLVTSCKSAPTCFLQGVGTFRYYVDRDTGEICTSQER
IRCGC) was evaluated on its antibacterial activity against S. aureus. Results evidenced 
that linear structure of this peptide have not any effect in the growth of S. aureus. The 
absence of cationic amino acids in the N-terminal sequence of this 64 amino acid peptide, 
reported as a crucial factor for antimicrobial activity, could be a possible justification for 
this result. 
In addition, comparison of resulting N-terminal sequence and peptide gi 489307730 
seems to suggest a N-terminal staggered from position 11 or 15. In this sense, further 
partial custom syntheses of the partial sequence 
SRCILQKLVTSCKSAPTCFLQGVGTFRYYVDRDTGEICTSQERIRCGC should be 
performed and antibacterial activity tested. 
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3.6.3. Secondary structure prediction 
Circular dichroism (CD) spectroscopy was employed in an attempt to elucidate secondary 
structure integrity of the 5kDa purified peptide. The linear conformation of the synthesized 
synthetic peptide was used for comparison. CD spectra suggested that Bs1 peptide 
presented a random coil, e.g. unstructured nature in solution with a characteristic 
minimum at approximately 200 nm (Figure 6 and 7). 
Most naturally antimicrobial peptides occurring in nature are cationic (i.e., the net charge 
at neutral pH varies from + 2 to + 9) and amphipathic molecules, which enables the 
peptides to interact with and disrupt lipid membranes. Moreover, they are very short in 
length, containing 5 to 40 amino acid residues, while others containing more than 40 
residues.  
Amino acid sequences of different AMPs are highly heterogeneous, nevertheless, 
positively charged residues such as Lys and Arg and substantial hydrophobic residues 
(∼ 30% or more) are commonly found in these peptides class. In addition, a great 
variation in their secondary structures has also been reported, such as α-helices, β-
sheets, or extended polyproline-like helices, due to the amphipathicity of these molecules 
which enhanced their antimicrobial mechanism of action. 
Nevertheless, most of the linear AMPs are unstructured in solution, with some exceptions, 
e.g.  LL37, a human antimicrobial peptide (Wildman et al., 2003; Dürr et al., 2006) and 
cyclic peptides due to the presence of one or more Cys–Cys disulfide bonds which 
possibly the formation β-sheets (Dhople et al., 2006).  
Moreover, these unstructured (linear) cationic peptides present the possibility to embrace 
an amphipathic α-helical structure. In fact, while these peptides lack a secondary structure 
in solution, interactions with lipid bilayers in membranes induce an amphipathic α-helical 
structure that is believed to be a pre-requisite for its antimicrobial activity (Jin et al 2005) 
by the formation of pore-like structures (He et al., 1995; Matsuzaki et al., 1995) or a more 
general disruption (Oren et al., 1998).  
Therefore, and since the mechanism by which an AMP executes its function depends on a 
number of physicochemical properties, such as the amino acid sequence, net charge, 
amphipathicity, hydrophobicity, structural folding (includes secondary structure, dynamics 
and orientation) in membranes, oligomerization, peptide concentration, and membrane 
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composition (Shai, 1999), further studies should be conducted in order to clarify the 
mechanisms of action of the unstructured Bs1 AMP to explain its antimicrobial activity. 
 
3.6.4. Detection of possible post-translational modifications: glycosylation 
Using SDS–PAGE electrophoresis followed by PAS staining, we did not observe any 
positive reaction for the purified BS1 CFS (Figure 8 (a)). Nevertheless, since limitations of 
this method are known, namely in the nature and in the degree of protein glycosylation, 
this results and evaluation of other possible post-translational modifications, as the 
determination of the presence of lipid moieties, should be attempted. 
 
3.6.5. Prediction of protein antimicrobial regions 
Due to the growing interest in AMPs, web applications as AMPA, based on algorithms, 
which provides the prediction of antimicrobial domains in proteins and can be used to 
propose short AMP, have been developed (Lata et al., 2007; Fjell et al., 2009; Torrent et 
al., 2011; Wang et al., 2011). This platform uses an antimicrobial propensity scale to 
generate an antimicrobial profile, for which antimicrobial IC50 values for all amino acid are 
determined. Therefore, from the IC50 data, an antimicrobial index is calculated, providing 
a tendency of such amino acid to be found within an AMPs sequence. 
Considering Bs1 sequence presenting N-terminal sequence starting in amino acid 15 from 
gi 489307730, SRCILQKLVTSCKSAPTCFLQGVGTFRYYVDRDTGEICTSQERIRCGC, 
AMPA detect an antimicrobial domain, presenting a high probability to pertain to an 
antimicrobial peptide (Figure 9). This antimicrobial stretch was found in amino acids 1 to 
13 positions, SRCILQKLVTSCK, from the resulting peptide. Statistic results revealed a 
propensity value 0.226 (9 %) and a mean antimicrobial value of 0.243, which permit to 
infer with 91% of probability that this sequence pertain to an antimicrobial peptide, 
supported by a low antimicrobial index, which also favor to be part of an AMP.  
In fact, an adequate combination of hydrophobic and cationic amino acid residues, such 
as Arg, Lys, Gly, Cys, Trp and Val, underlies the action of antimicrobial regions, generally 
by conferring them an amphipathic secondary structure that favors interaction with 
microbial membranes, which can induces cell damage (Wimley, 2010). Therefore, the 
antimicrobial activity is usually confined to discrete stretches of the protein, often located 
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at the N- or C-terminal of proteins, rather than spread over the entire sequence 
(Ramanathan et al., 2002). When gi 489307730 was analyzed by AMPA the stretch 
RCILQKLVTSCK is assigned to pertain to an antimicrobial peptide, with a propensity 
value 0.229 (12 %) and a mean antimicrobial value of 0.246. This results can confirm our 
previously assumption, that N-terminal of antimicrobial mature protein derived from gi 
489307730 start in position 17. 
Moreover Collection of Antimicrobial Peptide (CAMP) database 
(http://www.camp.bicnirrh.res.in/) was also used to confirm the previous established 
antimicrobial region, using different statistical algorithms, such as Support Vector Machine 
(SVM), Random Forests (RF) and Artificial Neural Network (ANN) (Schaffer et al., 2001). 
For biological activity structural or physical parameters could be considered critical, 
namely size, sequence, charge, degree of structuring (helicity), hydrophobicity, 
amphipathicity and angles subtended by hydrophobic and hydrophilic faces of the formed 
helix (Faccone et al., 2014). Therefore, physicochemical properties as amino acid 
composition, net charge, hydrophobicity, aliphatic index, instability index and pI were 
determined and results summarized in table 2.  
Physicochemical properties of the 48 amino acids predicted antibacterial peptide, 
revealed a pI of 8.65, an aliphatic index of 68.96, a net charge of 3 (total number of 
negatively charged residues (Asp + Glu): 4; total number of positively charged residues 
(Arg + Lys): 7), a hydropathy of -0.15 and an instability index of 46.36 (which classifying 
the peptide as unstable are in agreement with CD data). 
Moreover, using antimicrobial peptides and proteins collections deposited in CAMP 
database, homologous sequences searches using BLAST were performed (Table S1). 
Nevertheless, no significant similarity was observed among our antimicrobial peptide with 
available AMP´s present in this database, suggesting that probably a new peptide can be 
involved in the reported activity, despite some reported antimicrobial proteins and 
peptides, including a short fraction of subtilin, present some similarity with our peptide. 
Therefore, our finding and predictions prompt us to suggest the presence of a new 
alternative antibiotic as a potential candidate to circumvent S. aureus infections and thus a 
good possibility for its inclusion in topical use. Further investigations should be carried out 
to confirm the proposed amino acid composition and its structure elucidation. Moreover, 
its antimicrobial activity against a panel of clinical isolates expressing different 
mechanisms of resistance should also be extended. 
325
Chapter 3 
Table 1. Strains used in antimicrobial activity assays. 
Isolates Origin Susceptibility profile Reference 
Gram positive   
Staphylococcus aureus 
ATCC 29213 
 NA ATCC 
Staphylococcus aureus 
MRSA FFUP 001  
 Methicillin resistant FFUPCC 
Staphylococcus 
epidermidis Ste1 
Catheter - Portugal (2012) 
Methicillin- and 
Linezolid- resistant 
Barros et al., 
2014 
Staphylococcus 
epidermidis 55 
Human commensal flora– Italy (2011) Susceptible Cavallo, 2011 
Enterococcus faecium 
(VRE) E1 
Hospital sewage – Portugal (2001) Vancomycin resistant 
Freitas et al., 
2009 
Bacillus subtilis BGA  NA 
Spore 
suspension, 
Merck (Product 
number 
1106490001) 
Bacillus pumilus ATCC 
14884 
Animal commensal flora– Portugal (2004) NA ATCC 
Bacillus safensis Bs1  
Intermediate profile to 
Cefotaxime 
Branquinho et 
al., 2014 
Bacillus cereus FFUP 95  NA FFUPCC 
Lysinibacillus fusiformis Animal commensal flora– Portugal (2004) 
Intermediate profile to 
Clindamycin 
FFUPCC 
Listeria monocytogenes 
FFUP 35 
 NA FFUPCC 
Gram negative    
Acinetobacter baumanni 
ATCC 19606 
 NA ATCC 
Escherichia coli ATCC 
25922 
 NA ATCC 
Pseudomonas aeruginosa 
ATCC 27853 
 NA ATCC 
Salmonella Typhymurium 
F154/22 
Food – Portugal (2004)  Nitrofurantoin resistant 
FFUPCC; 
Antunes et al., 
2006 
Salmonella Enteritidis 
62/02 
Human – Portugal (2002)  Susceptible 
INSA; Antunes 
et al., 2006 
NA – not applied; ATCC - American Type Culture Collection; FFUPCC - Faculty of Pharmacy of Porto 
University Culture Collection; INSA - National Institute Dr. Ricardo Jorge Culture Collection 
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Table 2. Prediction of antimicrobial regions accordingly CAMP database. 
Algorithm Class AMP Probability 
Artificial Neural Network (ANN) classifier 
AMP 
NA 
Discriminant Analysis classifier 0.884 
Random Forest Classifier 0.7465 
Support Vector Machine (SVM) 0.646 
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Figure 1. Antibacterial activity against S. aureus ATCC 29213 of the purified peptide 
recovered from B. safensis Bs1, using well diffusion assay. Legend: (1) direct Bs1 CFS, 
(2) ultrafiltered fraction followed by peptide precipitation using 40% (w/v) and (3) 60% 
(w/v) of ammonium sulfate saturation. Bs1 peptide revealed 14, 16 and 17 mm of 
inhibition zones for S. aureus ATCC 29213, respectively. Similar results were obtained in 
the three individual experiments. 
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Figure 2. SDS-PAGE of the precipitated proteins from CFS of B. safensis Bs1. Lane 1: 
direct CFS Bs1, Lane 2: fraction ultrafiltered throughout >10 kDa, Lane 3: fraction 
ultrafiltered followed by peptide(s) precipitation using 40% (w/v) ammonium sulfate 
saturation, Lane 4: fraction ultrafiltered followed by peptide(s) precipitation using 60% 
(w/v) ammonium sulfate saturation, Mw: Molecular weight marker.  
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Figure 3. SDS-PAGE of the ultrafiltered peptide(s) recovered from CFS of B. safensis Bs1 
(a). Lane 1: CFS Bs1 ultrafiltered throughout >10 kDa, Lane 2: CFS Bs1 ultrafiltered 
throughout >3 kDa, Mw: Molecular weight marker. (b) and (c) direct detection of 
antimicrobial activity by overlaying the gel with nutrient agar containing the indicator 
strains S. aureus ATCC 29213 of the ultrafiltered fraction >10 kDa da and > 3 kDa, 
respectively . Inhibition zones were observed after 24h of incubation at 37ºC. 
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Figure 4. MALDI-TOF/MS of Bs1 peptide(s) acquired in positive linear mode from the 
resolved SDS-PAGE gel band purified using 60% (w/v) of ammonium sulfate saturation. A 
similar spectrum was obtained for 40% (w/v) of ammonium sulfate saturation.
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Figure 5. PMF analysis of Bs1 antimicrobial peptide. PMF followed by MASCOT search 
shows the matched residues (in red) of the peptide fragments with the putative protein (gi 
489307730) in genome of B. pumilus ATCC 7061T with 100% of identity. 
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Figure 6. Circular dichroism spectra, recorded in the far-UV region (190–260 nm), of 
purified Bs1 antimicrobial peptide using precipitation with 40% (w/v) of ammonium sulfate 
saturation followed by C18 ZipTips preparations (blue), CFS ultrafiltered fraction 
(>3000Da) (red) and synthetic Bs1 peptide (green), revealing its intrinsically disordered 
nature in solution. 
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Figure 7. Prediction of the protein secondary structure content estimated using Greenfield and Fasman method (a) and the DichroWeb server (b), 
supporting the unordered nature of Bs1 peptide in solution. 
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Figure 8. SDS-PAGE electrophoresis followed by PAS staining of the purified peptide 
recovered from CFS of B. safensis Bs1 (a). Lane 1: STI protein (negative control), Lane 2: 
HRP protein (positive control), Lane 3: fraction ultrafiltered followed by peptide 
precipitation using 60% (w/v) ammonium sulfate saturation, Lane 4: fraction ultrafiltered 
followed by peptide precipitation using 40% (w/v) ammonium sulfate saturation, Mw: 
Molecular weight marker. The same protein samples were electrophoresed in identical 
polyacrylamide gels and then stained with Comassie Blue to confirm the presence of the 
purified Bs1 peptide (b). 
335
Chapter 3 
 
 
Figure 9. AMPA results from the antimicrobial chart profile of the Bs1 sequence peptide. 
On X-axis is reported the amino acid position in the peptide and on the Y-axis the 
antimicrobial score at that position.  The probability values displayed correspond to the 
probability to find the predicted stretch in a non-antimicrobial protein.
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Table S1. Comparison resulting sequences producing significant alignment and blast results from homologous sequences using BLAST tool inside the CAMP 
database.  
CAMP ID UniProt ID Protein name Taxonomy Sequence Blast Score (bits) Values Expect Identities 
Bacteria 
CAMPSQ12
04  
P10946 Lantibiotic subtilin Bacillus subtilis WKSESLCTPGCVTGALQTCFLQTLTCNCKISK 18.1 bits (35)  9.9 6/11 (55%) 
CAMPSQ32
88  
P36961 Lactococcin G-a 
Lactococcus lactis 
LMGT2081 
GTWDDIGQGIGRVAYWVGKALGNLSDVNQASRINRKKKH 18.5 bits (36)  8.1 6/17 (35%) 
Animalia 
CAMPSQ23
90 
E1B2T7 Brevinin a) 
2LF
2 
Amphibians 
IMSTLKQFGISAIKGAAQNVLGVLSCKIAKTC 18.5 bits (36)  6.8 7/10 (70%) 
CAMPSQ42
90 
K7ZGR3 
Brevinin 2 
a)
AJ1 GLMSTFKRVGISAIKGAAKNVLDVLSCKIAKTC 18.5 bits (36)  7.0 7/10 (70%) 
CAMPSQ42
84 
K7ZAL2 AJ2 GLMSTFKQVGISAIKGAAKNVLDVLSCKIAKTC 18.5 bits (36)  7.0 7/10 (70%) 
CAMPSQ42
89 
K7Z432 AJ3 GLMSTFKQVGISAIKGAAQNVLGVLSCKLAKTC 18.5 bits (36 ) 7.0 7/10 (70%) 
CAMPSQ42
87 
K7ZAL3 AJ7 GLVSTFKQVGISAIKGAAKNVLDVLSCKIAKTC 18.5 bits (36)  7.0 7/10 (70%) 
CAMPSQ42
83 
K7ZJ56 AJ4 GFMSTFKQVGISAIKGAAKNVLDVLSCKIAKTC 18.5 bits (36)  7.0 7/10 (70%) 
CAMPSQ13
01 
Q9U6U0 
Antimicrobial 
peptide MGD2b 
Molluscs (Bivalvia) 
MKAVFVLLVVGLCIMMMDVATAGFGCPNNYACHQHCKSIRGY
CGGYCASWFRLRCTCYRCGGRRDDVEDIFDIYDNVAVERF 
19.6 bits (39)  4.7 7/14 (50%) 
a)antimicrobial peptide precursor
Bs1    3   CILQKLVTSCK  13 
  C LQ L  +CK 
Subtilin 19  CFLQTLTCNCK  29
Bs1   21  QGVGTFRYYVDRDTGEI  37 
  QG+G   Y+V +  G + 
Lactocin  8   QGIGRVAYWVGKALGNL  24
Bs1  9   VTSCKSAPTC  18 
  V SCK A TC 
Brevinin LF2  23  VLSCKIAKTC  32
Bs1   9   VTSCKSAPTC  18 
  V SCK A TC 
Brevinin 2AJ1  24  VLSCKIAKTC  33
Bs1   9   VTSCKSAPTC  18 
  V SCK A TC 
Brevinin 2AJ2  24  VLSCKIAKTC  33
Bs1   9   VTSCKSAPTC  18 
  V SCK A TC 
Brevinin 2AJ3  24  VLSCKLAKTC  33
Bs1   9   VTSCKSAPTC  18 
  V SCK A TC 
Brevinin 2AJ7  24  VLSCKIAKTC  33
Bs1   9   VTSCKSAPTC  18 
  V SCK A TC 
Brevinin 2AJ4  24  VLSCKIAKTC  33
Bs1    35  GEICTSQERIRCGC  48 
    G  C S  R+RC C 
MGD2b  44  GGYCASWFRLRCTC  57
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Figure S1. (a) FPLC chromatogram profiles of CFS Bs1 peptide(s) pre-purified using ultrafiltration throughout >10 kDa and >3kDa membranes, 
demonstrating the presence of an additional peak (when compared with the negative control - TSB), in the retention time between 50 and 60 min, 
which possibly corresponds to the active peptide with 5 kDa. 
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Figure S1. (b) FPLC chromatogram profiles of CFS Bs1 peptide(s) pre-purified using ultrafiltration throughout >10 kDa followed by and ammonium 
sulfate precipitation (40% and 60% of saturation).  
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Figure S1. (c) FPLC chromatogram profiles of CFS Bs1 peptide(s) pre-purified using ultrafiltration throughout >3 kDa followed by and ammonium 
sulfate precipitation (40% and 60% of saturation).  
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Figure S2. Reverse-phase HPLC chromatogram profiles of CFS Bs1 peptide (a) culture 
medium, (b) Bs1 CFS fraction ultrafiltered throughout >10 kDa membrane, (c) Bs1 CFS 
fraction ultrafiltered throughout >3 kDa membrane, (d) Bs1 CFS precipitated using 40% 
(w/v) ammonium sulfate saturation and (e) Bs1 CFS precipitated using 60% (w/v) 
ammonium sulfate saturation. Different fractions were lyophilized before the antibacterial 
assay. 
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Biosurfactants in B. pumilus group 
species: diversity and anti-biofilm 
activity of a surfactin-like biosurfactant 

Chapter 4 
4.1. Species-specific surfactin-like biosurfactants combination within 
Bacillus pumilus group 
Publication: 
Species-specific surfactin-like combinations of biosurfactants within Bacillus 
pumilus group  
This work addresses the species-specific combinations of biosurfactants, namely 
surfactin-like compounds achieved in Bacillus safensis and Bacillus pumilus. Remarkably, 
B. safensis isolates revealed the production of a mixture of biosurfactants composed of 
pumilacidin variants and, in smaller amounts of a surfactin variant, whereas in B. pumilus 
only pumilacidin variants were detected. Moreover B. altitudinis isolates doesn´t revealed 
surface-active compounds production. In addition absence of correlation between 
detection of lipopeptides synthetase genes by a PCR approach and biosurfactant 
production was also detected. 
Results disclosed from this work highlight these species as further exploring sources of 
bioactive compounds, broadening their potential applications. 
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Abstract 
Assessing the diversity of biosurfactants produced by B. pumilus group species we 
verified surface-active properties compatible with biosurfactant compounds in most B. 
pumilus (n=3 of 4 isolates) and B. safensis (n=9 of 15) isolates tested, and their absence 
in B. altitudinis (n=9). Moreover, srf/lch (100%) and fen (52%) genes were frequently 
detected, although iturin family genes were not observed. Interestingly, LC/ESI-MS/MS 
analysis revealed a mixture of pumilacidin variants and surfactin compounds in B. 
safensis, whereas in B. pumilus only pumilacidin variants were detected. These data 
contrast with B. subtilis were surfactin and fengycin were detected.  
In conclusion, despite the frequent detection of surfactin and fengycin genes in B. pumilus 
group isolates, surface-active properties were only associated with surfactin-like 
combinations in B. safensis and B. pumilus. Interestingly, a species-specific content in 
biosurfactant homologues was observed. Further studies of these biosurfactant variants 
could unveil interesting effects, broadening potential applications of these compounds. 
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1. Introduction
Biosurfactants (i. e. surface-active compound of microbial origin), are particular 
amphipathic molecules that recently have emerged as a promising class of bioactive 
secondary metabolites with increasing scientific, therapeutic and biotechnological interest 
(Banat et al., 2010, Fracchia et al., 2012, Gudiña et al., 2013, Martinotti et al., 2013, 
Seydlová et al., 2011).  
Among the different current classes, lipopeptides, due to their structural novelty and 
versatility, represent one of the most important ones widely produced among Bacillus 
species (Fracchia et al., 2012, Kalinovskaya et al., 2002, Martinotti et al., 2013, Soberón-
Chávez, 2011). Chemically, these compounds are constituted of 7–10 amino acids, which 
are cyclized by a lactone ring to a β-hydroxy fatty acid with distinct chain lengths. 
Moreover, they are classified into different families, encompassing surfactins (Arima et al., 
1968), iturins (Delcambe et al., 1977), fengycins (Vanittanakom et al., 1986), 
bacillomycins (Roongsawang et al., 2002), mycosubtilin (Duitman et al., 1999) and 
kurstakins (Hathout et al., 2000). 
Surfactin family encompasses about 20 different lipopeptides biosurfactants (also named 
surfactin-like compounds), which have been reported as widely produced by members of 
Bacillus subtilis complex (Soberón-Chávez, 2011). Moreover, B. pumilus species, 
taxonomically classified into B. pumilus group, which belong to B. subtilis complex, have 
also been described as surfactin-like producers, especially for a biosurfactant named 
pumilacidin (Melo et al., 2009, Morikawa et al., 1992, Naruse et al., 1990). Nevertheless, 
until our knowledge, its production was not demonstrated in other members of this group, 
namely in B. safensis and B. altitudinis. 
Since the discovery of surfactin (Arima et al., 1968) and the characterization of its 
molecular structure as a macrolide lipopeptide, it has been recognized its remarkable 
surface-, interface- and membrane-active properties, which have resulted in a high 
number of promising biological activities of great relevance in biotechnology (Fracchia et 
al., 2012, Seydlová et al., 2011), medicine (Banat et al., 2010, Fracchia et al., 2012, 
Gudiña et al., 2013, Martinotti et al., 2013, Seydlová et al., 2011) and environmental 
protection (Pacwa-Płociniczak et al., 2011). Nevertheless, the knowledge concerning 
surfactin-like biosurfactants as a class of molecules remains limited. In fact, there's a lack 
of a concerted effort to perform a comprehensive screening for biosurfactants producers 
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and, in addition, the present knowledge in the surfactin-like biosurfactants has been 
developed around a relatively small number of well-characterized molecules.  
Lipopeptide biosurfactants share a common mode of assembly through the action of 
multienzymatic proteins organized in modules, named non-ribosomal peptide synthetases 
(NRPSs) by a thiotemplate process (Tapi et al., 2010). Although the genetics of surfactin 
biosynthesis and its control have been most extensively studied in B. subtilis (Tapi et al., 
2010), genes homologous to their peptide synthetases have not yet been studied in B. 
pumilus group. Nevertheless, molecular approaches solely might not be useful for the 
screening of biosurfactant producers (Soberón-Chávez, 2011) thus methodologies for the 
detection of putative biosurfactant-like activity, such as surface tension analysis, should 
be incorporated for accurate detection/screening of these compounds. 
In this study we assessed the ability of species enclosed in Bacillus pumilus group to 
produce biosurfactants, screening for surface-active properties and representative 
lipopeptide family genes, in isolates collected from diverse sources and geographic 
locations. Moreover, structure and composition of the produced bioactive products was 
elucidated by liquid chromatography-electrospray ionization-tandem mass spectrometry 
(LC/ESI-MS/MS) analysis. 
  
 
358
Chapter 4 
2. Material and Methods
2.1. Bacterial isolates 
Fifteen B. safensis, nine B. altitudinis and four B. pumilus isolates previously identified by 
genotypic (16S rRNA, gyrB and rpoB gene sequences) methods were studied 
(Branquinho et al., 2014). They were recovered from different geographic terrestrial 
locations and sources, including food samples (Norway, Italy and Africa) (n=6), plants 
(USA) (n=4), gastropods (Portugal) (n=2), health  (n=12) and cosmetic (n=4) products 
(Portugal). B. pumilus ATCC 14884 was also include in the analyses. Additionally, a B. 
subtilis isolate recovered from a health product contaminant was included for comparison 
(Table 1). 
Bacillus isolates were maintained on Luria Bertani-Miller (LB) agar (Oxoid, United 
Kingdom) for short-term storage and in LB broth supplemented with 40% (v/v) glycerol at -
80ºC for long-term storage.  
2.2. Biosurfactant production and purification 
For biosurfactant production, a seed culture was prepared for each isolate by transferring 
a loop from a LB agar overnight culture into 10 mL of LB broth incubated for 4 h, at 28°C 
and 200 rpm, on an orbital shaker. Thereafter, 2 ml of these cultures were inoculated into 
500 mL of LB broth and incubated at 28°C and 120 rpm for 24 h. A cell-free preparation 
from these cultures was then prepared by centrifuging at 8,000 g-1 for 30 min. This 
supernatant was used for qualitative measurement of surface tension. 
For biosurfactant extraction, the cell-free preparation was acidified to pH 2 with HCl (6 mol 
L-1), and left for 12h at 4ºC for precipitation. The precipitate was then removed by 
centrifugation at 8,000xg for 10 min at 4ºC and the resulting solution extracted twice with 
ethyl acetate/methanol (4:1 v/v) mixture according to the method described by Rivardo et 
al. (2009). The remaining water present in the organic phase was then removed by 
anhydrous sodium sulfate. Finally, the organic phase was evaporated to dryness under 
vacuum condition and acetone was added to recover raw biosurfactant. Acetone was, 
then, evaporated and biosurfactant collected, weighted and quantified.  
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2.3. Evaluation of surface-active properties  
2.3.1. Qualitative measurement of surface tension.  
Screening of surface-active properties of biosurfactants was firstly conducted on the 
supernatant obtained as described in section 2.2, using the oil spreading assay (Morikawa 
et al 2000). Briefly, 20 μl of Motor Oil 10 W-40 (Selenia) were deposited onto a surface of 
20 mL of distilled water to form a thin layer. Subsequently, 20μl of the Bacillus spp. 
supernatants were gently put onto the center of the oil layer and the diameter of the oil 
displacement circle formed was measured to determine the presence of biosurfactant. 
 
2.3.2. Quantitative measurement of surface tension.  
Surface active tension of all supernatants revealing a positive result in the oil spreading 
assay was determined using a Sigma 703D tensiometer (KSV) equipped with a Du Noy 
platinum ring at 35 ºC, on a 20 ml of a biosurfactant solution which was prepared in 
alkaline sterile demineralized water at 500 μg ml−1. Distilled water was used for calibration. 
Critical Micelle Concentration (CMC) was then determined on serially diluted biosurfactant 
solutions in alkaline distilled water and was estimated from the intercept of two straight 
lines extrapolated from the concentration-dependent and concentration-independent 
sections of a curve plotted between biosurfactant concentration and surface tension 
values (Rivardo et al., 2009) 
 
2.3.3. Screening of bioemulsifier producers 
The capacity of these biosurfactants to emulsify a hydrophobic substance was also tested.  
Cell-free supernatants (5 mL) obtained in section 2.2 were mixed with 5 mL of 
hexadecane with a vortex mixer and allowed to stand for 24 h, 8 days and 3 months at 
room temperature. After this time the emulsifying index was determined. E24 index is 
defined as percentage of height of emulsified layer (mm) divided by the total height of the 
liquid column (mm) (Iqbal et al., 1995).  
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2.4. Detection of lipopetide synthethase genes by PCR 
The presence of genes srf/lch, sfp, lchAA, lchAB, lchAC, fen, fenA, fenB, fenD, pps , lpa-14 
and ituD, encoding lipopeptides families (surfactins/lichenysins, iturins and 
fengycins/plipastatins) previously reported in Bacillus spp.,  was searched by PCR, using 
degenerated and specific primers, and sequencing (Table 1) (Athukorala et al., 2009, 
Hsieh et al., 2004 and 2008, Nieminen et al., 2007, Tapi et al., 2010). Sequences 
obtained were compared on GenBank database using the BLAST search.   
2.5 Characterization of lipopeptides by LC/ESI-MS/MS 
2.5.1 Mass spectrometry analysis 
An aliquot of the biosurfactant extract was dissolved in methanol/acetonitrile (50/50 v/v) to 
obtain a 1000 μg ml-1 stock solution. Freshly prepared working solutions were made by 
diluting the stock solution with methanol/water (50/50 v/v) to achieve 15 μg ml-1 solutions. 
All mass spectrometry analyses were done on a LCQ DECA XP Plus (Thermo Finnigan, 
San Jose, CA, USA), Ion Trap mass instrument equipped with an ESI source. Samples 
(15 μg ml-1 solutions) were infused with a syringe at 5μg min-1 flow rate. Source voltage 
and capillary voltage were 4.80 kV and 23 V in positive ion mode, while 5 kV and -15 V in 
negative ion mode. Capillary temperature and sheath gas flow (N2) were, set respectively 
at 350ºC and 30 arbitrary units in both scan modes. Data were acquired in positive and 
negative MS total ion scan mode (mass scan range: m/z 100 2000) and in positive MS/MS 
product ion scan mode; the normalized collision energy (nce %) was optimized for each 
precursor ion selected: m/z 1030, 38%; 1044, 1058, 1072, 1086 and 1100, 39%; 1464, 
1478, 1492 and 1506, 35%. 
2.5.2. Liquid chromatography–mass spectrometry analysis 
A Surveyor HPLC on line with a LCQ DECA XP Plus (Thermo Finnigan, San Jose, CA, 
USA) Ion Trap mass spectrometer equipped with an ESI source was employed. 
Separations were performed on an analytical Luna 5 μm C18, 150×4.6mm (Phenomenex, 
Torrance, CA) protected with a C18-Security Guard cartridge, 4 × 3.0 mm (Phenomenex). 
The injection volume applied was 10 μl. Mobile phase components encompassed: A - 
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formic acid/ ammonium formate buffer and B- acetonitrile. Moreover, lipopeptides were 
eluted according the following gradients: gradient 1  A: B (60: 40) for 4 min, then A: B (0: 
100) over 24 min and finally 100% B over 6 min, at a flow rate of 0.8 ml min-1 ; gradient 2  
A: B (20: 80) for 5 min, then A: B (0: 100) over 20 min and finally 100% B over 15 min, at 
a flow rate of 0.8 ml min- LC/MS full scan positive mode was performed from m/z 100 to 
2000. Alternatively, LC/ESI-MS/MS modalities were applied to the selection of precursor 
ions, following the conditions set during the infusion analysis. 
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3. Results and Discussion
3.1. Surface-active producers within Bacillus pumilus group species 
Biosurfactant production ability was observed in most of B. pumilus (3 of 4 isolates) and B. 
safensis (9 of 15) isolates tested. Interestingly, none of B. altitudinis isolates revealed 
substantial surface tension reduction (Table 2) Biosurfactant producers belonging to B. 
pumilus (Bp7, Bp11 and Bp15) were recovered from contaminated health´s products of a 
pharmaceutical production unit. Moreover, with exception for food isolates, B. safensis 
from different origins produced biosurfactants (Bs2, Bs3, Bs13, Bs16, Bs17, Bs18, Bs19, 
Bs22 and Bs27). In addition, the B. subtilis isolate tested (Bsb28) also revealed a good 
reduction of surface tension.  
The putative emulsifying activity (E24 emulsification index) of the cell-free extracts, tested 
using kerosene (hydrophobic compound) was also investigated (Table 2). Due to their 
amphiphilic structure, biosurfactants increase the surface area of hydrophobic water-
insoluble substances, the water bioavailability of such substances and also change the 
properties of the bacterial cell surface. Therefore, this surface activity makes surfactants 
excellent emulsifiers. The emulsifying activity is determined by its strength in retaining the 
emulsion of the hydrocarbons in water (Fracchia et al., 2012). 
As expected, isolates not able to substantially decrease the superficial tension, didn't also 
reveal emulsifying activity. Moreover, none of the B. pumilus showed notable activity. 
Nevertheless, some of B. safensis isolates tested that revealed substantial surface 
tension reduction ability, presented emulsifying activity, e.g. animal isolates, Bs2 (E24 of
17.81%) and Bs3 (21.28%); cosmetic contaminants isolates, Bs18 (19.12%) and Bs19 
(20.00%) and the plant growth promoter isolate Bs22 (18.67%). Nevertheless, the highest 
emulsifying index (the E24) was observed in the cell-free extract of the non-B. pumilus 
group isolate tested, the B. subtilis isolate (40.00%). The fact that the emulsifying activity 
has been detected in the cell-free extract indicated that this activity was extracellular. 
In order to evaluate the stability of the emulsion, cell-free extracts were also evaluated 
after 8 days and 3 months. Results demonstrated that only Bs3, Bs18 and Bsb28 
produced stable emulsifying agents, being the remarkably E24 retained for Bsb28 
(E24=40.0). In fact, variations in the length of the fatty acids chains and differences in the 
amino acidic sequences (Table 4) could possibly explain the different emulsifying activity 
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detected. Bsb28 present a chromatogram profile correspondent to surfactin and fengycin 
families, while Bs3 and Bs18 with pumilacidin. To our knowledge, pumilacidin have not yet 
been reported so far, as presenting emulsifying activity. Nevertheless, a heteropolymer 
constituted by glucose, mannose, xylose, arabionose and N-acetyl glucosamine as 
monomers units, produced by B. pumilus UW-02, showed significant emulsifying activity 
(Chowdhury et al., 2011). Moreover, nC(14)-surfactin and anteisoC(15)-surfactin 
produced by a Bacillus velezensis H3 strain recovered from sea mud was found to 
evidence a good bioemulsifier funtion coupled with biosurfactant activity (Liu et al., 2010). 
In fact, high molecular weight biopolymers as carbohydrates, proteins, lipids and other 
organic and inorganic compounds, instead of low molecular weight polymers, are usually 
referred to as bioemulsifiers (Banat et al., 2010). In this sense, a more detailed chemically 
characterization should be performed in order to clarify the chemical origin of the 
observed emulsifier activity. 
 
3.2. Detection of lipopetide synthethase genes by PCR 
The presence of specific biosynthetic genes for the three lipopeptides families 
(surfactins/lichenysins, fengycins/plipastatins and iturins) commonly found in Bacillus spp. 
was evaluated by PCR amplification and sequencing.  
Primary structure and genetic organization of the operons encoding the non-ribosomal 
peptide synthetases (NRPSs) of surfactin, lichenysin, iturin, pliplastatin and fengycin were 
previously described (Athukorala et al., 2009, Hsieh et al., 2004 and 2008, Nieminen et 
al., 2007, Tapi et al., 2010). Recently, based on the alignment of nucleic acid sequences 
of adenylation and thiolation domains of these NRPSs, Tapi et al. (2010) designed 
specific degenerated primers, targeting NRPS genes particularly involved in Bacillus spp. 
lipopeptides biosynthesis. In addition to these specific degenerated primers, we have also 
selected different primers sequences previously constructed against the main lipopeptide 
synthetases families based on different Bacillus spp. genomes (Athukorala et al., 2009, 
Hsieh et al., 2004 and 2008, Nieminen et al., 2007). Despite the majority of these 
lipopeptides genes being relatively conserved at the species level, which highlights their 
importance, they also demonstrate some dissimilarities even among closely related 
species (Hsieh et al., 2004), which can stresses the fact that different species can 
produce distinct effective biosurfactant molecules.  
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In the case of surfactin, one of the genes required for its biosynthesis is a large operon of 
25kb, named srfA (Hsieh et al., 2004, Tapi et al., 2010). The sfp gene, encoding an 
enzyme belonging to the superfamily of 4´-phophopantetheinyltransferase, was mapped 
4kb downstream of the srfA operon, and reported as the second essential gene for the 
surfactin production (Tapi et al., 2010).  
Using the primers previously described by Hsieh et al. (2004), sfp gene was only detected 
in the B. subtilis isolate and the amplified fragment demonstrated 99% of homology with 
sfp gene of Bacillus subtilis subsp. subtilis 6051-HGW (GenBank accession number 
NC_020507.1). 
Clustal analyses of different sfp genes available in GenBank database, including 4´-
phophopantetheinyltransferase from B. pumilus SAFR-032 and ATCC 7061T, and others 
from Bacillus subtilis, demonstrated a high level of divergence between them. Moreover, 
the primers pair used for sfp amplification revealed low complementarity with B. pumilus 
SAFR-032 and ATCC 7061T sfp gene.  
In addition, using specific degenerated primers (Tapi et al., 2010) for the surfactin family 
(srf gene), results demonstrated that except for one B. safensis isolate, the  srf gene was 
detected in all isolates tested (Table 3), although this primers pair also amplify lch genes. 
Blast analysis of these amplicons sequences revealed 85% of homology with a non-
specified non-ribosomal peptide subunit present in B. pumilus SAFR-032 genome 
(GenBank accession number NC_009848.1).  
Lichenysin, a lipopetide whose structure presents the same multifunctional modular 
arrangement as seen in surfactin synthetase SrfA, is synthesized by a multienzyme 
complex, lichenysin synthetase (LchA/Lic) (32.4 kb) encoded by a lichenysin operon lchA 
(lic) (26.6 kb), which encoding the proteins LchAA (coding lchAA gene), LchAB (lchAB) 
and  LchAC (lchAC) (Nerurkar, 2010). 
No PCR amplification was obtained using primers specifically targeted to lichenysin 
synthetase genes lchAA, lchAB and lchAC, corroborating the absence of evidences of this 
lipopeptide in the LC/ESI-MS/MS analysis (explored below).  Additionally and 
contrastingly with B. subtilis, no previous reports of production of lichenysin in B. pumilus 
group were obtained.  
Fengycin is synthesized nonribosomally by five fengycin synthetases (37-kb), FenC, 
FenD, FenE, FenA and FenB, which are coded in the fengycin synthetase operon (Wu et 
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al.,  2007). Detection of fengycin synthetase genes using degenerated sequences of 
primers revealed that 55.2% (n=16) of isolates presented fen gene, and 15 of which also 
demonstrated the gene srf.  
Similarly to srf gene, blast analysis of the sequenced amplicons revealed 87% of 
homology with a non-specified non-ribosomal peptide subunit present in B. pumilus 
SAFR-032 genome (GenBank accession number NC_009848.1). No PCR amplification 
was detected using primers targeted to specific fengycin synthetase genes fenA, fenB and 
fenD. Moreover, LC/ESI-MS/MS (explored below in section 3.3) revealed the presence of 
four homologues, C16 and C17-fengycin A and C16 and C17-fengycin B in B. subtilis 
isolate and no evidences of its production were achieved among B. pumilus group 
members. 
In the case of plipastatin synthase NRPS subunits form a co-linear chain in the order 
ppsC-ppsD-ppsE-ppsA-ppsB (38 kb) (Batool et al., 2011). Using primers targeted to 
specific plipastatin synthetase gene pps, no PCR product was detected in the isolates 
tested. 
The iturin A operon (38 kb) is composed of four open reading frames: ituD, ituA, ituB, and 
ituC. The ituD gene encodes a putative malonyl coenzyme A transacylase, whose 
disruption results in a specific deficiency in iturin A production. The lpa-14 gene encodes 
the 40-phosphopantheteinyl transferase required for the maturation of the template 
enzyme of iturin A. Thus, both the ituD gene and the lpa- 14 gene play leading roles in the 
production of iturin A (Hsieh et al., 2008). 
No PCR amplification was detected with a set of two oligonucleotide primer pairs specific 
to the regions within ituD and lpa-14 genes of iturin A, respectively. Despite Hsieh et al. 
(2008) revealed that these set of primers could be applied to find different species or 
genera that contain homologous genes for ituD and/or lpa-14, they also not provided any 
amplification in B. pumilus ATCC 7061 (Hsieh et al., 2008). 
Indeed, the degenerated primer sets used to detect the presence of surfactin and fengycin 
families suggests a genetic potential of B. pumilus group isolates to produce lipopeptides. 
Nevertheless, surfactin and fengycin synthetases genes were detected in some isolates 
showing surface tension properties incompatible with the production of a biosurfactant 
(Table 3), e. g.  Bp ATCC 14884, Bs5, 23 Bs, Bs24, Bs 25, Bs 31, Bs 33 and all B. 
altitudins isolates. 
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In fact, the detection of a particular lipopeptide biosynthetic gene in a bacterial strain could 
not signify the function of its operon and consequently, its production (Mootz et al., 2001). 
Although we can’t discard the possibility of a gene mutation preventing lipopeptide 
production northat the appropriated culture conditions for expression of the correspondent 
compound were not applied. 
3.3. Lipopeptides characterization and structure elucidation by LC/ESI-MS/MS 
From the 13 biosurfactant-producing isolates, 6 were selected to biochemical and 
structure characterization based on the species producing, surface tension properties, E24 
activity and the presence of lipopetides biosynthetic genes detected by PCR. In the mass 
spectra of B. pumilus, B. safensis and B. subtilis studied, different types of lipopeptides, or 
its variants prevail, as summarized in Table 4. 
For the B. safensis Bs18 extract, full-scan mass spectra (Fig. 1) through ESI-MS direct 
infusion analysis, operating in positive full scan mode, showed one cluster of peaks with 
14 Da difference on its molecular ion species.  
Four main signals, corresponding to the sodiated molecules in the positive ion mode 
[M+Na]+ at m/z 1058, 1072, 1086 and 1100 were detected. Moreover, analyses in negative 
full scan mode revealed the presence of four main peaks at m/z 1034, 1048, 1062 and 
1076 corresponding to deprotonated molecules [M-M]-. Indeed, molecular weights for the 
four peaks can be attributed, specifically 1035, 1049, 1063 and 1077 Da, which are similar 
with the molecular weights reported for surfactin and pumilacidin lipopeptides. Then, LC-
ESI-MS/MS analysis was performed according gradient 2, on precursor ions [M+Na]+ at
m/z 1058, 1072, 1086 and 1100.  
LC-ESI-MS/MS from precursor ions [M+Na]+ at m/z 1072 and 1100 showed one main peak 
for each precursor ion, at retention times (Rt) of 18.03 and 23.01 min, respectively. 
Product ion spectra (Fig. 2a) from m/z 1072 resulted in the following series of ions: m/z 
1054, 959, 828, 731, 721, 608 and 477. Peak ion detected at m/z 1054 correspond to the 
loss of water (-18 Da) from the m/z 1072. Moreover, the remaining product ions were 
derived from the initial opening of the lactone ring,  
Thus, the first series included the fatty acid chain and the N-terminal product ions at m/z 
959, 828 and 731, corresponding to the losses of Leu (-113 Da), Leu-Leu-H2O (-244 Da) 
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and Leu-Leu-Asp (-341 Da) from the m/z 1072.  In addition, the second one enclosed the 
peptidic moiety inside the C-terminal product and corresponds to the ions peaks at m/z 
721, 608 and 477. Ion at m/z 721 correspond to the loss of C15–β-hydroxyl fatty acid chain 
-Glu (-351 Da) from the precursor ion, following double hydrogen transfer (DHT) 
mechanism of the ester bond of the cyclic skeleton and cleavage of one C-terminal amino 
acid residue (Yang et al., 2006). Moreover, ion at m/z 608 match to the successively loss 
of Leu (-113 Da) and ion at m/z 477 to the loss of Leu-Leu-H2O (-244 Da). 
LC-ESI-MS/MS spectra analysis from precursor ion [M+Na]+ at 1100 (Rt 23.01 min) (Fig. 
2b) revealed, as above mentioned, two product ion series, comprising m/z 1082, 987, 856 
and 759 related to the fatty acid chain, and ions at m/z 721, 608 and 477. Within the first 
series product ions belonging to m/z 1100 differ of 28 Da from those belonging to m/z 
1072, confirming the difference of a -CH2–CH2 in the side chain. Furthermore, in the 
second series all product ions are identical to the previous mentioned, thus, 
corresponding to the same amino acid sequences. 
Indeed, these ion signals are in accordance with two pumilacidin-Leul7 homologues, 
respectively C15-Glu/Leu/Leu/Leul/Asp/Leu/Leu and C17- Glu 
/Leu/Leu/Leul/Asp/Leu/Leu,  (Fig. 3a), which can be related with pumilacidin A ([M+Na]+ 
1073 m/z) or F ([M+Na]+ 1073 m/z) or G ([M+Na]+ 1073 m/z) and with C ([M+Na]+ 1101 
m/z) types, respectively (Burch et al., 2011, Naruse et al., 1990).  
Interestingly, the LC-ESI-MS/MS  analysis from the precursor ions [M+Na]+ at m/z 1058 
and 1086 showed three isobaric peaks for each precursor ion, at Rt 15.98, 16.56 and 
17.85 and also 20.46, 21.25 and 22.84 min, respectively. From the precursor ion [M+Na]+ 
at m/z 1058 the product ion spectra of the peak at Rt 15.98 min also demonstrates two 
product ion series. In the first series (m/z 1040, 945, 814) related to the fatty acid chain, 
product ion belonging to m/z 1058 differed of 14 Da from those belonging to m/z 1072, 
also confirming the difference of a –CH2 in the side chain. Within the second series (m/z 
721, 608, 477) all product ions are equal and consequently the amino acid sequences the 
same. Additionally, this signal was in accordance with C14-
Glu/Leu/Leu/Leul/Asp/Leu/Leu, the third homologue of pumilacidin-Leu7 molecules. 
Analysis of ion spectra of the peak at Rt 16.56 min (Fig. 4a) reveal ions products at m/z 
1040, 959, 828, 731, 707, 594 and 463. Ion at m/z 1040 correspond to the loss of water (-
18 Da) from m/z 1058 and the remaining product ions were deriving, as before, from the 
initial opening of the lactone ring. In addition, the first series contain the fatty acid chain 
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and the N-terminal product ions at m/z 959, 828 and 731, corresponding to the losses of 
Val (-99 Da), Val-Leu-H2O (-230 Da) and Val-Leu-Asp (-327 Da) from m/z 1058, 
respectively. The second series encompass a different peptidic moiety inside the C-
terminal product ions at m/z 707, 594 and 463, where ion at m/z 707 correspond to the 
loss of C15 –β-hydroxyl fatty acid chain-Glu (-351 Da) from the precursor ion, ion at m/z  
594 to the successively loss of Leu (-113 Da) and m/z  463 to the loss of Leu-Leu-H2O (-
244 Da). In fact, these signals are in agreement with the C15-
Glu/Leu/Leu/Leul/Asp/Leu/Val, pumilacidin-Val7 variant (Fig. 3 b). 
Related to resulting peak at Rt 17.85 min (Fig. 5a) ions product at m/z 1040, 945, 814, 
618, 707, 594 and 463 were detected. Ion at m/z 1040 correspond to the loss of water (-
18 Da) from m/z 1058. The resulting series contained the fatty acid chain and the N-
terminal product ions at m/z of 945, 814 and 618 corresponding to the losses of Leu (-113 
Da), Leu-Leu-H2O (-244 Da) and Leu-Leu-Asp-Val (-440) from m/z of 1058, respectively, 
in the first series, and in the second, enclose different peptidic moieties inside the C-
terminal products at m/z 707, 594, and 463. Moreover, ion at m/z 707 corresponds to the 
loss of C15–β-hydroxyl fatty acid chain-Glu (-351 Da) from the precursor ion, m/z 594 to 
the successively loss of Leu (-113 Da) and m/z of 463 to the loss of Leu-Leu-H2O (-244 
Da). These signals are in accordance with the C15-Glu/Leu/Leu/Vall/Asp/Leu/Leu 
homologue belonging to surfactin molecules (Pecci et al., 2010) (Fig. 3c). 
Precursor ion analysis at m/z 1086 showed three peaks at Rt 20.46, 21.25 and 22.84 min. 
Rt 20.46 min product ion spectra resulting, as before, into two product ion series. The 
peptidic series (m/z 721, 608 and 477) is relative to pumilacidin and the aliphatic series 
(m/z 1068, 973, 842, 745) differ of –CH2 of the previous homologue. These signals are in 
conformity with the C16-Glu/Leu/Leu/Leul/Asp/Leu/Leu, the fourth homologue of 
pumilacidin-Leu7. 
Rt 21.25 min product ion spectra, also show two product ion series (Fig. 4b), comprising 
the peptidic one, at m/z  707, 594 and 463, which is relative to the variant of Val7 of 
pumilacidin molecule and the aliphatic one, enclosing m/z 1068, 987, 856 and 759 which 
differ of -CH2–CH2 of the previous homologue. C17-Glu/Leu/Leu/Leu/Asp/Leu/Val, the 
second homologue of pumilacidin-Val7 match these masse signals observed. 
Finally, at Rt 22.84 min the product ion spectra (Fig. 5b) revealed the presence of the 
peptidic series (m/z 707, 594 and 463) relative to surfactin molecule, and the aliphatic 
series (m/z 1068, 973, 842 and 745) differing in -CH2–CH2 of the previous homologue, 
369
 Chapter 4 
 
which are in accordance with the C17-Glu/Leu/Leu/Vall/Asp/Leu/Leu, the second 
homologue of surfactin molecule. 
In fact, detection of chemical differences in pumilacidin and surfactin were previously 
observed to occur in amino acid position 4 or 7 of the peptidic ring. Thus, pumilacidin 
variants are consistent with Leu4, Leu7 or Val7 surfactins (Morikawa et al., 1992). 
The relative abundance of the three surfactin-like biosurfactants variants presented in B. 
safensis isolates analyzed (Bs2, Bs22, Bs18 and BS27) were inferred from sum of the 
product ions attributed to the relative precursor ions [M+Na]+. Beyond B. safensis Bs18, all 
the remaining isolates also presented the same relative abundance on its surfactin-like 
variants produced, being detected an average of 90% in pumilacidin variants and of 10% 
in surfactin ones (Table 4). 
These observations prompt us to suggest that the production of pumilacidin-Leu7, or its 
variant Val7, together with surfactin seems to be B. safensis species-specific and thus, 
can be related to its adaptability and defense mechanisms into different ecological niches 
(Branquinho et al., 2014). 
Related to B. pumilus species analyzed, full-scan mass spectra derived from Bp11, 
demonstrated that pumilacidin variant Leu7 and variant Val7 were present (Table 4) with a 
relative abundance average of 94 and 3%, respectively for each one. Characterization of 
B. pumilus Bp11 extracts through ESI-MS direct infusion analysis operating in positive full 
scan mode, showed one cluster of peaks with 14 Da difference on its molecular ion 
species. Four main signals at 1058, 1072, 1086 and 1100 m/z were detected, which 
correspond to the sodiated molecules [M+Na]+. The positive LC-ESI-MS/MS analysis on 
the sodiated molecule at m/z of 1058, 1072, 1086 and 1100 performed on B. pumilus 
extract, and similar to previously observed to B. safensis isolates, revealed that these 
signals were in according with the four homologues of pumilacidin-Leu7 variants 
compounds, respectively C-14, C-15, C-16 and C-17 and also C-15 and C-17 pumilacidin-
Val7 variant. 
In contrast with B. safensis, B. pumilus isolates seems to be able to produce just one type 
of surfactin-like compounds, specifically pumilacidin. Structure-activity relationships 
should be further conducted, in order to explain in what dimension these differences can 
interfere with the activity of these compounds. 
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Characterization of B. subtilis Bs28 extracts through ESI-MS direct infusion analysis 
operating in positive full scan mode, showed two clusters of peaks with 14 or 28 Da of 
difference in their molecular ion species (Fig. 6), which in accordance with other work 
performed by our research team (Pecci et al., 2010), correspond with spectral analysis of 
surfactin and fengycin compounds. Surfactin is represented by three main mass signals at 
[M+Na]+, namely at m/z of 1030, 1044 and 1058. Results derived from our LC/ESI-MS/MS 
analysis performed with gradient 1 are in accordance with the presence of three surfactin 
homologues, e.g. C13- Glu/Leu/Leu/Val/Asp/Leu/Leu, C14-Glu/Leu/Leu/Val/Asp/Leu/Leu 
and C15-Glu/Leu/Leu/Val/Asp/Leu/Leu and none of the pumilacidin variants detected for 
B. safensis or B. pumilus were here achieved. Moreover, fengycin was characterized by 
four mass signals at [M+H]+, namely at  m/z of 1478 and 1464 for fengycin A and m/z of 
1492 and 1506 for fengicyn B (Pecci et al., 2010). Our spectral results are in agreement 
with the previously description, revealing the presence of C16 and C17 homologues of 
fengycin A and C16 and C17 homologues of fengycin B. The relative abundance achieved 
in B. subtilis Bsp28 was of 90% for surfactin and of 10% for fengycin.  
Since biosurfactants production depends of the type and amounts of carbon source and of 
other nutrients present in the screening culture medium (Soberón-Chávez, 2011), it will 
consequently influence the composition content of the mixture and the amount of 
compounds produced. In fact, it is possible that other type of biosurfactants could be 
produced by these Bacillus spp., nevertheless the cultural optimization and screening 
conditions were not the aim of the present study. Therefore, a more comprehensive 
screening can be further performed in order to obtain new potential biosurfactants with 
putative possible different applications. LB broth has been reported as the culture medium 
more extensively used for Bacillus biosurfactant production (Rivardo et al., 2009), and 
therefore it was accepted and applied for our screening evaluation.  
The distribution of distinct combinations of these molecules within Bacillus pumilus group 
species recovered from different origins and geographic locations, suggested that 
biosurfactant production may represent an important survival tool of each species in a 
specific environment. Moreover, the differences observed in the length of the fatty acid 
chains and in the amino acid composition of the biosurfactants and its species-specificity, 
can suggest considerable consequences on its activity and consequently on its possible 
applications. 
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4. Conclusion 
The specificity of biosurfactants molecules produced by species belonging to B. pumilus 
group supports the speciation recently recognized within this taxonomic group 
(Branquinho et al., 2014, Liu et al., 2013) and might conferred a distinct niche adaptability. 
Contrasting with B. subtilis, pumilacidin seems to be the more predominant variant in B. 
pumilus group species. Further studies exploring the properties of the different 
biosurfactants characterized could uncover interesting effects broadening potential 
applications of these compounds. Moreover, our data highlights the failure in the 
prediction of biosurfactant production based merely on the detection of lipopeptides 
synthetase genes by a PCR approach. 
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Table 1. Primers sequences and amplification conditions for screening the main families 
of lipopeptides biosynthetic genes in Bacillus spp. 
Lipopetides Gene Primer name Primer sequences (5´to 3´) 
Annealing 
temperature 
(ºC) 
PCR product 
size expected References 
Surfactin/Lichenysin family 
Surfactin 
srf/lcha 
As1-F CGCGGMTACCGVATYGAGC 
43 419/422/425/431 Tapi et al., 2010 Ts2-R ATBCCTTTBTWDGAATGTCCGCC 
sfp 
sfp-f ATGAAGATTTACGGAATTTA 
46 675  
Hsieh et al., 
2004 sfp-r TTATAAAAGCTCTTCGTACG 
Lichenysin 
 
lchAA 
LicA-f GTGCCTGATGTAACGAATG 
60 735 Nieminen et al., 2007 LicA-r CACTTCCTGCCATATACC 
lchAB 
LicB2-f TGATCAGCCGGCCGTTGTCT 
60 904 Nieminen et al., 2007 LicB2-r GGCGAATTGTCCGATCATGTCC 
lchAC 
LicC-f GCCTATCTGCCGATTGAC 
57 1195 Nieminen et al., 2007 LicC-r TATATGCATCCGGCACCA 
Fengycin/Plipastation family 
Fengycin 
fena 
Af2-F GAATAYMTCGGMCGTMTKGA 
45 443/452 Tapi et al., 2010 Tf1-R GCTTTWADKGAATSBCCGCC 
fenA 
FENA1F GACAGTGCTGCCTGATGAAA 
62 964 Athukorala et al., 2009 
FENA1R GTCGGTGCATGAAATGTACG 
fenB 
FENB2F CAAGATATGCTGGACGCTGA 
62 964 Athukorala et al., 2009 
FENB2R ACACGACATTGCGATTGGTA 
fenD 
FEND1F TTTGGCAGCAGGAGAAGTTT 
62 964 Athukorala et al., 2009 
FEND1R GCTGTCCGTTCTGCTTTTTC 
Pliplastatin ppsa 
Ap1-F AGMCAGCKSGCMASATCMCC 
58 893/959/929 Tapi et al., 2010 Atp1-R GCKATWWTGAARRCCGGCGG 
Iturin family  
Iturin 
lpa-14 
lpa-14f ATGAAAATTTACGGAGTATA 
50 675 Hsieh et al., 2008  lpa-14r TTATAACAGCTCTTCATACG 
ituD 
ituD-f ATGAACAATCTTGCCTTT TTA 
50 1203 Hsieh et al., 2008 ituD-r TTATTTTAAAATCCGCAATT 
a degenerated primers  
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Table2. Surface tension and emulsification properties of Bacillus spp. studied. 
Bacillus 
species 
Bacterial 
isolates Origin/Product Year/Location 
Surface tension 
E24 (%) 
Qualitative (mm) Quantitative (mN/m) 
Cell-free supernatant Cell-free supernatant 
Purified 
Biosurfactant 
(500ug/mL) 
Cell-free supernatant 
Average SD Average SD Average SD 24 h 8 days 
3 
months 
B. 
pumilus 
Bp ATCC14884 3.00 0.00 58.29 0.40 3.90 2.60 2.60 
Bp7 
Health´s  product contaminants 
(n=3) 
2005/Portugal1 17.67 1.44 38.69 0.21 4.29 4.29 2.86 
Bp11* 2005/Portugal1 18.67 1.04 35.24 0.39 31.4 0.27 1.30 1.30 1.30 
Bp15 2005/Portugal1 17.83 0.76 36.38 0.17 6.67 5.33 5.33 
B. 
altitudinis 
Ba6 
Health´s  product ´ contaminants 
(n=5) 
2005/Portugal1 4.50 0.50 45.92 0.50 2.67 2.67 1.33 
Ba8 2005/Portugal1 6.00 0.50 41.64 0.37 1.33 1.33 1.33 
Ba9 2005/Portugal1 6.17 0.29 45.41 0.15 1.35 1.35 0.00 
Ba12 2005/Portugal1 5.00 0.50 47.19 0.29 2.86 2.86 1.43 
Ba14 2005/Portugal1 8.83 0.29 43.66 0.55 0.00 0.00 0.00 
Ba26 Food´s contaminants/rice (n=1) 2006/Norway2 6.67 0.29 51.24 0.41 0.00 0.00 0.00 
Ba20 Plant Growth Promoters (PGPR) 
(n=2) 
1996/USA4 6.00 0.50 47.66 0.30 1.30 1.30 0.00 
Ba21 1997/USA4 5.83 0.29 46.40 0.17 2.67 2.67 0.00 
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Ba30 Food/beans (n=1) 2003/Africa5 7.17 0.58 43.64 0.36 1.43 1.43 0.00 
Bacillus 
safensis 
Bs2* 
Animals Gastropods (n=2) 
2005/Portugal1 18.83 0.29 36.18 0.31 29.5 0.13 17.81 17.81 8.22 
Bs3 2007/Portugal1 19.33 0.76 35.37 0.25 21.28 21.28 21.28 
Bs13 
Health´s  product contaminants 
(n=3) 
2005/Portugal1 18.10 0.50 33.53 0.34 2.70 2.70 2.70 
Bs16 2005/Portugal1 18.33 2.36 34.19 0.26 3.85 3.85 2.56 
Bs17 2005/Portugal1 18.67 2.75 35.36 0.12 7.14 5.71 2.86 
Bs5 
Cosmetic´s contaminants (n=4) 
2002/Portugal1 4.00 0.50 49.67 0.32 2.86 2.86 1.43 
Bs18* 2002/Portugal1 19.17 0.29 34.32 0.20 33.4 0.29 19.12 19.12 16.18 
Bs19 2002/Portugal1 17.00 1.80 33.60 0.22 20.00 20.00 13.33 
Bs27* 2002/Portugal1 24.17 2.47 30.50 0.18 31.5 0.33 10.39 10.39 2.60 
Bs24 
Food´s contaminants/salame 
(n=3) 
2004/Italy3 3.50 0.50 46.51 0.42 0.00 0.00 0.00 
Bs25 2004/Italy3 4.00 0.50 44.40 0.34 6.49 6.49 2.60 
Bs33 2004/Italy3 6.00 0.50 42.59 0.28 1.33 1.33 1.33 
Bs22* Plant Growth Promoters (PGPR) 
(n=2) 
1997/USA4 20.10 0.50 32.27 0.13 18.67 16.00 6.67 
Bs23 1997/USA4 6.17 0.29 44.30 0.21 12.86 12.00 6.67 
Bs31 Food/beans (n=1) 2003/Africa5 7.00 0.50 40.28 0.33 11.54 11.54 2.56 
Bacillus 
subtilis 
Bsb28* Health´s  product contaminants (n=1) 2005/Portugal
1 19.67 1.15 30.53 0.31 30.4 0.27 40.00 40.00 40.00 
* isolates characterized by LC/ESI-MS/MS
SD – standard deviation 
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Table 3. PCR amplification results for main families of lipopeptides in B. pumilus, B. safensis, B. altitudinis and B. subtilis isolates. 
Species Isolates 
Surfactin/Lichenysin family Fengycin/Plipastatin family Iturin family 
srf/lch sfp lchAA lchAB lchAC fen fenA fenB fenD pps lpa-14 ituD 
B. pumilus 
Bp ATCC14884 + - - - - - - - - - - - 
Bp7 + - - - - + - - - - - - 
Bp11 + - - - - + - - - - - - 
Bp15 + - - - - + - - - - - - 
B. altitudinis 
Ba6 + - - - - - - - - - - - 
Ba8 + - - - - + - - - - - - 
Ba9 + - - - - - - - - - - - 
Ba12 + - - - - - - - - - - - 
Ba14 + - - - - + - - - - - - 
Ba26 + - - - - - - - - - - - 
Ba30 + - - - - + - - - - - - 
Ba20 + - - - - - - - - - - - 
B. safensis 
Bs2 + - - - - - - - - - - - 
Bs3 + - - - - - - - - - - - 
Bs5 - - - - - + - - - - - - 
Bs13 + - - - - - - - - - - - 
Bs16 + - - - - + - - - - - - 
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Bs17 + - - - - - - - - - - - 
Bs18 + - - - - + - - - - - - 
Bs19 + - - - - + - - - - - - 
Bs21 + - - - - - - - - - - - 
Bs22 + - - - - + - - - - - - 
Bs23 + - - - - + - - - - - - 
Bs24 + - - - - + - - - - - - 
Bs25 + - - - - - - - - - - - 
Bs27 + - - - - - - - - - - - 
Bs31 + - - - - + - - - - - - 
Bs33 + - - - - + - - - - - - 
B. subtilis Bsp28 + + - - - + - - - - - - 
B. safensis
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Table 4. LC/ESI-MS/MS analysis of pumilacidin, surfactin and fengycin homologues produced by B. safensis, B. pumilus and B. subtilis isolates. 
Species
Isolates 
Pumilacidin Leu7 homologues 
R-Pumilacidin Leu7
Pumilacidin Val7 homologues 
R-Pumilacidin Val7
Surfactin homologues 
R-surfactin 
Fengycin A/B  homologues 
R-fengycin A  /  R-fengycin B 
MW R M+Na]
+ 
m/z Relative % MW R 
M+Na]+ 
m/z Relative % MW R 
M+Na]+ 
m/z Relative % MW R 
M+H]+ 
m/z 
Relative 
% 
B. 
safensis 
Bs2 
1035 C14- 1058 
84 
1035 C15- 1058 
6 
1035 C15- 1058 
10 
1049 C15- 1072 
1063 C16- 1086 
1063 C17- 1086 1063 C17- 1086 
1077 C17- 1100 
Bs27 
1035 C14- 1058 
86 
1035 C15- 1058 
6 
1035 C15- 1058 
8 
1049 C15- 1072 
1063 C16- 1086 
1063 C17- 1086 1063 C17- 1086 
1077 C17- 1100 
Bs18 
1035 C14- 1058 
83 
1035 C15- 1058 
5 
1035 C15- 1058 
12 
1049 C15- 1072 
1063 C16- 1086 
1063 C17- 1086 1063 C17- 1086 
1077 C17- 1100 
Bs22 
1035 C14- 1058 
87 
1035 C15- 1058 
6 
1035 C15- 1058 
7 
1049 C15- 1072 
1063 C16- 1086 
1063 C17- 1086 1063 C17- 1086 
1077 C17- 1100 
B. 
pumilus Bp11 
1035 C14- 1058 
94 
1035 C15- 1058 
3 
1049 C15- 1072 
1063 C16- 1086 
1063 C17- 1086 
1077 C17- 1100 
B. 
subtilis Bsb28 
1007 C13- 1030 
90 
1463 C16 Fengicyn-A 1464 
10 
1477 C17 Fengicyn-A 1478 
1021 C14- 1044 1491 C16 Fengicyn-B 1492 
1035 C15- 1058 1505 C17 Fengicyn-B 1506 
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Figure 1. Full-scan mass spectra of Bs18 extract through (+) ESI-MS direct infusion analysis. Cluster of pumilacidin are shown in m/z 1000-1150. 
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Figure 2. Product ion spectra of the sodiated molecules [M + Na]+ of Bs18 pumilacidin 
group at m/z (a) 1072 (at Rt 18.03 min) and (b) 1100 (at Rt 23.01 min). Black boxes 
displayed cyclic structures and proposed fragmentations of (a) C15 pumilacidin Leu7 
variant and (b) C17 pumilacidin Leu7 variant. 
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Figure 3. Total cyclic structures and respective homologues of (a) Pumilacidin Leu7 
variant, (b) Pumilacidin Val7 variant and (c) Surfactin. 
Na+CH3-(CH2)n-CH2-CH-CH2-CO-Glu1-Leu2-Leu3-Val4-Asp5-Leu6-Leu7
O
n= 10 C15-Glu1-Leu2-Leu3-Val4-Asp5-Leu6-Leu7
C17-Glu1-Leu2-Leu3-Val4-Asp5-Leu6-Leu7
c) Surfactin
n= 12
Na+CH3-(CH2)n-CH2-CH-CH2-CO-Glu1-Leu2-Leu3-Leu4-Asp5-Leu6-Leu7
n=10 C15-Glu1-Leu2-Leu3-Leu4-Asp5-Leu6-Leu7
C17-Glu1-Leu2-Leu3-Leu4-Asp5-Leu6-Leu7
a) Pumilacidin Leu7
n= 12
O
b) Pumilacidin Val7
Na+CH3-(CH2)n-CH2-CH-CH2-CO-Glu1-Leu2-Leu3-Leu4-Asp5-Leu6-Val7
C15-Glu1-Leu2-Leu3-Leu4-Asp5-Leu6-Val7
C17-Glu1-Leu2-Leu3-Leu4-Asp5-Leu6-Val7
O
n=10
n= 12
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Figure 4. Product ion spectra of the sodiated molecules [M + Na]+ of Bs18 pumilacidin 
group at m/z (a) 1058 (at Rt 16.56 min) and (b) 1086 (at Rt 21.25 min). Black boxes 
displayed cyclic structures and proposed fragmentations of (a) C15 pumilacidin Val7 
variant and (b) C17 pumilacidin Val7 variant. 
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Figure 5. Product ion spectra of the sodiated molecules [M + Na]+ of Bs18 pumilacidin 
group at m/z (a) 1058 (at Rt 17.85 min) and (b) 1086 (at Rt 22.84 min). Black boxes 
displayed cyclic structures and proposed fragmentations of (a) C15 pumilacidin Val4 
variant and (b) C17 pumilacidin Val4 variant. 
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 Figure 
6. Full-scan mass spectra of Bsp28 extract through (+) ESI-MS direct infusion analysis. Clusters of surfactin and fengycin are shown in the ranges of
m/z 1000–1100 and 1450–1550, respectively. 
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4.2. Linezolid resistant ST2/CC5 Staphylococcus epidermidis – biofilm 
producer  
Publication: 
Emergence of Methicillin and Linezolid Resistant ST2/CC5 Staphylococcus 
epidermidis, Portugal, 2012  
This study, reports the emergency of clinical methicillin and linezolid Staphylococcus 
epidermidis strains in Portugal, which belong to the worldwide successful clonal lineage 
ST2/CC5 (former CC2), also including the ability of S. epidermidis from patient 1 adhere 
to abiotic surfaces as a biofilm form. This isolate was used in the study enclosed in 
section 3.3. The data described in this manuscript also highlight the need for strict 
infection control procedures along with revision of therapeutic strategies to preserve 
linezolid therapeutic effectiveness.  
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Linezolid is considered a therapeutic option for skin/soft tissue infections and pneumonia 
due to multidrug resistant (MDR) gram-positive bacteria (e.g., Staphylococcus spp.), 
which in Portugal occurs in significant rates comparing with other European countries 
(http://www.ecdc.europa.eu/en/publications/Publications/annual-epidemiological-report-
2013.pdf). Staphylococcus epidermidis are human skin and mucosal commensal bacteria 
causing different human infections, mostly linked to indwelling medical devices. Their 
ability to acquire antibiotic resistance and produce biofilm can seriously compromise the 
success of human therapy, with methicillin resistance rates exceeding 70% in many 
institutions worldwide (1). Linezolid resistance (LinR) among S. epidermidis has been 
described at low rates in different Continents, associated with mutations in the central loop 
of 23S rRNA V domain or ribosomal proteins (L3, L4 and L22) and with the acquisition of 
cfr gene codifying for a ribosomal methyltransferase (1,2,3). In Portugal, only one LinR S. 
epidermidis recovered from a dog presenting severe bilateral otitis was described (4).  
This study reports the emergence of nosocomial methicillin and LinR S. epidermidis in our 
country. 
Five Staphylococcus isolates identified as LinR, recovered from blood and catheter 
cultures of patients attending four different wards of a hospital (n=362 beds) located in the 
Centre of Portugal (May through November 2012), were further characterized. 
Epidemiological features of these isolates are described in the Table. The patients were 
treated with linezolid in the present (n=2) or in previous (n=2) hospitalizations, suggesting 
that the latter two could have been colonized with LinR strains in the moment of the first 
hospital discharged. S. epidermidis were identified by Vitek II system (bioMérieux) and 
antibiotic susceptibility was studied by agar dilution (linezolid, vancomycin) or disc 
diffusion (other 10 antibiotics; Table 1) (5). All isolates were screened for cfr gene, 
mutations in the 23S rRNA V domain and in genes (rplC, rplD and rplV) encoding the L3, 
L4 and L22 ribosomal proteins (6,7,8), by PCR and sequencing. Clonal relatedness was 
determined by Pulsed-Field-Gel-Electrophoresis (PFGE; macrorestriction with SmaI) and 
by multilocus sequence typing (MLST) (http://sepidermidis.mlst.net; 
http://www.cdc.gov/hai/pdfs/labsettings/ar_mras_pfge_s_aureus.pdf). In vitro adherence 
to abiotic surfaces was searched by a biomass quantification assay in S. epidermidis from 
patient 1 (9). All S. epidermidis were MDR, including to linezolid (MIC>32mg/L), cefoxitine, 
chloramphenicol, cotrimoxazol, ciprofloxacin, clindamycin and different aminoglycosides, 
remaining susceptible only to 4 antibiotics tested, as vancomycin (MIC = 2mg/L) (Table). 
To characterize LinR, our isolates were compared with the linezolid-susceptible (LinS) S. 
epidermidis RP62A/ATCC 35984 nucleotide sequence (GenBank accession no. 
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CP000029). They showed the previously described mutations T2530A, T2504A and 
G2631T, although T2504A and G2631T were also present in LinS S. epidermidis RP62A 
(1,2). The most common reported G2576T was not detected (1,2). Nucleotide mutations 
consistent with the amino acid changes L94V (L101V from S. epidermidis ATCC 12228; 
not related with LinR) and G152D previously described (2,8), as well as the new D159E 
and A160P in L3 ribossomal protein were observed, when comparing our isolates also 
with S. epidermidis RP62A. Mutations in this protein were linked to LinR, although 
definitive conclusions are not available (8). The cfr gene and mutations in ribosomal 
proteins L4 or L22 were not detected.  
All isolates recovered during the seven months survey had the same PFGE type and 
belonged to ST2/CC5 (formerly in CC2) (10), also detected among LinR S. epidermidis 
from Europe, Brazil and USA (1,2,3). S. epidermidis from patient 1, considered 
representative of the observed clone, revealed a high ability to adhere to abiotic surfaces 
and grow in the biofilm form, feature that can facilitate infections related to indwelling 
medical devices. This strain was classified as strongly adherent, presenting a higher 
optical density (OD570nm = 2.33±0.34) than blank sample (culture medium-LB+glucose; 
OD570nm = 0.2±0.03). The OD 570nm of the positive control S. epidermidis ICE9 was 
2.69±0.44. S. epidermidis ST2/CC5 is successfully disseminated in nosocomial setting 
worldwide and is characterized by a high level of genetic diversity, an increased 
recombination/mutation rate, biofilm production ability and a high number of SCCmec 
elements acquisition (10). In Portugal S. epidermidis ST2/CC5 was observed in 
community (10) but as far as we know, not yet described in the hospital setting as in the 
present study.  
In conclusion, we reported the emergence of a methicillin and LinR S. epidermidis in a 
Portuguese hospital, persisting at least during a seven-month period. The identification of 
the successful MDR S. epidermidis ST2/CC5 clonal lineage highlight the need for strict 
infection control procedures along with revision of therapeutic strategies (e.g., linezolid 
use for the treatment of methicillin resistant Staphylococcus spp. only when vancomycin is 
not an option, due to elevated MIC or clinical failures) to preserve linezolid therapeutic 
effectiveness. LinR S. epidermidis effective control, including in patients released from the 
hospital and with previous therapy with linezolid is critical to prevent a potential epidemic 
scenario in this particular hospital and, at a larger scale, in our country, as occurred for 
other gram-positive as methicillin resistant Staphylococcus aureus and vancomycin 
resistant enterococci. 
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Table 1. Epidemiological features and antibiotic resistance characterization of linezolid 
resistant Staphylococcus epidermidis isolates recovered in a Portuguese hospital. 
Patient  No.* 
1 2 3 4 5 
Epidemiological 
features 
Date of isolation 2012 May 8 2012 Aug 
7 
2012 Oct 
23 
2012 Nov 7 2012 Nov 11 
Hospital ward Men Surgery Unknown Medicine I Emergency 
unit†
Emergency 
unit†
Pathology Gastric 
neoplasy§‡ 
Unknown Multiple§ Acute lung 
edema 
Multiple 
Clinical sample Catheter Blood  Catheter Blood Blood 
Sex/Age Male/75 Unknown Female/87 Male/78 Male/87 
Previous therapy with 
linezolid 
 Yes Unknown  Yes# Yes† Yes†
PFGE A A A A A 
Sequence Type 2¶ 
Biofilm production 
(OD570nm)
Strong (2.33±0.34)¶  
Antibiotic 
resistance 
Linezolid (MIC-mg/L) R (32) R (32) R (32) R (32) R (32) 
Vancomycin (MIC-
mg/L) 
S (2) S (2) S (2) S (2) S (2) 
Cefoxitin R R R R R 
Gentamicin R R R R R 
Tobramycin R R R R R 
Ciprofloxacin R R R R R 
Clindamycin R R R R R 
Erythromycin S I S I S 
Quinupristin-dalfopristin S S S S S 
Chloramphenicol R R R R R 
Tetracycline S S S S S 
Cotrimoxazol R R R R R 
Molecular studies in linezolid resistance 
cfr gene  -  -  -  -  - 
23S rRNA 
mutations 
T2504A  +  +  +  +  + 
G2631T  +  +  +  +  + 
T2530A  +  +  +  +  + 
L3 ribosomal 
protein 
mutations 
Leu94Val +¶ 
Gly152Asp +¶ 
Asp159Glu +¶ 
Ala160Pro +¶ 
L4 or L22 
ribosomal 
protein 
mutations 
None¶
*A sixth linezolid resistant S. epidermidis was detected in December 2012, although the access to
this isolate was not possible during the time frame of the study.
†Patients 4 and 5 were both hospitalized in Medicine II a month before the isolation of linezolid
resistant S. epidermidis. Therapy with linezolid was made during this first hospitalization. For
patient 4, linezolid therapy was of at least 12 days. For patient 5 the duration of therapy is
unknown.
#Patient 3 received 11 days of linezolid before the recover of linezolid resistant S. epidermidis.
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‡Followed in oncology ward since 2011. 
§Long stay hospitalization. 
¶Studied in S. epidermidis from patient 1, representative isolate of the PFGE type A. 
ζFor the interpretation of the results, the cutoff optical density (ODc) was defined as three standard 
deviations above the mean OD of the negative control (culture medium). Strains were classified as 
non-adherent (OD≤ODc), weakly adherent (ODc<OD≤2xODc), moderately adherent 
(2xODc<OD≤4xODc) or strongly adherent (4xODc<OD). 
Abbreviations: R, resistant; S, susceptible; I, Intermediate resistance; MIC, minimum inhibitory 
concentration; +, positive; -, negative. 
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4.3. Anti-biofilm activity in Staphylococcus epidermidis and structural 
characterization of Bacillus safensis biosurfactant 
Publication: 
Anti-biofilm activity in Staphylococcus epidermidis and structural 
characterization of Bacillus safensis biosurfactant 
This study, reports the prevention of biofilm formation of a mixture of pumilacidin- and 
surfactin-type compounds, produced by a Bacillus safensis strain Bs1, against the most 
frequent undwelling related pathogen, Staphylococcus epidermidis, including multidrug 
resistant strains. 
Thus, our results evidence the potential of this mixture of biosurfactants towards the 
protection of surfaces, namely on medical devices. 
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Abstract 
Anti-adhesive or anti-biofilm properties in different bacterial species of B. pumilus group 
species biosurfactants have been reported. In this study, we evaluated the effectiveness 
of a biosurfactant produced by B. safensis Bs1, in the prevention of biofilm formation by 
multidrug resistant pathogenic S. epidermidis strains. Moreover, surface tension reduction 
activity, critical micelle concentration (CMC) and biochemical identification were 
determined. Remarkably, pre-conditioning and co-incubating experiments using Calgary 
Biofilm Device, with Bs1-biosurfactant significantly reduced the number of adherent cells 
of strong biofilm producing S. epidermidis isolates (>90% of inhibition) at concentrations 
lower than the CMC. Furthermore, our results demonstrate that the observed reduction is 
not a result of cell killing but instead, is the result of biofilm adhesion prevention.. LC/ESI-
MS/MS analysis of lipopetides produced by B. safensis Bs1, revealed a mixture of 
pumilacidin- and surfactin-type compounds, being the variant Leu7 of pumilacidin present 
in a higher abundance, which showed to highly reduce the surface tension of water from 
69.2 mN m−1 to 28.8 mN m−1. A CMC value of 33.18 mg L−1 was also identified. In 
conclusion, surfactin-like compounds produced by B. safensis Bs1 demonstrated a 
relevant anti-biofilm activity that could contribute to reduce the burden of infections by S. 
epidermidis, the most frequent undwelling related pathogen. 
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1. Introduction
Biosurfactants are biologically produced amphiphilic compounds that reduce the surface 
and interfacial tensions in both aqueous solutions and hydrocarbon mixtures (Banat et al., 
2010). Unlike their chemical counterparts, these compounds present lower toxicity, higher 
biodegradability and environmental compatibility, higher selectivity and specific activity at 
extreme temperatures, pH and salinity, as well as the ability to be synthesized from 
renewable feedstock (Cameotra and Makkar 1998; Banat et al., 2000; Banat et al., 2010; 
Kumar et al., 2006).  
Bacterial biosurfactants were proposed to act as hydrocarbons biodegrading, emulsifiers, 
wetting, solubilizing, detergent and phase-dispensing agents (Fracchia et al., 2012; 
Martinotti et al., 2013). In addition, they revealed to be useful as antibacterial, antifungal, 
antiviral and anti-adhesive agents, as well as potential immunomodulatory and vaccines 
adjuvants compounds (Fracchia et al., 2012; Martinotti et al., 2013). Therefore, they have 
been considered the new generation molecules for pharmaceutical, cosmetic, health care 
and food industries. 
Lipopetides represent one of the most predominant and efficient class of surface active 
agents. Surfactin family, comprising about 20 different compounds (Bonmatin et al., 
2003), includes the best studied lipopeptides. The chemical structural characteristic of this 
family, with exception of esperin (Thomas and Ito 1969), is a heptapeptide possessing a 
chiral sequence LLDLLDL, interlinked with a β-hydroxy fatty acid and with a D-Leu in 
position 3 and 6 and a L-Asp in position 4 (Seydlová et al., 2011). In addition, amino acids 
residues that can be present in position 2, 4 and 7 belong to the aliphatic class and 
enclosing Val, Leu and Ile (Peypoux et al., 1991; Itokawa et al.,, 1994; Bonmatin et al., 
1995). The presence of these variants provides a unique chemical structural diversity 
which enables a multiplicity of therapeutical applications.  
Production of surfactin-like compounds has been described in some different Bacillus 
species, including in some species of B. pumilus group members, as B. safensis and B. 
pumilus (Peypoux et al., 1999; Fox and Bala 2000; Moran et al., 2000; Kalinovskaya et al., 
2002; Branquinho et al., 2014b). In fact, recent structural analysis of B. safensis 
biosurfactants suggested the presence of a particular mixture containing pumilacidin and 
surfactin-type compounds in this species (Branquinho et al., 2014b). 
Staphylococcus epidermidis, a human skin and mucosal commensal bacteria, is an 
important opportunistic pathogen being the most frequent cause of indwelling medical 
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device-associated infections. Its ability to cause infections is linked to its natural niche on 
human skin and ability to attach and form biofilm on foreign bodies (Rupp, 2014). Cells in 
this mode of growth are inherently more resistant to antimicrobials (Cabrera-Contreras et 
al., 2010). Additionally, often hospital isolates are methicillin-resistant S. epidermidis 
(MRSE) and multidrug resistant (MDR) (Otto, 2009), belonging to different lineages that 
could be successfully disseminated in nosocomial setting worldwide, like ST2 lineage 
(Miragaia et al., 2007; Gordon et al., 2012). Those cumulative aspects turn S. epidermidis 
infections more difficult and expensive to treat. Bacterial adhesion to surfaces is one of 
the initial steps that direct the microorganisms to the biofilm formation (Donlan and 
Costerton 2002). Therefore, treating surfaces with microbial surface-active compounds 
appears as an interesting strategy to control/circumvent harmful adherent cells in forms of 
biofilms. Surfactin class molecules have been extensively explored in numerous 
applications, including its involvement in reducing pathogenic microbial adhesion and its 
detachment from surfaces (Ongena and Jacques 2008). Although B. pumilus group is 
known as producer of surfactin-like variants (Peypoux et al., 1999; Fox and Bala 2000; 
Moran et al., 2000; Kalinovskaya et al., 2002; Branquinho et al., 2014b), their use as anti-
adhesive/anti-biofilm agents against S. epidermidis is still poorly studied. 
In the present study, we demonstrate the effectiveness of a biosurfactant produced by B. 
safensis Bs1 in the prevention of biofilm formation by multidrug resistant pathogenic S. 
epidermidis strains.  The surface-active properties and the structural characterization of 
this biosurfactant are also elucidated. 
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2. Materials and methods
2.1. Bacterial strains and culture conditions 
2.1.1. Biosurfactant producing strain 
During a study assessing the diversity of Bacillus spp. isolates, we identified a B. safensis 
strain designated herein as Bs1, recovered from a gastropod (terrestrial slug) normal flora 
collected in the Northern of Portugal (Branquinho et al., 2012). Isolate identification was 
conducted by phenotypic and genotypic (16S rRNA, gyrB and rpoB gene sequences) 
methods (Branquinho et al., 2014a). The bacterial isolate was maintained on Luria 
Bertani-Miller (LB) Agar (Oxoid, United Kingdom) for short-term storage and in LB broth 
supplemented with 40% (v/v) glycerol at -80 ºC for long-term storage.  
2.1.2. Biofilm producing strains 
Three S. epidermidis nosocomial strains causing infections, recovered from a catheter, 
wound and sputum, and a human commensal strain, all previously identified as strong 
biofilm producers were used in biofilm inhibition assays (Table 1). These strains, 
recovered in different countries (2007-2013), belong to different lineages, including the 
most disseminated one in nosocomial settings (Sequence type (ST) 2), present different 
genetic features associated with biofilm formation, and are multidrug-resistant (including a 
methicillin and linezolid resistant (Ste1) strain involved in a recent hospital outbreak) 
(Barros et al., 2014). All S. epidermidis isolates were maintained on trypticase soy agar 
(TSA) (Oxoid, United Kingdom) for short-term storage and in trypticase soy broth (TSB) 
(Oxoid, United Kingdom) supplemented with 40% (v/v) glycerol at -80 ºC for long-term 
storage. 
2.2 Biosurfactant extraction, purification and quantification 
For biosurfactant production, a seed culture was prepared by transferring a loop of B. 
safensis Bs1 strain from a LB agar overnight culture, into 10 mL of LB broth incubated for 
4 h, at 28 °C and 200 rpm, on an orbital shaker. Thereafter, 2 ml of this culture were 
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inoculated into 500 mL of LB broth and incubated at 28 °C and 120 rpm for 24 h. A cell-
free preparation from this culture was then prepared by centrifuging at 8,000xg for 30 min.  
For biosurfactant extraction, the cell-free supernatant was acidified to pH 2 with HCl (6 
mol L-1), and left for 12 h at 4 ºC for precipitation. The precipitate was then recovered by 
centrifugation at 8000 g-1 for 10 min at 4ºC, and the resulting solution extracted twice with 
ethyl acetate/methanol (4:1 v/v) mixture according to the method described by Rivardo et 
al. (2009). The remaining water present in the organic phase was then removed by 
anhydrous sodium sulfate and finally evaporated to dryness under vacuum conditions. 
Acetone was added to recover raw biosurfactant, which after acetone evaporation was 
collected and weighted.  
 
2.2.1. Biosurfactant stock solution and dilutions  
The extracted Bs1-biosurfactant was dissolved in phosphate buffer (PBS, pH 7.2) at the 
final concentration of 5120 μg ml−1. This solution was filtered through 0.2-μm filter 
(Millipore Corp., Bedford MA) and stored at 4 °C. For experiments, stock solutions of Bs1-
biosurfactant were serially diluted 1:1 in PBS. 
 
2.2.2. Surface-active properties of Bs1-biosurfactant  
Screening of surface-active properties of Bs1-biosurfactant was initially conducted on the 
supernatant (defined accordingly conditions described in section 2.2). Oil spreading assay 
(Morikawa et al., 2000) was applied to measure the potential surface activity of the 
excreted biosurfactant. Briefly, 20 μl of Motor Oil 10 W-40 (Selenia, Italy) were added onto 
a surface of 20 mL of distilled water to form a thin layer. Subsequently, 20μl of the Bs1-
supernatant were gently put onto the center of the oil layer and the diameter of the oil 
displacement circle formed was measured to determine the presence of biosurfactant. 
Surface-active properties of the purified Bs1-biosurfactant were also evaluated. Surface 
tension was determined using a Sigma 703D tensiometer (KSV, NY, USA) equipped with 
a Du Noy platinum ring at 35 ºC, on a 20 ml of a biosurfactant solution, which was 
prepared in alkaline sterile demineralized water at 500 μg ml−1. Distilled water was used 
for calibration. Critical Micelle Concentration (CMC) was then determined on serially 
diluted biosurfactant solutions, prepared in alkaline distilled water, and was estimated 
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from the intercept of two straight lines extrapolated, from the concentration-dependent and 
concentration-independent sections of a curve plotted between biosurfactant 
concentration and surface tension values. 
2.3. Bacterial biofilm inhibition 
2.3.1. Bacterial biofilm production 
Biofilms were grown in the Calgary Biofilm device (CBD) (Innovotech Inc., Canada), 
commercially available as the MBEC assay system, as described by Harrison et al. 
(2006). 
Cultures of the S. epidermidis isolates (Table 1) were firstly incubated overnight at 37 °C 
on TSA. Colonies were then suspended in 0.9% saline solution to obtain a 1.0 McFarland 
standard solution (corresponding to approximately 3.0×108 cfu ml−1). This suspension was 
diluted 30-fold in TSB (corresponding to approximately 1.0×107 cfu ml−1) and constituted 
the inoculum for the CBD. Subsequently, 150 μl of this inoculum was added to each well 
of the 96-well plates, the CBD peg lid fitted inside and the assembled device placed on an 
orbital shaker (150 rpm), which was fixed in a humidified incubator for 24 h at 37 °C. After 
this period, biofilms were rinsed twice to remove loosely adherent cells, by inserting the 
peg lids into microtiter plates prepared with 200 μl well-1 of 0.9% saline, during 2 min. 
2.3.2. Pre-coating experiments 
CBD was previously coated with Bs1-biosurfactant by dipping the lid of the CBD into 200 
μl of biosurfactant solutions starting from 2560 to 80 μg ml−1. The CBD lid assembled with 
the microtiter plate was incubated at 37 °C on an orbital shaker at 125 rpm for 24 h, then 
removed and upside dried for 1 min before adding the correspondent S. epidermidis 
biofilm producer strains, as described in section 2.3.1. Each test was performed in 
triplicate on two separated biological replicates. 
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2.3.3. Co-incubation experiments 
Co-incubation experiments were carried out in uncoated CBD. S. epidermidis isolates 
were dispensed in each well together with Bs1-biosurfactant solutions to reach 
concentration ranges from 5 to 150 μg.ml−1 in the final volume of 200 μl. Each test was 
performed in triplicate on two separated biological replicates. 
 
2.3.4. Viable cell counting 
Inhibition of S. epidermidis biofilm formation using Bs1-biosurfactant was evaluated by 
biofilm viable cell-counting method. The lid of the CBD plates, treated as described in 
sections 2.3.2. and 2.3.3., were inserted into 200 μl of LB broth supplemented with 1% 
Tween 20 (Sigma-Aldrich, St. Louis, USA). Biofilms were then disrupted from the peg 
surface using an Aquasonic 250HT ultrasonic cleaner (VWR International, Mississauga, 
Canada) set at 60 Hz for 10 min. The biofilm cells were serially diluted in 0.9% saline, 
plated in triplicate onto TSA, which were further incubated for 24 h at 37 °C, and then 
colonies enumerated. Thus, anti-biofilm formation capacity of Bs1 biosurfactant was 
considered positive if, after 24 h of growth, there was a ≥1 log10 (90%) difference in the 
mean of CFU peg-1 compared to the growth control. 
 
2.5. Antibacterial activity 
To evaluate if Bs1-biosurfactant presented antibacterial effect against S. epidermidis 
isolates, well agar diffusion and broth dilution methods were used. Mueller Hinton (MH) 
agar cation adjusted (bioMérieux, France A) plates were swabbed with S. epidermidis 
suspension (0.5 McFarland adjusted). Purified Bs1-biosurfactant at concentrations of 
1024, 512, 256, 128, 64, 32, 16, 8, 4, 2 and 1 µg mL-1 were then loaded into wells (5 mm 
diameters) punched into the agar. Distilled water and PBS were used as negative 
controls. Plates were incubated overnight at 37 ºC and then observed for the inhibitory 
zones.  
In another set of experiments, the antibacterial effect of Bs1-biosurfactant extracts was 
detected by spectrophotometric method. Bacterial suspensions (0.5 McFarland adjusted) 
were incubated into 96 microtiter plates without and with Bs1-biosurfactant, at 
concentrations described above and analyzed spectrophotometrically at 600 nm after 24 h 
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of incubation at 37 ºC. Experiments were performed independently in duplicate with tree 
biological replicates each one. 
2.6. Detection of surfactin synthethase genes 
Screening for presence of the sfp gene, a member of the srfA operon required for the 
biosynthesis of surfactin, was carried out by PCR amplification using two set of primers. 
The first, sfp-f (5´-ATGAAGATTTACGGAATTTA-3´) and sfp-r (5´-
TTATAAAAGCTCTTCGTACG-3´) described by Hsieh et al. (2008), amplified a fragment 
of 675 bp, enclosed in the sfp gene of B. subtilis (GenBank accession no. X63158), from 
position 167 to 841. PCR amplification program accomplish an initial denaturation of 94 °C 
for 25 s, followed by 35 cycles at 94 °C for 10 s, 46 °C at 30 s, and 72 °C for 1.5 min and 
by a final extension of 72 °C for 10 min. 
Additionally, the detection of surfactin biosynthetic gene using degenerated primers As1 
(5´-FCGCGGMTACCGVATYGAGC-3´) and Ts2-R (5´-
ATBCCTTTBTWDGAATGTCCGCC-3´), described by Tapi et al. (2010) was also applied. 
PCR amplification included an initial denaturation at 94 °C for 3 min, followed by 30 
cycles, with a denaturation step at 94 °C for 1 min, an annealing step of 30 s at 45 °C, 
followed by extension step during 45 s at 72 °C and a final extension at 72 °C for 10 min. 
Amplicon sequencing was achieved for identity confirmation. 
Moreover, genomic DNA for PCR amplification was extracted using InstaGeneTM matrix 
(BioRad laboratories, Inc., Hercules, CA, USA) according to the manufacturer´s 
instructions. DNA was used directly for PCR amplification or stored at -20 ºC for further 
utilization.  
2.7 Characterization of lipopeptides by LC/ESI-MS/MS 
2.7.1 Mass spectrometry analysis 
An aliquot of the Bs1 biosurfactant extract was dissolved in methanol/acetonitrile (50/50 
v/v) to obtain a 1000 μg ml-1 stock solution. Freshly prepared working solutions were 
made by diluting the stock solution with methanol/water (50/50 v/v) to achieve 15 μg ml-1 
solutions. 
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Mass spectrometry analyses were done on a LCQ DECA XP Plus (Thermo Finnigan, San 
Jose, CA, USA), Ion Trap mass instrument equipped with an ESI source. Samples (15 μg 
ml-1 solutions) were infused with a syringe at 5 μg min-1 flow rate. Source voltage and 
capillary voltage were 4.80 kV and 23 V in positive ion mode, while 5 kV and -15 V in 
negative ion mode. Capillary temperature and sheath gas flow (N2) were, set respectively 
at 350ºC and 30 arbitrary units in both scan modes. Data were acquired in positive and 
negative MS total ion scan mode (mass scan range: m/z 100 2000) and in positive MS/MS 
product ion scan mode; the normalized collision energy (nce %) was optimized for each 
precursor ion selected: m/z 1030, 38%; 1044, 1058, 1072, 1086 and 1100, 39%; 1464, 
1478, 1492 and 1506, 35%. 
 
2.5.2. Liquid chromatography–mass spectrometry analysis 
A Surveyor HPLC on line with a LCQ DECA XP Plus (Thermo Finnigan, San Jose, CA, 
USA) Ion Trap mass spectrometer equipped with an ESI source was employed. 
Separations were performed on an analytical Luna 5 μm C18, 150×4.6mm (Phenomenex, 
Torrance, CA) protected with a C18-Security Guard cartridge, 4 × 3.0 mm (Phenomenex). 
The injection volume applied was 10 μl. Mobile phase components encompassed: A - 
formic acid/ ammonium formate buffer and B- acetonitrile. Moreover, lipopeptides were 
eluted according the following gradients: gradient 1  A: B (60: 40) for 4 min, then A: B (0: 
100  )over 24 min and finally 100% B over 6 min, at a flow rate of 0.8 ml min-1 ; gradient 2  
A: B (20: 80) for 5 min, then A: B (0: 100) over 20 min and finally 100% B over 15 min, at 
a flow rate of 0.8 ml min- LC/MS full scan positive mode was performed from m/z 100 to 
2000. Alternatively, LC/ESI-MS/MS modalities were applied to the selection of precursor 
ions, following the conditions set during the infusion analysis. 
 
2.8. Interpretation of results and statistical analysis 
The efficiency of biofilm inhibition was assessed by determining the minimal biofilm 
eradication concentration (MBEC) after 24 h, by viable cell count. The effect of Bs1-
biosurfactant was expressed as log10CFU mL-1 ± SD.  
Statistical analysis was performed using GraphPad Prism version 6.00 software 
(GraphPad, Sandiego, USA). Data were analyzed by ANOVA test and means were 
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compared using Kruskal-Wallis test with P value of 0.05. Treatments were considered 
significantly different if P≤0.05. 
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3. Results and Discussion 
 
3.1. Surface-active properties of Bs1-biosurfactant  
The production and chemical composition of biosurfactants depends among other factors, 
on the culture medium in which the producer’s strains are cultivated. Nevertheless, and 
since LB broth has been extensively used for biosurfactant production from Bacillus 
strains (Thaniyavarn et al., 2003; Rivardo et al., 2009), it was selected for the evaluation 
of B. safensis biosurfactant production. 
Initial screening of surface tension (ST) properties conducted on the BS1-supernatant by 
oil spreading assay revealed a clearly formed oil displacement circle of 20 mm. 
Additionally, surface tension of Bs1-supernatant, determined using a Du-Noy 
Tensiometer, revealed a ST value of 33.2 mN m-1 ±0.35 compared with 69.2 mN m-1 ±0.12 
of water, indicating the presence of a compound with a remarkably tensioactive property. 
Moreover, analyses of ST properties of the purified Bs1-biosurfactant revealed 
consistency with previous Bs1-supernatant ST results. Figure 1 shows ST values of the 
purified Bs1-biosurfactant at different concentrations. Bs1-biosurfactant exhibited an 
excellent surface tension reducing activity, decreasing the surface tension of water from 
69.2 mN m-1 to 28.8 mN m-1, at concentrations up to 500 µg mL-1. Then values slowly 
increased to 20 µg mL-1, concentration from which a sharp increment of surface tension 
was observed. 
This high efficiency property is similar to that reported for surfactin molecule, with a value 
of 27 mN m-1 (Mulligan, 2005). 
The critical micelle concentration (CMC) is an index to evaluate surface activity. By 
definition, CMC is the surfactant concentration above which micelles are spontaneously 
formed. Until the CMC is reached a decrease in the surface tension will be observed. 
Nevertheless, upon reaching the CMC, any further increase in the surfactant 
concentration will only increase the number of micelles and no alteration in the surface 
tension will be observed (Sobrinho et al., 2008). Critical micelle concentration determined 
for BS1-biosurfactant was 33.18 mg l-1.  
The Bs1-biosurfactant CMC value obtained is in agreement with those presented in the 
literature for other surfactin-like compounds. For instance, in the case of B. subtilis 
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surfactin producers strains Abdel-Mawgoud et al. (2008) characterized a surfactin-like 
compound produced by a B. subtilis BS5 isolate with a CMC value of 15.6 mg l-1, whereas 
other examples suggested values of 11 mg l-1 (Nitschke and Pastore, 2006; Mulligan, 
2005; Barros et al., 2008), 13, 17 and 22 mg l-1 (Ramkrishna and Swaminathan, 2004) 
and 40 mg l-1 (Vaz et al., 2012), for similar compounds. In addition, for B. pumilus 
producer’s strains, Slivinski et al. (2012) reported that B. pumilus UFPEDA 448 isolate 
was able to produce a ST reducing compound, which presented a CMC of 12.2 mg l-1. 
Contrastingly, Oliveira and Garcia-Cruz (2013) using vinasse, a byproduct of ethanol 
production, and a waste frying oil from vinasse as substrates for B. pumilus biosurfactant 
production, reported CMCs values for these biosurfactants, respectively of 1500 and 200 
mg l-1. Actually, the differences observed in these reported values may be attributed to a 
lower concentration of the surfactin-like compounds due to the low degree of purification, 
or even to the presence of a different variant. 
Moreover, organoleptic characteristics such as the peculiar bad odor observed for Bs1-
biosurfactant were also reported by other authors in Bacillus-derived biosurfactants 
(Abdel-Mawgoud et al., 2008; Rivardo et al., 2009). 
3.2. Capacity to inhibit or reduce biofilm formation of S. epidermidis isolates 
Biofilms are source of infections of many pathogenic microbes, Staphylococcus 
epidermidis is the most frequent cause of device-associated infections, because it is 
known to cause biofilms that grow on catheters or other surgical implants (Rupp, 2014) In 
these set of experiments, the potential of Bs1-biosurfactant to inhibit biofilm formation of 
four biofilm-producing MDR S. epidermidis strains and including a representative of a 
linezolid resistant strain causing a recent  nosocomial outbreak (Barros et al., 2014), was 
evaluated.  
The effect of pre-coating polystyrene surfaces with Bs1-biosurfactant on S. epidermidis 
isolates are shown in figure 2. Interestingly, results revealed that at low concentrations, 
Bs1-biosurfactant was able to reduce the biofilm formation of the four S. epidermidis 
strains. Indeed, it was observed that the concentrations ranging between 6.25 µg ml-1 and 
100 µg ml-1 were the most effective in preventing the biofilm formation of S. epidermidis 
isolates. In particular, in the presence of such concentrations S. epidermidis 55 biofilm 
was inhibited by >95.8% (Figure 2b), Ste1 by >93.7% (Figure 2a), Taw113 by >91.9% 
(Figure 2c) and Ice120 by >89.1% (Figure 2d), during 24 h of incubation.  
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Statistical analysis carried on the biofilm viable cell counts values demonstrated that there 
is a significant activity of Bs1-biosurfactant at these concentrations (p<0.05). Moreover, 
the increase of Bs1-biosurfactant concentration to 1280 and 2560 µg ml-1 did not 
significantly affect biofilm formation of multidrug resistant S. epidermidis isolates, namely, 
LinR, Taw 113 and Ice 120 (Figure 2 a, c and d), whereas biofilm of S. epidermidis 55 
isolate remains significantly affected (Figure 2 b). 
The effect of co-incubation of S. epidermidis biofilm producer strains and Bs1-
biosurfactant is shown in figure 3. Low concentrations of Bs1-biosurfactant (10-20 µg ml-1) 
revealed ability to reduce the biofilm formation of the four S. epidermidis strains. Biofilm 
formation of S. epidermidis Ste1 and 55 were reduced by 92.1% and 92.5% respectively, 
applying 10 µg ml-1 of Bs1-biosurfactant; Taw113 by 96.7% and Ice120 by 87.9%, 
applying 20 µg ml-1 of Bs1-biosurfactant.  
Statistical analysis carried out on the biofilm viable cell count values showed a significant 
activity of Bs1-biosurfcatant at these concentrations (p<0.05). Moreover, concentrations 
higher than 100 µg ml-1 did not significantly reduced the adherence of all S. epidermidis 
strains.  
Overall, considering results from pre-coating and co-incubation experiments our data 
corroborate previous observations by Rivardo et al. (2009), where an increase in 
biosurfactant concentration did not affect significantly biofilms formation or even its 
reduction. Moreover, other studies reported that high concentrations of biosurfactant can 
stimulate the cell growth, as they could be used as source of nutrients (Fowler et al., 
2008). In fact, Fowler et al. (2008) suggested that the adherence of S. aureus biofilms 
could be increased in the presence of certain concentrations of cyclic lipopetides, as they 
are analogous of quorum sensing auto-inducers, which stimulates the adhesion of these 
pathogens on surfaces. 
Beyond the observation that Bs1 displays an anti-biofilm effect, its ability to interfere in the 
adherence process of S. epidermidis pathogens to polystyrene surfaces can be also 
established. The process involved in the adherence of a bacterium to a surface, during the 
first few hours, is reversible (Marshall, 1994; Høiby et al., 2001). Hence, preventing 
bacterial adhesion at the preliminary stage of adherence can reduce the risk of biofilm 
formation. Therefore, since we have noticed that pre-coating and co-incubating surfaces 
with Bs1-biosurfactants reduced the number of S. epidermidis viable cells adhered to the 
pegs, this observation prompt us to suggest that this compound can also act as an anti-
adhesive molecule. 
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3.3. Antibacterial activity 
In parallel, the effect of Bs1-biosurfactant on S. epidermidis cells was also tested. In the 
well diffusion assay, no inhibition zones were observed at all concentrations tested, after 
24 h of incubation. Similarly, in the broth dilution method, no significant differences were 
observed between the OD values of controls and the treated cells at every concentration 
tested after 24 h of incubation, witha ΔOD<0.69±0.039 for strain 55, <0.97±0.05 for Ste1, 
<0.90±0.04 for ICE120 and of <0.77±0.04 for Taw113, suggesting that there was no 
apparent effect on S. epidermidis viability by the presence of Bs1-biosurfactant. 
3.4. Detection of surfactin synthethase genes by PCR 
Several genetic studies were undertaken to identify the genes required for the production 
of surfactin. One of the genes involved in surfactin biosynthesis is a large operon of 25kb, 
named srfA, which is also responsible for sporulation and competence development. The 
sfp gene was mapped 4kb downstream of the srfA operon and was associated with but 
not integrated in the latter, and was reported as the second gene essential for the 
production of surfactin. Its nucleotide sequence was established by Nakano et al. (1992) 
and the encoded enzyme, termed Sfp, belongs to the superfamily of 4´-
phosphopantetheinyl transferase, which comprises the surfactin synthetase complex.  
Using the primers described by Hsieh et al. (2004), sfp gene could not be detected in Bs1 
isolate. Cluster analyses of different sfp genes available in GenBank database, including 
4´-phosphopantetheinyl transferase from B. pumilus SAFR-032 and ATCC 7061 and 
others from B. subtilis, revealed a high level of dissimilarities between these structures, 
which can justify the fact that no amplicon was detected using this primers pair. Thus, B. 
safensis Bs1 possibly has a mutant allele of sfp that could not be detected by this pair of 
primers or has a slightly different homologue. 
Nevertheless, using the surfactin degenerated primers described by Tapi et al. (2010) for 
the biosynthetic gene of surfactin, an amplicon with the expected length was obtained. 
Blast comparisons results revealed a 75% of homology with gene srfAB of Bacillus 
amyloliquefaciens FZB42 (GenBank accession number CP000560.1), which encode for 
the surfactin synthetase II, suggesting the presence of a different homologue from the 
described surfactin gene and that possibly a surfactin-like compound may be involved in 
the reported tensioactive property. The expression of different homologues or different 
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ratios of the same homologue are common features described in the literature for B. 
subtilis group member’s biosurfactant producers. Using, LC/ESI-MS/MS characterization 
of Bs1 biosurfactant we confirmed the presence of a surfactin-like analogue produced by 
B. safensis Bs1, which can justify the level of homology found for the presented gene. 
 
3.5. Bs1 characterization and structure elucidation by LC/ESI-MS/MS  
Related to the B. safensis Bs1 characterization, full-scan mass spectra (Figure 4) through 
ESI-MS direct infusion analysis, operating in positive full scan mode, showed one cluster 
of peaks with 14 Da difference on its molecular ion species, which in accordance with 
other work performed by our research team (Branquinho et al., 2014b), correspond with 
spectral analysis of pumilacidin variants Leu7 and Val7, with a relative abundance 
average of 83 and 7%, respectively for each one (Table 2). Four main signals at 1058, 
1072, 1086 and 1100 m/z were detected, which correspond to the sodiated molecules 
[M+Na]+. Therefore, the positive LC-ESI-MS/MS analysis on the sodiated molecule at m/z 
of 1058, 1072, 1086 and 1100, revealed that these signals were in according with the four 
homologues of pumilacidin compounds, respectively C-14, C-15, C-16 and C-17 Leu7 
variants and also C-15 and C-17 Val7 pumilacidin variant (Branquinho et al., 2014b). 
Moreover, our results are also in accordance with the presence of two surfactin 
homologues, e.g. C15- Glu/Leu/Leu/Val/Asp/Leu/Leu and C7-
Glu/Leu/Leu/Val/Asp/Leu/Leu (m/z of 1058 and 1086), with a relative abundance average 
of 10% (Table 2).  
Thus, these results demonstrate that a mixture of pumilacidin and surfactin molecules 
produced by B. safensis interfered in S. epidermidis adhesion ability and consequently, on 
its biofilm formation capability to polystyrene surfaces, but did not inhibit the growth of 
these pathogens, despite the previous reports of an antibacterial activity of lipopeptides 
belonging to surfactin family (Compaoré et al., 2013). In addition, since Bs1-biosurfactant 
interferes with bacterial adhesion, this could be of great benefit as it could improve 
bacterial clearance by the host immune system. 
S. epidermidis is one of the most prevalent causes of nosocomial infections, and is often 
associated with infections caused by indwelling medical devices, namely due to its ability 
to produce biofilms, which seriously compromise the success of human therapy. 
Moreover, clinical S. epidermidis strains present a high rate of antibiotic resistance to 
methicillin (70%) and its overwhelming majority is also resistant to other antimicrobial 
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classes (Mendes et al., 2012). Nevertheless, among this species, low rates of resistance 
to linezolid have been described, and, in Portugal, just one outbreak of a clinical 
methicillin and linezolid resistant S. epidermidis (isolate Ste1, included in this study) was 
reported (Mendes et al., 2012; Barros et al., 2014). Thus, the use of an anti-adhesive/anti-
biofilm compound, with remarkably potential capacity to circumvent infection caused by 
MDR biofilm producers’ bacteria, is of great interest. In fact, biofilm formation is a complex 
phenomenon that is usually divided into five steps: reversible adhesion, EPS production, 
maturation and dispersion. The first and second steps involve microbial adhesion to 
surfaces and are the most important to the initiation of biofilm formation. These steps 
involve physico-chemical interactions that can be mediated by non- specific interactions 
with long-range forces, including Lifshitz-van der Walls interactions, electrostatic, acid-
base interactions and Brownian motion forces. In addition, the hydrophobic interactions 
between the abiotic surface and the microorganism have a major role in the initial 
microbial adhesion and, therefore, biofilm development in biological systems (Chae et al., 
2006; Goulter et al., 2009). Therefore, compromising this two first steps, by preventing or 
inhibiting bacterial adherence, with the application of a biosurfactant compound, can 
successfully avoid the spread of bacterial infections and also to produce a better clinical 
outcome, since without the formation of biofilm matrix there will be possible an 
improvement of antibiotic penetration.   
The biofilm inhibitory effect of a biosurfactant seems to be dependent on diverse factors 
such as type of compound, target microorganism and the surface properties (Walencka et 
al., 2008). In fact, biosurfactants penetrate into the interface between the solid substrate 
and the biofilm, adsorbing at the interface and reducing the interfacial tension. Then, 
attractive interactions between the bacterial surfaces and solid surfaces may be 
decreased, which would easily lead to the removal of the biofilm. Rodrigues et al. (2006) 
suggested that biosurfactants reduce hydrophobic interactions, resulting in a decrease in 
the hydrophobicity of the surface, which interferes with the microbial adhesion to the 
surface and consequently, alters biofilm development. In fact, hydrophobic surfaces have 
shown to be particularly colonized by microorganisms, probably because these surfaces 
can promote the contact between microorganism and solid substratum, favoring the 
elimination of interfacial water present in the interacting surfaces (Rodrigues et al., 2006). 
Therefore, when a surface is conditioned with a biosurfactant, it becomes more 
hydrophilic, leading to a decrease of microbial attachment. Thus, and considering that 
surfactin has an anionic nature due to aspartic and glutamic acid residues, which are 
negatively charged at neutral pH (Shen et al., 2011), the observed anti-biofilm formation 
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by Bs1 biosurfactant, can be due to the fact that this compound turns the polystyrene less 
hydrophobic, probably as consequence of its orientation on the surface. 
In the scientific literature, some reports have demonstrated the interest of surfactin-like 
molecules in the adhesion inhibition of pathogenic bacteria. Rivardo et al. (2009) showed 
that a biosurfactant containing surfactin and fengycin selectively inhibited biofilm formation 
of two pathogenic strains – S. aureus and Escherichia coli by 97% and 90%, respectively, 
on polystyrene surfaces but did not inhibit S. epidermidis biofilm producers. Additionally, 
other works showed that pre-coating of stainless steel and polypropylene surfaces with 
0.1% (w/v) surfactin reduced the number of adherent cells of L. monocytogenes and 
Chronobacter and the adsorption of surfactin on polystyrene surfaces reduced the 
colonization of L. monocytogenes, S. aureus, Salmonella enteritidis and Micrococcus 
luteus (Nitschke et al., 2009; Zeraik and Nitschke, 2010; Gomes and Nitschke, 2012).  
 
Thus, our results demonstrate an efficient reduction (>90%) in biofilm adherence and 
formation of multidrug resistant S. epidermidis isolates belonging to  different lineages 
causing infection, applying a mixture of surfactin-like biosurfactants, comprising mainly 
pumilacidin variant Leu7, produced by a B. safensis strain. Despite the B. pumilus and B. 
safensis being considered attractive sources of biotechnological and industrial commercial 
products, B. safensis biosurfactants are not yet explored, been the present work the first 
evidence of its application. 
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4. Conclusions
Our results demonstrate the potential of Bs1-biosurfactant towards the protection of 
surfaces, namely medical devices, from S. epidermidis contamination. 
Further investigations need to be done for a better comprehension of the mechanisms 
involved in S. epidermidis biofilm formation inhibition of Bs1-biosurfactant, including the 
effect of pH, ion force, temperature and nutrients in the hydrophobicity of the surfaces pre-
conditioned with this biosurfactant. 
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Table 1. Biofilm producing Staphylococccus epidermidis. 
S. epidermidis 
isolate Country Origin 
Biofilm 
forming 
capacitya 
Biofilm 
genes Sequence Type 
Antibiotic 
Resistance profile Reference 
Ste1 Portugal Medical device(catheter) ++ ND
b 2 
MRSEd 
LZD-Re 
Barros et al., 2014 
55 Italy Skin ++ ica, aap, atlE NA
c MRSE Cavallo, 2011 
Taw113 Taiwan Sputum ++ aap 85 MRSE Miragaia et al., 2007 
Ice120 Iceland Wound ++ ica, aap 89 MRSE Miragaia et al., 2007 
aBiofilm forming capacity previously tested by the microtiter assay using crystal violet. 
bND – not detected.  
cNA – not applicable. 
dMRSE - Methicillin-resistant S. epidermidis nosocomial outbreak isolates. 
eLZD-R - Linezolid (MIC>32mg/L) resistant S. epidermidis.
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Table 2. LC/ESI-MS/MS analysis of pumilacidin and  surfactin homologues produced by Bacillus safensis Bs1 strain. 
Isolate 
Pumilacidin-type Surfactin-type 
Pumilacidin Leu7 Pumilacidin Val7 
MW Leu2/Val4/Leu7 
M+Na]+ 
m/z 
Relative % 
MW Leu2/Leu4/Leu7 
M+Na]+ 
m/z 
Relative % MW Leu2/Leu4/Val7 
M+Na]+ 
m/z 
Relative % 
Bs1 
1035 C14-Leu2/Leu4/Leu7 1058 
83 
1035 C15-Leu2/Leu4/Val7 1058 
7 
1035 C15-Leu2/Val4/Leu7 1058 
10 
1049 C15-Leu2/Leu4/Leu7 1072 
1063 C16-Leu2/Leu4/Leu7 1086 
1063 C17-Leu2/Leu4/Val7 1086 1063 C17-Leu2/Val4/Leu7 1086 
1077 C17-Leu2/Leu4/Leu7 1100 
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Figure 1. A plot of surface tension as a function of concentration of purified Bs1-
biosurfactant. Standard deviation ranged between +/- 0.3 mN m-1. 
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Figure 2. Effect of different concentrations of Bs1-biosurfactant on the adhesion of S. 
epidermidis Ste1 (a), S. epidermidis 55 (b), S. epidermidis Taw113 (c), and S. epidermidis 
Ice120 (d) biofilm producers, using pre-conditioned CBD´s pegs.  
* indicates a significant (p<0.05) difference in the biofilm viable cell count at the 
correspondent concentration, when compared with control (without biosurfactant). 
(a) S. epidermidis Ste1
(b) S. epidermidis 55
(c) S. epidermidis Taw113
Pre-conditioned CBD´s pegs
(d) S. epidermidis Ice120
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Figure 3. Effect of different concentrations of Bs1-biosurfactant non-conditioning CBD´s 
pegs (biosurfactant co-incubation), on the adhesion of S. epidermidis Ste1 (a), S. 
epidermidis 55 (b), S. epidermidis Taw113 (c), and S. epidermidis Ice120 (d) biofilm 
producers.  
* indicates a significant (p<0.05) difference in the biofilm viable cell count at the 
correspondent concentration, when compared with control (without biosurfactant). 
(a) S. epidermidis Ste1
(c) S. epidermidis Taw113
Non-conditioned CBD´s pegs
(b) S. epidermidis 55
(d) S. epidermidis Ice120
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Figure 4. Full-scan mass spectra of Bs1 extract through (+) ESI-MS direct infusion analysis. Cluster of pumilacidin and surfactin are shown in m/z 
1000-1150. 
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CHAPTER 5 
GENERAL CONCLUSIONS

Chapter 5 
The overall results of this thesis indicate that Bacillus safensis Bs1 is an Arion ater 
adapted clonal lineage with antimicrobial activities of potential interest for the 
pharmaceutical and/or food industry sectors. Moreover, and beyond the contribution to 
accurately discriminate B. pumilus group species, the present work also demonstrates 
their genomic plasticity, which can justify their widespread into different environments and, 
consequently, its ability to produce a diverse array of distinct compounds with a broad 
range of activities. 
This general statement is based on the conclusions established after the accomplishment 
of the specific aims. They can be summarized as follows: 
1. Diversity and phylogeny within B. pumilus group species
• Delineation of B. pumilus group species should be supported on phylogenetic trees
based on concatenated housekeeping genes, due to the high similarity between gyrB
and rpoB gene sequences that prevents correct species assignments only based on
sequences homology.
• Phyogenetic tree analysis, based on gyrB and rpoB gene sequences, determined
the reclassification of the medicine-slug strain as B. safensis (Bs1) as well as most
B. pumilus isolates from multiple origins, which were assigned to either B. safensis or B.
altitudinis closed species. Moreover, this characterization extended B. safensis
recognized habitats and unveiled their biotechnological significance.
• A new species within B. pumilus group was recognized, which representative isolate
was recovered from a health’s product contaminant from Portugal, and for which the name
Bacillus invictus sp. nov. is proposed.
• B. pumilus group species comprises a clonally diverse population, which can justify
their great adaptation to different niches, and the variety of bioactive compounds
produced.
• Evidence of a clonal host specificity of B. safensis Bs1, suggests an adaptative
process leading to the production of characteristic bioactive compounds that enables its
survival to gut-slug conditions.
• Characteristic fingerprints of B. pumilus and B. safensis obtained by MALDI-TOF
MS and FTIR supports their phylogenetic assignment and demonstrate the suitability
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of these techniques to rapidly and at low cost discriminate bacterial species from B. 
pumilus group. Moreover, using MALDI-TOF MS analyses ribosomal or spore’s 
proteins were tentatively assigned as specific biomarkers of B. pumilus and B. 
safensis.  
 
2. Antimicrobial susceptibility and virulence within B. pumilus group species 
Microbiological antibiotic resistance to main antibiotic classes and virulence 
(entero-, emetic- and cyto-toxins) genes were absent, as required for their usage in 
the food sector. Nevertheless, from a clinical perspective non-susceptibility to cefotaxime 
was observed in all B. pumilus group isolates, which would lead to an empirical 
therapeutic failure with this commonly used antibiotic. Therefore, susceptibility testing to 
this antibiotic should be consider for granting a Qualitative Presumption of Safety status 
for a Bacillus spp. strain intended to use in the food sector.  
 
3. Peptides with antimicrobial activity of B. pumilus group species 
• Characterization of the antimicrobial peptides with anti-staphylococci activity in B. 
safensis strain Bs1 revealed the presence of a cationic peptide comprising 48 amino acid 
residues, which was not previously recognized as anti-bacterial. Further studies will 
elucidate its conformational structure, spectrum of activity, mode of action, toxicity and 
therapeutic efficacy in bacterial infections, relevant properties for a potential industrial 
application.  
• Most B. pumilus and B. safensis isolates were able to produce biosurfactants, 
although they were absent in B. altitudinis. Interestingly, a species-specific 
composition was detected, with a mixture of pumilacidin variants and surfactin 
compounds in B. safensis, whereas in B. pumilus only pumilacidin variants were identified.  
• A surfactin-like biosurfactant with strong anti-adhesive activity against biofilm 
producing Staphylococcus epidermidis isolates was produced by Bs1 strain, which did not 
result from planktonic bacterial growth inhibition. This activity was for the first time 
associated with a mixture of pumilacidin- and surfactin-type variants that could contribute 
to reduce the burden of infections by S. epidermidis, the most frequent indwelling medical 
devices related pathogen. 
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Table A1. Bacillus pumilus group members isolates (n=41) (B. pumilus, B. safensis and B. altitudinis) characterized in this thesis and correspondent 
assigned GenBank accession numbers. 
Species Isolate Origin/Product Year/ Location 
GenBank accession numbers 
References 
16S rDNA gene gyrB gene rpoB gene 
B. pumilus 
Bp ATCC14884 JF749284 KC895462 KC895450 Reference strain 
Bp ATCC7061T EU138517 AY167869 AB353945 Type-strain 
Bp7 
Healths´s contaminants (n=3) 
2005/Portugal1 JN699029 JX183193 JX183164 
Branquinho et al., 2012 Bp11 2005/Portugal
1
JN699027 JX183196 JX183167 
Bp15 2005/Portugal1 JN699025 JX183200 JX183171 
B. safensis 
BsFO-36bT Clean-room/ air particulate (n=1) 1999/USA
6 AF234854 AY167867 KC895451 
Satomi et al., 2006 
Bs32 Clean-room/entrance floor (n=1) 2001/USA
6 AY167886 AY167877 KC895453 
Bs42 Clean-room/anteroom (n=1) 2001/USA
6 AY167884 AY167876 KC895454 
Bs34 
Clean-room/floor (n=2) 
2001/USA6 AY167881 AY167873 KC895455 
Bs35 2001/USA6 AY167880 AY167872 KC895456 
Bs36 Clean-room/cabinet top (n=1) 2001/USA
6 AY030327 AY167878 KC895452 
Bs37 
Clean-room/Mars Odyssey 
spacecraft surface (n=5) 
2001/USA6 AF526907 KC895457 KC895445 
Bs38 2001/USA6 AF526902 KC895458 KC895446 
Bs39 2001/USA6 AF526898 KC895459 KC895447 
Bs40 2001/USA6 AF526896 KC895460 KC895448 
Bs41 2001/USA6 AF526895 KC895461 KC895449 
Bs1 
Animals Gastropods (n=3) 
2004/Portugal1 JN699032 JX183188 JX183159 
Branquinho et al., 2012 
Bs2 2005/Portugal1 JX183146 JX183189 JX183160 
Bs3 2007/Portugal1 JN699031 JX183190 JX183161 
Bs13 Healths´s contaminants (n=3) 2005/Portugal
1 JX183149 JX183198 JX183169 
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Bs16 2005/Portugal1 JN699024 JX183201 JX183172 
Bs17 2005/Portugal1 JX183151 JX183202 JX183173 
Bs5 
Cosmetic´s contaminants (n=4) 
2002/Portugal1 JN699030 JX183191 JX183162 
Bs18 2002/Portugal1 JN699023 JX183203 JX183174 
Bs19 2002/Portugal1 JN699022 JX183204 JX183175 
Bs27 2002/Portugal1 JN699021 JX183212 JX183183 
Bs24 
Food´s contaminants/salame (n=3) 
2004/Italy3 JX183156 JX183209 JX183180 
Matarante et al., 2004 Bs25 2004/Italy
3
JX183157 JX183210 JX183181 
Bs33 2004/Italy3 KC895444 KC895463 JX183187 
Bs22 
Plant Growth Promoters (PGPR) 
(n=2) 
1997/USA4 JX183154 JX183207 JX183178 
Jetiyanon 1997 Bs23 1997/USA4 JX183155 JX183208 JX183179 
Bs31 Food/beans (n=1) 2003/Africa
5 KC895443 JX183215 JX183186 Ouoba et al., 2004 
B. altitudinis 
Ba6 
Healths´s contaminants (n=5) 
2005/Portugal1 JX183147 JX183192 JX183163 
Branquinho et al., 2012 
Ba8 2005/Portugal1 JN699028 JX183194 JX183165 
Ba9 2005/Portugal1 JX183148 JX183195 JX183166 
Ba12 2005/Portugal1 JN699026 JX183197 JX183168 
Ba14 2005/Portugal1 JX183150 JX183199 JX183170 
Ba26 Food´s contaminants/rice (n=1) 2006/Norway
2 JX183158 JX183211 JX183182 From et al., 2007 
Ba20 
Plant Growth Promoters (PGPR) 
(n=2) 
1996/USA4 JX183152 JX183205 JX183176 Wei et al., 1996 
Ba21 1997/USA4 JX183153 JX183206 JX183177 Jetiyanon 1997 
Ba30 Food/beans (n=1) 2003/Africa
5 KF060662 JX183214 JX183185 Ouoba et al., 2004 
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Table A2. Control, reference and type strains used in this thesis. 
Species/Strain Source Control/Applicability Reference 
Gram positive 
Bacillus pumilus ATCC 7061 American Type Culture Collection (ATCC) 
Phylogenetic analysis; FTIR-ATR and 
MALDI-TOF/MS discrimination control 
Type Strain 
Bacillus pumilus ATCC 14884 American Type Culture Collection (ATCC) 
Phylogenetic analysis; MALDI-TOF/MS 
discrimination control 
Reference Strain 
Bacillus pumilus SAFR-032 
Spacecraft Assembly Facility - NASA Jet 
Propulsion Laboratory – USA (2007) 
Phylogenetic analysis Gioia et al., 2007 
Bacillus safensis FO36-b 
Spacecraft Assembly Facility - NASA Jet 
Propulsion Laboratory – USA (1999) 
Phylogenetic analysis; FTIR-ATR and 
MALDI-TOF/MS discrimination control 
Type Strain; Satomi et al., 2006 
Bacillus altitudinis Ba41KF2bT High-elevation air sample – India (2006) Phylogenetic analysis Type Strain; Shivaji et al., 2006 
Bacillus subtilis Bsb28 Medicine´s contaminants – Portugal (2005) Biosurfactant producer testing 
Bacillus subtilis BsbFFUP1 
Faculty of Pharmacy of Porto University 
Culture collection (FFUPCC) 
Antimicrobial susceptibility testing Branquinho et al., 2014b 
Bacillus subtilis BsbBGA Spore suspension Antimicrobial susceptibility testing 
Merck, Darmstadt, Germany – 
Product number 1106490001 
Bacillus cereusFFUP1 
Faculty of Pharmacy of Porto University 
Culture collection (FFUPCC) 
Toxin testing control strain Branquinho et al., 2014b 
Lysinibacillus fusiformis 
Faculty of Pharmacy of Porto University 
Culture collection (FFUPCC) 
Antimicrobial susceptibility testing Branquinho et al., 2007 
Staphylococcus aureus ATCC 29213 American Type Culture Collection (ATCC) 
Antimicrobial susceptibility testing control 
strain 
Reference Strain 
Staphylococcus aureus methicillin 
resistant (MRSA) FFUP 001 
Faculty of Pharmacy of Porto University 
Culture collection (FFUPCC) 
Antimicrobial susceptibility testing 
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Staphylococcus epidermidis linezolid 
resistant Ste1 
Medical device(catheter) – Portugal (2013) 
Biofilm producer control strain; Anti-adhesive 
testing activity 
Barros et al., 2014 
Staphylococcus epidermidis 55 Human skin – Italy (2011) 
Biofilm producer control strain; Anti-adhesive 
testing activity 
Cavallo, 2011 
Staphylococcus epidermidis Taw113 Sputum – Taiwan (2007) 
Biofilm producer control strain; Anti-adhesive 
testing activity 
Miragaia et al., 2007 
Staphylococcus epidermidis Ice120 Wound - Iceland (2007) 
Biofilm producer control strain; Anti-adhesive 
testing activity 
Miragaia et al., 2007 
Enterococcus faecium vancomycin 
resistant (VRE) E1 
Portuguese hospital sewage (2001) Antimicrobial susceptibility testing Freitas et al., 2009 
Listeria monocytogenes FFUP 35 
Faculty of Pharmacy of Porto University 
Culture collection (FFUPCC) 
Antimicrobial susceptibility testing 
Gram negative 
Acinetobacter baumanni ATCC 19606 American Type Culture Collection (ATCC) Antimicrobial susceptibility testing Reference Strain 
Escherichia coli ATCC 25922 American Type Culture Collection (ATCC) Antimicrobial susceptibility testing Reference Strain 
Pseudomonas aeruginosa ATCC 
27853 
American Type Culture Collection (ATCC) Antimicrobial susceptibility testing Reference Strain 
Salmonella Typhymurium F154/22 Food – Portugal (2004) Antimicrobial susceptibility testing Antunes et al., 2006 
Salmonella Enteretidis 62/02 
Human – Portugal (2002) - INSA Culture 
Collection 
Antimicrobial susceptibility testing Antunes et al., 2006 
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Table A3. Oligonucleotides used for the characterization of Bacillus isolates. 
Description/Gene Primer name Oligonucleotide sequence (5´to 3´) Amplicon size (bp) 
Annealing temperature 
(ºC) Reference 
Identification of Bacillus species 
16S rRNA 
SEQ A AGAGTTTGATCHTGGYTYAGA 
1500 55 Héritier et al., 2003 
SEQ B ACGYTACCTTGTTACGACTTC 
β-subunit of DNA 
gyrase (gyrB)  
UP-1S GAAGTCATCATGACCGTTCTGCAYGCNGGNGGNAARTTYGA 
1400 60 Yamamoto and Harayama, 1995 
UP-2Sr AGCAGGGTACGGATGTGCGAGCCRTCNACRTCNGCRTCNGTCAT 
β-subunit of RNA 
polymerase (rpoB ) 
rpoB1_fw CAGAAGCTACGCACGCATAA 
775 56 Branquinho et al., 2014a 
rpoB1_rv GCGTCCAACATTTGCTAGGT 
rpob2_fw CAACACGCTGGAAAAAGACA 
1028 56 Branquinho et al., 2014a 
rpoB2_rv TTCTCGGCGTCACTTTACCT 
rpoB3_fw CACCAGAGGGTCCAAACATT 
915 56 Branquinho et al., 2014a 
rpoB3_rv GGTTGCGTAAAGCATCTTCC 
rpoB4_fw CATGAGTGAGCGCCTTGTAA 
1255 56 Branquinho et al., 2014a 
rpoB4_rv CGTCTGCTTTCTTCGTTTCC 
PCR-based non-ribosomal lipopeptide biosynthetic genes detection 
Surfactin/Lichenysin family 
srf/lch 
As1-F CGCGGMTACCGVATYGAGC 
419/422/425/431 43 Tapi et al., 2010 
Ts2-R ATBCCTTTBTWDGAATGTCCGCC 
Surfactin 
sfp 
sfp-f ATGAAGATTTACGGAATTTA 
675 46 Hsieh et al., 2004 
sfp-r TTATAAAAGCTCTTCGTACG 
Lichenysin 
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lchAA 
LicA-f GTGCCTGATGTAACGAATG 
735 60 Nieminen et al.,  2007 
LicA-r CACTTCCTGCCATATACC 
lchAB 
LicB2-f TGATCAGCCGGCCGTTGTCT 
904 60 Nieminen et al.,  2007 
LicB2-r GGCGAATTGTCCGATCATGTCC 
lchAC 
LicC-f GCCTATCTGCCGATTGAC 
1195 57 Nieminen et al.,  2007 
LicC-r TATATGCATCCGGCACCA 
Fengycin/Plipastation family 
Fengycin 
fen 
Af2-F GAATAYMTCGGMCGTMTKGA 
443/452 45 Tapi et al.,  2010 
Tf1-R GCTTTWADKGAATSBCCGCC 
fenA 
FENA1F GACAGTGCTGCCTGATGAAA 
964 62 Athukorala et al.,  2009 
FENA1R GTCGGTGCATGAAATGTACG 
fenB 
FENB2F CAAGATATGCTGGACGCTGA 
964 62 Athukorala et al.,  2009 
FENB2R ACACGACATTGCGATTGGTA 
fenD 
FEND1F TTTGGCAGCAGGAGAAGTTT 
964 62 Athukorala et al.,  2009 
FEND1R GCTGTCCGTTCTGCTTTTTC 
Pliplastatin 
pps 
Ap1-F AGMCAGCKSGCMASATCMCC 
893/959/929 58 Tapi et al.,  2010 
Atp1-R GCKATWWTGAARRCCGGCGG 
Iturin family 
Iturin 
lpa-14 
lpa-14f ATGAAAATTTACGGAGTATA 
675 50 Hsieh et al., 2008 
lpa-14r TTATAACAGCTCTTCATACG 
ituD 
ituD-f ATGAACAATCTTGCCTTT TTA 
1203 50 Hsieh et al., 2008 
ituD-r TTATTTTAAAATCCGCAATT 
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PCR-based virulence detection 
Emetic toxins 
cesA 
CER1_Fw ATCATAAAGGACAAGA 
188 52 Ehling-Schulz et al., 2004 
EMT1_Rv AAGATCAACCCAACTG 
cesB 
EM1_Fw GACAAGAGAATACAAT 
635 60 Ehling-Schulz et al., 2004 
EM1_Rv GCAGCCTTCCCACAGT 
Cytotoxins 
cytK 
FC_Fw GTAACTTTCATTTGATGATC 
505 50 Ehling-Schulz et al., 2004 
RC_Rv GAATACATAAATAATTGGT 
hblC 
L2_Fw AGAAACTCAACAAGAAAACATGG 
444 50 Ehling-Schulz et al., 2004 
L2_Rv TTGCGCAGTTGCCACATTAG 
nheA 
0045_Fw GTTAGGATCACAATCACCGC 
264 50 Ehling-Schulz et al., 2004 
4091_Rv CCATATGCATTTGTAAAATCTG 
nheB 
517_Fw CGGTTCATCTGTTGCGACAGC 
335 50 Ehling-Schulz et al., 2004 
8368_Rv GATCCCATTGTGTACCATTGG 
nheC 
4924_Fw GCGATTGATCAAAAGGATAG 
411 50 Ehling-Schulz et al., 2004 
1141_Rv CGACTTCTGCTTGTGCTCCTG 
PCR-based resistance genes detection 
Tetracycline 
tet M 
tetM-F GTTAAATAGTGTTCTTGGAG 
657 53 Aarestrup et al., 2000. 
tetM-R CTAAGATATGGCTCTAACAA 
tet L 
tetL-F CATTTGGTCTTATTGGATCG 
475 53 Aarestrup et al., 2000. 
tetL-R ATTACACTTCCGATTTCGG 
tet S 
tetS-F TGGAACGCCAGAGAGGTATT 
661 56 Aarestrup et al., 2000. 
tetS-R ACATAGACAAGCCGTTGACC 
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tet K 
tetK-F TTAGGTGAAGGGTTAGGTCC 
718 56 Aarestrup et al., 2000. 
tetK-R GCAAACTCATTCCAGAAGCA 
tet O 
tetO-F CAATATCACCAGAGCAGGCT 
634 53 Aarestrup et al., 2000. 
tetO-R GATGGCATACAGGCACAGAC 
Macrolides 
ermA 
ermA1-F CTTCGATAGTTTATTAATATTAGT 
645 50 Sutcliffe et al., 1996 
ermA2-R TCTAAAAAGCATGTAAAAGAA 
ermB 
ermB1-F CATTTAACGACGAAACTGGC 
402 50 Sutcliffe et al., 1996 
ermB2-R GGAACATCTGTGGTATGGCG 
ermC 
ermC1-F TCAAAACATAATATAGATAAA 
642 50 Sutcliffe et al., 1996 
ermC2-R GCTAATATTGTTTAAATCGTCAAT 
Glycopeptides 
vanA 
vanA-F GGGAAAACGACAATTGC 
732 54 Dutka-Malen et al., 1995 
vanA-R GTACAATGCGGCCGTTA 
vanB 
vanB-F ATGGGAAGCCGATAGTC 
635 54 Dutka-Malen et al., 1995 
vanB-R GATTTCGTTCCTCGACC 
Aminoglicosydes 
aph(2'')-Ib 
aph(2'')-IbF CTTGGACGCTGAGATATATGAGCAC 
867 52 Vakulenko et al., 2003 
aph(2'')-IbR GTTTGTAGCAATTCAGAAACACCC TT 
aph(2'')-Id 
aph(2'')-IdF GTGGTTTTTACAGGAATGCCATC 
641 52 Vakulenko et al., 2003 
aph(2'')-IdR CCCTCTTCATACCAATCCATATAACC 
aph(2'')-Ic 
aph(2'')-IcF CCACAATGATAATGACTCAGTTCCC 
444 52 Vakulenko et al., 2003 
aph(2'')-IcR CCACAGCTTCCGATAGCAAGAG 
aph(3'')-IIIa 
aph(3'')-IIIaF GGCTAAAATGAGAATATCACCGG 
523 52 Vakulenko et al., 2003 
aph(3'')-IIIaR CTTTAAAAAATCATACAGCTCGCG 
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aac(6')-Ie-aph(2'')-Ia 
aac(6')-Ie-aph(2'')-IaF- CATTATACAGAGCCTTGGGAAGATG
778 52 Vakulenko et al., 2003 
aac(6')-Ie-aph(2'')-IaR GTCTTAAAAAACTGGCAATATCTCGTT
Chloramphenicol 
fexA 
fexA-F GTACTTGTAGGTGCAATTACGGCTGA 
1272 58 Kehrenberg and Schwarz 2006 
fexA-R CGCATCTGAGTAGGACATAGCGTC 
Florfenicol 
floR 
floR_F CACGTTGAGCCTCTATAT 
868 55 Guerra et al., 2004 
floR_R ATGCAGAAGTAGAACGCG 
Phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A 
cfr 
cfr-fw TGAAGTATAAAGCAGGTTGGGAGTCA 
746 48 Kehrenberg and Schwarz 2006 
cfr-rv ACCATATAATTGACCACAAGCAGC 
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